/*! For license information please see main.ea9af442.js.LICENSE.txt */
!function(){var e={76:function(e,t,n){"use strict";n.d(t,{Z:function(){return ae}});var r=function(){function e(e){var t=this;this._insertTag=function(e){var n;n=0===t.tags.length?t.insertionPoint?t.insertionPoint.nextSibling:t.prepend?t.container.firstChild:t.before:t.tags[t.tags.length-1].nextSibling,t.container.insertBefore(e,n),t.tags.push(e)},this.isSpeedy=void 0===e.speedy||e.speedy,this.tags=[],this.ctr=0,this.nonce=e.nonce,this.key=e.key,this.container=e.container,this.prepend=e.prepend,this.insertionPoint=e.insertionPoint,this.before=null}var t=e.prototype;return t.hydrate=function(e){e.forEach(this._insertTag)},t.insert=function(e){this.ctr%(this.isSpeedy?65e3:1)===0&&this._insertTag(function(e){var t=document.createElement("style");return t.setAttribute("data-emotion",e.key),void 0!==e.nonce&&t.setAttribute("nonce",e.nonce),t.appendChild(document.createTextNode("")),t.setAttribute("data-s",""),t}(this));var t=this.tags[this.tags.length-1];if(this.isSpeedy){var n=function(e){if(e.sheet)return e.sheet;for(var t=0;t<document.styleSheets.length;t++)if(document.styleSheets[t].ownerNode===e)return document.styleSheets[t]}(t);try{n.insertRule(e,n.cssRules.length)}catch(r){0}}else t.appendChild(document.createTextNode(e));this.ctr++},t.flush=function(){this.tags.forEach((function(e){return e.parentNode&&e.parentNode.removeChild(e)})),this.tags=[],this.ctr=0},e}(),a=Math.abs,o=String.fromCharCode,i=Object.assign;function s(e){return e.trim()}function l(e,t,n){return e.replace(t,n)}function u(e,t){return e.indexOf(t)}function c(e,t){return 0|e.charCodeAt(t)}function d(e,t,n){return e.slice(t,n)}function f(e){return e.length}function p(e){return e.length}function m(e,t){return t.push(e),e}var h=1,v=1,b=0,y=0,g=0,_="";function w(e,t,n,r,a,o,i){return{value:e,root:t,parent:n,type:r,props:a,children:o,line:h,column:v,length:i,return:""}}function S(e,t){return i(w("",null,null,"",null,null,0),e,{length:-e.length},t)}function k(){return g=y>0?c(_,--y):0,v--,10===g&&(v=1,h--),g}function C(){return g=y<b?c(_,y++):0,v++,10===g&&(v=1,h++),g}function T(){return c(_,y)}function x(){return y}function F(e,t){return d(_,e,t)}function P(e){switch(e){case 0:case 9:case 10:case 13:case 32:return 5;case 33:case 43:case 44:case 47:case 62:case 64:case 126:case 59:case 123:case 125:return 4;case 58:return 3;case 34:case 39:case 40:case 91:return 2;case 41:case 93:return 1}return 0}function A(e){return h=v=1,b=f(_=e),y=0,[]}function N(e){return _="",e}function E(e){return s(F(y-1,O(91===e?e+2:40===e?e+1:e)))}function M(e){for(;(g=T())&&g<33;)C();return P(e)>2||P(g)>3?"":" "}function R(e,t){for(;--t&&C()&&!(g<48||g>102||g>57&&g<65||g>70&&g<97););return F(e,x()+(t<6&&32==T()&&32==C()))}function O(e){for(;C();)switch(g){case e:return y;case 34:case 39:34!==e&&39!==e&&O(g);break;case 40:41===e&&O(e);break;case 92:C()}return y}function D(e,t){for(;C()&&e+g!==57&&(e+g!==84||47!==T()););return"/*"+F(t,y-1)+"*"+o(47===e?e:C())}function z(e){for(;!P(T());)C();return F(e,y)}var I="-ms-",L="-moz-",Z="-webkit-",j="comm",B="rule",V="decl",U="@keyframes";function J(e,t){for(var n="",r=p(e),a=0;a<r;a++)n+=t(e[a],a,e,t)||"";return n}function W(e,t,n,r){switch(e.type){case"@import":case V:return e.return=e.return||e.value;case j:return"";case U:return e.return=e.value+"{"+J(e.children,r)+"}";case B:e.value=e.props.join(",")}return f(n=J(e.children,r))?e.return=e.value+"{"+n+"}":""}function H(e,t){switch(function(e,t){return(((t<<2^c(e,0))<<2^c(e,1))<<2^c(e,2))<<2^c(e,3)}(e,t)){case 5103:return Z+"print-"+e+e;case 5737:case 4201:case 3177:case 3433:case 1641:case 4457:case 2921:case 5572:case 6356:case 5844:case 3191:case 6645:case 3005:case 6391:case 5879:case 5623:case 6135:case 4599:case 4855:case 4215:case 6389:case 5109:case 5365:case 5621:case 3829:return Z+e+e;case 5349:case 4246:case 4810:case 6968:case 2756:return Z+e+L+e+I+e+e;case 6828:case 4268:return Z+e+I+e+e;case 6165:return Z+e+I+"flex-"+e+e;case 5187:return Z+e+l(e,/(\w+).+(:[^]+)/,"-webkit-box-$1$2-ms-flex-$1$2")+e;case 5443:return Z+e+I+"flex-item-"+l(e,/flex-|-self/,"")+e;case 4675:return Z+e+I+"flex-line-pack"+l(e,/align-content|flex-|-self/,"")+e;case 5548:return Z+e+I+l(e,"shrink","negative")+e;case 5292:return Z+e+I+l(e,"basis","preferred-size")+e;case 6060:return Z+"box-"+l(e,"-grow","")+Z+e+I+l(e,"grow","positive")+e;case 4554:return Z+l(e,/([^-])(transform)/g,"$1-webkit-$2")+e;case 6187:return l(l(l(e,/(zoom-|grab)/,Z+"$1"),/(image-set)/,Z+"$1"),e,"")+e;case 5495:case 3959:return l(e,/(image-set\([^]*)/,Z+"$1$`$1");case 4968:return l(l(e,/(.+:)(flex-)?(.*)/,"-webkit-box-pack:$3-ms-flex-pack:$3"),/s.+-b[^;]+/,"justify")+Z+e+e;case 4095:case 3583:case 4068:case 2532:return l(e,/(.+)-inline(.+)/,Z+"$1$2")+e;case 8116:case 7059:case 5753:case 5535:case 5445:case 5701:case 4933:case 4677:case 5533:case 5789:case 5021:case 4765:if(f(e)-1-t>6)switch(c(e,t+1)){case 109:if(45!==c(e,t+4))break;case 102:return l(e,/(.+:)(.+)-([^]+)/,"$1-webkit-$2-$3$1"+L+(108==c(e,t+3)?"$3":"$2-$3"))+e;case 115:return~u(e,"stretch")?H(l(e,"stretch","fill-available"),t)+e:e}break;case 4949:if(115!==c(e,t+1))break;case 6444:switch(c(e,f(e)-3-(~u(e,"!important")&&10))){case 107:return l(e,":",":"+Z)+e;case 101:return l(e,/(.+:)([^;!]+)(;|!.+)?/,"$1"+Z+(45===c(e,14)?"inline-":"")+"box$3$1"+Z+"$2$3$1"+I+"$2box$3")+e}break;case 5936:switch(c(e,t+11)){case 114:return Z+e+I+l(e,/[svh]\w+-[tblr]{2}/,"tb")+e;case 108:return Z+e+I+l(e,/[svh]\w+-[tblr]{2}/,"tb-rl")+e;case 45:return Z+e+I+l(e,/[svh]\w+-[tblr]{2}/,"lr")+e}return Z+e+I+e+e}return e}function $(e){return N(q("",null,null,null,[""],e=A(e),0,[0],e))}function q(e,t,n,r,a,i,s,c,d){for(var p=0,h=0,v=s,b=0,y=0,g=0,_=1,w=1,S=1,F=0,P="",A=a,N=i,O=r,I=P;w;)switch(g=F,F=C()){case 40:if(108!=g&&58==I.charCodeAt(v-1)){-1!=u(I+=l(E(F),"&","&\f"),"&\f")&&(S=-1);break}case 34:case 39:case 91:I+=E(F);break;case 9:case 10:case 13:case 32:I+=M(g);break;case 92:I+=R(x()-1,7);continue;case 47:switch(T()){case 42:case 47:m(K(D(C(),x()),t,n),d);break;default:I+="/"}break;case 123*_:c[p++]=f(I)*S;case 125*_:case 59:case 0:switch(F){case 0:case 125:w=0;case 59+h:y>0&&f(I)-v&&m(y>32?Q(I+";",r,n,v-1):Q(l(I," ","")+";",r,n,v-2),d);break;case 59:I+=";";default:if(m(O=G(I,t,n,p,h,a,c,P,A=[],N=[],v),i),123===F)if(0===h)q(I,t,O,O,A,i,v,c,N);else switch(b){case 100:case 109:case 115:q(e,O,O,r&&m(G(e,O,O,0,0,a,c,P,a,A=[],v),N),a,N,v,c,r?A:N);break;default:q(I,O,O,O,[""],N,0,c,N)}}p=h=y=0,_=S=1,P=I="",v=s;break;case 58:v=1+f(I),y=g;default:if(_<1)if(123==F)--_;else if(125==F&&0==_++&&125==k())continue;switch(I+=o(F),F*_){case 38:S=h>0?1:(I+="\f",-1);break;case 44:c[p++]=(f(I)-1)*S,S=1;break;case 64:45===T()&&(I+=E(C())),b=T(),h=v=f(P=I+=z(x())),F++;break;case 45:45===g&&2==f(I)&&(_=0)}}return i}function G(e,t,n,r,o,i,u,c,f,m,h){for(var v=o-1,b=0===o?i:[""],y=p(b),g=0,_=0,S=0;g<r;++g)for(var k=0,C=d(e,v+1,v=a(_=u[g])),T=e;k<y;++k)(T=s(_>0?b[k]+" "+C:l(C,/&\f/g,b[k])))&&(f[S++]=T);return w(e,t,n,0===o?B:c,f,m,h)}function K(e,t,n){return w(e,t,n,j,o(g),d(e,2,-2),0)}function Q(e,t,n,r){return w(e,t,n,V,d(e,0,r),d(e,r+1,-1),r)}var Y=function(e,t,n){for(var r=0,a=0;r=a,a=T(),38===r&&12===a&&(t[n]=1),!P(a);)C();return F(e,y)},X=function(e,t){return N(function(e,t){var n=-1,r=44;do{switch(P(r)){case 0:38===r&&12===T()&&(t[n]=1),e[n]+=Y(y-1,t,n);break;case 2:e[n]+=E(r);break;case 4:if(44===r){e[++n]=58===T()?"&\f":"",t[n]=e[n].length;break}default:e[n]+=o(r)}}while(r=C());return e}(A(e),t))},ee=new WeakMap,te=function(e){if("rule"===e.type&&e.parent&&!(e.length<1)){for(var t=e.value,n=e.parent,r=e.column===n.column&&e.line===n.line;"rule"!==n.type;)if(!(n=n.parent))return;if((1!==e.props.length||58===t.charCodeAt(0)||ee.get(n))&&!r){ee.set(e,!0);for(var a=[],o=X(t,a),i=n.props,s=0,l=0;s<o.length;s++)for(var u=0;u<i.length;u++,l++)e.props[l]=a[s]?o[s].replace(/&\f/g,i[u]):i[u]+" "+o[s]}}},ne=function(e){if("decl"===e.type){var t=e.value;108===t.charCodeAt(0)&&98===t.charCodeAt(2)&&(e.return="",e.value="")}},re=[function(e,t,n,r){if(e.length>-1&&!e.return)switch(e.type){case V:e.return=H(e.value,e.length);break;case U:return J([S(e,{value:l(e.value,"@","@"+Z)})],r);case B:if(e.length)return function(e,t){return e.map(t).join("")}(e.props,(function(t){switch(function(e,t){return(e=t.exec(e))?e[0]:e}(t,/(::plac\w+|:read-\w+)/)){case":read-only":case":read-write":return J([S(e,{props:[l(t,/:(read-\w+)/,":-moz-$1")]})],r);case"::placeholder":return J([S(e,{props:[l(t,/:(plac\w+)/,":-webkit-input-$1")]}),S(e,{props:[l(t,/:(plac\w+)/,":-moz-$1")]}),S(e,{props:[l(t,/:(plac\w+)/,I+"input-$1")]})],r)}return""}))}}],ae=function(e){var t=e.key;if("css"===t){var n=document.querySelectorAll("style[data-emotion]:not([data-s])");Array.prototype.forEach.call(n,(function(e){-1!==e.getAttribute("data-emotion").indexOf(" ")&&(document.head.appendChild(e),e.setAttribute("data-s",""))}))}var a=e.stylisPlugins||re;var o,i,s={},l=[];o=e.container||document.head,Array.prototype.forEach.call(document.querySelectorAll('style[data-emotion^="'+t+' "]'),(function(e){for(var t=e.getAttribute("data-emotion").split(" "),n=1;n<t.length;n++)s[t[n]]=!0;l.push(e)}));var u,c,d=[W,(c=function(e){u.insert(e)},function(e){e.root||(e=e.return)&&c(e)})],f=function(e){var t=p(e);return function(n,r,a,o){for(var i="",s=0;s<t;s++)i+=e[s](n,r,a,o)||"";return i}}([te,ne].concat(a,d));i=function(e,t,n,r){u=n,J($(e?e+"{"+t.styles+"}":t.styles),f),r&&(m.inserted[t.name]=!0)};var m={key:t,sheet:new r({key:t,container:o,nonce:e.nonce,speedy:e.speedy,prepend:e.prepend,insertionPoint:e.insertionPoint}),nonce:e.nonce,inserted:s,registered:{},insert:i};return m.sheet.hydrate(l),m}},9797:function(e,t){"use strict";t.Z=function(e){var t=Object.create(null);return function(n){return void 0===t[n]&&(t[n]=e(n)),t[n]}}},9886:function(e,t,n){"use strict";n.d(t,{T:function(){return s},w:function(){return i}});var r=n(2791),a=n(76),o=(n(9140),n(2561),(0,r.createContext)("undefined"!==typeof HTMLElement?(0,a.Z)({key:"css"}):null));o.Provider;var i=function(e){return(0,r.forwardRef)((function(t,n){var a=(0,r.useContext)(o);return e(t,a,n)}))},s=(0,r.createContext)({})},9140:function(e,t,n){"use strict";n.d(t,{O:function(){return h}});var r=function(e){for(var t,n=0,r=0,a=e.length;a>=4;++r,a-=4)t=1540483477*(65535&(t=255&e.charCodeAt(r)|(255&e.charCodeAt(++r))<<8|(255&e.charCodeAt(++r))<<16|(255&e.charCodeAt(++r))<<24))+(59797*(t>>>16)<<16),n=1540483477*(65535&(t^=t>>>24))+(59797*(t>>>16)<<16)^1540483477*(65535&n)+(59797*(n>>>16)<<16);switch(a){case 3:n^=(255&e.charCodeAt(r+2))<<16;case 2:n^=(255&e.charCodeAt(r+1))<<8;case 1:n=1540483477*(65535&(n^=255&e.charCodeAt(r)))+(59797*(n>>>16)<<16)}return(((n=1540483477*(65535&(n^=n>>>13))+(59797*(n>>>16)<<16))^n>>>15)>>>0).toString(36)},a={animationIterationCount:1,borderImageOutset:1,borderImageSlice:1,borderImageWidth:1,boxFlex:1,boxFlexGroup:1,boxOrdinalGroup:1,columnCount:1,columns:1,flex:1,flexGrow:1,flexPositive:1,flexShrink:1,flexNegative:1,flexOrder:1,gridRow:1,gridRowEnd:1,gridRowSpan:1,gridRowStart:1,gridColumn:1,gridColumnEnd:1,gridColumnSpan:1,gridColumnStart:1,msGridRow:1,msGridRowSpan:1,msGridColumn:1,msGridColumnSpan:1,fontWeight:1,lineHeight:1,opacity:1,order:1,orphans:1,tabSize:1,widows:1,zIndex:1,zoom:1,WebkitLineClamp:1,fillOpacity:1,floodOpacity:1,stopOpacity:1,strokeDasharray:1,strokeDashoffset:1,strokeMiterlimit:1,strokeOpacity:1,strokeWidth:1},o=n(9797),i=/[A-Z]|^ms/g,s=/_EMO_([^_]+?)_([^]*?)_EMO_/g,l=function(e){return 45===e.charCodeAt(1)},u=function(e){return null!=e&&"boolean"!==typeof e},c=(0,o.Z)((function(e){return l(e)?e:e.replace(i,"-$&").toLowerCase()})),d=function(e,t){switch(e){case"animation":case"animationName":if("string"===typeof t)return t.replace(s,(function(e,t,n){return p={name:t,styles:n,next:p},t}))}return 1===a[e]||l(e)||"number"!==typeof t||0===t?t:t+"px"};function f(e,t,n){if(null==n)return"";if(void 0!==n.__emotion_styles)return n;switch(typeof n){case"boolean":return"";case"object":if(1===n.anim)return p={name:n.name,styles:n.styles,next:p},n.name;if(void 0!==n.styles){var r=n.next;if(void 0!==r)for(;void 0!==r;)p={name:r.name,styles:r.styles,next:p},r=r.next;return n.styles+";"}return function(e,t,n){var r="";if(Array.isArray(n))for(var a=0;a<n.length;a++)r+=f(e,t,n[a])+";";else for(var o in n){var i=n[o];if("object"!==typeof i)null!=t&&void 0!==t[i]?r+=o+"{"+t[i]+"}":u(i)&&(r+=c(o)+":"+d(o,i)+";");else if(!Array.isArray(i)||"string"!==typeof i[0]||null!=t&&void 0!==t[i[0]]){var s=f(e,t,i);switch(o){case"animation":case"animationName":r+=c(o)+":"+s+";";break;default:r+=o+"{"+s+"}"}}else for(var l=0;l<i.length;l++)u(i[l])&&(r+=c(o)+":"+d(o,i[l])+";")}return r}(e,t,n);case"function":if(void 0!==e){var a=p,o=n(e);return p=a,f(e,t,o)}}if(null==t)return n;var i=t[n];return void 0!==i?i:n}var p,m=/label:\s*([^\s;\n{]+)\s*(;|$)/g;var h=function(e,t,n){if(1===e.length&&"object"===typeof e[0]&&null!==e[0]&&void 0!==e[0].styles)return e[0];var a=!0,o="";p=void 0;var i=e[0];null==i||void 0===i.raw?(a=!1,o+=f(n,t,i)):o+=i[0];for(var s=1;s<e.length;s++)o+=f(n,t,e[s]),a&&(o+=i[s]);m.lastIndex=0;for(var l,u="";null!==(l=m.exec(o));)u+="-"+l[1];return{name:r(o)+u,styles:o,next:p}}},2561:function(e,t,n){"use strict";var r;n.d(t,{L:function(){return i},j:function(){return s}});var a=n(2791),o=!!(r||(r=n.t(a,2))).useInsertionEffect&&(r||(r=n.t(a,2))).useInsertionEffect,i=o||function(e){return e()},s=o||a.useLayoutEffect},5438:function(e,t,n){"use strict";n.d(t,{My:function(){return o},fp:function(){return r},hC:function(){return a}});function r(e,t,n){var r="";return n.split(" ").forEach((function(n){void 0!==e[n]?t.push(e[n]+";"):r+=n+" "})),r}var a=function(e,t,n){var r=e.key+"-"+t.name;!1===n&&void 0===e.registered[r]&&(e.registered[r]=t.styles)},o=function(e,t,n){a(e,t,n);var r=e.key+"-"+t.name;if(void 0===e.inserted[t.name]){var o=t;do{e.insert(t===o?"."+r:"",o,e.sheet,!0);o=o.next}while(void 0!==o)}}},2156:function(e,t,n){"use strict";var r=n(4836);t.Z=void 0;var a=r(n(5649)),o=n(184),i=(0,a.default)((0,o.jsx)("path",{d:"M15.41 7.41 14 6l-6 6 6 6 1.41-1.41L10.83 12z"}),"NavigateBefore");t.Z=i},5129:function(e,t,n){"use strict";var r=n(4836);t.Z=void 0;var a=r(n(5649)),o=n(184),i=(0,a.default)((0,o.jsx)("path",{d:"M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"}),"NavigateNext");t.Z=i},5649:function(e,t,n){"use strict";Object.defineProperty(t,"__esModule",{value:!0}),Object.defineProperty(t,"default",{enumerable:!0,get:function(){return r.createSvgIcon}});var r=n(3111)},4360:function(e,t,n){"use strict";n.d(t,{Z:function(){return Z}});var r=n(7462),a=n(3366),o=n(6189),i=n(2466),s=n(5080),l=n(4942);function u(e,t){var n;return(0,r.Z)({toolbar:(n={minHeight:56},(0,l.Z)(n,e.up("xs"),{"@media (orientation: landscape)":{minHeight:48}}),(0,l.Z)(n,e.up("sm"),{minHeight:64}),n)},t)}var c=n(2065),d={black:"#000",white:"#fff"},f={50:"#fafafa",100:"#f5f5f5",200:"#eeeeee",300:"#e0e0e0",400:"#bdbdbd",500:"#9e9e9e",600:"#757575",700:"#616161",800:"#424242",900:"#212121",A100:"#f5f5f5",A200:"#eeeeee",A400:"#bdbdbd",A700:"#616161"},p={50:"#f3e5f5",100:"#e1bee7",200:"#ce93d8",300:"#ba68c8",400:"#ab47bc",500:"#9c27b0",600:"#8e24aa",700:"#7b1fa2",800:"#6a1b9a",900:"#4a148c",A100:"#ea80fc",A200:"#e040fb",A400:"#d500f9",A700:"#aa00ff"},m={50:"#ffebee",100:"#ffcdd2",200:"#ef9a9a",300:"#e57373",400:"#ef5350",500:"#f44336",600:"#e53935",700:"#d32f2f",800:"#c62828",900:"#b71c1c",A100:"#ff8a80",A200:"#ff5252",A400:"#ff1744",A700:"#d50000"},h={50:"#fff3e0",100:"#ffe0b2",200:"#ffcc80",300:"#ffb74d",400:"#ffa726",500:"#ff9800",600:"#fb8c00",700:"#f57c00",800:"#ef6c00",900:"#e65100",A100:"#ffd180",A200:"#ffab40",A400:"#ff9100",A700:"#ff6d00"},v={50:"#e3f2fd",100:"#bbdefb",200:"#90caf9",300:"#64b5f6",400:"#42a5f5",500:"#2196f3",600:"#1e88e5",700:"#1976d2",800:"#1565c0",900:"#0d47a1",A100:"#82b1ff",A200:"#448aff",A400:"#2979ff",A700:"#2962ff"},b={50:"#e1f5fe",100:"#b3e5fc",200:"#81d4fa",300:"#4fc3f7",400:"#29b6f6",500:"#03a9f4",600:"#039be5",700:"#0288d1",800:"#0277bd",900:"#01579b",A100:"#80d8ff",A200:"#40c4ff",A400:"#00b0ff",A700:"#0091ea"},y={50:"#e8f5e9",100:"#c8e6c9",200:"#a5d6a7",300:"#81c784",400:"#66bb6a",500:"#4caf50",600:"#43a047",700:"#388e3c",800:"#2e7d32",900:"#1b5e20",A100:"#b9f6ca",A200:"#69f0ae",A400:"#00e676",A700:"#00c853"},g=["mode","contrastThreshold","tonalOffset"],_={text:{primary:"rgba(0, 0, 0, 0.87)",secondary:"rgba(0, 0, 0, 0.6)",disabled:"rgba(0, 0, 0, 0.38)"},divider:"rgba(0, 0, 0, 0.12)",background:{paper:d.white,default:d.white},action:{active:"rgba(0, 0, 0, 0.54)",hover:"rgba(0, 0, 0, 0.04)",hoverOpacity:.04,selected:"rgba(0, 0, 0, 0.08)",selectedOpacity:.08,disabled:"rgba(0, 0, 0, 0.26)",disabledBackground:"rgba(0, 0, 0, 0.12)",disabledOpacity:.38,focus:"rgba(0, 0, 0, 0.12)",focusOpacity:.12,activatedOpacity:.12}},w={text:{primary:d.white,secondary:"rgba(255, 255, 255, 0.7)",disabled:"rgba(255, 255, 255, 0.5)",icon:"rgba(255, 255, 255, 0.5)"},divider:"rgba(255, 255, 255, 0.12)",background:{paper:"#121212",default:"#121212"},action:{active:d.white,hover:"rgba(255, 255, 255, 0.08)",hoverOpacity:.08,selected:"rgba(255, 255, 255, 0.16)",selectedOpacity:.16,disabled:"rgba(255, 255, 255, 0.3)",disabledBackground:"rgba(255, 255, 255, 0.12)",disabledOpacity:.38,focus:"rgba(255, 255, 255, 0.12)",focusOpacity:.12,activatedOpacity:.24}};function S(e,t,n,r){var a=r.light||r,o=r.dark||1.5*r;e[t]||(e.hasOwnProperty(n)?e[t]=e[n]:"light"===t?e.light=(0,c.$n)(e.main,a):"dark"===t&&(e.dark=(0,c._j)(e.main,o)))}function k(e){var t=e.mode,n=void 0===t?"light":t,s=e.contrastThreshold,l=void 0===s?3:s,u=e.tonalOffset,k=void 0===u?.2:u,C=(0,a.Z)(e,g),T=e.primary||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:v[200],light:v[50],dark:v[400]}:{main:v[700],light:v[400],dark:v[800]}}(n),x=e.secondary||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:p[200],light:p[50],dark:p[400]}:{main:p[500],light:p[300],dark:p[700]}}(n),F=e.error||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:m[500],light:m[300],dark:m[700]}:{main:m[700],light:m[400],dark:m[800]}}(n),P=e.info||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:b[400],light:b[300],dark:b[700]}:{main:b[700],light:b[500],dark:b[900]}}(n),A=e.success||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:y[400],light:y[300],dark:y[700]}:{main:y[800],light:y[500],dark:y[900]}}(n),N=e.warning||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:h[400],light:h[300],dark:h[700]}:{main:"#ed6c02",light:h[500],dark:h[900]}}(n);function E(e){return(0,c.mi)(e,w.text.primary)>=l?w.text.primary:_.text.primary}var M=function(e){var t=e.color,n=e.name,a=e.mainShade,i=void 0===a?500:a,s=e.lightShade,l=void 0===s?300:s,u=e.darkShade,c=void 0===u?700:u;if(!(t=(0,r.Z)({},t)).main&&t[i]&&(t.main=t[i]),!t.hasOwnProperty("main"))throw new Error((0,o.Z)(11,n?" (".concat(n,")"):"",i));if("string"!==typeof t.main)throw new Error((0,o.Z)(12,n?" (".concat(n,")"):"",JSON.stringify(t.main)));return S(t,"light",l,k),S(t,"dark",c,k),t.contrastText||(t.contrastText=E(t.main)),t},R={dark:w,light:_};return(0,i.Z)((0,r.Z)({common:(0,r.Z)({},d),mode:n,primary:M({color:T,name:"primary"}),secondary:M({color:x,name:"secondary",mainShade:"A400",lightShade:"A200",darkShade:"A700"}),error:M({color:F,name:"error"}),warning:M({color:N,name:"warning"}),info:M({color:P,name:"info"}),success:M({color:A,name:"success"}),grey:f,contrastThreshold:l,getContrastText:E,augmentColor:M,tonalOffset:k},R[n]),C)}var C=["fontFamily","fontSize","fontWeightLight","fontWeightRegular","fontWeightMedium","fontWeightBold","htmlFontSize","allVariants","pxToRem"];var T={textTransform:"uppercase"},x='"Roboto", "Helvetica", "Arial", sans-serif';function F(e,t){var n="function"===typeof t?t(e):t,o=n.fontFamily,s=void 0===o?x:o,l=n.fontSize,u=void 0===l?14:l,c=n.fontWeightLight,d=void 0===c?300:c,f=n.fontWeightRegular,p=void 0===f?400:f,m=n.fontWeightMedium,h=void 0===m?500:m,v=n.fontWeightBold,b=void 0===v?700:v,y=n.htmlFontSize,g=void 0===y?16:y,_=n.allVariants,w=n.pxToRem,S=(0,a.Z)(n,C);var k=u/14,F=w||function(e){return"".concat(e/g*k,"rem")},P=function(e,t,n,a,o){return(0,r.Z)({fontFamily:s,fontWeight:e,fontSize:F(t),lineHeight:n},s===x?{letterSpacing:"".concat((i=a/t,Math.round(1e5*i)/1e5),"em")}:{},o,_);var i},A={h1:P(d,96,1.167,-1.5),h2:P(d,60,1.2,-.5),h3:P(p,48,1.167,0),h4:P(p,34,1.235,.25),h5:P(p,24,1.334,0),h6:P(h,20,1.6,.15),subtitle1:P(p,16,1.75,.15),subtitle2:P(h,14,1.57,.1),body1:P(p,16,1.5,.15),body2:P(p,14,1.43,.15),button:P(h,14,1.75,.4,T),caption:P(p,12,1.66,.4),overline:P(p,12,2.66,1,T)};return(0,i.Z)((0,r.Z)({htmlFontSize:g,pxToRem:F,fontFamily:s,fontSize:u,fontWeightLight:d,fontWeightRegular:p,fontWeightMedium:h,fontWeightBold:b},A),S,{clone:!1})}function P(){return["".concat(arguments.length<=0?void 0:arguments[0],"px ").concat(arguments.length<=1?void 0:arguments[1],"px ").concat(arguments.length<=2?void 0:arguments[2],"px ").concat(arguments.length<=3?void 0:arguments[3],"px rgba(0,0,0,").concat(.2,")"),"".concat(arguments.length<=4?void 0:arguments[4],"px ").concat(arguments.length<=5?void 0:arguments[5],"px ").concat(arguments.length<=6?void 0:arguments[6],"px ").concat(arguments.length<=7?void 0:arguments[7],"px rgba(0,0,0,").concat(.14,")"),"".concat(arguments.length<=8?void 0:arguments[8],"px ").concat(arguments.length<=9?void 0:arguments[9],"px ").concat(arguments.length<=10?void 0:arguments[10],"px ").concat(arguments.length<=11?void 0:arguments[11],"px rgba(0,0,0,").concat(.12,")")].join(",")}var A=["none",P(0,2,1,-1,0,1,1,0,0,1,3,0),P(0,3,1,-2,0,2,2,0,0,1,5,0),P(0,3,3,-2,0,3,4,0,0,1,8,0),P(0,2,4,-1,0,4,5,0,0,1,10,0),P(0,3,5,-1,0,5,8,0,0,1,14,0),P(0,3,5,-1,0,6,10,0,0,1,18,0),P(0,4,5,-2,0,7,10,1,0,2,16,1),P(0,5,5,-3,0,8,10,1,0,3,14,2),P(0,5,6,-3,0,9,12,1,0,3,16,2),P(0,6,6,-3,0,10,14,1,0,4,18,3),P(0,6,7,-4,0,11,15,1,0,4,20,3),P(0,7,8,-4,0,12,17,2,0,5,22,4),P(0,7,8,-4,0,13,19,2,0,5,24,4),P(0,7,9,-4,0,14,21,2,0,5,26,4),P(0,8,9,-5,0,15,22,2,0,6,28,5),P(0,8,10,-5,0,16,24,2,0,6,30,5),P(0,8,11,-5,0,17,26,2,0,6,32,5),P(0,9,11,-5,0,18,28,2,0,7,34,6),P(0,9,12,-6,0,19,29,2,0,7,36,6),P(0,10,13,-6,0,20,31,3,0,8,38,7),P(0,10,13,-6,0,21,33,3,0,8,40,7),P(0,10,14,-6,0,22,35,3,0,8,42,7),P(0,11,14,-7,0,23,36,3,0,9,44,8),P(0,11,15,-7,0,24,38,3,0,9,46,8)],N=["duration","easing","delay"],E={easeInOut:"cubic-bezier(0.4, 0, 0.2, 1)",easeOut:"cubic-bezier(0.0, 0, 0.2, 1)",easeIn:"cubic-bezier(0.4, 0, 1, 1)",sharp:"cubic-bezier(0.4, 0, 0.6, 1)"},M={shortest:150,shorter:200,short:250,standard:300,complex:375,enteringScreen:225,leavingScreen:195};function R(e){return"".concat(Math.round(e),"ms")}function O(e){if(!e)return 0;var t=e/36;return Math.round(10*(4+15*Math.pow(t,.25)+t/5))}function D(e){var t=(0,r.Z)({},E,e.easing),n=(0,r.Z)({},M,e.duration);return(0,r.Z)({getAutoHeightDuration:O,create:function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:["all"],r=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},o=r.duration,i=void 0===o?n.standard:o,s=r.easing,l=void 0===s?t.easeInOut:s,u=r.delay,c=void 0===u?0:u;(0,a.Z)(r,N);return(Array.isArray(e)?e:[e]).map((function(e){return"".concat(e," ").concat("string"===typeof i?i:R(i)," ").concat(l," ").concat("string"===typeof c?c:R(c))})).join(",")}},e,{easing:t,duration:n})}var z={mobileStepper:1e3,fab:1050,speedDial:1050,appBar:1100,drawer:1200,modal:1300,snackbar:1400,tooltip:1500},I=["breakpoints","mixins","spacing","palette","transitions","typography","shape"];function L(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},t=e.mixins,n=void 0===t?{}:t,l=e.palette,c=void 0===l?{}:l,d=e.transitions,f=void 0===d?{}:d,p=e.typography,m=void 0===p?{}:p,h=(0,a.Z)(e,I);if(e.vars)throw new Error((0,o.Z)(18));var v=k(c),b=(0,s.Z)(e),y=(0,i.Z)(b,{mixins:u(b.breakpoints,n),palette:v,shadows:A.slice(),typography:F(v,m),transitions:D(f),zIndex:(0,r.Z)({},z)});y=(0,i.Z)(y,h);for(var g=arguments.length,_=new Array(g>1?g-1:0),w=1;w<g;w++)_[w-1]=arguments[w];return y=_.reduce((function(e,t){return(0,i.Z)(e,t)}),y)}var Z=L},4205:function(e,t,n){"use strict";var r=(0,n(4360).Z)();t.Z=r},277:function(e,t,n){"use strict";var r=n(4046),a=n(4205),o=(0,r.ZP)({defaultTheme:a.Z,rootShouldForwardProp:function(e){return(0,r.x9)(e)&&"classes"!==e}});t.ZP=o},5513:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(8691),a=n(4205);function o(e){var t=e.props,n=e.name;return(0,r.Z)({props:t,name:n,defaultTheme:a.Z})}},9853:function(e,t,n){"use strict";var r=n(7312);t.Z=r.Z},3111:function(e,t,n){"use strict";n.r(t),n.d(t,{capitalize:function(){return a.Z},createChainedFunction:function(){return o},createSvgIcon:function(){return w},debounce:function(){return S},deprecatedPropType:function(){return k},isMuiElement:function(){return C},ownerDocument:function(){return x},ownerWindow:function(){return F},requirePropFactory:function(){return P},setRef:function(){return A},unstable_ClassNameGenerator:function(){return j},unstable_useEnhancedEffect:function(){return N},unstable_useId:function(){return O},unsupportedProp:function(){return D},useControlled:function(){return z},useEventCallback:function(){return I.Z},useForkRef:function(){return L.Z},useIsFocusVisible:function(){return Z.Z}});var r=n(5902),a=n(9853);var o=function(){for(var e=arguments.length,t=new Array(e),n=0;n<e;n++)t[n]=arguments[n];return t.reduce((function(e,t){return null==t?e:function(){for(var n=arguments.length,r=new Array(n),a=0;a<n;a++)r[a]=arguments[a];e.apply(this,r),t.apply(this,r)}}),(function(){}))},i=n(7462),s=n(2791),l=n.t(s,2),u=n(3366),c=n(8182),d=n(4419),f=n(5513),p=n(277),m=n(1217);function h(e){return(0,m.Z)("MuiSvgIcon",e)}(0,n(5878).Z)("MuiSvgIcon",["root","colorPrimary","colorSecondary","colorAction","colorError","colorDisabled","fontSizeInherit","fontSizeSmall","fontSizeMedium","fontSizeLarge"]);var v=n(184),b=["children","className","color","component","fontSize","htmlColor","inheritViewBox","titleAccess","viewBox"],y=(0,p.ZP)("svg",{name:"MuiSvgIcon",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,"inherit"!==n.color&&t["color".concat((0,a.Z)(n.color))],t["fontSize".concat((0,a.Z)(n.fontSize))]]}})((function(e){var t,n,r,a,o,i,s,l,u,c,d,f,p,m,h,v,b,y=e.theme,g=e.ownerState;return{userSelect:"none",width:"1em",height:"1em",display:"inline-block",fill:"currentColor",flexShrink:0,transition:null==(t=y.transitions)||null==(n=t.create)?void 0:n.call(t,"fill",{duration:null==(r=y.transitions)||null==(a=r.duration)?void 0:a.shorter}),fontSize:{inherit:"inherit",small:(null==(o=y.typography)||null==(i=o.pxToRem)?void 0:i.call(o,20))||"1.25rem",medium:(null==(s=y.typography)||null==(l=s.pxToRem)?void 0:l.call(s,24))||"1.5rem",large:(null==(u=y.typography)||null==(c=u.pxToRem)?void 0:c.call(u,35))||"2.1875rem"}[g.fontSize],color:null!=(d=null==(f=(y.vars||y).palette)||null==(p=f[g.color])?void 0:p.main)?d:{action:null==(m=(y.vars||y).palette)||null==(h=m.action)?void 0:h.active,disabled:null==(v=(y.vars||y).palette)||null==(b=v.action)?void 0:b.disabled,inherit:void 0}[g.color]}})),g=s.forwardRef((function(e,t){var n=(0,f.Z)({props:e,name:"MuiSvgIcon"}),r=n.children,o=n.className,s=n.color,l=void 0===s?"inherit":s,p=n.component,m=void 0===p?"svg":p,g=n.fontSize,_=void 0===g?"medium":g,w=n.htmlColor,S=n.inheritViewBox,k=void 0!==S&&S,C=n.titleAccess,T=n.viewBox,x=void 0===T?"0 0 24 24":T,F=(0,u.Z)(n,b),P=(0,i.Z)({},n,{color:l,component:m,fontSize:_,instanceFontSize:e.fontSize,inheritViewBox:k,viewBox:x}),A={};k||(A.viewBox=x);var N=function(e){var t=e.color,n=e.fontSize,r=e.classes,o={root:["root","inherit"!==t&&"color".concat((0,a.Z)(t)),"fontSize".concat((0,a.Z)(n))]};return(0,d.Z)(o,h,r)}(P);return(0,v.jsxs)(y,(0,i.Z)({as:m,className:(0,c.Z)(N.root,o),focusable:"false",color:w,"aria-hidden":!C||void 0,role:C?"img":void 0,ref:t},A,F,{ownerState:P,children:[r,C?(0,v.jsx)("title",{children:C}):null]}))}));g.muiName="SvgIcon";var _=g;function w(e,t){var n=function(n,r){return(0,v.jsx)(_,(0,i.Z)({"data-testid":"".concat(t,"Icon"),ref:r},n,{children:e}))};return n.muiName=_.muiName,s.memo(s.forwardRef(n))}var S=function(e){var t,n=arguments.length>1&&void 0!==arguments[1]?arguments[1]:166;function r(){for(var r=this,a=arguments.length,o=new Array(a),i=0;i<a;i++)o[i]=arguments[i];var s=function(){e.apply(r,o)};clearTimeout(t),t=setTimeout(s,n)}return r.clear=function(){clearTimeout(t)},r};var k=function(e,t){return function(){return null}};var C=function(e,t){return s.isValidElement(e)&&-1!==t.indexOf(e.type.muiName)};function T(e){return e&&e.ownerDocument||document}var x=T;var F=function(e){return T(e).defaultView||window};var P=function(e,t){return function(){return null}},A=n(2971).Z,N=n(5721).Z,E=n(885),M=0;var R=l.useId;var O=function(e){if(void 0!==R){var t=R();return null!=e?e:t}return function(e){var t=s.useState(e),n=(0,E.Z)(t,2),r=n[0],a=n[1],o=e||r;return s.useEffect((function(){null==r&&a("mui-".concat(M+=1))}),[r]),o}(e)};var D=function(e,t,n,r,a){return null};var z=function(e){var t=e.controlled,n=e.default,r=(e.name,e.state,s.useRef(void 0!==t).current),a=s.useState(n),o=(0,E.Z)(a,2),i=o[0],l=o[1];return[r?t:i,s.useCallback((function(e){r||l(e)}),[])]},I=n(6702),L=n(792),Z=n(2763),j={configure:function(e){console.warn(["MUI: `ClassNameGenerator` import from `@mui/material/utils` is outdated and might cause unexpected issues.","","You should use `import { unstable_ClassNameGenerator } from '@mui/material/className'` instead","","The detail of the issue: https://github.com/mui/material-ui/issues/30011#issuecomment-1024993401","","The updated documentation: https://mui.com/guides/classname-generator/"].join("\n")),r.Z.configure(e)}}},6702:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(2791),a=n(5721);var o=function(e){var t=r.useRef(e);return(0,a.Z)((function(){t.current=e})),r.useCallback((function(){return t.current.apply(void 0,arguments)}),[])}},792:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(2791),a=n(2971);var o=function(e,t){return r.useMemo((function(){return null==e&&null==t?null:function(n){(0,a.Z)(e,n),(0,a.Z)(t,n)}}),[e,t])}},2763:function(e,t,n){"use strict";n.d(t,{Z:function(){return f}});var r,a=n(2791),o=!0,i=!1,s={text:!0,search:!0,url:!0,tel:!0,email:!0,password:!0,number:!0,date:!0,month:!0,week:!0,time:!0,datetime:!0,"datetime-local":!0};function l(e){e.metaKey||e.altKey||e.ctrlKey||(o=!0)}function u(){o=!1}function c(){"hidden"===this.visibilityState&&i&&(o=!0)}function d(e){var t=e.target;try{return t.matches(":focus-visible")}catch(n){}return o||function(e){var t=e.type,n=e.tagName;return!("INPUT"!==n||!s[t]||e.readOnly)||"TEXTAREA"===n&&!e.readOnly||!!e.isContentEditable}(t)}var f=function(){var e=a.useCallback((function(e){var t;null!=e&&((t=e.ownerDocument).addEventListener("keydown",l,!0),t.addEventListener("mousedown",u,!0),t.addEventListener("pointerdown",u,!0),t.addEventListener("touchstart",u,!0),t.addEventListener("visibilitychange",c,!0))}),[]),t=a.useRef(!1);return{isFocusVisibleRef:t,onFocus:function(e){return!!d(e)&&(t.current=!0,!0)},onBlur:function(){return!!t.current&&(i=!0,window.clearTimeout(r),r=window.setTimeout((function(){i=!1}),100),t.current=!1,!0)},ref:e}}},2421:function(e,t,n){"use strict";n.d(t,{ZP:function(){return _},Co:function(){return w}});var r=n(2791),a=n(7462),o=n(9797),i=/^((children|dangerouslySetInnerHTML|key|ref|autoFocus|defaultValue|defaultChecked|innerHTML|suppressContentEditableWarning|suppressHydrationWarning|valueLink|abbr|accept|acceptCharset|accessKey|action|allow|allowUserMedia|allowPaymentRequest|allowFullScreen|allowTransparency|alt|async|autoComplete|autoPlay|capture|cellPadding|cellSpacing|challenge|charSet|checked|cite|classID|className|cols|colSpan|content|contentEditable|contextMenu|controls|controlsList|coords|crossOrigin|data|dateTime|decoding|default|defer|dir|disabled|disablePictureInPicture|download|draggable|encType|enterKeyHint|form|formAction|formEncType|formMethod|formNoValidate|formTarget|frameBorder|headers|height|hidden|high|href|hrefLang|htmlFor|httpEquiv|id|inputMode|integrity|is|keyParams|keyType|kind|label|lang|list|loading|loop|low|marginHeight|marginWidth|max|maxLength|media|mediaGroup|method|min|minLength|multiple|muted|name|nonce|noValidate|open|optimum|pattern|placeholder|playsInline|poster|preload|profile|radioGroup|readOnly|referrerPolicy|rel|required|reversed|role|rows|rowSpan|sandbox|scope|scoped|scrolling|seamless|selected|shape|size|sizes|slot|span|spellCheck|src|srcDoc|srcLang|srcSet|start|step|style|summary|tabIndex|target|title|translate|type|useMap|value|width|wmode|wrap|about|datatype|inlist|prefix|property|resource|typeof|vocab|autoCapitalize|autoCorrect|autoSave|color|incremental|fallback|inert|itemProp|itemScope|itemType|itemID|itemRef|on|option|results|security|unselectable|accentHeight|accumulate|additive|alignmentBaseline|allowReorder|alphabetic|amplitude|arabicForm|ascent|attributeName|attributeType|autoReverse|azimuth|baseFrequency|baselineShift|baseProfile|bbox|begin|bias|by|calcMode|capHeight|clip|clipPathUnits|clipPath|clipRule|colorInterpolation|colorInterpolationFilters|colorProfile|colorRendering|contentScriptType|contentStyleType|cursor|cx|cy|d|decelerate|descent|diffuseConstant|direction|display|divisor|dominantBaseline|dur|dx|dy|edgeMode|elevation|enableBackground|end|exponent|externalResourcesRequired|fill|fillOpacity|fillRule|filter|filterRes|filterUnits|floodColor|floodOpacity|focusable|fontFamily|fontSize|fontSizeAdjust|fontStretch|fontStyle|fontVariant|fontWeight|format|from|fr|fx|fy|g1|g2|glyphName|glyphOrientationHorizontal|glyphOrientationVertical|glyphRef|gradientTransform|gradientUnits|hanging|horizAdvX|horizOriginX|ideographic|imageRendering|in|in2|intercept|k|k1|k2|k3|k4|kernelMatrix|kernelUnitLength|kerning|keyPoints|keySplines|keyTimes|lengthAdjust|letterSpacing|lightingColor|limitingConeAngle|local|markerEnd|markerMid|markerStart|markerHeight|markerUnits|markerWidth|mask|maskContentUnits|maskUnits|mathematical|mode|numOctaves|offset|opacity|operator|order|orient|orientation|origin|overflow|overlinePosition|overlineThickness|panose1|paintOrder|pathLength|patternContentUnits|patternTransform|patternUnits|pointerEvents|points|pointsAtX|pointsAtY|pointsAtZ|preserveAlpha|preserveAspectRatio|primitiveUnits|r|radius|refX|refY|renderingIntent|repeatCount|repeatDur|requiredExtensions|requiredFeatures|restart|result|rotate|rx|ry|scale|seed|shapeRendering|slope|spacing|specularConstant|specularExponent|speed|spreadMethod|startOffset|stdDeviation|stemh|stemv|stitchTiles|stopColor|stopOpacity|strikethroughPosition|strikethroughThickness|string|stroke|strokeDasharray|strokeDashoffset|strokeLinecap|strokeLinejoin|strokeMiterlimit|strokeOpacity|strokeWidth|surfaceScale|systemLanguage|tableValues|targetX|targetY|textAnchor|textDecoration|textRendering|textLength|to|transform|u1|u2|underlinePosition|underlineThickness|unicode|unicodeBidi|unicodeRange|unitsPerEm|vAlphabetic|vHanging|vIdeographic|vMathematical|values|vectorEffect|version|vertAdvY|vertOriginX|vertOriginY|viewBox|viewTarget|visibility|widths|wordSpacing|writingMode|x|xHeight|x1|x2|xChannelSelector|xlinkActuate|xlinkArcrole|xlinkHref|xlinkRole|xlinkShow|xlinkTitle|xlinkType|xmlBase|xmlns|xmlnsXlink|xmlLang|xmlSpace|y|y1|y2|yChannelSelector|z|zoomAndPan|for|class|autofocus)|(([Dd][Aa][Tt][Aa]|[Aa][Rr][Ii][Aa]|x)-.*))$/,s=(0,o.Z)((function(e){return i.test(e)||111===e.charCodeAt(0)&&110===e.charCodeAt(1)&&e.charCodeAt(2)<91})),l=n(9886),u=n(5438),c=n(9140),d=n(2561),f=s,p=function(e){return"theme"!==e},m=function(e){return"string"===typeof e&&e.charCodeAt(0)>96?f:p},h=function(e,t,n){var r;if(t){var a=t.shouldForwardProp;r=e.__emotion_forwardProp&&a?function(t){return e.__emotion_forwardProp(t)&&a(t)}:a}return"function"!==typeof r&&n&&(r=e.__emotion_forwardProp),r},v=function(e){var t=e.cache,n=e.serialized,r=e.isStringTag;(0,u.hC)(t,n,r);(0,d.L)((function(){return(0,u.My)(t,n,r)}));return null},b=function e(t,n){var o,i,s=t.__emotion_real===t,d=s&&t.__emotion_base||t;void 0!==n&&(o=n.label,i=n.target);var f=h(t,n,s),p=f||m(d),b=!p("as");return function(){var y=arguments,g=s&&void 0!==t.__emotion_styles?t.__emotion_styles.slice(0):[];if(void 0!==o&&g.push("label:"+o+";"),null==y[0]||void 0===y[0].raw)g.push.apply(g,y);else{0,g.push(y[0][0]);for(var _=y.length,w=1;w<_;w++)g.push(y[w],y[0][w])}var S=(0,l.w)((function(e,t,n){var a=b&&e.as||d,o="",s=[],h=e;if(null==e.theme){for(var y in h={},e)h[y]=e[y];h.theme=(0,r.useContext)(l.T)}"string"===typeof e.className?o=(0,u.fp)(t.registered,s,e.className):null!=e.className&&(o=e.className+" ");var _=(0,c.O)(g.concat(s),t.registered,h);o+=t.key+"-"+_.name,void 0!==i&&(o+=" "+i);var w=b&&void 0===f?m(a):p,S={};for(var k in e)b&&"as"===k||w(k)&&(S[k]=e[k]);return S.className=o,S.ref=n,(0,r.createElement)(r.Fragment,null,(0,r.createElement)(v,{cache:t,serialized:_,isStringTag:"string"===typeof a}),(0,r.createElement)(a,S))}));return S.displayName=void 0!==o?o:"Styled("+("string"===typeof d?d:d.displayName||d.name||"Component")+")",S.defaultProps=t.defaultProps,S.__emotion_real=S,S.__emotion_base=d,S.__emotion_styles=g,S.__emotion_forwardProp=f,Object.defineProperty(S,"toString",{value:function(){return"."+i}}),S.withComponent=function(t,r){return e(t,(0,a.Z)({},n,r,{shouldForwardProp:h(S,r,!0)})).apply(void 0,g)},S}},y=b.bind();["a","abbr","address","area","article","aside","audio","b","base","bdi","bdo","big","blockquote","body","br","button","canvas","caption","cite","code","col","colgroup","data","datalist","dd","del","details","dfn","dialog","div","dl","dt","em","embed","fieldset","figcaption","figure","footer","form","h1","h2","h3","h4","h5","h6","head","header","hgroup","hr","html","i","iframe","img","input","ins","kbd","keygen","label","legend","li","link","main","map","mark","marquee","menu","menuitem","meta","meter","nav","noscript","object","ol","optgroup","option","output","p","param","picture","pre","progress","q","rp","rt","ruby","s","samp","script","section","select","small","source","span","strong","style","sub","summary","sup","table","tbody","td","textarea","tfoot","th","thead","time","title","tr","track","u","ul","var","video","wbr","circle","clipPath","defs","ellipse","foreignObject","g","image","line","linearGradient","mask","path","pattern","polygon","polyline","radialGradient","rect","stop","svg","text","tspan"].forEach((function(e){y[e]=y(e)}));var g=y;function _(e,t){return g(e,t)}var w=function(e,t){Array.isArray(e.__emotion_styles)&&(e.__emotion_styles=t(e.__emotion_styles))}},1184:function(e,t,n){"use strict";n.d(t,{L7:function(){return l},P$:function(){return c},VO:function(){return a},W8:function(){return s},dt:function(){return u},k9:function(){return i}});var r=n(2466),a={xs:0,sm:600,md:900,lg:1200,xl:1536},o={keys:["xs","sm","md","lg","xl"],up:function(e){return"@media (min-width:".concat(a[e],"px)")}};function i(e,t,n){var r=e.theme||{};if(Array.isArray(t)){var i=r.breakpoints||o;return t.reduce((function(e,r,a){return e[i.up(i.keys[a])]=n(t[a]),e}),{})}if("object"===typeof t){var s=r.breakpoints||o;return Object.keys(t).reduce((function(e,r){if(-1!==Object.keys(s.values||a).indexOf(r)){e[s.up(r)]=n(t[r],r)}else{var o=r;e[o]=t[o]}return e}),{})}return n(t)}function s(){var e,t=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},n=null==(e=t.keys)?void 0:e.reduce((function(e,n){return e[t.up(n)]={},e}),{});return n||{}}function l(e,t){return e.reduce((function(e,t){var n=e[t];return(!n||0===Object.keys(n).length)&&delete e[t],e}),t)}function u(e){for(var t=s(e),n=arguments.length,a=new Array(n>1?n-1:0),o=1;o<n;o++)a[o-1]=arguments[o];var i=[t].concat(a).reduce((function(e,t){return(0,r.Z)(e,t)}),{});return l(Object.keys(t),i)}function c(e){var t,n=e.values,r=e.breakpoints,a=e.base||function(e,t){if("object"!==typeof e)return{};var n={},r=Object.keys(t);return Array.isArray(e)?r.forEach((function(t,r){r<e.length&&(n[t]=!0)})):r.forEach((function(t){null!=e[t]&&(n[t]=!0)})),n}(n,r),o=Object.keys(a);return 0===o.length?n:o.reduce((function(e,r,a){return Array.isArray(n)?(e[r]=null!=n[a]?n[a]:n[t],t=a):"object"===typeof n?(e[r]=null!=n[r]?n[r]:n[t],t=r):e[r]=n,e}),{})}},2065:function(e,t,n){"use strict";n.d(t,{$n:function(){return d},Fq:function(){return u},_j:function(){return c},mi:function(){return l}});var r=n(6189);function a(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:0,n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:1;return Math.min(Math.max(t,e),n)}function o(e){if(e.type)return e;if("#"===e.charAt(0))return o(function(e){e=e.slice(1);var t=new RegExp(".{1,".concat(e.length>=6?2:1,"}"),"g"),n=e.match(t);return n&&1===n[0].length&&(n=n.map((function(e){return e+e}))),n?"rgb".concat(4===n.length?"a":"","(").concat(n.map((function(e,t){return t<3?parseInt(e,16):Math.round(parseInt(e,16)/255*1e3)/1e3})).join(", "),")"):""}(e));var t=e.indexOf("("),n=e.substring(0,t);if(-1===["rgb","rgba","hsl","hsla","color"].indexOf(n))throw new Error((0,r.Z)(9,e));var a,i=e.substring(t+1,e.length-1);if("color"===n){if(a=(i=i.split(" ")).shift(),4===i.length&&"/"===i[3].charAt(0)&&(i[3]=i[3].slice(1)),-1===["srgb","display-p3","a98-rgb","prophoto-rgb","rec-2020"].indexOf(a))throw new Error((0,r.Z)(10,a))}else i=i.split(",");return{type:n,values:i=i.map((function(e){return parseFloat(e)})),colorSpace:a}}function i(e){var t=e.type,n=e.colorSpace,r=e.values;return-1!==t.indexOf("rgb")?r=r.map((function(e,t){return t<3?parseInt(e,10):e})):-1!==t.indexOf("hsl")&&(r[1]="".concat(r[1],"%"),r[2]="".concat(r[2],"%")),r=-1!==t.indexOf("color")?"".concat(n," ").concat(r.join(" ")):"".concat(r.join(", ")),"".concat(t,"(").concat(r,")")}function s(e){var t="hsl"===(e=o(e)).type||"hsla"===e.type?o(function(e){var t=(e=o(e)).values,n=t[0],r=t[1]/100,a=t[2]/100,s=r*Math.min(a,1-a),l=function(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(e+n/30)%12;return a-s*Math.max(Math.min(t-3,9-t,1),-1)},u="rgb",c=[Math.round(255*l(0)),Math.round(255*l(8)),Math.round(255*l(4))];return"hsla"===e.type&&(u+="a",c.push(t[3])),i({type:u,values:c})}(e)).values:e.values;return t=t.map((function(t){return"color"!==e.type&&(t/=255),t<=.03928?t/12.92:Math.pow((t+.055)/1.055,2.4)})),Number((.2126*t[0]+.7152*t[1]+.0722*t[2]).toFixed(3))}function l(e,t){var n=s(e),r=s(t);return(Math.max(n,r)+.05)/(Math.min(n,r)+.05)}function u(e,t){return e=o(e),t=a(t),"rgb"!==e.type&&"hsl"!==e.type||(e.type+="a"),"color"===e.type?e.values[3]="/".concat(t):e.values[3]=t,i(e)}function c(e,t){if(e=o(e),t=a(t),-1!==e.type.indexOf("hsl"))e.values[2]*=1-t;else if(-1!==e.type.indexOf("rgb")||-1!==e.type.indexOf("color"))for(var n=0;n<3;n+=1)e.values[n]*=1-t;return i(e)}function d(e,t){if(e=o(e),t=a(t),-1!==e.type.indexOf("hsl"))e.values[2]+=(100-e.values[2])*t;else if(-1!==e.type.indexOf("rgb"))for(var n=0;n<3;n+=1)e.values[n]+=(255-e.values[n])*t;else if(-1!==e.type.indexOf("color"))for(var r=0;r<3;r+=1)e.values[r]+=(1-e.values[r])*t;return i(e)}},4046:function(e,t,n){"use strict";n.d(t,{ZP:function(){return C},x9:function(){return S}});var r=n(2982),a=n(885),o=n(3366),i=n(7462),s=n(2421),l=n(5080),u=n(7312),c=["variant"];function d(e){return 0===e.length}function f(e){var t=e.variant,n=(0,o.Z)(e,c),r=t||"";return Object.keys(n).sort().forEach((function(t){r+="color"===t?d(r)?e[t]:(0,u.Z)(e[t]):"".concat(d(r)?t:(0,u.Z)(t)).concat((0,u.Z)(e[t].toString()))})),r}var p=n(104),m=["name","slot","skipVariantsResolver","skipSx","overridesResolver"],h=["theme"],v=["theme"];function b(e){return 0===Object.keys(e).length}function y(e){return"string"===typeof e&&e.charCodeAt(0)>96}var g=function(e,t){return t.components&&t.components[e]&&t.components[e].styleOverrides?t.components[e].styleOverrides:null},_=function(e,t){var n=[];t&&t.components&&t.components[e]&&t.components[e].variants&&(n=t.components[e].variants);var r={};return n.forEach((function(e){var t=f(e.props);r[t]=e.style})),r},w=function(e,t,n,r){var a,o,i=e.ownerState,s=void 0===i?{}:i,l=[],u=null==n||null==(a=n.components)||null==(o=a[r])?void 0:o.variants;return u&&u.forEach((function(n){var r=!0;Object.keys(n.props).forEach((function(t){s[t]!==n.props[t]&&e[t]!==n.props[t]&&(r=!1)})),r&&l.push(t[f(n.props)])})),l};function S(e){return"ownerState"!==e&&"theme"!==e&&"sx"!==e&&"as"!==e}var k=(0,l.Z)();function C(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},t=e.defaultTheme,n=void 0===t?k:t,l=e.rootShouldForwardProp,u=void 0===l?S:l,c=e.slotShouldForwardProp,d=void 0===c?S:c,f=e.styleFunctionSx,C=void 0===f?p.Z:f,T=function(e){var t=b(e.theme)?n:e.theme;return C((0,i.Z)({},e,{theme:t}))};return T.__mui_systemSx=!0,function(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{};(0,s.Co)(e,(function(e){return e.filter((function(e){return!(null!=e&&e.__mui_systemSx)}))}));var l,c=t.name,f=t.slot,p=t.skipVariantsResolver,k=t.skipSx,C=t.overridesResolver,x=(0,o.Z)(t,m),F=void 0!==p?p:f&&"Root"!==f||!1,P=k||!1;var A=S;"Root"===f?A=u:f?A=d:y(e)&&(A=void 0);var N=(0,s.ZP)(e,(0,i.Z)({shouldForwardProp:A,label:l},x)),E=function(e){for(var t=arguments.length,s=new Array(t>1?t-1:0),l=1;l<t;l++)s[l-1]=arguments[l];var u=s?s.map((function(e){return"function"===typeof e&&e.__emotion_real!==e?function(t){var r=t.theme,a=(0,o.Z)(t,h);return e((0,i.Z)({theme:b(r)?n:r},a))}:e})):[],d=e;c&&C&&u.push((function(e){var t=b(e.theme)?n:e.theme,r=g(c,t);if(r){var o={};return Object.entries(r).forEach((function(n){var r=(0,a.Z)(n,2),s=r[0],l=r[1];o[s]="function"===typeof l?l((0,i.Z)({},e,{theme:t})):l})),C(e,o)}return null})),c&&!F&&u.push((function(e){var t=b(e.theme)?n:e.theme;return w(e,_(c,t),t,c)})),P||u.push(T);var f=u.length-s.length;if(Array.isArray(e)&&f>0){var p=new Array(f).fill("");(d=[].concat((0,r.Z)(e),(0,r.Z)(p))).raw=[].concat((0,r.Z)(e.raw),(0,r.Z)(p))}else"function"===typeof e&&e.__emotion_real!==e&&(d=function(t){var r=t.theme,a=(0,o.Z)(t,v);return e((0,i.Z)({theme:b(r)?n:r},a))});var m=N.apply(void 0,[d].concat((0,r.Z)(u)));return m};return N.withConfig&&(E.withConfig=N.withConfig),E}}},5080:function(e,t,n){"use strict";n.d(t,{Z:function(){return p}});var r=n(7462),a=n(3366),o=n(2466),i=n(4942),s=["values","unit","step"];function l(e){var t=e.values,n=void 0===t?{xs:0,sm:600,md:900,lg:1200,xl:1536}:t,o=e.unit,l=void 0===o?"px":o,u=e.step,c=void 0===u?5:u,d=(0,a.Z)(e,s),f=function(e){var t=Object.keys(e).map((function(t){return{key:t,val:e[t]}}))||[];return t.sort((function(e,t){return e.val-t.val})),t.reduce((function(e,t){return(0,r.Z)({},e,(0,i.Z)({},t.key,t.val))}),{})}(n),p=Object.keys(f);function m(e){var t="number"===typeof n[e]?n[e]:e;return"@media (min-width:".concat(t).concat(l,")")}function h(e){var t="number"===typeof n[e]?n[e]:e;return"@media (max-width:".concat(t-c/100).concat(l,")")}function v(e,t){var r=p.indexOf(t);return"@media (min-width:".concat("number"===typeof n[e]?n[e]:e).concat(l,") and ")+"(max-width:".concat((-1!==r&&"number"===typeof n[p[r]]?n[p[r]]:t)-c/100).concat(l,")")}return(0,r.Z)({keys:p,values:f,up:m,down:h,between:v,only:function(e){return p.indexOf(e)+1<p.length?v(e,p[p.indexOf(e)+1]):m(e)},not:function(e){var t=p.indexOf(e);return 0===t?m(p[1]):t===p.length-1?h(p[t]):v(e,p[p.indexOf(e)+1]).replace("@media","@media not all and")},unit:l},d)}var u={borderRadius:4},c=n(5682);function d(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:8;if(e.mui)return e;var t=(0,c.hB)({spacing:e}),n=function(){for(var e=arguments.length,n=new Array(e),r=0;r<e;r++)n[r]=arguments[r];var a=0===n.length?[1]:n;return a.map((function(e){var n=t(e);return"number"===typeof n?"".concat(n,"px"):n})).join(" ")};return n.mui=!0,n}var f=["breakpoints","palette","spacing","shape"];var p=function(){for(var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},t=e.breakpoints,n=void 0===t?{}:t,i=e.palette,s=void 0===i?{}:i,c=e.spacing,p=e.shape,m=void 0===p?{}:p,h=(0,a.Z)(e,f),v=l(n),b=d(c),y=(0,o.Z)({breakpoints:v,direction:"ltr",components:{},palette:(0,r.Z)({mode:"light"},s),spacing:b,shape:(0,r.Z)({},u,m)},h),g=arguments.length,_=new Array(g>1?g-1:0),w=1;w<g;w++)_[w-1]=arguments[w];return y=_.reduce((function(e,t){return(0,o.Z)(e,t)}),y)}},114:function(e,t,n){"use strict";n.d(t,{Gc:function(){return G},G$:function(){return q}});var r=n(8529),a=n(8247);var o=function(){for(var e=arguments.length,t=new Array(e),n=0;n<e;n++)t[n]=arguments[n];var r=t.reduce((function(e,t){return t.filterProps.forEach((function(n){e[n]=t})),e}),{}),o=function(e){return Object.keys(e).reduce((function(t,n){return r[n]?(0,a.Z)(t,r[n](e)):t}),{})};return o.propTypes={},o.filterProps=t.reduce((function(e,t){return e.concat(t.filterProps)}),[]),o},i=n(5682),s=n(1184);function l(e){return"number"!==typeof e?e:"".concat(e,"px solid")}var u=(0,r.Z)({prop:"border",themeKey:"borders",transform:l}),c=(0,r.Z)({prop:"borderTop",themeKey:"borders",transform:l}),d=(0,r.Z)({prop:"borderRight",themeKey:"borders",transform:l}),f=(0,r.Z)({prop:"borderBottom",themeKey:"borders",transform:l}),p=(0,r.Z)({prop:"borderLeft",themeKey:"borders",transform:l}),m=(0,r.Z)({prop:"borderColor",themeKey:"palette"}),h=(0,r.Z)({prop:"borderTopColor",themeKey:"palette"}),v=(0,r.Z)({prop:"borderRightColor",themeKey:"palette"}),b=(0,r.Z)({prop:"borderBottomColor",themeKey:"palette"}),y=(0,r.Z)({prop:"borderLeftColor",themeKey:"palette"}),g=function(e){if(void 0!==e.borderRadius&&null!==e.borderRadius){var t=(0,i.eI)(e.theme,"shape.borderRadius",4,"borderRadius");return(0,s.k9)(e,e.borderRadius,(function(e){return{borderRadius:(0,i.NA)(t,e)}}))}return null};g.propTypes={},g.filterProps=["borderRadius"];var _=o(u,c,d,f,p,m,h,v,b,y,g),w=o((0,r.Z)({prop:"displayPrint",cssProperty:!1,transform:function(e){return{"@media print":{display:e}}}}),(0,r.Z)({prop:"display"}),(0,r.Z)({prop:"overflow"}),(0,r.Z)({prop:"textOverflow"}),(0,r.Z)({prop:"visibility"}),(0,r.Z)({prop:"whiteSpace"})),S=o((0,r.Z)({prop:"flexBasis"}),(0,r.Z)({prop:"flexDirection"}),(0,r.Z)({prop:"flexWrap"}),(0,r.Z)({prop:"justifyContent"}),(0,r.Z)({prop:"alignItems"}),(0,r.Z)({prop:"alignContent"}),(0,r.Z)({prop:"order"}),(0,r.Z)({prop:"flex"}),(0,r.Z)({prop:"flexGrow"}),(0,r.Z)({prop:"flexShrink"}),(0,r.Z)({prop:"alignSelf"}),(0,r.Z)({prop:"justifyItems"}),(0,r.Z)({prop:"justifySelf"})),k=function(e){if(void 0!==e.gap&&null!==e.gap){var t=(0,i.eI)(e.theme,"spacing",8,"gap");return(0,s.k9)(e,e.gap,(function(e){return{gap:(0,i.NA)(t,e)}}))}return null};k.propTypes={},k.filterProps=["gap"];var C=function(e){if(void 0!==e.columnGap&&null!==e.columnGap){var t=(0,i.eI)(e.theme,"spacing",8,"columnGap");return(0,s.k9)(e,e.columnGap,(function(e){return{columnGap:(0,i.NA)(t,e)}}))}return null};C.propTypes={},C.filterProps=["columnGap"];var T=function(e){if(void 0!==e.rowGap&&null!==e.rowGap){var t=(0,i.eI)(e.theme,"spacing",8,"rowGap");return(0,s.k9)(e,e.rowGap,(function(e){return{rowGap:(0,i.NA)(t,e)}}))}return null};T.propTypes={},T.filterProps=["rowGap"];var x=o(k,C,T,(0,r.Z)({prop:"gridColumn"}),(0,r.Z)({prop:"gridRow"}),(0,r.Z)({prop:"gridAutoFlow"}),(0,r.Z)({prop:"gridAutoColumns"}),(0,r.Z)({prop:"gridAutoRows"}),(0,r.Z)({prop:"gridTemplateColumns"}),(0,r.Z)({prop:"gridTemplateRows"}),(0,r.Z)({prop:"gridTemplateAreas"}),(0,r.Z)({prop:"gridArea"})),F=o((0,r.Z)({prop:"position"}),(0,r.Z)({prop:"zIndex",themeKey:"zIndex"}),(0,r.Z)({prop:"top"}),(0,r.Z)({prop:"right"}),(0,r.Z)({prop:"bottom"}),(0,r.Z)({prop:"left"})),P=o((0,r.Z)({prop:"color",themeKey:"palette"}),(0,r.Z)({prop:"bgcolor",cssProperty:"backgroundColor",themeKey:"palette"}),(0,r.Z)({prop:"backgroundColor",themeKey:"palette"})),A=(0,r.Z)({prop:"boxShadow",themeKey:"shadows"});function N(e){return e<=1&&0!==e?"".concat(100*e,"%"):e}var E=(0,r.Z)({prop:"width",transform:N}),M=function(e){if(void 0!==e.maxWidth&&null!==e.maxWidth){return(0,s.k9)(e,e.maxWidth,(function(t){var n,r,a;return{maxWidth:(null==(n=e.theme)||null==(r=n.breakpoints)||null==(a=r.values)?void 0:a[t])||s.VO[t]||N(t)}}))}return null};M.filterProps=["maxWidth"];var R=(0,r.Z)({prop:"minWidth",transform:N}),O=(0,r.Z)({prop:"height",transform:N}),D=(0,r.Z)({prop:"maxHeight",transform:N}),z=(0,r.Z)({prop:"minHeight",transform:N}),I=((0,r.Z)({prop:"size",cssProperty:"width",transform:N}),(0,r.Z)({prop:"size",cssProperty:"height",transform:N}),o(E,M,R,O,D,z,(0,r.Z)({prop:"boxSizing"}))),L=(0,r.Z)({prop:"fontFamily",themeKey:"typography"}),Z=(0,r.Z)({prop:"fontSize",themeKey:"typography"}),j=(0,r.Z)({prop:"fontStyle",themeKey:"typography"}),B=(0,r.Z)({prop:"fontWeight",themeKey:"typography"}),V=(0,r.Z)({prop:"letterSpacing"}),U=(0,r.Z)({prop:"textTransform"}),J=(0,r.Z)({prop:"lineHeight"}),W=(0,r.Z)({prop:"textAlign"}),H=o((0,r.Z)({prop:"typography",cssProperty:!1,themeKey:"typography"}),L,Z,j,B,V,J,W,U),$={borders:_.filterProps,display:w.filterProps,flexbox:S.filterProps,grid:x.filterProps,positions:F.filterProps,palette:P.filterProps,shadows:A.filterProps,sizing:I.filterProps,spacing:i.ZP.filterProps,typography:H.filterProps},q={borders:_,display:w,flexbox:S,grid:x,positions:F,palette:P,shadows:A,sizing:I,spacing:i.ZP,typography:H},G=Object.keys($).reduce((function(e,t){return $[t].forEach((function(n){e[n]=q[t]})),e}),{})},8247:function(e,t,n){"use strict";var r=n(2466);t.Z=function(e,t){return t?(0,r.Z)(e,t,{clone:!1}):e}},5682:function(e,t,n){"use strict";n.d(t,{hB:function(){return h},eI:function(){return m},ZP:function(){return S},NA:function(){return v}});var r=n(885),a=n(1184),o=n(8529),i=n(8247);var s={m:"margin",p:"padding"},l={t:"Top",r:"Right",b:"Bottom",l:"Left",x:["Left","Right"],y:["Top","Bottom"]},u={marginX:"mx",marginY:"my",paddingX:"px",paddingY:"py"},c=function(e){var t={};return function(n){return void 0===t[n]&&(t[n]=e(n)),t[n]}}((function(e){if(e.length>2){if(!u[e])return[e];e=u[e]}var t=e.split(""),n=(0,r.Z)(t,2),a=n[0],o=n[1],i=s[a],c=l[o]||"";return Array.isArray(c)?c.map((function(e){return i+e})):[i+c]})),d=["m","mt","mr","mb","ml","mx","my","margin","marginTop","marginRight","marginBottom","marginLeft","marginX","marginY","marginInline","marginInlineStart","marginInlineEnd","marginBlock","marginBlockStart","marginBlockEnd"],f=["p","pt","pr","pb","pl","px","py","padding","paddingTop","paddingRight","paddingBottom","paddingLeft","paddingX","paddingY","paddingInline","paddingInlineStart","paddingInlineEnd","paddingBlock","paddingBlockStart","paddingBlockEnd"],p=[].concat(d,f);function m(e,t,n,r){var a,i=null!=(a=(0,o.D)(e,t,!1))?a:n;return"number"===typeof i?function(e){return"string"===typeof e?e:i*e}:Array.isArray(i)?function(e){return"string"===typeof e?e:i[e]}:"function"===typeof i?i:function(){}}function h(e){return m(e,"spacing",8)}function v(e,t){if("string"===typeof t||null==t)return t;var n=e(Math.abs(t));return t>=0?n:"number"===typeof n?-n:"-".concat(n)}function b(e,t,n,r){if(-1===t.indexOf(n))return null;var o=function(e,t){return function(n){return e.reduce((function(e,r){return e[r]=v(t,n),e}),{})}}(c(n),r),i=e[n];return(0,a.k9)(e,i,o)}function y(e,t){var n=h(e.theme);return Object.keys(e).map((function(r){return b(e,t,r,n)})).reduce(i.Z,{})}function g(e){return y(e,d)}function _(e){return y(e,f)}function w(e){return y(e,p)}g.propTypes={},g.filterProps=d,_.propTypes={},_.filterProps=f,w.propTypes={},w.filterProps=p;var S=w},8529:function(e,t,n){"use strict";n.d(t,{D:function(){return i}});var r=n(4942),a=n(7312),o=n(1184);function i(e,t){var n=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(!t||"string"!==typeof t)return null;if(e&&e.vars&&n){var r="vars.".concat(t).split(".").reduce((function(e,t){return e&&e[t]?e[t]:null}),e);if(null!=r)return r}return t.split(".").reduce((function(e,t){return e&&null!=e[t]?e[t]:null}),e)}function s(e,t,n){var r,a=arguments.length>3&&void 0!==arguments[3]?arguments[3]:n;return r="function"===typeof e?e(n):Array.isArray(e)?e[n]||a:i(e,n)||a,t&&(r=t(r)),r}t.Z=function(e){var t=e.prop,n=e.cssProperty,l=void 0===n?e.prop:n,u=e.themeKey,c=e.transform,d=function(e){if(null==e[t])return null;var n=e[t],d=i(e.theme,u)||{};return(0,o.k9)(e,n,(function(e){var n=s(d,c,e);return e===n&&"string"===typeof e&&(n=s(d,c,"".concat(t).concat("default"===e?"":(0,a.Z)(e)),e)),!1===l?n:(0,r.Z)({},l,n)}))};return d.propTypes={},d.filterProps=[t],d}},104:function(e,t,n){"use strict";var r=n(4942),a=n(8247),o=n(114),i=n(1184);function s(){for(var e=arguments.length,t=new Array(e),n=0;n<e;n++)t[n]=arguments[n];var r=t.reduce((function(e,t){return e.concat(Object.keys(t))}),[]),a=new Set(r);return t.every((function(e){return a.size===Object.keys(e).length}))}function l(e,t){return"function"===typeof e?e(t):e}var u=function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:o.G$,t=Object.keys(e).reduce((function(t,n){return e[n].filterProps.forEach((function(r){t[r]=e[n]})),t}),{});function n(e,n,a){var o,i=(o={},(0,r.Z)(o,e,n),(0,r.Z)(o,"theme",a),o),s=t[e];return s?s(i):(0,r.Z)({},e,n)}function u(e){var o=e||{},c=o.sx,d=o.theme,f=void 0===d?{}:d;if(!c)return null;function p(e){var o=e;if("function"===typeof e)o=e(f);else if("object"!==typeof e)return e;if(!o)return null;var c=(0,i.W8)(f.breakpoints),d=Object.keys(c),p=c;return Object.keys(o).forEach((function(e){var c=l(o[e],f);if(null!==c&&void 0!==c)if("object"===typeof c)if(t[e])p=(0,a.Z)(p,n(e,c,f));else{var d=(0,i.k9)({theme:f},c,(function(t){return(0,r.Z)({},e,t)}));s(d,c)?p[e]=u({sx:c,theme:f}):p=(0,a.Z)(p,d)}else p=(0,a.Z)(p,n(e,c,f))})),(0,i.L7)(d,p)}return Array.isArray(c)?c.map(p):p(c)}return u}();u.filterProps=["sx"],t.Z=u},886:function(e,t,n){"use strict";n.d(t,{Z:function(){return c}});var r=n(5080),a=n(2791);var o=a.createContext(null);function i(){return a.useContext(o)}function s(e){return 0===Object.keys(e).length}var l=function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:null,t=i();return!t||s(t)?e:t},u=(0,r.Z)();var c=function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:u;return l(e)}},8691:function(e,t,n){"use strict";n.d(t,{Z:function(){return i}});var r=n(7462);function a(e){var t=e.theme,n=e.name,a=e.props;return t&&t.components&&t.components[n]&&t.components[n].defaultProps?function(e,t){var n=(0,r.Z)({},t);return Object.keys(e).forEach((function(t){void 0===n[t]&&(n[t]=e[t])})),n}(t.components[n].defaultProps,a):a}var o=n(886);function i(e){var t=e.props,n=e.name,r=e.defaultTheme;return a({theme:(0,o.Z)(r),name:n,props:t})}},5902:function(e,t){"use strict";var n=function(e){return e},r=function(){var e=n;return{configure:function(t){e=t},generate:function(t){return e(t)},reset:function(){e=n}}}();t.Z=r},7312:function(e,t,n){"use strict";n.d(t,{Z:function(){return a}});var r=n(6189);function a(e){if("string"!==typeof e)throw new Error((0,r.Z)(7));return e.charAt(0).toUpperCase()+e.slice(1)}},4419:function(e,t,n){"use strict";function r(e,t,n){var r={};return Object.keys(e).forEach((function(a){r[a]=e[a].reduce((function(e,r){return r&&(e.push(t(r)),n&&n[r]&&e.push(n[r])),e}),[]).join(" ")})),r}n.d(t,{Z:function(){return r}})},2466:function(e,t,n){"use strict";n.d(t,{P:function(){return a},Z:function(){return o}});var r=n(7462);function a(e){return null!==e&&"object"===typeof e&&e.constructor===Object}function o(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:{clone:!0},i=n.clone?(0,r.Z)({},e):e;return a(e)&&a(t)&&Object.keys(t).forEach((function(r){"__proto__"!==r&&(a(t[r])&&r in e&&a(e[r])?i[r]=o(e[r],t[r],n):i[r]=t[r])})),i}},6189:function(e,t,n){"use strict";function r(e){for(var t="https://mui.com/production-error/?code="+e,n=1;n<arguments.length;n+=1)t+="&args[]="+encodeURIComponent(arguments[n]);return"Minified MUI error #"+e+"; visit "+t+" for the full message."}n.d(t,{Z:function(){return r}})},1217:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(5902),a={active:"active",checked:"checked",completed:"completed",disabled:"disabled",error:"error",expanded:"expanded",focused:"focused",focusVisible:"focusVisible",required:"required",selected:"selected"};function o(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:"Mui",o=a[t];return o?"".concat(n,"-").concat(o):"".concat(r.Z.generate(e),"-").concat(t)}},5878:function(e,t,n){"use strict";n.d(t,{Z:function(){return a}});var r=n(1217);function a(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:"Mui",a={};return t.forEach((function(t){a[t]=(0,r.Z)(e,t,n)})),a}},2971:function(e,t,n){"use strict";function r(e,t){"function"===typeof e?e(t):e&&(e.current=t)}n.d(t,{Z:function(){return r}})},5721:function(e,t,n){"use strict";var r=n(2791),a="undefined"!==typeof window?r.useLayoutEffect:r.useEffect;t.Z=a},1694:function(e,t){var n;!function(){"use strict";var r={}.hasOwnProperty;function a(){for(var e=[],t=0;t<arguments.length;t++){var n=arguments[t];if(n){var o=typeof n;if("string"===o||"number"===o)e.push(n);else if(Array.isArray(n)){if(n.length){var i=a.apply(null,n);i&&e.push(i)}}else if("object"===o){if(n.toString!==Object.prototype.toString&&!n.toString.toString().includes("[native code]")){e.push(n.toString());continue}for(var s in n)r.call(n,s)&&n[s]&&e.push(s)}}}return e.join(" ")}e.exports?(a.default=a,e.exports=a):void 0===(n=function(){return a}.apply(t,[]))||(e.exports=n)}()},8182:function(e,t,n){"use strict";function r(e){var t,n,a="";if("string"==typeof e||"number"==typeof e)a+=e;else if("object"==typeof e)if(Array.isArray(e))for(t=0;t<e.length;t++)e[t]&&(n=r(e[t]))&&(a&&(a+=" "),a+=n);else for(t in e)e[t]&&(a&&(a+=" "),a+=t);return a}t.Z=function(){for(var e,t,n=0,a="";n<arguments.length;)(e=arguments[n++])&&(t=r(e))&&(a&&(a+=" "),a+=t);return a}},4173:function(e,t){!function(e){"use strict";function t(){}function n(e,t,n,r,a){for(var o=0,i=t.length,s=0,l=0;o<i;o++){var u=t[o];if(u.removed){if(u.value=e.join(r.slice(l,l+u.count)),l+=u.count,o&&t[o-1].added){var c=t[o-1];t[o-1]=t[o],t[o]=c}}else{if(!u.added&&a){var d=n.slice(s,s+u.count);d=d.map((function(e,t){var n=r[l+t];return n.length>e.length?n:e})),u.value=e.join(d)}else u.value=e.join(n.slice(s,s+u.count));s+=u.count,u.added||(l+=u.count)}}var f=t[i-1];return i>1&&"string"===typeof f.value&&(f.added||f.removed)&&e.equals("",f.value)&&(t[i-2].value+=f.value,t.pop()),t}function r(e){return{newPos:e.newPos,components:e.components.slice(0)}}t.prototype={diff:function(e,t){var a=arguments.length>2&&void 0!==arguments[2]?arguments[2]:{},o=a.callback;"function"===typeof a&&(o=a,a={}),this.options=a;var i=this;function s(e){return o?(setTimeout((function(){o(void 0,e)}),0),!0):e}e=this.castInput(e),t=this.castInput(t),e=this.removeEmpty(this.tokenize(e));var l=(t=this.removeEmpty(this.tokenize(t))).length,u=e.length,c=1,d=l+u,f=[{newPos:-1,components:[]}],p=this.extractCommon(f[0],t,e,0);if(f[0].newPos+1>=l&&p+1>=u)return s([{value:this.join(t),count:t.length}]);function m(){for(var a=-1*c;a<=c;a+=2){var o=void 0,d=f[a-1],p=f[a+1],m=(p?p.newPos:0)-a;d&&(f[a-1]=void 0);var h=d&&d.newPos+1<l,v=p&&0<=m&&m<u;if(h||v){if(!h||v&&d.newPos<p.newPos?(o=r(p),i.pushComponent(o.components,void 0,!0)):((o=d).newPos++,i.pushComponent(o.components,!0,void 0)),m=i.extractCommon(o,t,e,a),o.newPos+1>=l&&m+1>=u)return s(n(i,o.components,t,e,i.useLongestToken));f[a]=o}else f[a]=void 0}c++}if(o)!function e(){setTimeout((function(){if(c>d)return o();m()||e()}),0)}();else for(;c<=d;){var h=m();if(h)return h}},pushComponent:function(e,t,n){var r=e[e.length-1];r&&r.added===t&&r.removed===n?e[e.length-1]={count:r.count+1,added:t,removed:n}:e.push({count:1,added:t,removed:n})},extractCommon:function(e,t,n,r){for(var a=t.length,o=n.length,i=e.newPos,s=i-r,l=0;i+1<a&&s+1<o&&this.equals(t[i+1],n[s+1]);)i++,s++,l++;return l&&e.components.push({count:l}),e.newPos=i,s},equals:function(e,t){return this.options.comparator?this.options.comparator(e,t):e===t||this.options.ignoreCase&&e.toLowerCase()===t.toLowerCase()},removeEmpty:function(e){for(var t=[],n=0;n<e.length;n++)e[n]&&t.push(e[n]);return t},castInput:function(e){return e},tokenize:function(e){return e.split("")},join:function(e){return e.join("")}};var a=new t;function o(e,t,n){return a.diff(e,t,n)}function i(e,t){if("function"===typeof e)t.callback=e;else if(e)for(var n in e)e.hasOwnProperty(n)&&(t[n]=e[n]);return t}var s=/^[A-Za-z\xC0-\u02C6\u02C8-\u02D7\u02DE-\u02FF\u1E00-\u1EFF]+$/,l=/\S/,u=new t;function c(e,t,n){return n=i(n,{ignoreWhitespace:!0}),u.diff(e,t,n)}function d(e,t,n){return u.diff(e,t,n)}u.equals=function(e,t){return this.options.ignoreCase&&(e=e.toLowerCase(),t=t.toLowerCase()),e===t||this.options.ignoreWhitespace&&!l.test(e)&&!l.test(t)},u.tokenize=function(e){for(var t=e.split(/(\s+|[()[\]{}'"]|\b)/),n=0;n<t.length-1;n++)!t[n+1]&&t[n+2]&&s.test(t[n])&&s.test(t[n+2])&&(t[n]+=t[n+2],t.splice(n+1,2),n--);return t};var f=new t;function p(e,t,n){return f.diff(e,t,n)}function m(e,t,n){var r=i(n,{ignoreWhitespace:!0});return f.diff(e,t,r)}f.tokenize=function(e){var t=[],n=e.split(/(\n|\r\n)/);n[n.length-1]||n.pop();for(var r=0;r<n.length;r++){var a=n[r];r%2&&!this.options.newlineIsToken?t[t.length-1]+=a:(this.options.ignoreWhitespace&&(a=a.trim()),t.push(a))}return t};var h=new t;function v(e,t,n){return h.diff(e,t,n)}h.tokenize=function(e){return e.split(/(\S.+?[.!?])(?=\s+|$)/)};var b=new t;function y(e,t,n){return b.diff(e,t,n)}function g(e){return g="function"===typeof Symbol&&"symbol"===typeof Symbol.iterator?function(e){return typeof e}:function(e){return e&&"function"===typeof Symbol&&e.constructor===Symbol&&e!==Symbol.prototype?"symbol":typeof e},g(e)}function _(e){return w(e)||S(e)||k()}function w(e){if(Array.isArray(e)){for(var t=0,n=new Array(e.length);t<e.length;t++)n[t]=e[t];return n}}function S(e){if(Symbol.iterator in Object(e)||"[object Arguments]"===Object.prototype.toString.call(e))return Array.from(e)}function k(){throw new TypeError("Invalid attempt to spread non-iterable instance")}b.tokenize=function(e){return e.split(/([{}:;,]|\s+)/)};var C=Object.prototype.toString,T=new t;function x(e,t,n){return T.diff(e,t,n)}function F(e,t,n,r,a){var o,i;for(t=t||[],n=n||[],r&&(e=r(a,e)),o=0;o<t.length;o+=1)if(t[o]===e)return n[o];if("[object Array]"===C.call(e)){for(t.push(e),i=new Array(e.length),n.push(i),o=0;o<e.length;o+=1)i[o]=F(e[o],t,n,r,a);return t.pop(),n.pop(),i}if(e&&e.toJSON&&(e=e.toJSON()),"object"===g(e)&&null!==e){t.push(e),i={},n.push(i);var s,l=[];for(s in e)e.hasOwnProperty(s)&&l.push(s);for(l.sort(),o=0;o<l.length;o+=1)i[s=l[o]]=F(e[s],t,n,r,s);t.pop(),n.pop()}else i=e;return i}T.useLongestToken=!0,T.tokenize=f.tokenize,T.castInput=function(e){var t=this.options,n=t.undefinedReplacement,r=t.stringifyReplacer,a=void 0===r?function(e,t){return"undefined"===typeof t?n:t}:r;return"string"===typeof e?e:JSON.stringify(F(e,null,null,a),a,"  ")},T.equals=function(e,n){return t.prototype.equals.call(T,e.replace(/,([\r\n])/g,"$1"),n.replace(/,([\r\n])/g,"$1"))};var P=new t;function A(e,t,n){return P.diff(e,t,n)}function N(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},n=e.split(/\r\n|[\n\v\f\r\x85]/),r=e.match(/\r\n|[\n\v\f\r\x85]/g)||[],a=[],o=0;function i(){var e={};for(a.push(e);o<n.length;){var r=n[o];if(/^(\-\-\-|\+\+\+|@@)\s/.test(r))break;var i=/^(?:Index:|diff(?: -r \w+)+)\s+(.+?)\s*$/.exec(r);i&&(e.index=i[1]),o++}for(s(e),s(e),e.hunks=[];o<n.length;){var u=n[o];if(/^(Index:|diff|\-\-\-|\+\+\+)\s/.test(u))break;if(/^@@/.test(u))e.hunks.push(l());else{if(u&&t.strict)throw new Error("Unknown line "+(o+1)+" "+JSON.stringify(u));o++}}}function s(e){var t=/^(---|\+\+\+)\s+(.*)$/.exec(n[o]);if(t){var r="---"===t[1]?"old":"new",a=t[2].split("\t",2),i=a[0].replace(/\\\\/g,"\\");/^".*"$/.test(i)&&(i=i.substr(1,i.length-2)),e[r+"FileName"]=i,e[r+"Header"]=(a[1]||"").trim(),o++}}function l(){for(var e=o,a=n[o++].split(/@@ -(\d+)(?:,(\d+))? \+(\d+)(?:,(\d+))? @@/),i={oldStart:+a[1],oldLines:+a[2]||1,newStart:+a[3],newLines:+a[4]||1,lines:[],linedelimiters:[]},s=0,l=0;o<n.length&&!(0===n[o].indexOf("--- ")&&o+2<n.length&&0===n[o+1].indexOf("+++ ")&&0===n[o+2].indexOf("@@"));o++){var u=0==n[o].length&&o!=n.length-1?" ":n[o][0];if("+"!==u&&"-"!==u&&" "!==u&&"\\"!==u)break;i.lines.push(n[o]),i.linedelimiters.push(r[o]||"\n"),"+"===u?s++:"-"===u?l++:" "===u&&(s++,l++)}if(s||1!==i.newLines||(i.newLines=0),l||1!==i.oldLines||(i.oldLines=0),t.strict){if(s!==i.newLines)throw new Error("Added line count did not match for hunk at line "+(e+1));if(l!==i.oldLines)throw new Error("Removed line count did not match for hunk at line "+(e+1))}return i}for(;o<n.length;)i();return a}function E(e,t,n){var r=!0,a=!1,o=!1,i=1;return function s(){if(r&&!o){if(a?i++:r=!1,e+i<=n)return i;o=!0}if(!a)return o||(r=!0),t<=e-i?-i++:(a=!0,s())}}function M(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:{};if("string"===typeof t&&(t=N(t)),Array.isArray(t)){if(t.length>1)throw new Error("applyPatch only works with a single input.");t=t[0]}var r,a,o=e.split(/\r\n|[\n\v\f\r\x85]/),i=e.match(/\r\n|[\n\v\f\r\x85]/g)||[],s=t.hunks,l=n.compareLine||function(e,t,n,r){return t===r},u=0,c=n.fuzzFactor||0,d=0,f=0;function p(e,t){for(var n=0;n<e.lines.length;n++){var r=e.lines[n],a=r.length>0?r[0]:" ",i=r.length>0?r.substr(1):r;if(" "===a||"-"===a){if(!l(t+1,o[t],a,i)&&++u>c)return!1;t++}}return!0}for(var m=0;m<s.length;m++){for(var h=s[m],v=o.length-h.oldLines,b=0,y=f+h.oldStart-1,g=E(y,d,v);void 0!==b;b=g())if(p(h,y+b)){h.offset=f+=b;break}if(void 0===b)return!1;d=h.offset+h.oldStart+h.oldLines}for(var _=0,w=0;w<s.length;w++){var S=s[w],k=S.oldStart+S.offset+_-1;_+=S.newLines-S.oldLines,k<0&&(k=0);for(var C=0;C<S.lines.length;C++){var T=S.lines[C],x=T.length>0?T[0]:" ",F=T.length>0?T.substr(1):T,P=S.linedelimiters[C];if(" "===x)k++;else if("-"===x)o.splice(k,1),i.splice(k,1);else if("+"===x)o.splice(k,0,F),i.splice(k,0,P),k++;else if("\\"===x){var A=S.lines[C-1]?S.lines[C-1][0]:null;"+"===A?r=!0:"-"===A&&(a=!0)}}}if(r)for(;!o[o.length-1];)o.pop(),i.pop();else a&&(o.push(""),i.push("\n"));for(var M=0;M<o.length-1;M++)o[M]=o[M]+i[M];return o.join("")}function R(e,t){"string"===typeof e&&(e=N(e));var n=0;function r(){var a=e[n++];if(!a)return t.complete();t.loadFile(a,(function(e,n){if(e)return t.complete(e);var o=M(n,a,t);t.patched(a,o,(function(e){if(e)return t.complete(e);r()}))}))}r()}function O(e,t,n,r,a,o,i){i||(i={}),"undefined"===typeof i.context&&(i.context=4);var s=p(n,r,i);function l(e){return e.map((function(e){return" "+e}))}s.push({value:"",lines:[]});for(var u=[],c=0,d=0,f=[],m=1,h=1,v=function(e){var t=s[e],a=t.lines||t.value.replace(/\n$/,"").split("\n");if(t.lines=a,t.added||t.removed){var o;if(!c){var p=s[e-1];c=m,d=h,p&&(f=i.context>0?l(p.lines.slice(-i.context)):[],c-=f.length,d-=f.length)}(o=f).push.apply(o,_(a.map((function(e){return(t.added?"+":"-")+e})))),t.added?h+=a.length:m+=a.length}else{if(c)if(a.length<=2*i.context&&e<s.length-2){var v;(v=f).push.apply(v,_(l(a)))}else{var b,y=Math.min(a.length,i.context);(b=f).push.apply(b,_(l(a.slice(0,y))));var g={oldStart:c,oldLines:m-c+y,newStart:d,newLines:h-d+y,lines:f};if(e>=s.length-2&&a.length<=i.context){var w=/\n$/.test(n),S=/\n$/.test(r),k=0==a.length&&f.length>g.oldLines;!w&&k&&f.splice(g.oldLines,0,"\\ No newline at end of file"),(w||k)&&S||f.push("\\ No newline at end of file")}u.push(g),c=0,d=0,f=[]}m+=a.length,h+=a.length}},b=0;b<s.length;b++)v(b);return{oldFileName:e,newFileName:t,oldHeader:a,newHeader:o,hunks:u}}function D(e,t,n,r,a,o,i){var s=O(e,t,n,r,a,o,i),l=[];e==t&&l.push("Index: "+e),l.push("==================================================================="),l.push("--- "+s.oldFileName+("undefined"===typeof s.oldHeader?"":"\t"+s.oldHeader)),l.push("+++ "+s.newFileName+("undefined"===typeof s.newHeader?"":"\t"+s.newHeader));for(var u=0;u<s.hunks.length;u++){var c=s.hunks[u];l.push("@@ -"+c.oldStart+","+c.oldLines+" +"+c.newStart+","+c.newLines+" @@"),l.push.apply(l,c.lines)}return l.join("\n")+"\n"}function z(e,t,n,r,a,o){return D(e,e,t,n,r,a,o)}function I(e,t){return e.length===t.length&&L(e,t)}function L(e,t){if(t.length>e.length)return!1;for(var n=0;n<t.length;n++)if(t[n]!==e[n])return!1;return!0}function Z(e){var t=ne(e.lines),n=t.oldLines,r=t.newLines;void 0!==n?e.oldLines=n:delete e.oldLines,void 0!==r?e.newLines=r:delete e.newLines}function j(e,t,n){e=B(e,n),t=B(t,n);var r={};(e.index||t.index)&&(r.index=e.index||t.index),(e.newFileName||t.newFileName)&&(V(e)?V(t)?(r.oldFileName=U(r,e.oldFileName,t.oldFileName),r.newFileName=U(r,e.newFileName,t.newFileName),r.oldHeader=U(r,e.oldHeader,t.oldHeader),r.newHeader=U(r,e.newHeader,t.newHeader)):(r.oldFileName=e.oldFileName,r.newFileName=e.newFileName,r.oldHeader=e.oldHeader,r.newHeader=e.newHeader):(r.oldFileName=t.oldFileName||e.oldFileName,r.newFileName=t.newFileName||e.newFileName,r.oldHeader=t.oldHeader||e.oldHeader,r.newHeader=t.newHeader||e.newHeader)),r.hunks=[];for(var a=0,o=0,i=0,s=0;a<e.hunks.length||o<t.hunks.length;){var l=e.hunks[a]||{oldStart:1/0},u=t.hunks[o]||{oldStart:1/0};if(J(l,u))r.hunks.push(W(l,i)),a++,s+=l.newLines-l.oldLines;else if(J(u,l))r.hunks.push(W(u,s)),o++,i+=u.newLines-u.oldLines;else{var c={oldStart:Math.min(l.oldStart,u.oldStart),oldLines:0,newStart:Math.min(l.newStart+i,u.oldStart+s),newLines:0,lines:[]};H(c,l.oldStart,l.lines,u.oldStart,u.lines),o++,a++,r.hunks.push(c)}}return r}function B(e,t){if("string"===typeof e){if(/^@@/m.test(e)||/^Index:/m.test(e))return N(e)[0];if(!t)throw new Error("Must provide a base reference or pass in a patch");return O(void 0,void 0,t,e)}return e}function V(e){return e.newFileName&&e.newFileName!==e.oldFileName}function U(e,t,n){return t===n?t:(e.conflict=!0,{mine:t,theirs:n})}function J(e,t){return e.oldStart<t.oldStart&&e.oldStart+e.oldLines<t.oldStart}function W(e,t){return{oldStart:e.oldStart,oldLines:e.oldLines,newStart:e.newStart+t,newLines:e.newLines,lines:e.lines}}function H(e,t,n,r,a){var o={offset:t,lines:n,index:0},i={offset:r,lines:a,index:0};for(K(e,o,i),K(e,i,o);o.index<o.lines.length&&i.index<i.lines.length;){var s=o.lines[o.index],l=i.lines[i.index];if("-"!==s[0]&&"+"!==s[0]||"-"!==l[0]&&"+"!==l[0])if("+"===s[0]&&" "===l[0]){var u;(u=e.lines).push.apply(u,_(Y(o)))}else if("+"===l[0]&&" "===s[0]){var c;(c=e.lines).push.apply(c,_(Y(i)))}else"-"===s[0]&&" "===l[0]?q(e,o,i):"-"===l[0]&&" "===s[0]?q(e,i,o,!0):s===l?(e.lines.push(s),o.index++,i.index++):G(e,Y(o),Y(i));else $(e,o,i)}Q(e,o),Q(e,i),Z(e)}function $(e,t,n){var r=Y(t),a=Y(n);if(ee(r)&&ee(a)){var o,i;if(L(r,a)&&te(n,r,r.length-a.length))return void(o=e.lines).push.apply(o,_(r));if(L(a,r)&&te(t,a,a.length-r.length))return void(i=e.lines).push.apply(i,_(a))}else if(I(r,a)){var s;return void(s=e.lines).push.apply(s,_(r))}G(e,r,a)}function q(e,t,n,r){var a,o=Y(t),i=X(n,o);i.merged?(a=e.lines).push.apply(a,_(i.merged)):G(e,r?i:o,r?o:i)}function G(e,t,n){e.conflict=!0,e.lines.push({conflict:!0,mine:t,theirs:n})}function K(e,t,n){for(;t.offset<n.offset&&t.index<t.lines.length;){var r=t.lines[t.index++];e.lines.push(r),t.offset++}}function Q(e,t){for(;t.index<t.lines.length;){var n=t.lines[t.index++];e.lines.push(n)}}function Y(e){for(var t=[],n=e.lines[e.index][0];e.index<e.lines.length;){var r=e.lines[e.index];if("-"===n&&"+"===r[0]&&(n="+"),n!==r[0])break;t.push(r),e.index++}return t}function X(e,t){for(var n=[],r=[],a=0,o=!1,i=!1;a<t.length&&e.index<e.lines.length;){var s=e.lines[e.index],l=t[a];if("+"===l[0])break;if(o=o||" "!==s[0],r.push(l),a++,"+"===s[0])for(i=!0;"+"===s[0];)n.push(s),s=e.lines[++e.index];l.substr(1)===s.substr(1)?(n.push(s),e.index++):i=!0}if("+"===(t[a]||"")[0]&&o&&(i=!0),i)return n;for(;a<t.length;)r.push(t[a++]);return{merged:r,changes:n}}function ee(e){return e.reduce((function(e,t){return e&&"-"===t[0]}),!0)}function te(e,t,n){for(var r=0;r<n;r++){var a=t[t.length-n+r].substr(1);if(e.lines[e.index+r]!==" "+a)return!1}return e.index+=n,!0}function ne(e){var t=0,n=0;return e.forEach((function(e){if("string"!==typeof e){var r=ne(e.mine),a=ne(e.theirs);void 0!==t&&(r.oldLines===a.oldLines?t+=r.oldLines:t=void 0),void 0!==n&&(r.newLines===a.newLines?n+=r.newLines:n=void 0)}else void 0===n||"+"!==e[0]&&" "!==e[0]||n++,void 0===t||"-"!==e[0]&&" "!==e[0]||t++})),{oldLines:t,newLines:n}}function re(e){for(var t,n,r=[],a=0;a<e.length;a++)n=(t=e[a]).added?1:t.removed?-1:0,r.push([n,t.value]);return r}function ae(e){for(var t=[],n=0;n<e.length;n++){var r=e[n];r.added?t.push("<ins>"):r.removed&&t.push("<del>"),t.push(oe(r.value)),r.added?t.push("</ins>"):r.removed&&t.push("</del>")}return t.join("")}function oe(e){var t=e;return t=(t=(t=(t=t.replace(/&/g,"&amp;")).replace(/</g,"&lt;")).replace(/>/g,"&gt;")).replace(/"/g,"&quot;")}P.tokenize=function(e){return e.slice()},P.join=P.removeEmpty=function(e){return e},e.Diff=t,e.diffChars=o,e.diffWords=c,e.diffWordsWithSpace=d,e.diffLines=p,e.diffTrimmedLines=m,e.diffSentences=v,e.diffCss=y,e.diffJson=x,e.diffArrays=A,e.structuredPatch=O,e.createTwoFilesPatch=D,e.createPatch=z,e.applyPatch=M,e.applyPatches=R,e.parsePatch=N,e.merge=j,e.convertChangesToDMP=re,e.convertChangesToXML=ae,e.canonicalize=F,Object.defineProperty(e,"__esModule",{value:!0})}(t)},6025:function(e,t,n){"use strict";n.r(t),n.d(t,{cache:function(){return Z},css:function(){return I},cx:function(){return M},flush:function(){return N},getRegisteredStyles:function(){return O},hydrate:function(){return E},injectGlobal:function(){return D},keyframes:function(){return z},merge:function(){return R},sheet:function(){return L}});var r=function(){function e(e){this.isSpeedy=void 0===e.speedy||e.speedy,this.tags=[],this.ctr=0,this.nonce=e.nonce,this.key=e.key,this.container=e.container,this.before=null}var t=e.prototype;return t.insert=function(e){if(this.ctr%(this.isSpeedy?65e3:1)===0){var t,n=function(e){var t=document.createElement("style");return t.setAttribute("data-emotion",e.key),void 0!==e.nonce&&t.setAttribute("nonce",e.nonce),t.appendChild(document.createTextNode("")),t}(this);t=0===this.tags.length?this.before:this.tags[this.tags.length-1].nextSibling,this.container.insertBefore(n,t),this.tags.push(n)}var r=this.tags[this.tags.length-1];if(this.isSpeedy){var a=function(e){if(e.sheet)return e.sheet;for(var t=0;t<document.styleSheets.length;t++)if(document.styleSheets[t].ownerNode===e)return document.styleSheets[t]}(r);try{var o=105===e.charCodeAt(1)&&64===e.charCodeAt(0);a.insertRule(e,o?0:a.cssRules.length)}catch(i){0}}else r.appendChild(document.createTextNode(e));this.ctr++},t.flush=function(){this.tags.forEach((function(e){return e.parentNode.removeChild(e)})),this.tags=[],this.ctr=0},e}();var a=function(e){function t(e,r,l,u,f){for(var p,m,h,v,_,S=0,k=0,C=0,T=0,x=0,M=0,O=h=p=0,z=0,I=0,L=0,Z=0,j=l.length,B=j-1,V="",U="",J="",W="";z<j;){if(m=l.charCodeAt(z),z===B&&0!==k+T+C+S&&(0!==k&&(m=47===k?10:47),T=C=S=0,j++,B++),0===k+T+C+S){if(z===B&&(0<I&&(V=V.replace(d,"")),0<V.trim().length)){switch(m){case 32:case 9:case 59:case 13:case 10:break;default:V+=l.charAt(z)}m=59}switch(m){case 123:for(p=(V=V.trim()).charCodeAt(0),h=1,Z=++z;z<j;){switch(m=l.charCodeAt(z)){case 123:h++;break;case 125:h--;break;case 47:switch(m=l.charCodeAt(z+1)){case 42:case 47:e:{for(O=z+1;O<B;++O)switch(l.charCodeAt(O)){case 47:if(42===m&&42===l.charCodeAt(O-1)&&z+2!==O){z=O+1;break e}break;case 10:if(47===m){z=O+1;break e}}z=O}}break;case 91:m++;case 40:m++;case 34:case 39:for(;z++<B&&l.charCodeAt(z)!==m;);}if(0===h)break;z++}if(h=l.substring(Z,z),0===p&&(p=(V=V.replace(c,"").trim()).charCodeAt(0)),64===p){switch(0<I&&(V=V.replace(d,"")),m=V.charCodeAt(1)){case 100:case 109:case 115:case 45:I=r;break;default:I=E}if(Z=(h=t(r,I,h,m,f+1)).length,0<R&&(_=s(3,h,I=n(E,V,L),r,P,F,Z,m,f,u),V=I.join(""),void 0!==_&&0===(Z=(h=_.trim()).length)&&(m=0,h="")),0<Z)switch(m){case 115:V=V.replace(w,i);case 100:case 109:case 45:h=V+"{"+h+"}";break;case 107:h=(V=V.replace(b,"$1 $2"))+"{"+h+"}",h=1===N||2===N&&o("@"+h,3)?"@-webkit-"+h+"@"+h:"@"+h;break;default:h=V+h,112===u&&(U+=h,h="")}else h=""}else h=t(r,n(r,V,L),h,u,f+1);J+=h,h=L=I=O=p=0,V="",m=l.charCodeAt(++z);break;case 125:case 59:if(1<(Z=(V=(0<I?V.replace(d,""):V).trim()).length))switch(0===O&&(p=V.charCodeAt(0),45===p||96<p&&123>p)&&(Z=(V=V.replace(" ",":")).length),0<R&&void 0!==(_=s(1,V,r,e,P,F,U.length,u,f,u))&&0===(Z=(V=_.trim()).length)&&(V="\0\0"),p=V.charCodeAt(0),m=V.charCodeAt(1),p){case 0:break;case 64:if(105===m||99===m){W+=V+l.charAt(z);break}default:58!==V.charCodeAt(Z-1)&&(U+=a(V,p,m,V.charCodeAt(2)))}L=I=O=p=0,V="",m=l.charCodeAt(++z)}}switch(m){case 13:case 10:47===k?k=0:0===1+p&&107!==u&&0<V.length&&(I=1,V+="\0"),0<R*D&&s(0,V,r,e,P,F,U.length,u,f,u),F=1,P++;break;case 59:case 125:if(0===k+T+C+S){F++;break}default:switch(F++,v=l.charAt(z),m){case 9:case 32:if(0===T+S+k)switch(x){case 44:case 58:case 9:case 32:v="";break;default:32!==m&&(v=" ")}break;case 0:v="\\0";break;case 12:v="\\f";break;case 11:v="\\v";break;case 38:0===T+k+S&&(I=L=1,v="\f"+v);break;case 108:if(0===T+k+S+A&&0<O)switch(z-O){case 2:112===x&&58===l.charCodeAt(z-3)&&(A=x);case 8:111===M&&(A=M)}break;case 58:0===T+k+S&&(O=z);break;case 44:0===k+C+T+S&&(I=1,v+="\r");break;case 34:case 39:0===k&&(T=T===m?0:0===T?m:T);break;case 91:0===T+k+C&&S++;break;case 93:0===T+k+C&&S--;break;case 41:0===T+k+S&&C--;break;case 40:if(0===T+k+S){if(0===p)if(2*x+3*M===533);else p=1;C++}break;case 64:0===k+C+T+S+O+h&&(h=1);break;case 42:case 47:if(!(0<T+S+C))switch(k){case 0:switch(2*m+3*l.charCodeAt(z+1)){case 235:k=47;break;case 220:Z=z,k=42}break;case 42:47===m&&42===x&&Z+2!==z&&(33===l.charCodeAt(Z+2)&&(U+=l.substring(Z,z+1)),v="",k=0)}}0===k&&(V+=v)}M=x,x=m,z++}if(0<(Z=U.length)){if(I=r,0<R&&(void 0!==(_=s(2,U,I,e,P,F,Z,u,f,u))&&0===(U=_).length))return W+U+J;if(U=I.join(",")+"{"+U+"}",0!==N*A){switch(2!==N||o(U,2)||(A=0),A){case 111:U=U.replace(g,":-moz-$1")+U;break;case 112:U=U.replace(y,"::-webkit-input-$1")+U.replace(y,"::-moz-$1")+U.replace(y,":-ms-input-$1")+U}A=0}}return W+U+J}function n(e,t,n){var a=t.trim().split(h);t=a;var o=a.length,i=e.length;switch(i){case 0:case 1:var s=0;for(e=0===i?"":e[0]+" ";s<o;++s)t[s]=r(e,t[s],n).trim();break;default:var l=s=0;for(t=[];s<o;++s)for(var u=0;u<i;++u)t[l++]=r(e[u]+" ",a[s],n).trim()}return t}function r(e,t,n){var r=t.charCodeAt(0);switch(33>r&&(r=(t=t.trim()).charCodeAt(0)),r){case 38:return t.replace(v,"$1"+e.trim());case 58:return e.trim()+t.replace(v,"$1"+e.trim());default:if(0<1*n&&0<t.indexOf("\f"))return t.replace(v,(58===e.charCodeAt(0)?"":"$1")+e.trim())}return e+t}function a(e,t,n,r){var i=e+";",s=2*t+3*n+4*r;if(944===s){e=i.indexOf(":",9)+1;var l=i.substring(e,i.length-1).trim();return l=i.substring(0,e).trim()+l+";",1===N||2===N&&o(l,1)?"-webkit-"+l+l:l}if(0===N||2===N&&!o(i,1))return i;switch(s){case 1015:return 97===i.charCodeAt(10)?"-webkit-"+i+i:i;case 951:return 116===i.charCodeAt(3)?"-webkit-"+i+i:i;case 963:return 110===i.charCodeAt(5)?"-webkit-"+i+i:i;case 1009:if(100!==i.charCodeAt(4))break;case 969:case 942:return"-webkit-"+i+i;case 978:return"-webkit-"+i+"-moz-"+i+i;case 1019:case 983:return"-webkit-"+i+"-moz-"+i+"-ms-"+i+i;case 883:if(45===i.charCodeAt(8))return"-webkit-"+i+i;if(0<i.indexOf("image-set(",11))return i.replace(x,"$1-webkit-$2")+i;break;case 932:if(45===i.charCodeAt(4))switch(i.charCodeAt(5)){case 103:return"-webkit-box-"+i.replace("-grow","")+"-webkit-"+i+"-ms-"+i.replace("grow","positive")+i;case 115:return"-webkit-"+i+"-ms-"+i.replace("shrink","negative")+i;case 98:return"-webkit-"+i+"-ms-"+i.replace("basis","preferred-size")+i}return"-webkit-"+i+"-ms-"+i+i;case 964:return"-webkit-"+i+"-ms-flex-"+i+i;case 1023:if(99!==i.charCodeAt(8))break;return"-webkit-box-pack"+(l=i.substring(i.indexOf(":",15)).replace("flex-","").replace("space-between","justify"))+"-webkit-"+i+"-ms-flex-pack"+l+i;case 1005:return p.test(i)?i.replace(f,":-webkit-")+i.replace(f,":-moz-")+i:i;case 1e3:switch(t=(l=i.substring(13).trim()).indexOf("-")+1,l.charCodeAt(0)+l.charCodeAt(t)){case 226:l=i.replace(_,"tb");break;case 232:l=i.replace(_,"tb-rl");break;case 220:l=i.replace(_,"lr");break;default:return i}return"-webkit-"+i+"-ms-"+l+i;case 1017:if(-1===i.indexOf("sticky",9))break;case 975:switch(t=(i=e).length-10,s=(l=(33===i.charCodeAt(t)?i.substring(0,t):i).substring(e.indexOf(":",7)+1).trim()).charCodeAt(0)+(0|l.charCodeAt(7))){case 203:if(111>l.charCodeAt(8))break;case 115:i=i.replace(l,"-webkit-"+l)+";"+i;break;case 207:case 102:i=i.replace(l,"-webkit-"+(102<s?"inline-":"")+"box")+";"+i.replace(l,"-webkit-"+l)+";"+i.replace(l,"-ms-"+l+"box")+";"+i}return i+";";case 938:if(45===i.charCodeAt(5))switch(i.charCodeAt(6)){case 105:return l=i.replace("-items",""),"-webkit-"+i+"-webkit-box-"+l+"-ms-flex-"+l+i;case 115:return"-webkit-"+i+"-ms-flex-item-"+i.replace(k,"")+i;default:return"-webkit-"+i+"-ms-flex-line-pack"+i.replace("align-content","").replace(k,"")+i}break;case 973:case 989:if(45!==i.charCodeAt(3)||122===i.charCodeAt(4))break;case 931:case 953:if(!0===T.test(e))return 115===(l=e.substring(e.indexOf(":")+1)).charCodeAt(0)?a(e.replace("stretch","fill-available"),t,n,r).replace(":fill-available",":stretch"):i.replace(l,"-webkit-"+l)+i.replace(l,"-moz-"+l.replace("fill-",""))+i;break;case 962:if(i="-webkit-"+i+(102===i.charCodeAt(5)?"-ms-"+i:"")+i,211===n+r&&105===i.charCodeAt(13)&&0<i.indexOf("transform",10))return i.substring(0,i.indexOf(";",27)+1).replace(m,"$1-webkit-$2")+i}return i}function o(e,t){var n=e.indexOf(1===t?":":"{"),r=e.substring(0,3!==t?n:10);return n=e.substring(n+1,e.length-1),O(2!==t?r:r.replace(C,"$1"),n,t)}function i(e,t){var n=a(t,t.charCodeAt(0),t.charCodeAt(1),t.charCodeAt(2));return n!==t+";"?n.replace(S," or ($1)").substring(4):"("+t+")"}function s(e,t,n,r,a,o,i,s,l,c){for(var d,f=0,p=t;f<R;++f)switch(d=M[f].call(u,e,p,n,r,a,o,i,s,l,c)){case void 0:case!1:case!0:case null:break;default:p=d}if(p!==t)return p}function l(e){return void 0!==(e=e.prefix)&&(O=null,e?"function"!==typeof e?N=1:(N=2,O=e):N=0),l}function u(e,n){var r=e;if(33>r.charCodeAt(0)&&(r=r.trim()),r=[r],0<R){var a=s(-1,n,r,r,P,F,0,0,0,0);void 0!==a&&"string"===typeof a&&(n=a)}var o=t(E,r,n,0,0);return 0<R&&(void 0!==(a=s(-2,o,r,r,P,F,o.length,0,0,0))&&(o=a)),"",A=0,F=P=1,o}var c=/^\0+/g,d=/[\0\r\f]/g,f=/: */g,p=/zoo|gra/,m=/([,: ])(transform)/g,h=/,\r+?/g,v=/([\t\r\n ])*\f?&/g,b=/@(k\w+)\s*(\S*)\s*/,y=/::(place)/g,g=/:(read-only)/g,_=/[svh]\w+-[tblr]{2}/,w=/\(\s*(.*)\s*\)/g,S=/([\s\S]*?);/g,k=/-self|flex-/g,C=/[^]*?(:[rp][el]a[\w-]+)[^]*/,T=/stretch|:\s*\w+\-(?:conte|avail)/,x=/([^-])(image-set\()/,F=1,P=1,A=0,N=1,E=[],M=[],R=0,O=null,D=0;return u.use=function e(t){switch(t){case void 0:case null:R=M.length=0;break;default:if("function"===typeof t)M[R++]=t;else if("object"===typeof t)for(var n=0,r=t.length;n<r;++n)e(t[n]);else D=0|!!t}return e},u.set=l,void 0!==e&&l(e),u},o="/*|*/";function i(e){e&&s.current.insert(e+"}")}var s={current:null},l=function(e,t,n,r,a,l,u,c,d,f){switch(e){case 1:switch(t.charCodeAt(0)){case 64:return s.current.insert(t+";"),"";case 108:if(98===t.charCodeAt(2))return""}break;case 2:if(0===c)return t+o;break;case 3:switch(c){case 102:case 112:return s.current.insert(n[0]+t),"";default:return t+(0===f?o:"")}case-2:t.split("/*|*/}").forEach(i)}},u=function(e){void 0===e&&(e={});var t,n=e.key||"css";void 0!==e.prefix&&(t={prefix:e.prefix});var o=new a(t);var i,u={};i=e.container||document.head;var c,d=document.querySelectorAll("style[data-emotion-"+n+"]");Array.prototype.forEach.call(d,(function(e){e.getAttribute("data-emotion-"+n).split(" ").forEach((function(e){u[e]=!0})),e.parentNode!==i&&i.appendChild(e)})),o.use(e.stylisPlugins)(l),c=function(e,t,n,r){var a=t.name;s.current=n,o(e,t.styles),r&&(f.inserted[a]=!0)};var f={key:n,sheet:new r({key:n,container:i,nonce:e.nonce,speedy:e.speedy}),nonce:e.nonce,inserted:u,registered:{},insert:c};return f};var c=function(e){for(var t,n=0,r=0,a=e.length;a>=4;++r,a-=4)t=1540483477*(65535&(t=255&e.charCodeAt(r)|(255&e.charCodeAt(++r))<<8|(255&e.charCodeAt(++r))<<16|(255&e.charCodeAt(++r))<<24))+(59797*(t>>>16)<<16),n=1540483477*(65535&(t^=t>>>24))+(59797*(t>>>16)<<16)^1540483477*(65535&n)+(59797*(n>>>16)<<16);switch(a){case 3:n^=(255&e.charCodeAt(r+2))<<16;case 2:n^=(255&e.charCodeAt(r+1))<<8;case 1:n=1540483477*(65535&(n^=255&e.charCodeAt(r)))+(59797*(n>>>16)<<16)}return(((n=1540483477*(65535&(n^=n>>>13))+(59797*(n>>>16)<<16))^n>>>15)>>>0).toString(36)},d={animationIterationCount:1,borderImageOutset:1,borderImageSlice:1,borderImageWidth:1,boxFlex:1,boxFlexGroup:1,boxOrdinalGroup:1,columnCount:1,columns:1,flex:1,flexGrow:1,flexPositive:1,flexShrink:1,flexNegative:1,flexOrder:1,gridRow:1,gridRowEnd:1,gridRowSpan:1,gridRowStart:1,gridColumn:1,gridColumnEnd:1,gridColumnSpan:1,gridColumnStart:1,msGridRow:1,msGridRowSpan:1,msGridColumn:1,msGridColumnSpan:1,fontWeight:1,lineHeight:1,opacity:1,order:1,orphans:1,tabSize:1,widows:1,zIndex:1,zoom:1,WebkitLineClamp:1,fillOpacity:1,floodOpacity:1,stopOpacity:1,strokeDasharray:1,strokeDashoffset:1,strokeMiterlimit:1,strokeOpacity:1,strokeWidth:1};var f=function(e){var t={};return function(n){return void 0===t[n]&&(t[n]=e(n)),t[n]}},p=/[A-Z]|^ms/g,m=/_EMO_([^_]+?)_([^]*?)_EMO_/g,h=function(e){return 45===e.charCodeAt(1)},v=function(e){return null!=e&&"boolean"!==typeof e},b=f((function(e){return h(e)?e:e.replace(p,"-$&").toLowerCase()})),y=function(e,t){switch(e){case"animation":case"animationName":if("string"===typeof t)return t.replace(m,(function(e,t,n){return _={name:t,styles:n,next:_},t}))}return 1===d[e]||h(e)||"number"!==typeof t||0===t?t:t+"px"};function g(e,t,n,r){if(null==n)return"";if(void 0!==n.__emotion_styles)return n;switch(typeof n){case"boolean":return"";case"object":if(1===n.anim)return _={name:n.name,styles:n.styles,next:_},n.name;if(void 0!==n.styles){var a=n.next;if(void 0!==a)for(;void 0!==a;)_={name:a.name,styles:a.styles,next:_},a=a.next;return n.styles+";"}return function(e,t,n){var r="";if(Array.isArray(n))for(var a=0;a<n.length;a++)r+=g(e,t,n[a],!1);else for(var o in n){var i=n[o];if("object"!==typeof i)null!=t&&void 0!==t[i]?r+=o+"{"+t[i]+"}":v(i)&&(r+=b(o)+":"+y(o,i)+";");else if(!Array.isArray(i)||"string"!==typeof i[0]||null!=t&&void 0!==t[i[0]]){var s=g(e,t,i,!1);switch(o){case"animation":case"animationName":r+=b(o)+":"+s+";";break;default:r+=o+"{"+s+"}"}}else for(var l=0;l<i.length;l++)v(i[l])&&(r+=b(o)+":"+y(o,i[l])+";")}return r}(e,t,n);case"function":if(void 0!==e){var o=_,i=n(e);return _=o,g(e,t,i,r)}}if(null==t)return n;var s=t[n];return void 0===s||r?n:s}var _,w=/label:\s*([^\s;\n{]+)\s*;/g;var S=function(e,t,n){if(1===e.length&&"object"===typeof e[0]&&null!==e[0]&&void 0!==e[0].styles)return e[0];var r=!0,a="";_=void 0;var o=e[0];null==o||void 0===o.raw?(r=!1,a+=g(n,t,o,!1)):a+=o[0];for(var i=1;i<e.length;i++)a+=g(n,t,e[i],46===a.charCodeAt(a.length-1)),r&&(a+=o[i]);w.lastIndex=0;for(var s,l="";null!==(s=w.exec(a));)l+="-"+s[1];return{name:c(a)+l,styles:a,next:_}};function k(e,t,n){var r="";return n.split(" ").forEach((function(n){void 0!==e[n]?t.push(e[n]):r+=n+" "})),r}var C=function(e,t,n){var r=e.key+"-"+t.name;if(!1===n&&void 0===e.registered[r]&&(e.registered[r]=t.styles),void 0===e.inserted[t.name]){var a=t;do{e.insert("."+r,a,e.sheet,!0);a=a.next}while(void 0!==a)}};function T(e,t){if(void 0===e.inserted[t.name])return e.insert("",t,e.sheet,!0)}function x(e,t,n){var r=[],a=k(e,r,n);return r.length<2?n:a+t(r)}var F=function e(t){for(var n="",r=0;r<t.length;r++){var a=t[r];if(null!=a){var o=void 0;switch(typeof a){case"boolean":break;case"object":if(Array.isArray(a))o=e(a);else for(var i in o="",a)a[i]&&i&&(o&&(o+=" "),o+=i);break;default:o=a}o&&(n&&(n+=" "),n+=o)}}return n},P=function(e){var t=u(e);t.sheet.speedy=function(e){this.isSpeedy=e},t.compat=!0;var n=function(){for(var e=arguments.length,n=new Array(e),r=0;r<e;r++)n[r]=arguments[r];var a=S(n,t.registered,void 0);return C(t,a,!1),t.key+"-"+a.name};return{css:n,cx:function(){for(var e=arguments.length,r=new Array(e),a=0;a<e;a++)r[a]=arguments[a];return x(t.registered,n,F(r))},injectGlobal:function(){for(var e=arguments.length,n=new Array(e),r=0;r<e;r++)n[r]=arguments[r];var a=S(n,t.registered);T(t,a)},keyframes:function(){for(var e=arguments.length,n=new Array(e),r=0;r<e;r++)n[r]=arguments[r];var a=S(n,t.registered),o="animation-"+a.name;return T(t,{name:a.name,styles:"@keyframes "+o+"{"+a.styles+"}"}),o},hydrate:function(e){e.forEach((function(e){t.inserted[e]=!0}))},flush:function(){t.registered={},t.inserted={},t.sheet.flush()},sheet:t.sheet,cache:t,getRegisteredStyles:k.bind(null,t.registered),merge:x.bind(null,t.registered,n)}},A=P(),N=A.flush,E=A.hydrate,M=A.cx,R=A.merge,O=A.getRegisteredStyles,D=A.injectGlobal,z=A.keyframes,I=A.css,L=A.sheet,Z=A.cache},2110:function(e,t,n){"use strict";var r=n(8309),a={childContextTypes:!0,contextType:!0,contextTypes:!0,defaultProps:!0,displayName:!0,getDefaultProps:!0,getDerivedStateFromError:!0,getDerivedStateFromProps:!0,mixins:!0,propTypes:!0,type:!0},o={name:!0,length:!0,prototype:!0,caller:!0,callee:!0,arguments:!0,arity:!0},i={$$typeof:!0,compare:!0,defaultProps:!0,displayName:!0,propTypes:!0,type:!0},s={};function l(e){return r.isMemo(e)?i:s[e.$$typeof]||a}s[r.ForwardRef]={$$typeof:!0,render:!0,defaultProps:!0,displayName:!0,propTypes:!0},s[r.Memo]=i;var u=Object.defineProperty,c=Object.getOwnPropertyNames,d=Object.getOwnPropertySymbols,f=Object.getOwnPropertyDescriptor,p=Object.getPrototypeOf,m=Object.prototype;e.exports=function e(t,n,r){if("string"!==typeof n){if(m){var a=p(n);a&&a!==m&&e(t,a,r)}var i=c(n);d&&(i=i.concat(d(n)));for(var s=l(t),h=l(n),v=0;v<i.length;++v){var b=i[v];if(!o[b]&&(!r||!r[b])&&(!h||!h[b])&&(!s||!s[b])){var y=f(n,b);try{u(t,b,y)}catch(g){}}}}return t}},746:function(e,t){"use strict";var n="function"===typeof Symbol&&Symbol.for,r=n?Symbol.for("react.element"):60103,a=n?Symbol.for("react.portal"):60106,o=n?Symbol.for("react.fragment"):60107,i=n?Symbol.for("react.strict_mode"):60108,s=n?Symbol.for("react.profiler"):60114,l=n?Symbol.for("react.provider"):60109,u=n?Symbol.for("react.context"):60110,c=n?Symbol.for("react.async_mode"):60111,d=n?Symbol.for("react.concurrent_mode"):60111,f=n?Symbol.for("react.forward_ref"):60112,p=n?Symbol.for("react.suspense"):60113,m=n?Symbol.for("react.suspense_list"):60120,h=n?Symbol.for("react.memo"):60115,v=n?Symbol.for("react.lazy"):60116,b=n?Symbol.for("react.block"):60121,y=n?Symbol.for("react.fundamental"):60117,g=n?Symbol.for("react.responder"):60118,_=n?Symbol.for("react.scope"):60119;function w(e){if("object"===typeof e&&null!==e){var t=e.$$typeof;switch(t){case r:switch(e=e.type){case c:case d:case o:case s:case i:case p:return e;default:switch(e=e&&e.$$typeof){case u:case f:case v:case h:case l:return e;default:return t}}case a:return t}}}function S(e){return w(e)===d}t.AsyncMode=c,t.ConcurrentMode=d,t.ContextConsumer=u,t.ContextProvider=l,t.Element=r,t.ForwardRef=f,t.Fragment=o,t.Lazy=v,t.Memo=h,t.Portal=a,t.Profiler=s,t.StrictMode=i,t.Suspense=p,t.isAsyncMode=function(e){return S(e)||w(e)===c},t.isConcurrentMode=S,t.isContextConsumer=function(e){return w(e)===u},t.isContextProvider=function(e){return w(e)===l},t.isElement=function(e){return"object"===typeof e&&null!==e&&e.$$typeof===r},t.isForwardRef=function(e){return w(e)===f},t.isFragment=function(e){return w(e)===o},t.isLazy=function(e){return w(e)===v},t.isMemo=function(e){return w(e)===h},t.isPortal=function(e){return w(e)===a},t.isProfiler=function(e){return w(e)===s},t.isStrictMode=function(e){return w(e)===i},t.isSuspense=function(e){return w(e)===p},t.isValidElementType=function(e){return"string"===typeof e||"function"===typeof e||e===o||e===d||e===s||e===i||e===p||e===m||"object"===typeof e&&null!==e&&(e.$$typeof===v||e.$$typeof===h||e.$$typeof===l||e.$$typeof===u||e.$$typeof===f||e.$$typeof===y||e.$$typeof===g||e.$$typeof===_||e.$$typeof===b)},t.typeOf=w},8309:function(e,t,n){"use strict";e.exports=n(746)},5781:function(e,t,n){"use strict";n.r(t);var r=Number.isNaN||function(e){return"number"===typeof e&&e!==e};function a(e,t){if(e.length!==t.length)return!1;for(var n=0;n<e.length;n++)if(a=e[n],o=t[n],!(a===o||r(a)&&r(o)))return!1;var a,o;return!0}t.default=function(e,t){var n;void 0===t&&(t=a);var r,o=[],i=!1;return function(){for(var a=[],s=0;s<arguments.length;s++)a[s]=arguments[s];return i&&n===this&&t(a,o)||(r=e.apply(this,a),i=!0,n=this,o=a),r}}},888:function(e,t,n){"use strict";var r=n(9047);function a(){}function o(){}o.resetWarningCache=a,e.exports=function(){function e(e,t,n,a,o,i){if(i!==r){var s=new Error("Calling PropTypes validators directly is not supported by the `prop-types` package. Use PropTypes.checkPropTypes() to call them. Read more at http://fb.me/use-check-prop-types");throw s.name="Invariant Violation",s}}function t(){return e}e.isRequired=e;var n={array:e,bigint:e,bool:e,func:e,number:e,object:e,string:e,symbol:e,any:e,arrayOf:t,element:e,elementType:e,instanceOf:t,node:e,objectOf:t,oneOf:t,oneOfType:t,shape:t,exact:t,checkPropTypes:o,resetWarningCache:a};return n.PropTypes=n,n}},2007:function(e,t,n){e.exports=n(888)()},9047:function(e){"use strict";e.exports="SECRET_DO_NOT_PASS_THIS_OR_YOU_WILL_BE_FIRED"},8472:function(e,t,n){n(3561)},8015:function(e,t,n){"use strict";Object.defineProperty(t,"__esModule",{value:!0});var r,a=function(){function e(e,t){for(var n=0;n<t.length;n++){var r=t[n];r.enumerable=r.enumerable||!1,r.configurable=!0,"value"in r&&(r.writable=!0),Object.defineProperty(e,r.key,r)}}return function(t,n,r){return n&&e(t.prototype,n),r&&e(t,r),t}}(),o=n(2791),i=(r=o)&&r.__esModule?r:{default:r},s=n(1509),l=n(8333);var u=function(e){function t(e){!function(e,t){if(!(e instanceof t))throw new TypeError("Cannot call a class as a function")}(this,t);var n=function(e,t){if(!e)throw new ReferenceError("this hasn't been initialised - super() hasn't been called");return!t||"object"!==typeof t&&"function"!==typeof t?e:t}(this,(t.__proto__||Object.getPrototypeOf(t)).call(this,e));return n.state={},n}return function(e,t){if("function"!==typeof t&&null!==t)throw new TypeError("Super expression must either be null or a function, not "+typeof t);e.prototype=Object.create(t&&t.prototype,{constructor:{value:e,enumerable:!1,writable:!0,configurable:!0}}),t&&(Object.setPrototypeOf?Object.setPrototypeOf(e,t):e.__proto__=t)}(t,e),a(t,[{key:"buildURI",value:function(){return s.buildURI.apply(void 0,arguments)}},{key:"componentDidMount",value:function(){var e=this.props,t=e.data,n=e.headers,r=e.separator,a=e.enclosingCharacter,o=e.uFEFF,i=e.target,s=e.specs,l=e.replace;this.state.page=window.open(this.buildURI(t,o,n,r,a),i,s,l)}},{key:"getWindow",value:function(){return this.state.page}},{key:"render",value:function(){return null}}]),t}(i.default.Component);u.defaultProps=Object.assign(l.defaultProps,{target:"_blank"}),u.propTypes=l.propTypes,t.default=u},9088:function(e,t,n){"use strict";Object.defineProperty(t,"__esModule",{value:!0});var r,a=Object.assign||function(e){for(var t=1;t<arguments.length;t++){var n=arguments[t];for(var r in n)Object.prototype.hasOwnProperty.call(n,r)&&(e[r]=n[r])}return e},o=function(){function e(e,t){for(var n=0;n<t.length;n++){var r=t[n];r.enumerable=r.enumerable||!1,r.configurable=!0,"value"in r&&(r.writable=!0),Object.defineProperty(e,r.key,r)}}return function(t,n,r){return n&&e(t.prototype,n),r&&e(t,r),t}}(),i=n(2791),s=(r=i)&&r.__esModule?r:{default:r},l=n(1509),u=n(8333);var c=function(e){function t(e){!function(e,t){if(!(e instanceof t))throw new TypeError("Cannot call a class as a function")}(this,t);var n=function(e,t){if(!e)throw new ReferenceError("this hasn't been initialised - super() hasn't been called");return!t||"object"!==typeof t&&"function"!==typeof t?e:t}(this,(t.__proto__||Object.getPrototypeOf(t)).call(this,e));return n.buildURI=n.buildURI.bind(n),n}return function(e,t){if("function"!==typeof t&&null!==t)throw new TypeError("Super expression must either be null or a function, not "+typeof t);e.prototype=Object.create(t&&t.prototype,{constructor:{value:e,enumerable:!1,writable:!0,configurable:!0}}),t&&(Object.setPrototypeOf?Object.setPrototypeOf(e,t):e.__proto__=t)}(t,e),o(t,[{key:"buildURI",value:function(){return l.buildURI.apply(void 0,arguments)}},{key:"handleLegacy",value:function(e){var t=arguments.length>1&&void 0!==arguments[1]&&arguments[1];if(window.navigator.msSaveOrOpenBlob){e.preventDefault();var n=this.props,r=n.data,a=n.headers,o=n.separator,i=n.filename,s=n.enclosingCharacter,u=n.uFEFF,c=t&&"function"===typeof r?r():r,d=new Blob([u?"\ufeff":"",(0,l.toCSV)(c,a,o,s)]);return window.navigator.msSaveBlob(d,i),!1}}},{key:"handleAsyncClick",value:function(e){var t=this;this.props.onClick(e,(function(n){!1!==n?t.handleLegacy(e,!0):e.preventDefault()}))}},{key:"handleSyncClick",value:function(e){!1===this.props.onClick(e)?e.preventDefault():this.handleLegacy(e)}},{key:"handleClick",value:function(){var e=this;return function(t){if("function"===typeof e.props.onClick)return e.props.asyncOnClick?e.handleAsyncClick(t):e.handleSyncClick(t);e.handleLegacy(t)}}},{key:"render",value:function(){var e=this,t=this.props,n=t.data,r=t.headers,o=t.separator,i=t.filename,l=t.uFEFF,u=t.children,c=(t.onClick,t.asyncOnClick,t.enclosingCharacter),d=function(e,t){var n={};for(var r in e)t.indexOf(r)>=0||Object.prototype.hasOwnProperty.call(e,r)&&(n[r]=e[r]);return n}(t,["data","headers","separator","filename","uFEFF","children","onClick","asyncOnClick","enclosingCharacter"]),f="undefined"===typeof window?"":this.buildURI(n,l,r,o,c);return s.default.createElement("a",a({download:i},d,{ref:function(t){return e.link=t},target:"_self",href:f,onClick:this.handleClick()}),u)}}]),t}(s.default.Component);c.defaultProps=u.defaultProps,c.propTypes=u.propTypes,t.default=c},1509:function(e,t){"use strict";Object.defineProperty(t,"__esModule",{value:!0});var n="function"===typeof Symbol&&"symbol"===typeof Symbol.iterator?function(e){return typeof e}:function(e){return e&&"function"===typeof Symbol&&e.constructor===Symbol&&e!==Symbol.prototype?"symbol":typeof e};function r(e){if(Array.isArray(e)){for(var t=0,n=Array(e.length);t<e.length;t++)n[t]=e[t];return n}return Array.from(e)}var a=t.isSafari=function(){return/^((?!chrome|android).)*safari/i.test(navigator.userAgent)},o=t.isJsons=function(e){return Array.isArray(e)&&e.every((function(e){return"object"===("undefined"===typeof e?"undefined":n(e))&&!(e instanceof Array)}))},i=t.isArrays=function(e){return Array.isArray(e)&&e.every((function(e){return Array.isArray(e)}))},s=t.jsonsHeaders=function(e){return Array.from(e.map((function(e){return Object.keys(e)})).reduce((function(e,t){return new Set([].concat(r(e),r(t)))}),[]))},l=t.jsons2arrays=function(e,t){var n=t=t||s(e),a=t;o(t)&&(n=t.map((function(e){return e.label})),a=t.map((function(e){return e.key})));var i=e.map((function(e){return a.map((function(t){return u(t,e)}))}));return[n].concat(r(i))},u=t.getHeaderValue=function(e,t){var n=e.replace(/\[([^\]]+)]/g,".$1").split(".").reduce((function(e,t,n,r){var a=e[t];if(void 0!==a&&null!==a)return a;r.splice(1)}),t);return void 0===n?e in t?t[e]:"":n},c=t.elementOrEmpty=function(e){return"undefined"===typeof e||null===e?"":e},d=t.joiner=function(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:",",n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:'"';return e.filter((function(e){return e})).map((function(e){return e.map((function(e){return c(e)})).map((function(e){return""+n+e+n})).join(t)})).join("\n")},f=t.arrays2csv=function(e,t,n,a){return d(t?[t].concat(r(e)):e,n,a)},p=t.jsons2csv=function(e,t,n,r){return d(l(e,t),n,r)},m=t.string2csv=function(e,t,n,r){return t?t.join(n)+"\n"+e:e.replace(/"/g,'""')},h=t.toCSV=function(e,t,n,r){if(o(e))return p(e,t,n,r);if(i(e))return f(e,t,n,r);if("string"===typeof e)return m(e,t,n);throw new TypeError('Data should be a "String", "Array of arrays" OR "Array of objects" ')};t.buildURI=function(e,t,n,r,o){var i=h(e,n,r,o),s=a()?"application/csv":"text/csv",l=new Blob([t?"\ufeff":"",i],{type:s}),u="data:"+s+";charset=utf-8,"+(t?"\ufeff":"")+i,c=window.URL||window.webkitURL;return"undefined"===typeof c.createObjectURL?u:c.createObjectURL(l)}},3561:function(e,t,n){"use strict";var r=o(n(8015)),a=o(n(9088));function o(e){return e&&e.__esModule?e:{default:e}}r.default,a.default},8333:function(e,t,n){"use strict";Object.defineProperty(t,"__esModule",{value:!0}),t.PropsNotForwarded=t.defaultProps=t.propTypes=void 0;var r,a=n(2791),o=((r=a)&&r.__esModule,n(2007));t.propTypes={data:(0,o.oneOfType)([o.string,o.array,o.func]).isRequired,headers:o.array,target:o.string,separator:o.string,filename:o.string,uFEFF:o.bool,onClick:o.func,asyncOnClick:o.bool,enclosingCharacter:o.string},t.defaultProps={separator:",",filename:"generatedBy_react-csv.csv",uFEFF:!0,asyncOnClick:!1,enclosingCharacter:'"'},t.PropsNotForwarded=["data","headers"]},7786:function(e,t,n){"use strict";var r=this&&this.__read||function(e,t){var n="function"===typeof Symbol&&e[Symbol.iterator];if(!n)return e;var r,a,o=n.call(e),i=[];try{for(;(void 0===t||t-- >0)&&!(r=o.next()).done;)i.push(r.value)}catch(s){a={error:s}}finally{try{r&&!r.done&&(n=o.return)&&n.call(o)}finally{if(a)throw a.error}}return i},a=this&&this.__spread||function(){for(var e=[],t=0;t<arguments.length;t++)e=e.concat(r(arguments[t]));return e};Object.defineProperty(t,"__esModule",{value:!0});var o,i,s=n(4173),l=s;!function(e){e[e.DEFAULT=0]="DEFAULT",e[e.ADDED=1]="ADDED",e[e.REMOVED=2]="REMOVED"}(o=t.DiffType||(t.DiffType={})),function(e){e.CHARS="diffChars",e.WORDS="diffWords",e.WORDS_WITH_SPACE="diffWordsWithSpace",e.LINES="diffLines",e.TRIMMED_LINES="diffTrimmedLines",e.SENTENCES="diffSentences",e.CSS="diffCss"}(i=t.DiffMethod||(t.DiffMethod={}));var u=function(e){var t=e.split("\n");if(t.every((function(e){return!e})))return 2===t.length?[]:(t.pop(),t);var n=t[t.length-1],r=t[0];return n||t.pop(),r||t.shift(),t};t.computeLineInformation=function(e,t,n,r,c){void 0===n&&(n=!1),void 0===r&&(r=i.CHARS),void 0===c&&(c=0);var d=s.diffLines(e.trimRight(),t.trimRight(),{newlineIsToken:!0,ignoreWhitespace:!1,ignoreCase:!1}),f=c,p=c,m=[],h=0,v=[],b=[],y=function e(t,a,s,c,m){return u(t).map((function(t,y){var g={},_={};if(!(b.includes(a+"-"+y)||m&&0!==y)){if(s||c)if(v.includes(h)||v.push(h),c){p+=1,g.lineNumber=p,g.type=o.REMOVED,g.value=t||" ";var w=d[a+1];if(w&&w.added)if(u(w.value)[y]){var S=e(w.value,a,!0,!1,!0)[0].right,k=S.value,C=S.lineNumber,T=S.type;if(b.push(a+1+"-"+y),_.lineNumber=C,_.type=T,n)_.value=k;else{var x=function(e,t,n){void 0===n&&(n=i.CHARS);var r=l[n](e,t),a={left:[],right:[]};return r.forEach((function(e){var t=e.added,n=e.removed,r=e.value,i={};return t&&(i.type=o.ADDED,i.value=r,a.right.push(i)),n&&(i.type=o.REMOVED,i.value=r,a.left.push(i)),n||t||(i.type=o.DEFAULT,i.value=r,a.right.push(i),a.left.push(i)),i})),a}(t,k,r);_.value=x.right,g.value=x.left}}}else f+=1,_.lineNumber=f,_.type=o.ADDED,_.value=t;else p+=1,f+=1,g.lineNumber=p,g.type=o.DEFAULT,g.value=t,_.lineNumber=f,_.type=o.DEFAULT,_.value=t;return h+=1,{right:_,left:g}}})).filter(Boolean)};return d.forEach((function(e,t){var n=e.added,r=e.removed,o=e.value;m=a(m,y(o,t,n,r))})),{lineInformation:m,diffLines:v}}},1774:function(e,t,n){"use strict";var r=this&&this.__extends||function(){var e=function(t,n){return e=Object.setPrototypeOf||{__proto__:[]}instanceof Array&&function(e,t){e.__proto__=t}||function(e,t){for(var n in t)t.hasOwnProperty(n)&&(e[n]=t[n])},e(t,n)};return function(t,n){function r(){this.constructor=t}e(t,n),t.prototype=null===n?Object.create(n):(r.prototype=n.prototype,new r)}}();Object.defineProperty(t,"__esModule",{value:!0});var a=n(2791),o=n(2007),i=n(1694),s=n(7786);t.DiffMethod=s.DiffMethod;var l,u=n(2813),c=n(5781),d=c.default||c;!function(e){e.LEFT="L",e.RIGHT="R"}(l=t.LineNumberPrefix||(t.LineNumberPrefix={}));var f=function(e){function t(t){var n=e.call(this,t)||this;return n.resetCodeBlocks=function(){return n.state.expandedBlocks.length>0&&(n.setState({expandedBlocks:[]}),!0)},n.onBlockExpand=function(e){var t=n.state.expandedBlocks.slice();t.push(e),n.setState({expandedBlocks:t})},n.computeStyles=d(u.default),n.onLineNumberClickProxy=function(e){return n.props.onLineNumberClick?function(t){return n.props.onLineNumberClick(e,t)}:function(){}},n.renderWordDiff=function(e,t){return e.map((function(e,r){var o;return a.createElement("span",{key:r,className:i.default(n.styles.wordDiff,(o={},o[n.styles.wordAdded]=e.type===s.DiffType.ADDED,o[n.styles.wordRemoved]=e.type===s.DiffType.REMOVED,o))},t?t(e.value):e.value)}))},n.renderLine=function(e,t,r,o,l,u){var c,d,f,p,m,h=r+"-"+e,v=u+"-"+l,b=n.props.highlightLines.includes(h)||n.props.highlightLines.includes(v),y=t===s.DiffType.ADDED,g=t===s.DiffType.REMOVED;return m=Array.isArray(o)?n.renderWordDiff(o,n.props.renderContent):n.props.renderContent?n.props.renderContent(o):o,a.createElement(a.Fragment,null,!n.props.hideLineNumbers&&a.createElement("td",{onClick:e&&n.onLineNumberClickProxy(h),className:i.default(n.styles.gutter,(c={},c[n.styles.emptyGutter]=!e,c[n.styles.diffAdded]=y,c[n.styles.diffRemoved]=g,c[n.styles.highlightedGutter]=b,c))},a.createElement("pre",{className:n.styles.lineNumber},e)),!n.props.splitView&&!n.props.hideLineNumbers&&a.createElement("td",{onClick:l&&n.onLineNumberClickProxy(v),className:i.default(n.styles.gutter,(d={},d[n.styles.emptyGutter]=!l,d[n.styles.diffAdded]=y,d[n.styles.diffRemoved]=g,d[n.styles.highlightedGutter]=b,d))},a.createElement("pre",{className:n.styles.lineNumber},l)),a.createElement("td",{className:i.default(n.styles.marker,(f={},f[n.styles.emptyLine]=!m,f[n.styles.diffAdded]=y,f[n.styles.diffRemoved]=g,f[n.styles.highlightedLine]=b,f))},a.createElement("pre",null,y&&"+",g&&"-")),a.createElement("td",{className:i.default(n.styles.content,(p={},p[n.styles.emptyLine]=!m,p[n.styles.diffAdded]=y,p[n.styles.diffRemoved]=g,p[n.styles.highlightedLine]=b,p))},a.createElement("pre",{className:n.styles.contentText},m)))},n.renderSplitView=function(e,t){var r=e.left,o=e.right;return a.createElement("tr",{key:t,className:n.styles.line},n.renderLine(r.lineNumber,r.type,l.LEFT,r.value),n.renderLine(o.lineNumber,o.type,l.RIGHT,o.value))},n.renderInlineView=function(e,t){var r,o=e.left,i=e.right;return o.type===s.DiffType.REMOVED&&i.type===s.DiffType.ADDED?a.createElement(a.Fragment,{key:t},a.createElement("tr",{className:n.styles.line},n.renderLine(o.lineNumber,o.type,l.LEFT,o.value,null)),a.createElement("tr",{className:n.styles.line},n.renderLine(null,i.type,l.RIGHT,i.value,i.lineNumber))):(o.type===s.DiffType.REMOVED&&(r=n.renderLine(o.lineNumber,o.type,l.LEFT,o.value,null)),o.type===s.DiffType.DEFAULT&&(r=n.renderLine(o.lineNumber,o.type,l.LEFT,o.value,i.lineNumber,l.RIGHT)),i.type===s.DiffType.ADDED&&(r=n.renderLine(null,i.type,l.RIGHT,i.value,i.lineNumber)),a.createElement("tr",{key:t,className:n.styles.line},r))},n.onBlockClickProxy=function(e){return function(){return n.onBlockExpand(e)}},n.renderSkippedLineIndicator=function(e,t,r,o){var s,l=n.props,u=l.hideLineNumbers,c=l.splitView,d=n.props.codeFoldMessageRenderer?n.props.codeFoldMessageRenderer(e,r,o):a.createElement("pre",{className:n.styles.codeFoldContent},"Expand ",e," lines ..."),f=a.createElement("td",null,a.createElement("a",{onClick:n.onBlockClickProxy(t),tabIndex:0},d)),p=!c&&!u;return a.createElement("tr",{key:r+"-"+o,className:n.styles.codeFold},!u&&a.createElement("td",{className:n.styles.codeFoldGutter}),a.createElement("td",{className:i.default((s={},s[n.styles.codeFoldGutter]=p,s))}),p?a.createElement(a.Fragment,null,a.createElement("td",null),f):a.createElement(a.Fragment,null,f,a.createElement("td",null)),a.createElement("td",null),a.createElement("td",null))},n.renderDiff=function(){var e=n.props,t=e.oldValue,r=e.newValue,o=e.splitView,i=e.disableWordDiff,l=e.compareMethod,u=e.linesOffset,c=s.computeLineInformation(t,r,i,l,u),d=c.lineInformation,f=c.diffLines,p=n.props.extraLinesSurroundingDiff<0?0:n.props.extraLinesSurroundingDiff,m=[];return d.map((function(e,t){var r=f[0],i=r-t;if(n.props.showDiffOnly&&(i===-p&&(m=[],f.shift()),e.left.type===s.DiffType.DEFAULT&&(i>p||"undefined"===typeof r)&&!n.state.expandedBlocks.includes(r)))return m.push(t+1),t===d.length-1&&m.length>1?n.renderSkippedLineIndicator(m.length,r,e.left.lineNumber,e.right.lineNumber):null;var l=o?n.renderSplitView(e,t):n.renderInlineView(e,t);if(i===p&&m.length>0){var u=m.length;return m=[],a.createElement(a.Fragment,{key:t},n.renderSkippedLineIndicator(u,r,e.left.lineNumber,e.right.lineNumber),l)}return l}))},n.render=function(){var e,t=n.props,r=t.oldValue,o=t.newValue,s=t.useDarkTheme,l=t.leftTitle,u=t.rightTitle,c=t.splitView,d=t.hideLineNumbers;if("string"!==typeof r||"string"!==typeof o)throw Error('"oldValue" and "newValue" should be strings');n.styles=n.computeStyles(n.props.styles,s);var f=n.renderDiff(),p=d?2:3,m=d?2:4,h=(l||u)&&a.createElement("tr",null,a.createElement("td",{colSpan:c?p:m,className:n.styles.titleBlock},a.createElement("pre",{className:n.styles.contentText},l)),c&&a.createElement("td",{colSpan:p,className:n.styles.titleBlock},a.createElement("pre",{className:n.styles.contentText},u)));return a.createElement("table",{className:i.default(n.styles.diffContainer,(e={},e[n.styles.splitView]=c,e))},a.createElement("tbody",null,h,f))},n.state={expandedBlocks:[]},n}return r(t,e),t.defaultProps={oldValue:"",newValue:"",splitView:!0,highlightLines:[],disableWordDiff:!1,compareMethod:s.DiffMethod.CHARS,styles:{},hideLineNumbers:!1,extraLinesSurroundingDiff:3,showDiffOnly:!0,useDarkTheme:!1,linesOffset:0},t.propTypes={oldValue:o.string.isRequired,newValue:o.string.isRequired,splitView:o.bool,disableWordDiff:o.bool,compareMethod:o.oneOf(Object.values(s.DiffMethod)),renderContent:o.func,onLineNumberClick:o.func,extraLinesSurroundingDiff:o.number,styles:o.object,hideLineNumbers:o.bool,showDiffOnly:o.bool,highlightLines:o.arrayOf(o.string),leftTitle:o.oneOfType([o.string,o.element]),rightTitle:o.oneOfType([o.string,o.element]),linesOffset:o.number},t}(a.Component);t.default=f},2813:function(e,t,n){"use strict";var r=this&&this.__assign||function(){return r=Object.assign||function(e){for(var t,n=1,r=arguments.length;n<r;n++)for(var a in t=arguments[n])Object.prototype.hasOwnProperty.call(t,a)&&(e[a]=t[a]);return e},r.apply(this,arguments)},a=this&&this.__rest||function(e,t){var n={};for(var r in e)Object.prototype.hasOwnProperty.call(e,r)&&t.indexOf(r)<0&&(n[r]=e[r]);if(null!=e&&"function"===typeof Object.getOwnPropertySymbols){var a=0;for(r=Object.getOwnPropertySymbols(e);a<r.length;a++)t.indexOf(r[a])<0&&Object.prototype.propertyIsEnumerable.call(e,r[a])&&(n[r[a]]=e[r[a]])}return n};Object.defineProperty(t,"__esModule",{value:!0});var o=n(6025);t.default=function(e,t){var n,i,s,l,u,c,d;void 0===t&&(t=!1);var f=e.variables,p=void 0===f?{}:f,m=a(e,["variables"]),h={light:r({diffViewerBackground:"#fff",diffViewerColor:"212529",addedBackground:"#e6ffed",addedColor:"#24292e",removedBackground:"#ffeef0",removedColor:"#24292e",wordAddedBackground:"#acf2bd",wordRemovedBackground:"#fdb8c0",addedGutterBackground:"#cdffd8",removedGutterBackground:"#ffdce0",gutterBackground:"#f7f7f7",gutterBackgroundDark:"#f3f1f1",highlightBackground:"#fffbdd",highlightGutterBackground:"#fff5b1",codeFoldGutterBackground:"#dbedff",codeFoldBackground:"#f1f8ff",emptyLineBackground:"#fafbfc",gutterColor:"#212529",addedGutterColor:"#212529",removedGutterColor:"#212529",codeFoldContentColor:"#212529",diffViewerTitleBackground:"#fafbfc",diffViewerTitleColor:"#212529",diffViewerTitleBorderColor:"#eee"},p.light||{}),dark:r({diffViewerBackground:"#2e303c",diffViewerColor:"#FFF",addedBackground:"#044B53",addedColor:"white",removedBackground:"#632F34",removedColor:"white",wordAddedBackground:"#055d67",wordRemovedBackground:"#7d383f",addedGutterBackground:"#034148",removedGutterBackground:"#632b30",gutterBackground:"#2c2f3a",gutterBackgroundDark:"#262933",highlightBackground:"#2a3967",highlightGutterBackground:"#2d4077",codeFoldGutterBackground:"#21232b",codeFoldBackground:"#262831",emptyLineBackground:"#363946",gutterColor:"#464c67",addedGutterColor:"#8c8c8c",removedGutterColor:"#8c8c8c",codeFoldContentColor:"#555a7b",diffViewerTitleBackground:"#2f323e",diffViewerTitleColor:"#555a7b",diffViewerTitleBorderColor:"#353846"},p.dark||{})},v=t?h.dark:h.light,b=o.css({width:"100%",label:"content"}),y=o.css(((n={})["."+b]={width:"50%"},n.label="split-view",n)),g=o.css({width:"100%",background:v.diffViewerBackground,pre:{margin:0,whiteSpace:"pre-wrap",lineHeight:"25px"},label:"diff-container",borderCollapse:"collapse"}),_=o.css({color:v.codeFoldContentColor,label:"code-fold-content"}),w=o.css({color:v.diffViewerColor,label:"content-text"}),S=o.css(((i={background:v.diffViewerTitleBackground,padding:10,borderBottom:"1px solid "+v.diffViewerTitleBorderColor,label:"title-block",":last-child":{borderLeft:"1px solid "+v.diffViewerTitleBorderColor}})["."+w]={color:v.diffViewerTitleColor},i)),k=o.css({color:v.gutterColor,label:"line-number"}),C=o.css(((s={background:v.removedBackground,color:v.removedColor,pre:{color:v.removedColor}})["."+k]={color:v.removedGutterColor},s.label="diff-removed",s)),T=o.css(((l={background:v.addedBackground,color:v.addedColor,pre:{color:v.addedColor}})["."+k]={color:v.addedGutterColor},l.label="diff-added",l)),x=o.css({padding:2,display:"inline-flex",borderRadius:1,label:"word-diff"}),F=o.css({background:v.wordAddedBackground,label:"word-added"}),P=o.css({background:v.wordRemovedBackground,label:"word-removed"}),A=o.css({backgroundColor:v.codeFoldGutterBackground,label:"code-fold-gutter"}),N=o.css({backgroundColor:v.codeFoldBackground,height:40,fontSize:14,fontWeight:700,label:"code-fold",a:{textDecoration:"underline !important",cursor:"pointer",pre:{display:"inline"}}}),E=o.css({backgroundColor:v.emptyLineBackground,label:"empty-line"}),M=o.css(((u={width:25,paddingLeft:10,paddingRight:10,userSelect:"none",label:"marker"})["&."+T]={pre:{color:v.addedColor}},u["&."+C]={pre:{color:v.removedColor}},u)),R=o.css(((c={background:v.highlightBackground,label:"highlighted-line"})["."+F+", ."+P]={backgroundColor:"initial"},c)),O=o.css({label:"highlighted-gutter"}),D=o.css(((d={userSelect:"none",minWidth:50,padding:"0 10px",label:"gutter",textAlign:"right",background:v.gutterBackground,"&:hover":{cursor:"pointer",background:v.gutterBackgroundDark,pre:{opacity:1}},pre:{opacity:.5}})["&."+T]={background:v.addedGutterBackground},d["&."+C]={background:v.removedGutterBackground},d["&."+O]={background:v.highlightGutterBackground,"&:hover":{background:v.highlightGutterBackground}},d)),z=o.css({"&:hover":{background:v.gutterBackground,cursor:"initial"},label:"empty-gutter"}),I={diffContainer:g,diffRemoved:C,diffAdded:T,splitView:y,marker:M,highlightedGutter:O,highlightedLine:R,gutter:D,line:o.css({verticalAlign:"baseline",label:"line"}),wordDiff:x,wordAdded:F,wordRemoved:P,codeFoldGutter:A,codeFold:N,emptyGutter:z,emptyLine:E,lineNumber:k,contentText:w,content:b,codeFoldContent:_,titleBlock:S},L=Object.keys(m).reduce((function(e,t){var n;return r({},e,((n={})[t]=o.css(m[t]),n))}),{});return Object.keys(I).reduce((function(e,t){var n;return r({},e,((n={})[t]=L[t]?o.cx(I[t],L[t]):I[t],n))}),{})}},4463:function(e,t,n){"use strict";var r=n(2791),a=n(5296);function o(e){for(var t="https://reactjs.org/docs/error-decoder.html?invariant="+e,n=1;n<arguments.length;n++)t+="&args[]="+encodeURIComponent(arguments[n]);return"Minified React error #"+e+"; visit "+t+" for the full message or use the non-minified dev environment for full errors and additional helpful warnings."}var i=new Set,s={};function l(e,t){u(e,t),u(e+"Capture",t)}function u(e,t){for(s[e]=t,e=0;e<t.length;e++)i.add(t[e])}var c=!("undefined"===typeof window||"undefined"===typeof window.document||"undefined"===typeof window.document.createElement),d=Object.prototype.hasOwnProperty,f=/^[:A-Z_a-z\u00C0-\u00D6\u00D8-\u00F6\u00F8-\u02FF\u0370-\u037D\u037F-\u1FFF\u200C-\u200D\u2070-\u218F\u2C00-\u2FEF\u3001-\uD7FF\uF900-\uFDCF\uFDF0-\uFFFD][:A-Z_a-z\u00C0-\u00D6\u00D8-\u00F6\u00F8-\u02FF\u0370-\u037D\u037F-\u1FFF\u200C-\u200D\u2070-\u218F\u2C00-\u2FEF\u3001-\uD7FF\uF900-\uFDCF\uFDF0-\uFFFD\-.0-9\u00B7\u0300-\u036F\u203F-\u2040]*$/,p={},m={};function h(e,t,n,r,a,o,i){this.acceptsBooleans=2===t||3===t||4===t,this.attributeName=r,this.attributeNamespace=a,this.mustUseProperty=n,this.propertyName=e,this.type=t,this.sanitizeURL=o,this.removeEmptyString=i}var v={};"children dangerouslySetInnerHTML defaultValue defaultChecked innerHTML suppressContentEditableWarning suppressHydrationWarning style".split(" ").forEach((function(e){v[e]=new h(e,0,!1,e,null,!1,!1)})),[["acceptCharset","accept-charset"],["className","class"],["htmlFor","for"],["httpEquiv","http-equiv"]].forEach((function(e){var t=e[0];v[t]=new h(t,1,!1,e[1],null,!1,!1)})),["contentEditable","draggable","spellCheck","value"].forEach((function(e){v[e]=new h(e,2,!1,e.toLowerCase(),null,!1,!1)})),["autoReverse","externalResourcesRequired","focusable","preserveAlpha"].forEach((function(e){v[e]=new h(e,2,!1,e,null,!1,!1)})),"allowFullScreen async autoFocus autoPlay controls default defer disabled disablePictureInPicture disableRemotePlayback formNoValidate hidden loop noModule noValidate open playsInline readOnly required reversed scoped seamless itemScope".split(" ").forEach((function(e){v[e]=new h(e,3,!1,e.toLowerCase(),null,!1,!1)})),["checked","multiple","muted","selected"].forEach((function(e){v[e]=new h(e,3,!0,e,null,!1,!1)})),["capture","download"].forEach((function(e){v[e]=new h(e,4,!1,e,null,!1,!1)})),["cols","rows","size","span"].forEach((function(e){v[e]=new h(e,6,!1,e,null,!1,!1)})),["rowSpan","start"].forEach((function(e){v[e]=new h(e,5,!1,e.toLowerCase(),null,!1,!1)}));var b=/[\-:]([a-z])/g;function y(e){return e[1].toUpperCase()}function g(e,t,n,r){var a=v.hasOwnProperty(t)?v[t]:null;(null!==a?0!==a.type:r||!(2<t.length)||"o"!==t[0]&&"O"!==t[0]||"n"!==t[1]&&"N"!==t[1])&&(function(e,t,n,r){if(null===t||"undefined"===typeof t||function(e,t,n,r){if(null!==n&&0===n.type)return!1;switch(typeof t){case"function":case"symbol":return!0;case"boolean":return!r&&(null!==n?!n.acceptsBooleans:"data-"!==(e=e.toLowerCase().slice(0,5))&&"aria-"!==e);default:return!1}}(e,t,n,r))return!0;if(r)return!1;if(null!==n)switch(n.type){case 3:return!t;case 4:return!1===t;case 5:return isNaN(t);case 6:return isNaN(t)||1>t}return!1}(t,n,a,r)&&(n=null),r||null===a?function(e){return!!d.call(m,e)||!d.call(p,e)&&(f.test(e)?m[e]=!0:(p[e]=!0,!1))}(t)&&(null===n?e.removeAttribute(t):e.setAttribute(t,""+n)):a.mustUseProperty?e[a.propertyName]=null===n?3!==a.type&&"":n:(t=a.attributeName,r=a.attributeNamespace,null===n?e.removeAttribute(t):(n=3===(a=a.type)||4===a&&!0===n?"":""+n,r?e.setAttributeNS(r,t,n):e.setAttribute(t,n))))}"accent-height alignment-baseline arabic-form baseline-shift cap-height clip-path clip-rule color-interpolation color-interpolation-filters color-profile color-rendering dominant-baseline enable-background fill-opacity fill-rule flood-color flood-opacity font-family font-size font-size-adjust font-stretch font-style font-variant font-weight glyph-name glyph-orientation-horizontal glyph-orientation-vertical horiz-adv-x horiz-origin-x image-rendering letter-spacing lighting-color marker-end marker-mid marker-start overline-position overline-thickness paint-order panose-1 pointer-events rendering-intent shape-rendering stop-color stop-opacity strikethrough-position strikethrough-thickness stroke-dasharray stroke-dashoffset stroke-linecap stroke-linejoin stroke-miterlimit stroke-opacity stroke-width text-anchor text-decoration text-rendering underline-position underline-thickness unicode-bidi unicode-range units-per-em v-alphabetic v-hanging v-ideographic v-mathematical vector-effect vert-adv-y vert-origin-x vert-origin-y word-spacing writing-mode xmlns:xlink x-height".split(" ").forEach((function(e){var t=e.replace(b,y);v[t]=new h(t,1,!1,e,null,!1,!1)})),"xlink:actuate xlink:arcrole xlink:role xlink:show xlink:title xlink:type".split(" ").forEach((function(e){var t=e.replace(b,y);v[t]=new h(t,1,!1,e,"http://www.w3.org/1999/xlink",!1,!1)})),["xml:base","xml:lang","xml:space"].forEach((function(e){var t=e.replace(b,y);v[t]=new h(t,1,!1,e,"http://www.w3.org/XML/1998/namespace",!1,!1)})),["tabIndex","crossOrigin"].forEach((function(e){v[e]=new h(e,1,!1,e.toLowerCase(),null,!1,!1)})),v.xlinkHref=new h("xlinkHref",1,!1,"xlink:href","http://www.w3.org/1999/xlink",!0,!1),["src","href","action","formAction"].forEach((function(e){v[e]=new h(e,1,!1,e.toLowerCase(),null,!0,!0)}));var _=r.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED,w=Symbol.for("react.element"),S=Symbol.for("react.portal"),k=Symbol.for("react.fragment"),C=Symbol.for("react.strict_mode"),T=Symbol.for("react.profiler"),x=Symbol.for("react.provider"),F=Symbol.for("react.context"),P=Symbol.for("react.forward_ref"),A=Symbol.for("react.suspense"),N=Symbol.for("react.suspense_list"),E=Symbol.for("react.memo"),M=Symbol.for("react.lazy");Symbol.for("react.scope"),Symbol.for("react.debug_trace_mode");var R=Symbol.for("react.offscreen");Symbol.for("react.legacy_hidden"),Symbol.for("react.cache"),Symbol.for("react.tracing_marker");var O=Symbol.iterator;function D(e){return null===e||"object"!==typeof e?null:"function"===typeof(e=O&&e[O]||e["@@iterator"])?e:null}var z,I=Object.assign;function L(e){if(void 0===z)try{throw Error()}catch(n){var t=n.stack.trim().match(/\n( *(at )?)/);z=t&&t[1]||""}return"\n"+z+e}var Z=!1;function j(e,t){if(!e||Z)return"";Z=!0;var n=Error.prepareStackTrace;Error.prepareStackTrace=void 0;try{if(t)if(t=function(){throw Error()},Object.defineProperty(t.prototype,"props",{set:function(){throw Error()}}),"object"===typeof Reflect&&Reflect.construct){try{Reflect.construct(t,[])}catch(u){var r=u}Reflect.construct(e,[],t)}else{try{t.call()}catch(u){r=u}e.call(t.prototype)}else{try{throw Error()}catch(u){r=u}e()}}catch(u){if(u&&r&&"string"===typeof u.stack){for(var a=u.stack.split("\n"),o=r.stack.split("\n"),i=a.length-1,s=o.length-1;1<=i&&0<=s&&a[i]!==o[s];)s--;for(;1<=i&&0<=s;i--,s--)if(a[i]!==o[s]){if(1!==i||1!==s)do{if(i--,0>--s||a[i]!==o[s]){var l="\n"+a[i].replace(" at new "," at ");return e.displayName&&l.includes("<anonymous>")&&(l=l.replace("<anonymous>",e.displayName)),l}}while(1<=i&&0<=s);break}}}finally{Z=!1,Error.prepareStackTrace=n}return(e=e?e.displayName||e.name:"")?L(e):""}function B(e){switch(e.tag){case 5:return L(e.type);case 16:return L("Lazy");case 13:return L("Suspense");case 19:return L("SuspenseList");case 0:case 2:case 15:return e=j(e.type,!1);case 11:return e=j(e.type.render,!1);case 1:return e=j(e.type,!0);default:return""}}function V(e){if(null==e)return null;if("function"===typeof e)return e.displayName||e.name||null;if("string"===typeof e)return e;switch(e){case k:return"Fragment";case S:return"Portal";case T:return"Profiler";case C:return"StrictMode";case A:return"Suspense";case N:return"SuspenseList"}if("object"===typeof e)switch(e.$$typeof){case F:return(e.displayName||"Context")+".Consumer";case x:return(e._context.displayName||"Context")+".Provider";case P:var t=e.render;return(e=e.displayName)||(e=""!==(e=t.displayName||t.name||"")?"ForwardRef("+e+")":"ForwardRef"),e;case E:return null!==(t=e.displayName||null)?t:V(e.type)||"Memo";case M:t=e._payload,e=e._init;try{return V(e(t))}catch(n){}}return null}function U(e){var t=e.type;switch(e.tag){case 24:return"Cache";case 9:return(t.displayName||"Context")+".Consumer";case 10:return(t._context.displayName||"Context")+".Provider";case 18:return"DehydratedFragment";case 11:return e=(e=t.render).displayName||e.name||"",t.displayName||(""!==e?"ForwardRef("+e+")":"ForwardRef");case 7:return"Fragment";case 5:return t;case 4:return"Portal";case 3:return"Root";case 6:return"Text";case 16:return V(t);case 8:return t===C?"StrictMode":"Mode";case 22:return"Offscreen";case 12:return"Profiler";case 21:return"Scope";case 13:return"Suspense";case 19:return"SuspenseList";case 25:return"TracingMarker";case 1:case 0:case 17:case 2:case 14:case 15:if("function"===typeof t)return t.displayName||t.name||null;if("string"===typeof t)return t}return null}function J(e){switch(typeof e){case"boolean":case"number":case"string":case"undefined":case"object":return e;default:return""}}function W(e){var t=e.type;return(e=e.nodeName)&&"input"===e.toLowerCase()&&("checkbox"===t||"radio"===t)}function H(e){e._valueTracker||(e._valueTracker=function(e){var t=W(e)?"checked":"value",n=Object.getOwnPropertyDescriptor(e.constructor.prototype,t),r=""+e[t];if(!e.hasOwnProperty(t)&&"undefined"!==typeof n&&"function"===typeof n.get&&"function"===typeof n.set){var a=n.get,o=n.set;return Object.defineProperty(e,t,{configurable:!0,get:function(){return a.call(this)},set:function(e){r=""+e,o.call(this,e)}}),Object.defineProperty(e,t,{enumerable:n.enumerable}),{getValue:function(){return r},setValue:function(e){r=""+e},stopTracking:function(){e._valueTracker=null,delete e[t]}}}}(e))}function $(e){if(!e)return!1;var t=e._valueTracker;if(!t)return!0;var n=t.getValue(),r="";return e&&(r=W(e)?e.checked?"true":"false":e.value),(e=r)!==n&&(t.setValue(e),!0)}function q(e){if("undefined"===typeof(e=e||("undefined"!==typeof document?document:void 0)))return null;try{return e.activeElement||e.body}catch(t){return e.body}}function G(e,t){var n=t.checked;return I({},t,{defaultChecked:void 0,defaultValue:void 0,value:void 0,checked:null!=n?n:e._wrapperState.initialChecked})}function K(e,t){var n=null==t.defaultValue?"":t.defaultValue,r=null!=t.checked?t.checked:t.defaultChecked;n=J(null!=t.value?t.value:n),e._wrapperState={initialChecked:r,initialValue:n,controlled:"checkbox"===t.type||"radio"===t.type?null!=t.checked:null!=t.value}}function Q(e,t){null!=(t=t.checked)&&g(e,"checked",t,!1)}function Y(e,t){Q(e,t);var n=J(t.value),r=t.type;if(null!=n)"number"===r?(0===n&&""===e.value||e.value!=n)&&(e.value=""+n):e.value!==""+n&&(e.value=""+n);else if("submit"===r||"reset"===r)return void e.removeAttribute("value");t.hasOwnProperty("value")?ee(e,t.type,n):t.hasOwnProperty("defaultValue")&&ee(e,t.type,J(t.defaultValue)),null==t.checked&&null!=t.defaultChecked&&(e.defaultChecked=!!t.defaultChecked)}function X(e,t,n){if(t.hasOwnProperty("value")||t.hasOwnProperty("defaultValue")){var r=t.type;if(!("submit"!==r&&"reset"!==r||void 0!==t.value&&null!==t.value))return;t=""+e._wrapperState.initialValue,n||t===e.value||(e.value=t),e.defaultValue=t}""!==(n=e.name)&&(e.name=""),e.defaultChecked=!!e._wrapperState.initialChecked,""!==n&&(e.name=n)}function ee(e,t,n){"number"===t&&q(e.ownerDocument)===e||(null==n?e.defaultValue=""+e._wrapperState.initialValue:e.defaultValue!==""+n&&(e.defaultValue=""+n))}var te=Array.isArray;function ne(e,t,n,r){if(e=e.options,t){t={};for(var a=0;a<n.length;a++)t["$"+n[a]]=!0;for(n=0;n<e.length;n++)a=t.hasOwnProperty("$"+e[n].value),e[n].selected!==a&&(e[n].selected=a),a&&r&&(e[n].defaultSelected=!0)}else{for(n=""+J(n),t=null,a=0;a<e.length;a++){if(e[a].value===n)return e[a].selected=!0,void(r&&(e[a].defaultSelected=!0));null!==t||e[a].disabled||(t=e[a])}null!==t&&(t.selected=!0)}}function re(e,t){if(null!=t.dangerouslySetInnerHTML)throw Error(o(91));return I({},t,{value:void 0,defaultValue:void 0,children:""+e._wrapperState.initialValue})}function ae(e,t){var n=t.value;if(null==n){if(n=t.children,t=t.defaultValue,null!=n){if(null!=t)throw Error(o(92));if(te(n)){if(1<n.length)throw Error(o(93));n=n[0]}t=n}null==t&&(t=""),n=t}e._wrapperState={initialValue:J(n)}}function oe(e,t){var n=J(t.value),r=J(t.defaultValue);null!=n&&((n=""+n)!==e.value&&(e.value=n),null==t.defaultValue&&e.defaultValue!==n&&(e.defaultValue=n)),null!=r&&(e.defaultValue=""+r)}function ie(e){var t=e.textContent;t===e._wrapperState.initialValue&&""!==t&&null!==t&&(e.value=t)}function se(e){switch(e){case"svg":return"http://www.w3.org/2000/svg";case"math":return"http://www.w3.org/1998/Math/MathML";default:return"http://www.w3.org/1999/xhtml"}}function le(e,t){return null==e||"http://www.w3.org/1999/xhtml"===e?se(t):"http://www.w3.org/2000/svg"===e&&"foreignObject"===t?"http://www.w3.org/1999/xhtml":e}var ue,ce,de=(ce=function(e,t){if("http://www.w3.org/2000/svg"!==e.namespaceURI||"innerHTML"in e)e.innerHTML=t;else{for((ue=ue||document.createElement("div")).innerHTML="<svg>"+t.valueOf().toString()+"</svg>",t=ue.firstChild;e.firstChild;)e.removeChild(e.firstChild);for(;t.firstChild;)e.appendChild(t.firstChild)}},"undefined"!==typeof MSApp&&MSApp.execUnsafeLocalFunction?function(e,t,n,r){MSApp.execUnsafeLocalFunction((function(){return ce(e,t)}))}:ce);function fe(e,t){if(t){var n=e.firstChild;if(n&&n===e.lastChild&&3===n.nodeType)return void(n.nodeValue=t)}e.textContent=t}var pe={animationIterationCount:!0,aspectRatio:!0,borderImageOutset:!0,borderImageSlice:!0,borderImageWidth:!0,boxFlex:!0,boxFlexGroup:!0,boxOrdinalGroup:!0,columnCount:!0,columns:!0,flex:!0,flexGrow:!0,flexPositive:!0,flexShrink:!0,flexNegative:!0,flexOrder:!0,gridArea:!0,gridRow:!0,gridRowEnd:!0,gridRowSpan:!0,gridRowStart:!0,gridColumn:!0,gridColumnEnd:!0,gridColumnSpan:!0,gridColumnStart:!0,fontWeight:!0,lineClamp:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,tabSize:!0,widows:!0,zIndex:!0,zoom:!0,fillOpacity:!0,floodOpacity:!0,stopOpacity:!0,strokeDasharray:!0,strokeDashoffset:!0,strokeMiterlimit:!0,strokeOpacity:!0,strokeWidth:!0},me=["Webkit","ms","Moz","O"];function he(e,t,n){return null==t||"boolean"===typeof t||""===t?"":n||"number"!==typeof t||0===t||pe.hasOwnProperty(e)&&pe[e]?(""+t).trim():t+"px"}function ve(e,t){for(var n in e=e.style,t)if(t.hasOwnProperty(n)){var r=0===n.indexOf("--"),a=he(n,t[n],r);"float"===n&&(n="cssFloat"),r?e.setProperty(n,a):e[n]=a}}Object.keys(pe).forEach((function(e){me.forEach((function(t){t=t+e.charAt(0).toUpperCase()+e.substring(1),pe[t]=pe[e]}))}));var be=I({menuitem:!0},{area:!0,base:!0,br:!0,col:!0,embed:!0,hr:!0,img:!0,input:!0,keygen:!0,link:!0,meta:!0,param:!0,source:!0,track:!0,wbr:!0});function ye(e,t){if(t){if(be[e]&&(null!=t.children||null!=t.dangerouslySetInnerHTML))throw Error(o(137,e));if(null!=t.dangerouslySetInnerHTML){if(null!=t.children)throw Error(o(60));if("object"!==typeof t.dangerouslySetInnerHTML||!("__html"in t.dangerouslySetInnerHTML))throw Error(o(61))}if(null!=t.style&&"object"!==typeof t.style)throw Error(o(62))}}function ge(e,t){if(-1===e.indexOf("-"))return"string"===typeof t.is;switch(e){case"annotation-xml":case"color-profile":case"font-face":case"font-face-src":case"font-face-uri":case"font-face-format":case"font-face-name":case"missing-glyph":return!1;default:return!0}}var _e=null;function we(e){return(e=e.target||e.srcElement||window).correspondingUseElement&&(e=e.correspondingUseElement),3===e.nodeType?e.parentNode:e}var Se=null,ke=null,Ce=null;function Te(e){if(e=ga(e)){if("function"!==typeof Se)throw Error(o(280));var t=e.stateNode;t&&(t=wa(t),Se(e.stateNode,e.type,t))}}function xe(e){ke?Ce?Ce.push(e):Ce=[e]:ke=e}function Fe(){if(ke){var e=ke,t=Ce;if(Ce=ke=null,Te(e),t)for(e=0;e<t.length;e++)Te(t[e])}}function Pe(e,t){return e(t)}function Ae(){}var Ne=!1;function Ee(e,t,n){if(Ne)return e(t,n);Ne=!0;try{return Pe(e,t,n)}finally{Ne=!1,(null!==ke||null!==Ce)&&(Ae(),Fe())}}function Me(e,t){var n=e.stateNode;if(null===n)return null;var r=wa(n);if(null===r)return null;n=r[t];e:switch(t){case"onClick":case"onClickCapture":case"onDoubleClick":case"onDoubleClickCapture":case"onMouseDown":case"onMouseDownCapture":case"onMouseMove":case"onMouseMoveCapture":case"onMouseUp":case"onMouseUpCapture":case"onMouseEnter":(r=!r.disabled)||(r=!("button"===(e=e.type)||"input"===e||"select"===e||"textarea"===e)),e=!r;break e;default:e=!1}if(e)return null;if(n&&"function"!==typeof n)throw Error(o(231,t,typeof n));return n}var Re=!1;if(c)try{var Oe={};Object.defineProperty(Oe,"passive",{get:function(){Re=!0}}),window.addEventListener("test",Oe,Oe),window.removeEventListener("test",Oe,Oe)}catch(ce){Re=!1}function De(e,t,n,r,a,o,i,s,l){var u=Array.prototype.slice.call(arguments,3);try{t.apply(n,u)}catch(c){this.onError(c)}}var ze=!1,Ie=null,Le=!1,Ze=null,je={onError:function(e){ze=!0,Ie=e}};function Be(e,t,n,r,a,o,i,s,l){ze=!1,Ie=null,De.apply(je,arguments)}function Ve(e){var t=e,n=e;if(e.alternate)for(;t.return;)t=t.return;else{e=t;do{0!==(4098&(t=e).flags)&&(n=t.return),e=t.return}while(e)}return 3===t.tag?n:null}function Ue(e){if(13===e.tag){var t=e.memoizedState;if(null===t&&(null!==(e=e.alternate)&&(t=e.memoizedState)),null!==t)return t.dehydrated}return null}function Je(e){if(Ve(e)!==e)throw Error(o(188))}function We(e){return null!==(e=function(e){var t=e.alternate;if(!t){if(null===(t=Ve(e)))throw Error(o(188));return t!==e?null:e}for(var n=e,r=t;;){var a=n.return;if(null===a)break;var i=a.alternate;if(null===i){if(null!==(r=a.return)){n=r;continue}break}if(a.child===i.child){for(i=a.child;i;){if(i===n)return Je(a),e;if(i===r)return Je(a),t;i=i.sibling}throw Error(o(188))}if(n.return!==r.return)n=a,r=i;else{for(var s=!1,l=a.child;l;){if(l===n){s=!0,n=a,r=i;break}if(l===r){s=!0,r=a,n=i;break}l=l.sibling}if(!s){for(l=i.child;l;){if(l===n){s=!0,n=i,r=a;break}if(l===r){s=!0,r=i,n=a;break}l=l.sibling}if(!s)throw Error(o(189))}}if(n.alternate!==r)throw Error(o(190))}if(3!==n.tag)throw Error(o(188));return n.stateNode.current===n?e:t}(e))?He(e):null}function He(e){if(5===e.tag||6===e.tag)return e;for(e=e.child;null!==e;){var t=He(e);if(null!==t)return t;e=e.sibling}return null}var $e=a.unstable_scheduleCallback,qe=a.unstable_cancelCallback,Ge=a.unstable_shouldYield,Ke=a.unstable_requestPaint,Qe=a.unstable_now,Ye=a.unstable_getCurrentPriorityLevel,Xe=a.unstable_ImmediatePriority,et=a.unstable_UserBlockingPriority,tt=a.unstable_NormalPriority,nt=a.unstable_LowPriority,rt=a.unstable_IdlePriority,at=null,ot=null;var it=Math.clz32?Math.clz32:function(e){return 0===(e>>>=0)?32:31-(st(e)/lt|0)|0},st=Math.log,lt=Math.LN2;var ut=64,ct=4194304;function dt(e){switch(e&-e){case 1:return 1;case 2:return 2;case 4:return 4;case 8:return 8;case 16:return 16;case 32:return 32;case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return 4194240&e;case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:return 130023424&e;case 134217728:return 134217728;case 268435456:return 268435456;case 536870912:return 536870912;case 1073741824:return 1073741824;default:return e}}function ft(e,t){var n=e.pendingLanes;if(0===n)return 0;var r=0,a=e.suspendedLanes,o=e.pingedLanes,i=268435455&n;if(0!==i){var s=i&~a;0!==s?r=dt(s):0!==(o&=i)&&(r=dt(o))}else 0!==(i=n&~a)?r=dt(i):0!==o&&(r=dt(o));if(0===r)return 0;if(0!==t&&t!==r&&0===(t&a)&&((a=r&-r)>=(o=t&-t)||16===a&&0!==(4194240&o)))return t;if(0!==(4&r)&&(r|=16&n),0!==(t=e.entangledLanes))for(e=e.entanglements,t&=r;0<t;)a=1<<(n=31-it(t)),r|=e[n],t&=~a;return r}function pt(e,t){switch(e){case 1:case 2:case 4:return t+250;case 8:case 16:case 32:case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return t+5e3;default:return-1}}function mt(e){return 0!==(e=-1073741825&e.pendingLanes)?e:1073741824&e?1073741824:0}function ht(){var e=ut;return 0===(4194240&(ut<<=1))&&(ut=64),e}function vt(e){for(var t=[],n=0;31>n;n++)t.push(e);return t}function bt(e,t,n){e.pendingLanes|=t,536870912!==t&&(e.suspendedLanes=0,e.pingedLanes=0),(e=e.eventTimes)[t=31-it(t)]=n}function yt(e,t){var n=e.entangledLanes|=t;for(e=e.entanglements;n;){var r=31-it(n),a=1<<r;a&t|e[r]&t&&(e[r]|=t),n&=~a}}var gt=0;function _t(e){return 1<(e&=-e)?4<e?0!==(268435455&e)?16:536870912:4:1}var wt,St,kt,Ct,Tt,xt=!1,Ft=[],Pt=null,At=null,Nt=null,Et=new Map,Mt=new Map,Rt=[],Ot="mousedown mouseup touchcancel touchend touchstart auxclick dblclick pointercancel pointerdown pointerup dragend dragstart drop compositionend compositionstart keydown keypress keyup input textInput copy cut paste click change contextmenu reset submit".split(" ");function Dt(e,t){switch(e){case"focusin":case"focusout":Pt=null;break;case"dragenter":case"dragleave":At=null;break;case"mouseover":case"mouseout":Nt=null;break;case"pointerover":case"pointerout":Et.delete(t.pointerId);break;case"gotpointercapture":case"lostpointercapture":Mt.delete(t.pointerId)}}function zt(e,t,n,r,a,o){return null===e||e.nativeEvent!==o?(e={blockedOn:t,domEventName:n,eventSystemFlags:r,nativeEvent:o,targetContainers:[a]},null!==t&&(null!==(t=ga(t))&&St(t)),e):(e.eventSystemFlags|=r,t=e.targetContainers,null!==a&&-1===t.indexOf(a)&&t.push(a),e)}function It(e){var t=ya(e.target);if(null!==t){var n=Ve(t);if(null!==n)if(13===(t=n.tag)){if(null!==(t=Ue(n)))return e.blockedOn=t,void Tt(e.priority,(function(){kt(n)}))}else if(3===t&&n.stateNode.current.memoizedState.isDehydrated)return void(e.blockedOn=3===n.tag?n.stateNode.containerInfo:null)}e.blockedOn=null}function Lt(e){if(null!==e.blockedOn)return!1;for(var t=e.targetContainers;0<t.length;){var n=Gt(e.domEventName,e.eventSystemFlags,t[0],e.nativeEvent);if(null!==n)return null!==(t=ga(n))&&St(t),e.blockedOn=n,!1;var r=new(n=e.nativeEvent).constructor(n.type,n);_e=r,n.target.dispatchEvent(r),_e=null,t.shift()}return!0}function Zt(e,t,n){Lt(e)&&n.delete(t)}function jt(){xt=!1,null!==Pt&&Lt(Pt)&&(Pt=null),null!==At&&Lt(At)&&(At=null),null!==Nt&&Lt(Nt)&&(Nt=null),Et.forEach(Zt),Mt.forEach(Zt)}function Bt(e,t){e.blockedOn===t&&(e.blockedOn=null,xt||(xt=!0,a.unstable_scheduleCallback(a.unstable_NormalPriority,jt)))}function Vt(e){function t(t){return Bt(t,e)}if(0<Ft.length){Bt(Ft[0],e);for(var n=1;n<Ft.length;n++){var r=Ft[n];r.blockedOn===e&&(r.blockedOn=null)}}for(null!==Pt&&Bt(Pt,e),null!==At&&Bt(At,e),null!==Nt&&Bt(Nt,e),Et.forEach(t),Mt.forEach(t),n=0;n<Rt.length;n++)(r=Rt[n]).blockedOn===e&&(r.blockedOn=null);for(;0<Rt.length&&null===(n=Rt[0]).blockedOn;)It(n),null===n.blockedOn&&Rt.shift()}var Ut=_.ReactCurrentBatchConfig,Jt=!0;function Wt(e,t,n,r){var a=gt,o=Ut.transition;Ut.transition=null;try{gt=1,$t(e,t,n,r)}finally{gt=a,Ut.transition=o}}function Ht(e,t,n,r){var a=gt,o=Ut.transition;Ut.transition=null;try{gt=4,$t(e,t,n,r)}finally{gt=a,Ut.transition=o}}function $t(e,t,n,r){if(Jt){var a=Gt(e,t,n,r);if(null===a)Jr(e,t,r,qt,n),Dt(e,r);else if(function(e,t,n,r,a){switch(t){case"focusin":return Pt=zt(Pt,e,t,n,r,a),!0;case"dragenter":return At=zt(At,e,t,n,r,a),!0;case"mouseover":return Nt=zt(Nt,e,t,n,r,a),!0;case"pointerover":var o=a.pointerId;return Et.set(o,zt(Et.get(o)||null,e,t,n,r,a)),!0;case"gotpointercapture":return o=a.pointerId,Mt.set(o,zt(Mt.get(o)||null,e,t,n,r,a)),!0}return!1}(a,e,t,n,r))r.stopPropagation();else if(Dt(e,r),4&t&&-1<Ot.indexOf(e)){for(;null!==a;){var o=ga(a);if(null!==o&&wt(o),null===(o=Gt(e,t,n,r))&&Jr(e,t,r,qt,n),o===a)break;a=o}null!==a&&r.stopPropagation()}else Jr(e,t,r,null,n)}}var qt=null;function Gt(e,t,n,r){if(qt=null,null!==(e=ya(e=we(r))))if(null===(t=Ve(e)))e=null;else if(13===(n=t.tag)){if(null!==(e=Ue(t)))return e;e=null}else if(3===n){if(t.stateNode.current.memoizedState.isDehydrated)return 3===t.tag?t.stateNode.containerInfo:null;e=null}else t!==e&&(e=null);return qt=e,null}function Kt(e){switch(e){case"cancel":case"click":case"close":case"contextmenu":case"copy":case"cut":case"auxclick":case"dblclick":case"dragend":case"dragstart":case"drop":case"focusin":case"focusout":case"input":case"invalid":case"keydown":case"keypress":case"keyup":case"mousedown":case"mouseup":case"paste":case"pause":case"play":case"pointercancel":case"pointerdown":case"pointerup":case"ratechange":case"reset":case"resize":case"seeked":case"submit":case"touchcancel":case"touchend":case"touchstart":case"volumechange":case"change":case"selectionchange":case"textInput":case"compositionstart":case"compositionend":case"compositionupdate":case"beforeblur":case"afterblur":case"beforeinput":case"blur":case"fullscreenchange":case"focus":case"hashchange":case"popstate":case"select":case"selectstart":return 1;case"drag":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"mousemove":case"mouseout":case"mouseover":case"pointermove":case"pointerout":case"pointerover":case"scroll":case"toggle":case"touchmove":case"wheel":case"mouseenter":case"mouseleave":case"pointerenter":case"pointerleave":return 4;case"message":switch(Ye()){case Xe:return 1;case et:return 4;case tt:case nt:return 16;case rt:return 536870912;default:return 16}default:return 16}}var Qt=null,Yt=null,Xt=null;function en(){if(Xt)return Xt;var e,t,n=Yt,r=n.length,a="value"in Qt?Qt.value:Qt.textContent,o=a.length;for(e=0;e<r&&n[e]===a[e];e++);var i=r-e;for(t=1;t<=i&&n[r-t]===a[o-t];t++);return Xt=a.slice(e,1<t?1-t:void 0)}function tn(e){var t=e.keyCode;return"charCode"in e?0===(e=e.charCode)&&13===t&&(e=13):e=t,10===e&&(e=13),32<=e||13===e?e:0}function nn(){return!0}function rn(){return!1}function an(e){function t(t,n,r,a,o){for(var i in this._reactName=t,this._targetInst=r,this.type=n,this.nativeEvent=a,this.target=o,this.currentTarget=null,e)e.hasOwnProperty(i)&&(t=e[i],this[i]=t?t(a):a[i]);return this.isDefaultPrevented=(null!=a.defaultPrevented?a.defaultPrevented:!1===a.returnValue)?nn:rn,this.isPropagationStopped=rn,this}return I(t.prototype,{preventDefault:function(){this.defaultPrevented=!0;var e=this.nativeEvent;e&&(e.preventDefault?e.preventDefault():"unknown"!==typeof e.returnValue&&(e.returnValue=!1),this.isDefaultPrevented=nn)},stopPropagation:function(){var e=this.nativeEvent;e&&(e.stopPropagation?e.stopPropagation():"unknown"!==typeof e.cancelBubble&&(e.cancelBubble=!0),this.isPropagationStopped=nn)},persist:function(){},isPersistent:nn}),t}var on,sn,ln,un={eventPhase:0,bubbles:0,cancelable:0,timeStamp:function(e){return e.timeStamp||Date.now()},defaultPrevented:0,isTrusted:0},cn=an(un),dn=I({},un,{view:0,detail:0}),fn=an(dn),pn=I({},dn,{screenX:0,screenY:0,clientX:0,clientY:0,pageX:0,pageY:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,getModifierState:Tn,button:0,buttons:0,relatedTarget:function(e){return void 0===e.relatedTarget?e.fromElement===e.srcElement?e.toElement:e.fromElement:e.relatedTarget},movementX:function(e){return"movementX"in e?e.movementX:(e!==ln&&(ln&&"mousemove"===e.type?(on=e.screenX-ln.screenX,sn=e.screenY-ln.screenY):sn=on=0,ln=e),on)},movementY:function(e){return"movementY"in e?e.movementY:sn}}),mn=an(pn),hn=an(I({},pn,{dataTransfer:0})),vn=an(I({},dn,{relatedTarget:0})),bn=an(I({},un,{animationName:0,elapsedTime:0,pseudoElement:0})),yn=I({},un,{clipboardData:function(e){return"clipboardData"in e?e.clipboardData:window.clipboardData}}),gn=an(yn),_n=an(I({},un,{data:0})),wn={Esc:"Escape",Spacebar:" ",Left:"ArrowLeft",Up:"ArrowUp",Right:"ArrowRight",Down:"ArrowDown",Del:"Delete",Win:"OS",Menu:"ContextMenu",Apps:"ContextMenu",Scroll:"ScrollLock",MozPrintableKey:"Unidentified"},Sn={8:"Backspace",9:"Tab",12:"Clear",13:"Enter",16:"Shift",17:"Control",18:"Alt",19:"Pause",20:"CapsLock",27:"Escape",32:" ",33:"PageUp",34:"PageDown",35:"End",36:"Home",37:"ArrowLeft",38:"ArrowUp",39:"ArrowRight",40:"ArrowDown",45:"Insert",46:"Delete",112:"F1",113:"F2",114:"F3",115:"F4",116:"F5",117:"F6",118:"F7",119:"F8",120:"F9",121:"F10",122:"F11",123:"F12",144:"NumLock",145:"ScrollLock",224:"Meta"},kn={Alt:"altKey",Control:"ctrlKey",Meta:"metaKey",Shift:"shiftKey"};function Cn(e){var t=this.nativeEvent;return t.getModifierState?t.getModifierState(e):!!(e=kn[e])&&!!t[e]}function Tn(){return Cn}var xn=I({},dn,{key:function(e){if(e.key){var t=wn[e.key]||e.key;if("Unidentified"!==t)return t}return"keypress"===e.type?13===(e=tn(e))?"Enter":String.fromCharCode(e):"keydown"===e.type||"keyup"===e.type?Sn[e.keyCode]||"Unidentified":""},code:0,location:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,repeat:0,locale:0,getModifierState:Tn,charCode:function(e){return"keypress"===e.type?tn(e):0},keyCode:function(e){return"keydown"===e.type||"keyup"===e.type?e.keyCode:0},which:function(e){return"keypress"===e.type?tn(e):"keydown"===e.type||"keyup"===e.type?e.keyCode:0}}),Fn=an(xn),Pn=an(I({},pn,{pointerId:0,width:0,height:0,pressure:0,tangentialPressure:0,tiltX:0,tiltY:0,twist:0,pointerType:0,isPrimary:0})),An=an(I({},dn,{touches:0,targetTouches:0,changedTouches:0,altKey:0,metaKey:0,ctrlKey:0,shiftKey:0,getModifierState:Tn})),Nn=an(I({},un,{propertyName:0,elapsedTime:0,pseudoElement:0})),En=I({},pn,{deltaX:function(e){return"deltaX"in e?e.deltaX:"wheelDeltaX"in e?-e.wheelDeltaX:0},deltaY:function(e){return"deltaY"in e?e.deltaY:"wheelDeltaY"in e?-e.wheelDeltaY:"wheelDelta"in e?-e.wheelDelta:0},deltaZ:0,deltaMode:0}),Mn=an(En),Rn=[9,13,27,32],On=c&&"CompositionEvent"in window,Dn=null;c&&"documentMode"in document&&(Dn=document.documentMode);var zn=c&&"TextEvent"in window&&!Dn,In=c&&(!On||Dn&&8<Dn&&11>=Dn),Ln=String.fromCharCode(32),Zn=!1;function jn(e,t){switch(e){case"keyup":return-1!==Rn.indexOf(t.keyCode);case"keydown":return 229!==t.keyCode;case"keypress":case"mousedown":case"focusout":return!0;default:return!1}}function Bn(e){return"object"===typeof(e=e.detail)&&"data"in e?e.data:null}var Vn=!1;var Un={color:!0,date:!0,datetime:!0,"datetime-local":!0,email:!0,month:!0,number:!0,password:!0,range:!0,search:!0,tel:!0,text:!0,time:!0,url:!0,week:!0};function Jn(e){var t=e&&e.nodeName&&e.nodeName.toLowerCase();return"input"===t?!!Un[e.type]:"textarea"===t}function Wn(e,t,n,r){xe(r),0<(t=Hr(t,"onChange")).length&&(n=new cn("onChange","change",null,n,r),e.push({event:n,listeners:t}))}var Hn=null,$n=null;function qn(e){Lr(e,0)}function Gn(e){if($(_a(e)))return e}function Kn(e,t){if("change"===e)return t}var Qn=!1;if(c){var Yn;if(c){var Xn="oninput"in document;if(!Xn){var er=document.createElement("div");er.setAttribute("oninput","return;"),Xn="function"===typeof er.oninput}Yn=Xn}else Yn=!1;Qn=Yn&&(!document.documentMode||9<document.documentMode)}function tr(){Hn&&(Hn.detachEvent("onpropertychange",nr),$n=Hn=null)}function nr(e){if("value"===e.propertyName&&Gn($n)){var t=[];Wn(t,$n,e,we(e)),Ee(qn,t)}}function rr(e,t,n){"focusin"===e?(tr(),$n=n,(Hn=t).attachEvent("onpropertychange",nr)):"focusout"===e&&tr()}function ar(e){if("selectionchange"===e||"keyup"===e||"keydown"===e)return Gn($n)}function or(e,t){if("click"===e)return Gn(t)}function ir(e,t){if("input"===e||"change"===e)return Gn(t)}var sr="function"===typeof Object.is?Object.is:function(e,t){return e===t&&(0!==e||1/e===1/t)||e!==e&&t!==t};function lr(e,t){if(sr(e,t))return!0;if("object"!==typeof e||null===e||"object"!==typeof t||null===t)return!1;var n=Object.keys(e),r=Object.keys(t);if(n.length!==r.length)return!1;for(r=0;r<n.length;r++){var a=n[r];if(!d.call(t,a)||!sr(e[a],t[a]))return!1}return!0}function ur(e){for(;e&&e.firstChild;)e=e.firstChild;return e}function cr(e,t){var n,r=ur(e);for(e=0;r;){if(3===r.nodeType){if(n=e+r.textContent.length,e<=t&&n>=t)return{node:r,offset:t-e};e=n}e:{for(;r;){if(r.nextSibling){r=r.nextSibling;break e}r=r.parentNode}r=void 0}r=ur(r)}}function dr(e,t){return!(!e||!t)&&(e===t||(!e||3!==e.nodeType)&&(t&&3===t.nodeType?dr(e,t.parentNode):"contains"in e?e.contains(t):!!e.compareDocumentPosition&&!!(16&e.compareDocumentPosition(t))))}function fr(){for(var e=window,t=q();t instanceof e.HTMLIFrameElement;){try{var n="string"===typeof t.contentWindow.location.href}catch(r){n=!1}if(!n)break;t=q((e=t.contentWindow).document)}return t}function pr(e){var t=e&&e.nodeName&&e.nodeName.toLowerCase();return t&&("input"===t&&("text"===e.type||"search"===e.type||"tel"===e.type||"url"===e.type||"password"===e.type)||"textarea"===t||"true"===e.contentEditable)}function mr(e){var t=fr(),n=e.focusedElem,r=e.selectionRange;if(t!==n&&n&&n.ownerDocument&&dr(n.ownerDocument.documentElement,n)){if(null!==r&&pr(n))if(t=r.start,void 0===(e=r.end)&&(e=t),"selectionStart"in n)n.selectionStart=t,n.selectionEnd=Math.min(e,n.value.length);else if((e=(t=n.ownerDocument||document)&&t.defaultView||window).getSelection){e=e.getSelection();var a=n.textContent.length,o=Math.min(r.start,a);r=void 0===r.end?o:Math.min(r.end,a),!e.extend&&o>r&&(a=r,r=o,o=a),a=cr(n,o);var i=cr(n,r);a&&i&&(1!==e.rangeCount||e.anchorNode!==a.node||e.anchorOffset!==a.offset||e.focusNode!==i.node||e.focusOffset!==i.offset)&&((t=t.createRange()).setStart(a.node,a.offset),e.removeAllRanges(),o>r?(e.addRange(t),e.extend(i.node,i.offset)):(t.setEnd(i.node,i.offset),e.addRange(t)))}for(t=[],e=n;e=e.parentNode;)1===e.nodeType&&t.push({element:e,left:e.scrollLeft,top:e.scrollTop});for("function"===typeof n.focus&&n.focus(),n=0;n<t.length;n++)(e=t[n]).element.scrollLeft=e.left,e.element.scrollTop=e.top}}var hr=c&&"documentMode"in document&&11>=document.documentMode,vr=null,br=null,yr=null,gr=!1;function _r(e,t,n){var r=n.window===n?n.document:9===n.nodeType?n:n.ownerDocument;gr||null==vr||vr!==q(r)||("selectionStart"in(r=vr)&&pr(r)?r={start:r.selectionStart,end:r.selectionEnd}:r={anchorNode:(r=(r.ownerDocument&&r.ownerDocument.defaultView||window).getSelection()).anchorNode,anchorOffset:r.anchorOffset,focusNode:r.focusNode,focusOffset:r.focusOffset},yr&&lr(yr,r)||(yr=r,0<(r=Hr(br,"onSelect")).length&&(t=new cn("onSelect","select",null,t,n),e.push({event:t,listeners:r}),t.target=vr)))}function wr(e,t){var n={};return n[e.toLowerCase()]=t.toLowerCase(),n["Webkit"+e]="webkit"+t,n["Moz"+e]="moz"+t,n}var Sr={animationend:wr("Animation","AnimationEnd"),animationiteration:wr("Animation","AnimationIteration"),animationstart:wr("Animation","AnimationStart"),transitionend:wr("Transition","TransitionEnd")},kr={},Cr={};function Tr(e){if(kr[e])return kr[e];if(!Sr[e])return e;var t,n=Sr[e];for(t in n)if(n.hasOwnProperty(t)&&t in Cr)return kr[e]=n[t];return e}c&&(Cr=document.createElement("div").style,"AnimationEvent"in window||(delete Sr.animationend.animation,delete Sr.animationiteration.animation,delete Sr.animationstart.animation),"TransitionEvent"in window||delete Sr.transitionend.transition);var xr=Tr("animationend"),Fr=Tr("animationiteration"),Pr=Tr("animationstart"),Ar=Tr("transitionend"),Nr=new Map,Er="abort auxClick cancel canPlay canPlayThrough click close contextMenu copy cut drag dragEnd dragEnter dragExit dragLeave dragOver dragStart drop durationChange emptied encrypted ended error gotPointerCapture input invalid keyDown keyPress keyUp load loadedData loadedMetadata loadStart lostPointerCapture mouseDown mouseMove mouseOut mouseOver mouseUp paste pause play playing pointerCancel pointerDown pointerMove pointerOut pointerOver pointerUp progress rateChange reset resize seeked seeking stalled submit suspend timeUpdate touchCancel touchEnd touchStart volumeChange scroll toggle touchMove waiting wheel".split(" ");function Mr(e,t){Nr.set(e,t),l(t,[e])}for(var Rr=0;Rr<Er.length;Rr++){var Or=Er[Rr];Mr(Or.toLowerCase(),"on"+(Or[0].toUpperCase()+Or.slice(1)))}Mr(xr,"onAnimationEnd"),Mr(Fr,"onAnimationIteration"),Mr(Pr,"onAnimationStart"),Mr("dblclick","onDoubleClick"),Mr("focusin","onFocus"),Mr("focusout","onBlur"),Mr(Ar,"onTransitionEnd"),u("onMouseEnter",["mouseout","mouseover"]),u("onMouseLeave",["mouseout","mouseover"]),u("onPointerEnter",["pointerout","pointerover"]),u("onPointerLeave",["pointerout","pointerover"]),l("onChange","change click focusin focusout input keydown keyup selectionchange".split(" ")),l("onSelect","focusout contextmenu dragend focusin keydown keyup mousedown mouseup selectionchange".split(" ")),l("onBeforeInput",["compositionend","keypress","textInput","paste"]),l("onCompositionEnd","compositionend focusout keydown keypress keyup mousedown".split(" ")),l("onCompositionStart","compositionstart focusout keydown keypress keyup mousedown".split(" ")),l("onCompositionUpdate","compositionupdate focusout keydown keypress keyup mousedown".split(" "));var Dr="abort canplay canplaythrough durationchange emptied encrypted ended error loadeddata loadedmetadata loadstart pause play playing progress ratechange resize seeked seeking stalled suspend timeupdate volumechange waiting".split(" "),zr=new Set("cancel close invalid load scroll toggle".split(" ").concat(Dr));function Ir(e,t,n){var r=e.type||"unknown-event";e.currentTarget=n,function(e,t,n,r,a,i,s,l,u){if(Be.apply(this,arguments),ze){if(!ze)throw Error(o(198));var c=Ie;ze=!1,Ie=null,Le||(Le=!0,Ze=c)}}(r,t,void 0,e),e.currentTarget=null}function Lr(e,t){t=0!==(4&t);for(var n=0;n<e.length;n++){var r=e[n],a=r.event;r=r.listeners;e:{var o=void 0;if(t)for(var i=r.length-1;0<=i;i--){var s=r[i],l=s.instance,u=s.currentTarget;if(s=s.listener,l!==o&&a.isPropagationStopped())break e;Ir(a,s,u),o=l}else for(i=0;i<r.length;i++){if(l=(s=r[i]).instance,u=s.currentTarget,s=s.listener,l!==o&&a.isPropagationStopped())break e;Ir(a,s,u),o=l}}}if(Le)throw e=Ze,Le=!1,Ze=null,e}function Zr(e,t){var n=t[ha];void 0===n&&(n=t[ha]=new Set);var r=e+"__bubble";n.has(r)||(Ur(t,e,2,!1),n.add(r))}function jr(e,t,n){var r=0;t&&(r|=4),Ur(n,e,r,t)}var Br="_reactListening"+Math.random().toString(36).slice(2);function Vr(e){if(!e[Br]){e[Br]=!0,i.forEach((function(t){"selectionchange"!==t&&(zr.has(t)||jr(t,!1,e),jr(t,!0,e))}));var t=9===e.nodeType?e:e.ownerDocument;null===t||t[Br]||(t[Br]=!0,jr("selectionchange",!1,t))}}function Ur(e,t,n,r){switch(Kt(t)){case 1:var a=Wt;break;case 4:a=Ht;break;default:a=$t}n=a.bind(null,t,n,e),a=void 0,!Re||"touchstart"!==t&&"touchmove"!==t&&"wheel"!==t||(a=!0),r?void 0!==a?e.addEventListener(t,n,{capture:!0,passive:a}):e.addEventListener(t,n,!0):void 0!==a?e.addEventListener(t,n,{passive:a}):e.addEventListener(t,n,!1)}function Jr(e,t,n,r,a){var o=r;if(0===(1&t)&&0===(2&t)&&null!==r)e:for(;;){if(null===r)return;var i=r.tag;if(3===i||4===i){var s=r.stateNode.containerInfo;if(s===a||8===s.nodeType&&s.parentNode===a)break;if(4===i)for(i=r.return;null!==i;){var l=i.tag;if((3===l||4===l)&&((l=i.stateNode.containerInfo)===a||8===l.nodeType&&l.parentNode===a))return;i=i.return}for(;null!==s;){if(null===(i=ya(s)))return;if(5===(l=i.tag)||6===l){r=o=i;continue e}s=s.parentNode}}r=r.return}Ee((function(){var r=o,a=we(n),i=[];e:{var s=Nr.get(e);if(void 0!==s){var l=cn,u=e;switch(e){case"keypress":if(0===tn(n))break e;case"keydown":case"keyup":l=Fn;break;case"focusin":u="focus",l=vn;break;case"focusout":u="blur",l=vn;break;case"beforeblur":case"afterblur":l=vn;break;case"click":if(2===n.button)break e;case"auxclick":case"dblclick":case"mousedown":case"mousemove":case"mouseup":case"mouseout":case"mouseover":case"contextmenu":l=mn;break;case"drag":case"dragend":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"dragstart":case"drop":l=hn;break;case"touchcancel":case"touchend":case"touchmove":case"touchstart":l=An;break;case xr:case Fr:case Pr:l=bn;break;case Ar:l=Nn;break;case"scroll":l=fn;break;case"wheel":l=Mn;break;case"copy":case"cut":case"paste":l=gn;break;case"gotpointercapture":case"lostpointercapture":case"pointercancel":case"pointerdown":case"pointermove":case"pointerout":case"pointerover":case"pointerup":l=Pn}var c=0!==(4&t),d=!c&&"scroll"===e,f=c?null!==s?s+"Capture":null:s;c=[];for(var p,m=r;null!==m;){var h=(p=m).stateNode;if(5===p.tag&&null!==h&&(p=h,null!==f&&(null!=(h=Me(m,f))&&c.push(Wr(m,h,p)))),d)break;m=m.return}0<c.length&&(s=new l(s,u,null,n,a),i.push({event:s,listeners:c}))}}if(0===(7&t)){if(l="mouseout"===e||"pointerout"===e,(!(s="mouseover"===e||"pointerover"===e)||n===_e||!(u=n.relatedTarget||n.fromElement)||!ya(u)&&!u[ma])&&(l||s)&&(s=a.window===a?a:(s=a.ownerDocument)?s.defaultView||s.parentWindow:window,l?(l=r,null!==(u=(u=n.relatedTarget||n.toElement)?ya(u):null)&&(u!==(d=Ve(u))||5!==u.tag&&6!==u.tag)&&(u=null)):(l=null,u=r),l!==u)){if(c=mn,h="onMouseLeave",f="onMouseEnter",m="mouse","pointerout"!==e&&"pointerover"!==e||(c=Pn,h="onPointerLeave",f="onPointerEnter",m="pointer"),d=null==l?s:_a(l),p=null==u?s:_a(u),(s=new c(h,m+"leave",l,n,a)).target=d,s.relatedTarget=p,h=null,ya(a)===r&&((c=new c(f,m+"enter",u,n,a)).target=p,c.relatedTarget=d,h=c),d=h,l&&u)e:{for(f=u,m=0,p=c=l;p;p=$r(p))m++;for(p=0,h=f;h;h=$r(h))p++;for(;0<m-p;)c=$r(c),m--;for(;0<p-m;)f=$r(f),p--;for(;m--;){if(c===f||null!==f&&c===f.alternate)break e;c=$r(c),f=$r(f)}c=null}else c=null;null!==l&&qr(i,s,l,c,!1),null!==u&&null!==d&&qr(i,d,u,c,!0)}if("select"===(l=(s=r?_a(r):window).nodeName&&s.nodeName.toLowerCase())||"input"===l&&"file"===s.type)var v=Kn;else if(Jn(s))if(Qn)v=ir;else{v=ar;var b=rr}else(l=s.nodeName)&&"input"===l.toLowerCase()&&("checkbox"===s.type||"radio"===s.type)&&(v=or);switch(v&&(v=v(e,r))?Wn(i,v,n,a):(b&&b(e,s,r),"focusout"===e&&(b=s._wrapperState)&&b.controlled&&"number"===s.type&&ee(s,"number",s.value)),b=r?_a(r):window,e){case"focusin":(Jn(b)||"true"===b.contentEditable)&&(vr=b,br=r,yr=null);break;case"focusout":yr=br=vr=null;break;case"mousedown":gr=!0;break;case"contextmenu":case"mouseup":case"dragend":gr=!1,_r(i,n,a);break;case"selectionchange":if(hr)break;case"keydown":case"keyup":_r(i,n,a)}var y;if(On)e:{switch(e){case"compositionstart":var g="onCompositionStart";break e;case"compositionend":g="onCompositionEnd";break e;case"compositionupdate":g="onCompositionUpdate";break e}g=void 0}else Vn?jn(e,n)&&(g="onCompositionEnd"):"keydown"===e&&229===n.keyCode&&(g="onCompositionStart");g&&(In&&"ko"!==n.locale&&(Vn||"onCompositionStart"!==g?"onCompositionEnd"===g&&Vn&&(y=en()):(Yt="value"in(Qt=a)?Qt.value:Qt.textContent,Vn=!0)),0<(b=Hr(r,g)).length&&(g=new _n(g,e,null,n,a),i.push({event:g,listeners:b}),y?g.data=y:null!==(y=Bn(n))&&(g.data=y))),(y=zn?function(e,t){switch(e){case"compositionend":return Bn(t);case"keypress":return 32!==t.which?null:(Zn=!0,Ln);case"textInput":return(e=t.data)===Ln&&Zn?null:e;default:return null}}(e,n):function(e,t){if(Vn)return"compositionend"===e||!On&&jn(e,t)?(e=en(),Xt=Yt=Qt=null,Vn=!1,e):null;switch(e){case"paste":default:return null;case"keypress":if(!(t.ctrlKey||t.altKey||t.metaKey)||t.ctrlKey&&t.altKey){if(t.char&&1<t.char.length)return t.char;if(t.which)return String.fromCharCode(t.which)}return null;case"compositionend":return In&&"ko"!==t.locale?null:t.data}}(e,n))&&(0<(r=Hr(r,"onBeforeInput")).length&&(a=new _n("onBeforeInput","beforeinput",null,n,a),i.push({event:a,listeners:r}),a.data=y))}Lr(i,t)}))}function Wr(e,t,n){return{instance:e,listener:t,currentTarget:n}}function Hr(e,t){for(var n=t+"Capture",r=[];null!==e;){var a=e,o=a.stateNode;5===a.tag&&null!==o&&(a=o,null!=(o=Me(e,n))&&r.unshift(Wr(e,o,a)),null!=(o=Me(e,t))&&r.push(Wr(e,o,a))),e=e.return}return r}function $r(e){if(null===e)return null;do{e=e.return}while(e&&5!==e.tag);return e||null}function qr(e,t,n,r,a){for(var o=t._reactName,i=[];null!==n&&n!==r;){var s=n,l=s.alternate,u=s.stateNode;if(null!==l&&l===r)break;5===s.tag&&null!==u&&(s=u,a?null!=(l=Me(n,o))&&i.unshift(Wr(n,l,s)):a||null!=(l=Me(n,o))&&i.push(Wr(n,l,s))),n=n.return}0!==i.length&&e.push({event:t,listeners:i})}var Gr=/\r\n?/g,Kr=/\u0000|\uFFFD/g;function Qr(e){return("string"===typeof e?e:""+e).replace(Gr,"\n").replace(Kr,"")}function Yr(e,t,n){if(t=Qr(t),Qr(e)!==t&&n)throw Error(o(425))}function Xr(){}var ea=null,ta=null;function na(e,t){return"textarea"===e||"noscript"===e||"string"===typeof t.children||"number"===typeof t.children||"object"===typeof t.dangerouslySetInnerHTML&&null!==t.dangerouslySetInnerHTML&&null!=t.dangerouslySetInnerHTML.__html}var ra="function"===typeof setTimeout?setTimeout:void 0,aa="function"===typeof clearTimeout?clearTimeout:void 0,oa="function"===typeof Promise?Promise:void 0,ia="function"===typeof queueMicrotask?queueMicrotask:"undefined"!==typeof oa?function(e){return oa.resolve(null).then(e).catch(sa)}:ra;function sa(e){setTimeout((function(){throw e}))}function la(e,t){var n=t,r=0;do{var a=n.nextSibling;if(e.removeChild(n),a&&8===a.nodeType)if("/$"===(n=a.data)){if(0===r)return e.removeChild(a),void Vt(t);r--}else"$"!==n&&"$?"!==n&&"$!"!==n||r++;n=a}while(n);Vt(t)}function ua(e){for(;null!=e;e=e.nextSibling){var t=e.nodeType;if(1===t||3===t)break;if(8===t){if("$"===(t=e.data)||"$!"===t||"$?"===t)break;if("/$"===t)return null}}return e}function ca(e){e=e.previousSibling;for(var t=0;e;){if(8===e.nodeType){var n=e.data;if("$"===n||"$!"===n||"$?"===n){if(0===t)return e;t--}else"/$"===n&&t++}e=e.previousSibling}return null}var da=Math.random().toString(36).slice(2),fa="__reactFiber$"+da,pa="__reactProps$"+da,ma="__reactContainer$"+da,ha="__reactEvents$"+da,va="__reactListeners$"+da,ba="__reactHandles$"+da;function ya(e){var t=e[fa];if(t)return t;for(var n=e.parentNode;n;){if(t=n[ma]||n[fa]){if(n=t.alternate,null!==t.child||null!==n&&null!==n.child)for(e=ca(e);null!==e;){if(n=e[fa])return n;e=ca(e)}return t}n=(e=n).parentNode}return null}function ga(e){return!(e=e[fa]||e[ma])||5!==e.tag&&6!==e.tag&&13!==e.tag&&3!==e.tag?null:e}function _a(e){if(5===e.tag||6===e.tag)return e.stateNode;throw Error(o(33))}function wa(e){return e[pa]||null}var Sa=[],ka=-1;function Ca(e){return{current:e}}function Ta(e){0>ka||(e.current=Sa[ka],Sa[ka]=null,ka--)}function xa(e,t){ka++,Sa[ka]=e.current,e.current=t}var Fa={},Pa=Ca(Fa),Aa=Ca(!1),Na=Fa;function Ea(e,t){var n=e.type.contextTypes;if(!n)return Fa;var r=e.stateNode;if(r&&r.__reactInternalMemoizedUnmaskedChildContext===t)return r.__reactInternalMemoizedMaskedChildContext;var a,o={};for(a in n)o[a]=t[a];return r&&((e=e.stateNode).__reactInternalMemoizedUnmaskedChildContext=t,e.__reactInternalMemoizedMaskedChildContext=o),o}function Ma(e){return null!==(e=e.childContextTypes)&&void 0!==e}function Ra(){Ta(Aa),Ta(Pa)}function Oa(e,t,n){if(Pa.current!==Fa)throw Error(o(168));xa(Pa,t),xa(Aa,n)}function Da(e,t,n){var r=e.stateNode;if(t=t.childContextTypes,"function"!==typeof r.getChildContext)return n;for(var a in r=r.getChildContext())if(!(a in t))throw Error(o(108,U(e)||"Unknown",a));return I({},n,r)}function za(e){return e=(e=e.stateNode)&&e.__reactInternalMemoizedMergedChildContext||Fa,Na=Pa.current,xa(Pa,e),xa(Aa,Aa.current),!0}function Ia(e,t,n){var r=e.stateNode;if(!r)throw Error(o(169));n?(e=Da(e,t,Na),r.__reactInternalMemoizedMergedChildContext=e,Ta(Aa),Ta(Pa),xa(Pa,e)):Ta(Aa),xa(Aa,n)}var La=null,Za=!1,ja=!1;function Ba(e){null===La?La=[e]:La.push(e)}function Va(){if(!ja&&null!==La){ja=!0;var e=0,t=gt;try{var n=La;for(gt=1;e<n.length;e++){var r=n[e];do{r=r(!0)}while(null!==r)}La=null,Za=!1}catch(a){throw null!==La&&(La=La.slice(e+1)),$e(Xe,Va),a}finally{gt=t,ja=!1}}return null}var Ua=[],Ja=0,Wa=null,Ha=0,$a=[],qa=0,Ga=null,Ka=1,Qa="";function Ya(e,t){Ua[Ja++]=Ha,Ua[Ja++]=Wa,Wa=e,Ha=t}function Xa(e,t,n){$a[qa++]=Ka,$a[qa++]=Qa,$a[qa++]=Ga,Ga=e;var r=Ka;e=Qa;var a=32-it(r)-1;r&=~(1<<a),n+=1;var o=32-it(t)+a;if(30<o){var i=a-a%5;o=(r&(1<<i)-1).toString(32),r>>=i,a-=i,Ka=1<<32-it(t)+a|n<<a|r,Qa=o+e}else Ka=1<<o|n<<a|r,Qa=e}function eo(e){null!==e.return&&(Ya(e,1),Xa(e,1,0))}function to(e){for(;e===Wa;)Wa=Ua[--Ja],Ua[Ja]=null,Ha=Ua[--Ja],Ua[Ja]=null;for(;e===Ga;)Ga=$a[--qa],$a[qa]=null,Qa=$a[--qa],$a[qa]=null,Ka=$a[--qa],$a[qa]=null}var no=null,ro=null,ao=!1,oo=null;function io(e,t){var n=Eu(5,null,null,0);n.elementType="DELETED",n.stateNode=t,n.return=e,null===(t=e.deletions)?(e.deletions=[n],e.flags|=16):t.push(n)}function so(e,t){switch(e.tag){case 5:var n=e.type;return null!==(t=1!==t.nodeType||n.toLowerCase()!==t.nodeName.toLowerCase()?null:t)&&(e.stateNode=t,no=e,ro=ua(t.firstChild),!0);case 6:return null!==(t=""===e.pendingProps||3!==t.nodeType?null:t)&&(e.stateNode=t,no=e,ro=null,!0);case 13:return null!==(t=8!==t.nodeType?null:t)&&(n=null!==Ga?{id:Ka,overflow:Qa}:null,e.memoizedState={dehydrated:t,treeContext:n,retryLane:1073741824},(n=Eu(18,null,null,0)).stateNode=t,n.return=e,e.child=n,no=e,ro=null,!0);default:return!1}}function lo(e){return 0!==(1&e.mode)&&0===(128&e.flags)}function uo(e){if(ao){var t=ro;if(t){var n=t;if(!so(e,t)){if(lo(e))throw Error(o(418));t=ua(n.nextSibling);var r=no;t&&so(e,t)?io(r,n):(e.flags=-4097&e.flags|2,ao=!1,no=e)}}else{if(lo(e))throw Error(o(418));e.flags=-4097&e.flags|2,ao=!1,no=e}}}function co(e){for(e=e.return;null!==e&&5!==e.tag&&3!==e.tag&&13!==e.tag;)e=e.return;no=e}function fo(e){if(e!==no)return!1;if(!ao)return co(e),ao=!0,!1;var t;if((t=3!==e.tag)&&!(t=5!==e.tag)&&(t="head"!==(t=e.type)&&"body"!==t&&!na(e.type,e.memoizedProps)),t&&(t=ro)){if(lo(e))throw po(),Error(o(418));for(;t;)io(e,t),t=ua(t.nextSibling)}if(co(e),13===e.tag){if(!(e=null!==(e=e.memoizedState)?e.dehydrated:null))throw Error(o(317));e:{for(e=e.nextSibling,t=0;e;){if(8===e.nodeType){var n=e.data;if("/$"===n){if(0===t){ro=ua(e.nextSibling);break e}t--}else"$"!==n&&"$!"!==n&&"$?"!==n||t++}e=e.nextSibling}ro=null}}else ro=no?ua(e.stateNode.nextSibling):null;return!0}function po(){for(var e=ro;e;)e=ua(e.nextSibling)}function mo(){ro=no=null,ao=!1}function ho(e){null===oo?oo=[e]:oo.push(e)}var vo=_.ReactCurrentBatchConfig;function bo(e,t){if(e&&e.defaultProps){for(var n in t=I({},t),e=e.defaultProps)void 0===t[n]&&(t[n]=e[n]);return t}return t}var yo=Ca(null),go=null,_o=null,wo=null;function So(){wo=_o=go=null}function ko(e){var t=yo.current;Ta(yo),e._currentValue=t}function Co(e,t,n){for(;null!==e;){var r=e.alternate;if((e.childLanes&t)!==t?(e.childLanes|=t,null!==r&&(r.childLanes|=t)):null!==r&&(r.childLanes&t)!==t&&(r.childLanes|=t),e===n)break;e=e.return}}function To(e,t){go=e,wo=_o=null,null!==(e=e.dependencies)&&null!==e.firstContext&&(0!==(e.lanes&t)&&(_s=!0),e.firstContext=null)}function xo(e){var t=e._currentValue;if(wo!==e)if(e={context:e,memoizedValue:t,next:null},null===_o){if(null===go)throw Error(o(308));_o=e,go.dependencies={lanes:0,firstContext:e}}else _o=_o.next=e;return t}var Fo=null;function Po(e){null===Fo?Fo=[e]:Fo.push(e)}function Ao(e,t,n,r){var a=t.interleaved;return null===a?(n.next=n,Po(t)):(n.next=a.next,a.next=n),t.interleaved=n,No(e,r)}function No(e,t){e.lanes|=t;var n=e.alternate;for(null!==n&&(n.lanes|=t),n=e,e=e.return;null!==e;)e.childLanes|=t,null!==(n=e.alternate)&&(n.childLanes|=t),n=e,e=e.return;return 3===n.tag?n.stateNode:null}var Eo=!1;function Mo(e){e.updateQueue={baseState:e.memoizedState,firstBaseUpdate:null,lastBaseUpdate:null,shared:{pending:null,interleaved:null,lanes:0},effects:null}}function Ro(e,t){e=e.updateQueue,t.updateQueue===e&&(t.updateQueue={baseState:e.baseState,firstBaseUpdate:e.firstBaseUpdate,lastBaseUpdate:e.lastBaseUpdate,shared:e.shared,effects:e.effects})}function Oo(e,t){return{eventTime:e,lane:t,tag:0,payload:null,callback:null,next:null}}function Do(e,t,n){var r=e.updateQueue;if(null===r)return null;if(r=r.shared,0!==(2&Pl)){var a=r.pending;return null===a?t.next=t:(t.next=a.next,a.next=t),r.pending=t,No(e,n)}return null===(a=r.interleaved)?(t.next=t,Po(r)):(t.next=a.next,a.next=t),r.interleaved=t,No(e,n)}function zo(e,t,n){if(null!==(t=t.updateQueue)&&(t=t.shared,0!==(4194240&n))){var r=t.lanes;n|=r&=e.pendingLanes,t.lanes=n,yt(e,n)}}function Io(e,t){var n=e.updateQueue,r=e.alternate;if(null!==r&&n===(r=r.updateQueue)){var a=null,o=null;if(null!==(n=n.firstBaseUpdate)){do{var i={eventTime:n.eventTime,lane:n.lane,tag:n.tag,payload:n.payload,callback:n.callback,next:null};null===o?a=o=i:o=o.next=i,n=n.next}while(null!==n);null===o?a=o=t:o=o.next=t}else a=o=t;return n={baseState:r.baseState,firstBaseUpdate:a,lastBaseUpdate:o,shared:r.shared,effects:r.effects},void(e.updateQueue=n)}null===(e=n.lastBaseUpdate)?n.firstBaseUpdate=t:e.next=t,n.lastBaseUpdate=t}function Lo(e,t,n,r){var a=e.updateQueue;Eo=!1;var o=a.firstBaseUpdate,i=a.lastBaseUpdate,s=a.shared.pending;if(null!==s){a.shared.pending=null;var l=s,u=l.next;l.next=null,null===i?o=u:i.next=u,i=l;var c=e.alternate;null!==c&&((s=(c=c.updateQueue).lastBaseUpdate)!==i&&(null===s?c.firstBaseUpdate=u:s.next=u,c.lastBaseUpdate=l))}if(null!==o){var d=a.baseState;for(i=0,c=u=l=null,s=o;;){var f=s.lane,p=s.eventTime;if((r&f)===f){null!==c&&(c=c.next={eventTime:p,lane:0,tag:s.tag,payload:s.payload,callback:s.callback,next:null});e:{var m=e,h=s;switch(f=t,p=n,h.tag){case 1:if("function"===typeof(m=h.payload)){d=m.call(p,d,f);break e}d=m;break e;case 3:m.flags=-65537&m.flags|128;case 0:if(null===(f="function"===typeof(m=h.payload)?m.call(p,d,f):m)||void 0===f)break e;d=I({},d,f);break e;case 2:Eo=!0}}null!==s.callback&&0!==s.lane&&(e.flags|=64,null===(f=a.effects)?a.effects=[s]:f.push(s))}else p={eventTime:p,lane:f,tag:s.tag,payload:s.payload,callback:s.callback,next:null},null===c?(u=c=p,l=d):c=c.next=p,i|=f;if(null===(s=s.next)){if(null===(s=a.shared.pending))break;s=(f=s).next,f.next=null,a.lastBaseUpdate=f,a.shared.pending=null}}if(null===c&&(l=d),a.baseState=l,a.firstBaseUpdate=u,a.lastBaseUpdate=c,null!==(t=a.shared.interleaved)){a=t;do{i|=a.lane,a=a.next}while(a!==t)}else null===o&&(a.shared.lanes=0);zl|=i,e.lanes=i,e.memoizedState=d}}function Zo(e,t,n){if(e=t.effects,t.effects=null,null!==e)for(t=0;t<e.length;t++){var r=e[t],a=r.callback;if(null!==a){if(r.callback=null,r=n,"function"!==typeof a)throw Error(o(191,a));a.call(r)}}}var jo=(new r.Component).refs;function Bo(e,t,n,r){n=null===(n=n(r,t=e.memoizedState))||void 0===n?t:I({},t,n),e.memoizedState=n,0===e.lanes&&(e.updateQueue.baseState=n)}var Vo={isMounted:function(e){return!!(e=e._reactInternals)&&Ve(e)===e},enqueueSetState:function(e,t,n){e=e._reactInternals;var r=eu(),a=tu(e),o=Oo(r,a);o.payload=t,void 0!==n&&null!==n&&(o.callback=n),null!==(t=Do(e,o,a))&&(nu(t,e,a,r),zo(t,e,a))},enqueueReplaceState:function(e,t,n){e=e._reactInternals;var r=eu(),a=tu(e),o=Oo(r,a);o.tag=1,o.payload=t,void 0!==n&&null!==n&&(o.callback=n),null!==(t=Do(e,o,a))&&(nu(t,e,a,r),zo(t,e,a))},enqueueForceUpdate:function(e,t){e=e._reactInternals;var n=eu(),r=tu(e),a=Oo(n,r);a.tag=2,void 0!==t&&null!==t&&(a.callback=t),null!==(t=Do(e,a,r))&&(nu(t,e,r,n),zo(t,e,r))}};function Uo(e,t,n,r,a,o,i){return"function"===typeof(e=e.stateNode).shouldComponentUpdate?e.shouldComponentUpdate(r,o,i):!t.prototype||!t.prototype.isPureReactComponent||(!lr(n,r)||!lr(a,o))}function Jo(e,t,n){var r=!1,a=Fa,o=t.contextType;return"object"===typeof o&&null!==o?o=xo(o):(a=Ma(t)?Na:Pa.current,o=(r=null!==(r=t.contextTypes)&&void 0!==r)?Ea(e,a):Fa),t=new t(n,o),e.memoizedState=null!==t.state&&void 0!==t.state?t.state:null,t.updater=Vo,e.stateNode=t,t._reactInternals=e,r&&((e=e.stateNode).__reactInternalMemoizedUnmaskedChildContext=a,e.__reactInternalMemoizedMaskedChildContext=o),t}function Wo(e,t,n,r){e=t.state,"function"===typeof t.componentWillReceiveProps&&t.componentWillReceiveProps(n,r),"function"===typeof t.UNSAFE_componentWillReceiveProps&&t.UNSAFE_componentWillReceiveProps(n,r),t.state!==e&&Vo.enqueueReplaceState(t,t.state,null)}function Ho(e,t,n,r){var a=e.stateNode;a.props=n,a.state=e.memoizedState,a.refs=jo,Mo(e);var o=t.contextType;"object"===typeof o&&null!==o?a.context=xo(o):(o=Ma(t)?Na:Pa.current,a.context=Ea(e,o)),a.state=e.memoizedState,"function"===typeof(o=t.getDerivedStateFromProps)&&(Bo(e,t,o,n),a.state=e.memoizedState),"function"===typeof t.getDerivedStateFromProps||"function"===typeof a.getSnapshotBeforeUpdate||"function"!==typeof a.UNSAFE_componentWillMount&&"function"!==typeof a.componentWillMount||(t=a.state,"function"===typeof a.componentWillMount&&a.componentWillMount(),"function"===typeof a.UNSAFE_componentWillMount&&a.UNSAFE_componentWillMount(),t!==a.state&&Vo.enqueueReplaceState(a,a.state,null),Lo(e,n,a,r),a.state=e.memoizedState),"function"===typeof a.componentDidMount&&(e.flags|=4194308)}function $o(e,t,n){if(null!==(e=n.ref)&&"function"!==typeof e&&"object"!==typeof e){if(n._owner){if(n=n._owner){if(1!==n.tag)throw Error(o(309));var r=n.stateNode}if(!r)throw Error(o(147,e));var a=r,i=""+e;return null!==t&&null!==t.ref&&"function"===typeof t.ref&&t.ref._stringRef===i?t.ref:(t=function(e){var t=a.refs;t===jo&&(t=a.refs={}),null===e?delete t[i]:t[i]=e},t._stringRef=i,t)}if("string"!==typeof e)throw Error(o(284));if(!n._owner)throw Error(o(290,e))}return e}function qo(e,t){throw e=Object.prototype.toString.call(t),Error(o(31,"[object Object]"===e?"object with keys {"+Object.keys(t).join(", ")+"}":e))}function Go(e){return(0,e._init)(e._payload)}function Ko(e){function t(t,n){if(e){var r=t.deletions;null===r?(t.deletions=[n],t.flags|=16):r.push(n)}}function n(n,r){if(!e)return null;for(;null!==r;)t(n,r),r=r.sibling;return null}function r(e,t){for(e=new Map;null!==t;)null!==t.key?e.set(t.key,t):e.set(t.index,t),t=t.sibling;return e}function a(e,t){return(e=Ru(e,t)).index=0,e.sibling=null,e}function i(t,n,r){return t.index=r,e?null!==(r=t.alternate)?(r=r.index)<n?(t.flags|=2,n):r:(t.flags|=2,n):(t.flags|=1048576,n)}function s(t){return e&&null===t.alternate&&(t.flags|=2),t}function l(e,t,n,r){return null===t||6!==t.tag?((t=Iu(n,e.mode,r)).return=e,t):((t=a(t,n)).return=e,t)}function u(e,t,n,r){var o=n.type;return o===k?d(e,t,n.props.children,r,n.key):null!==t&&(t.elementType===o||"object"===typeof o&&null!==o&&o.$$typeof===M&&Go(o)===t.type)?((r=a(t,n.props)).ref=$o(e,t,n),r.return=e,r):((r=Ou(n.type,n.key,n.props,null,e.mode,r)).ref=$o(e,t,n),r.return=e,r)}function c(e,t,n,r){return null===t||4!==t.tag||t.stateNode.containerInfo!==n.containerInfo||t.stateNode.implementation!==n.implementation?((t=Lu(n,e.mode,r)).return=e,t):((t=a(t,n.children||[])).return=e,t)}function d(e,t,n,r,o){return null===t||7!==t.tag?((t=Du(n,e.mode,r,o)).return=e,t):((t=a(t,n)).return=e,t)}function f(e,t,n){if("string"===typeof t&&""!==t||"number"===typeof t)return(t=Iu(""+t,e.mode,n)).return=e,t;if("object"===typeof t&&null!==t){switch(t.$$typeof){case w:return(n=Ou(t.type,t.key,t.props,null,e.mode,n)).ref=$o(e,null,t),n.return=e,n;case S:return(t=Lu(t,e.mode,n)).return=e,t;case M:return f(e,(0,t._init)(t._payload),n)}if(te(t)||D(t))return(t=Du(t,e.mode,n,null)).return=e,t;qo(e,t)}return null}function p(e,t,n,r){var a=null!==t?t.key:null;if("string"===typeof n&&""!==n||"number"===typeof n)return null!==a?null:l(e,t,""+n,r);if("object"===typeof n&&null!==n){switch(n.$$typeof){case w:return n.key===a?u(e,t,n,r):null;case S:return n.key===a?c(e,t,n,r):null;case M:return p(e,t,(a=n._init)(n._payload),r)}if(te(n)||D(n))return null!==a?null:d(e,t,n,r,null);qo(e,n)}return null}function m(e,t,n,r,a){if("string"===typeof r&&""!==r||"number"===typeof r)return l(t,e=e.get(n)||null,""+r,a);if("object"===typeof r&&null!==r){switch(r.$$typeof){case w:return u(t,e=e.get(null===r.key?n:r.key)||null,r,a);case S:return c(t,e=e.get(null===r.key?n:r.key)||null,r,a);case M:return m(e,t,n,(0,r._init)(r._payload),a)}if(te(r)||D(r))return d(t,e=e.get(n)||null,r,a,null);qo(t,r)}return null}function h(a,o,s,l){for(var u=null,c=null,d=o,h=o=0,v=null;null!==d&&h<s.length;h++){d.index>h?(v=d,d=null):v=d.sibling;var b=p(a,d,s[h],l);if(null===b){null===d&&(d=v);break}e&&d&&null===b.alternate&&t(a,d),o=i(b,o,h),null===c?u=b:c.sibling=b,c=b,d=v}if(h===s.length)return n(a,d),ao&&Ya(a,h),u;if(null===d){for(;h<s.length;h++)null!==(d=f(a,s[h],l))&&(o=i(d,o,h),null===c?u=d:c.sibling=d,c=d);return ao&&Ya(a,h),u}for(d=r(a,d);h<s.length;h++)null!==(v=m(d,a,h,s[h],l))&&(e&&null!==v.alternate&&d.delete(null===v.key?h:v.key),o=i(v,o,h),null===c?u=v:c.sibling=v,c=v);return e&&d.forEach((function(e){return t(a,e)})),ao&&Ya(a,h),u}function v(a,s,l,u){var c=D(l);if("function"!==typeof c)throw Error(o(150));if(null==(l=c.call(l)))throw Error(o(151));for(var d=c=null,h=s,v=s=0,b=null,y=l.next();null!==h&&!y.done;v++,y=l.next()){h.index>v?(b=h,h=null):b=h.sibling;var g=p(a,h,y.value,u);if(null===g){null===h&&(h=b);break}e&&h&&null===g.alternate&&t(a,h),s=i(g,s,v),null===d?c=g:d.sibling=g,d=g,h=b}if(y.done)return n(a,h),ao&&Ya(a,v),c;if(null===h){for(;!y.done;v++,y=l.next())null!==(y=f(a,y.value,u))&&(s=i(y,s,v),null===d?c=y:d.sibling=y,d=y);return ao&&Ya(a,v),c}for(h=r(a,h);!y.done;v++,y=l.next())null!==(y=m(h,a,v,y.value,u))&&(e&&null!==y.alternate&&h.delete(null===y.key?v:y.key),s=i(y,s,v),null===d?c=y:d.sibling=y,d=y);return e&&h.forEach((function(e){return t(a,e)})),ao&&Ya(a,v),c}return function e(r,o,i,l){if("object"===typeof i&&null!==i&&i.type===k&&null===i.key&&(i=i.props.children),"object"===typeof i&&null!==i){switch(i.$$typeof){case w:e:{for(var u=i.key,c=o;null!==c;){if(c.key===u){if((u=i.type)===k){if(7===c.tag){n(r,c.sibling),(o=a(c,i.props.children)).return=r,r=o;break e}}else if(c.elementType===u||"object"===typeof u&&null!==u&&u.$$typeof===M&&Go(u)===c.type){n(r,c.sibling),(o=a(c,i.props)).ref=$o(r,c,i),o.return=r,r=o;break e}n(r,c);break}t(r,c),c=c.sibling}i.type===k?((o=Du(i.props.children,r.mode,l,i.key)).return=r,r=o):((l=Ou(i.type,i.key,i.props,null,r.mode,l)).ref=$o(r,o,i),l.return=r,r=l)}return s(r);case S:e:{for(c=i.key;null!==o;){if(o.key===c){if(4===o.tag&&o.stateNode.containerInfo===i.containerInfo&&o.stateNode.implementation===i.implementation){n(r,o.sibling),(o=a(o,i.children||[])).return=r,r=o;break e}n(r,o);break}t(r,o),o=o.sibling}(o=Lu(i,r.mode,l)).return=r,r=o}return s(r);case M:return e(r,o,(c=i._init)(i._payload),l)}if(te(i))return h(r,o,i,l);if(D(i))return v(r,o,i,l);qo(r,i)}return"string"===typeof i&&""!==i||"number"===typeof i?(i=""+i,null!==o&&6===o.tag?(n(r,o.sibling),(o=a(o,i)).return=r,r=o):(n(r,o),(o=Iu(i,r.mode,l)).return=r,r=o),s(r)):n(r,o)}}var Qo=Ko(!0),Yo=Ko(!1),Xo={},ei=Ca(Xo),ti=Ca(Xo),ni=Ca(Xo);function ri(e){if(e===Xo)throw Error(o(174));return e}function ai(e,t){switch(xa(ni,t),xa(ti,e),xa(ei,Xo),e=t.nodeType){case 9:case 11:t=(t=t.documentElement)?t.namespaceURI:le(null,"");break;default:t=le(t=(e=8===e?t.parentNode:t).namespaceURI||null,e=e.tagName)}Ta(ei),xa(ei,t)}function oi(){Ta(ei),Ta(ti),Ta(ni)}function ii(e){ri(ni.current);var t=ri(ei.current),n=le(t,e.type);t!==n&&(xa(ti,e),xa(ei,n))}function si(e){ti.current===e&&(Ta(ei),Ta(ti))}var li=Ca(0);function ui(e){for(var t=e;null!==t;){if(13===t.tag){var n=t.memoizedState;if(null!==n&&(null===(n=n.dehydrated)||"$?"===n.data||"$!"===n.data))return t}else if(19===t.tag&&void 0!==t.memoizedProps.revealOrder){if(0!==(128&t.flags))return t}else if(null!==t.child){t.child.return=t,t=t.child;continue}if(t===e)break;for(;null===t.sibling;){if(null===t.return||t.return===e)return null;t=t.return}t.sibling.return=t.return,t=t.sibling}return null}var ci=[];function di(){for(var e=0;e<ci.length;e++)ci[e]._workInProgressVersionPrimary=null;ci.length=0}var fi=_.ReactCurrentDispatcher,pi=_.ReactCurrentBatchConfig,mi=0,hi=null,vi=null,bi=null,yi=!1,gi=!1,_i=0,wi=0;function Si(){throw Error(o(321))}function ki(e,t){if(null===t)return!1;for(var n=0;n<t.length&&n<e.length;n++)if(!sr(e[n],t[n]))return!1;return!0}function Ci(e,t,n,r,a,i){if(mi=i,hi=t,t.memoizedState=null,t.updateQueue=null,t.lanes=0,fi.current=null===e||null===e.memoizedState?ss:ls,e=n(r,a),gi){i=0;do{if(gi=!1,_i=0,25<=i)throw Error(o(301));i+=1,bi=vi=null,t.updateQueue=null,fi.current=us,e=n(r,a)}while(gi)}if(fi.current=is,t=null!==vi&&null!==vi.next,mi=0,bi=vi=hi=null,yi=!1,t)throw Error(o(300));return e}function Ti(){var e=0!==_i;return _i=0,e}function xi(){var e={memoizedState:null,baseState:null,baseQueue:null,queue:null,next:null};return null===bi?hi.memoizedState=bi=e:bi=bi.next=e,bi}function Fi(){if(null===vi){var e=hi.alternate;e=null!==e?e.memoizedState:null}else e=vi.next;var t=null===bi?hi.memoizedState:bi.next;if(null!==t)bi=t,vi=e;else{if(null===e)throw Error(o(310));e={memoizedState:(vi=e).memoizedState,baseState:vi.baseState,baseQueue:vi.baseQueue,queue:vi.queue,next:null},null===bi?hi.memoizedState=bi=e:bi=bi.next=e}return bi}function Pi(e,t){return"function"===typeof t?t(e):t}function Ai(e){var t=Fi(),n=t.queue;if(null===n)throw Error(o(311));n.lastRenderedReducer=e;var r=vi,a=r.baseQueue,i=n.pending;if(null!==i){if(null!==a){var s=a.next;a.next=i.next,i.next=s}r.baseQueue=a=i,n.pending=null}if(null!==a){i=a.next,r=r.baseState;var l=s=null,u=null,c=i;do{var d=c.lane;if((mi&d)===d)null!==u&&(u=u.next={lane:0,action:c.action,hasEagerState:c.hasEagerState,eagerState:c.eagerState,next:null}),r=c.hasEagerState?c.eagerState:e(r,c.action);else{var f={lane:d,action:c.action,hasEagerState:c.hasEagerState,eagerState:c.eagerState,next:null};null===u?(l=u=f,s=r):u=u.next=f,hi.lanes|=d,zl|=d}c=c.next}while(null!==c&&c!==i);null===u?s=r:u.next=l,sr(r,t.memoizedState)||(_s=!0),t.memoizedState=r,t.baseState=s,t.baseQueue=u,n.lastRenderedState=r}if(null!==(e=n.interleaved)){a=e;do{i=a.lane,hi.lanes|=i,zl|=i,a=a.next}while(a!==e)}else null===a&&(n.lanes=0);return[t.memoizedState,n.dispatch]}function Ni(e){var t=Fi(),n=t.queue;if(null===n)throw Error(o(311));n.lastRenderedReducer=e;var r=n.dispatch,a=n.pending,i=t.memoizedState;if(null!==a){n.pending=null;var s=a=a.next;do{i=e(i,s.action),s=s.next}while(s!==a);sr(i,t.memoizedState)||(_s=!0),t.memoizedState=i,null===t.baseQueue&&(t.baseState=i),n.lastRenderedState=i}return[i,r]}function Ei(){}function Mi(e,t){var n=hi,r=Fi(),a=t(),i=!sr(r.memoizedState,a);if(i&&(r.memoizedState=a,_s=!0),r=r.queue,Ji(Di.bind(null,n,r,e),[e]),r.getSnapshot!==t||i||null!==bi&&1&bi.memoizedState.tag){if(n.flags|=2048,Zi(9,Oi.bind(null,n,r,a,t),void 0,null),null===Al)throw Error(o(349));0!==(30&mi)||Ri(n,t,a)}return a}function Ri(e,t,n){e.flags|=16384,e={getSnapshot:t,value:n},null===(t=hi.updateQueue)?(t={lastEffect:null,stores:null},hi.updateQueue=t,t.stores=[e]):null===(n=t.stores)?t.stores=[e]:n.push(e)}function Oi(e,t,n,r){t.value=n,t.getSnapshot=r,zi(t)&&Ii(e)}function Di(e,t,n){return n((function(){zi(t)&&Ii(e)}))}function zi(e){var t=e.getSnapshot;e=e.value;try{var n=t();return!sr(e,n)}catch(r){return!0}}function Ii(e){var t=No(e,1);null!==t&&nu(t,e,1,-1)}function Li(e){var t=xi();return"function"===typeof e&&(e=e()),t.memoizedState=t.baseState=e,e={pending:null,interleaved:null,lanes:0,dispatch:null,lastRenderedReducer:Pi,lastRenderedState:e},t.queue=e,e=e.dispatch=ns.bind(null,hi,e),[t.memoizedState,e]}function Zi(e,t,n,r){return e={tag:e,create:t,destroy:n,deps:r,next:null},null===(t=hi.updateQueue)?(t={lastEffect:null,stores:null},hi.updateQueue=t,t.lastEffect=e.next=e):null===(n=t.lastEffect)?t.lastEffect=e.next=e:(r=n.next,n.next=e,e.next=r,t.lastEffect=e),e}function ji(){return Fi().memoizedState}function Bi(e,t,n,r){var a=xi();hi.flags|=e,a.memoizedState=Zi(1|t,n,void 0,void 0===r?null:r)}function Vi(e,t,n,r){var a=Fi();r=void 0===r?null:r;var o=void 0;if(null!==vi){var i=vi.memoizedState;if(o=i.destroy,null!==r&&ki(r,i.deps))return void(a.memoizedState=Zi(t,n,o,r))}hi.flags|=e,a.memoizedState=Zi(1|t,n,o,r)}function Ui(e,t){return Bi(8390656,8,e,t)}function Ji(e,t){return Vi(2048,8,e,t)}function Wi(e,t){return Vi(4,2,e,t)}function Hi(e,t){return Vi(4,4,e,t)}function $i(e,t){return"function"===typeof t?(e=e(),t(e),function(){t(null)}):null!==t&&void 0!==t?(e=e(),t.current=e,function(){t.current=null}):void 0}function qi(e,t,n){return n=null!==n&&void 0!==n?n.concat([e]):null,Vi(4,4,$i.bind(null,t,e),n)}function Gi(){}function Ki(e,t){var n=Fi();t=void 0===t?null:t;var r=n.memoizedState;return null!==r&&null!==t&&ki(t,r[1])?r[0]:(n.memoizedState=[e,t],e)}function Qi(e,t){var n=Fi();t=void 0===t?null:t;var r=n.memoizedState;return null!==r&&null!==t&&ki(t,r[1])?r[0]:(e=e(),n.memoizedState=[e,t],e)}function Yi(e,t,n){return 0===(21&mi)?(e.baseState&&(e.baseState=!1,_s=!0),e.memoizedState=n):(sr(n,t)||(n=ht(),hi.lanes|=n,zl|=n,e.baseState=!0),t)}function Xi(e,t){var n=gt;gt=0!==n&&4>n?n:4,e(!0);var r=pi.transition;pi.transition={};try{e(!1),t()}finally{gt=n,pi.transition=r}}function es(){return Fi().memoizedState}function ts(e,t,n){var r=tu(e);if(n={lane:r,action:n,hasEagerState:!1,eagerState:null,next:null},rs(e))as(t,n);else if(null!==(n=Ao(e,t,n,r))){nu(n,e,r,eu()),os(n,t,r)}}function ns(e,t,n){var r=tu(e),a={lane:r,action:n,hasEagerState:!1,eagerState:null,next:null};if(rs(e))as(t,a);else{var o=e.alternate;if(0===e.lanes&&(null===o||0===o.lanes)&&null!==(o=t.lastRenderedReducer))try{var i=t.lastRenderedState,s=o(i,n);if(a.hasEagerState=!0,a.eagerState=s,sr(s,i)){var l=t.interleaved;return null===l?(a.next=a,Po(t)):(a.next=l.next,l.next=a),void(t.interleaved=a)}}catch(u){}null!==(n=Ao(e,t,a,r))&&(nu(n,e,r,a=eu()),os(n,t,r))}}function rs(e){var t=e.alternate;return e===hi||null!==t&&t===hi}function as(e,t){gi=yi=!0;var n=e.pending;null===n?t.next=t:(t.next=n.next,n.next=t),e.pending=t}function os(e,t,n){if(0!==(4194240&n)){var r=t.lanes;n|=r&=e.pendingLanes,t.lanes=n,yt(e,n)}}var is={readContext:xo,useCallback:Si,useContext:Si,useEffect:Si,useImperativeHandle:Si,useInsertionEffect:Si,useLayoutEffect:Si,useMemo:Si,useReducer:Si,useRef:Si,useState:Si,useDebugValue:Si,useDeferredValue:Si,useTransition:Si,useMutableSource:Si,useSyncExternalStore:Si,useId:Si,unstable_isNewReconciler:!1},ss={readContext:xo,useCallback:function(e,t){return xi().memoizedState=[e,void 0===t?null:t],e},useContext:xo,useEffect:Ui,useImperativeHandle:function(e,t,n){return n=null!==n&&void 0!==n?n.concat([e]):null,Bi(4194308,4,$i.bind(null,t,e),n)},useLayoutEffect:function(e,t){return Bi(4194308,4,e,t)},useInsertionEffect:function(e,t){return Bi(4,2,e,t)},useMemo:function(e,t){var n=xi();return t=void 0===t?null:t,e=e(),n.memoizedState=[e,t],e},useReducer:function(e,t,n){var r=xi();return t=void 0!==n?n(t):t,r.memoizedState=r.baseState=t,e={pending:null,interleaved:null,lanes:0,dispatch:null,lastRenderedReducer:e,lastRenderedState:t},r.queue=e,e=e.dispatch=ts.bind(null,hi,e),[r.memoizedState,e]},useRef:function(e){return e={current:e},xi().memoizedState=e},useState:Li,useDebugValue:Gi,useDeferredValue:function(e){return xi().memoizedState=e},useTransition:function(){var e=Li(!1),t=e[0];return e=Xi.bind(null,e[1]),xi().memoizedState=e,[t,e]},useMutableSource:function(){},useSyncExternalStore:function(e,t,n){var r=hi,a=xi();if(ao){if(void 0===n)throw Error(o(407));n=n()}else{if(n=t(),null===Al)throw Error(o(349));0!==(30&mi)||Ri(r,t,n)}a.memoizedState=n;var i={value:n,getSnapshot:t};return a.queue=i,Ui(Di.bind(null,r,i,e),[e]),r.flags|=2048,Zi(9,Oi.bind(null,r,i,n,t),void 0,null),n},useId:function(){var e=xi(),t=Al.identifierPrefix;if(ao){var n=Qa;t=":"+t+"R"+(n=(Ka&~(1<<32-it(Ka)-1)).toString(32)+n),0<(n=_i++)&&(t+="H"+n.toString(32)),t+=":"}else t=":"+t+"r"+(n=wi++).toString(32)+":";return e.memoizedState=t},unstable_isNewReconciler:!1},ls={readContext:xo,useCallback:Ki,useContext:xo,useEffect:Ji,useImperativeHandle:qi,useInsertionEffect:Wi,useLayoutEffect:Hi,useMemo:Qi,useReducer:Ai,useRef:ji,useState:function(){return Ai(Pi)},useDebugValue:Gi,useDeferredValue:function(e){return Yi(Fi(),vi.memoizedState,e)},useTransition:function(){return[Ai(Pi)[0],Fi().memoizedState]},useMutableSource:Ei,useSyncExternalStore:Mi,useId:es,unstable_isNewReconciler:!1},us={readContext:xo,useCallback:Ki,useContext:xo,useEffect:Ji,useImperativeHandle:qi,useInsertionEffect:Wi,useLayoutEffect:Hi,useMemo:Qi,useReducer:Ni,useRef:ji,useState:function(){return Ni(Pi)},useDebugValue:Gi,useDeferredValue:function(e){var t=Fi();return null===vi?t.memoizedState=e:Yi(t,vi.memoizedState,e)},useTransition:function(){return[Ni(Pi)[0],Fi().memoizedState]},useMutableSource:Ei,useSyncExternalStore:Mi,useId:es,unstable_isNewReconciler:!1};function cs(e,t){try{var n="",r=t;do{n+=B(r),r=r.return}while(r);var a=n}catch(o){a="\nError generating stack: "+o.message+"\n"+o.stack}return{value:e,source:t,stack:a,digest:null}}function ds(e,t,n){return{value:e,source:null,stack:null!=n?n:null,digest:null!=t?t:null}}function fs(e,t){try{console.error(t.value)}catch(n){setTimeout((function(){throw n}))}}var ps="function"===typeof WeakMap?WeakMap:Map;function ms(e,t,n){(n=Oo(-1,n)).tag=3,n.payload={element:null};var r=t.value;return n.callback=function(){Jl||(Jl=!0,Wl=r),fs(0,t)},n}function hs(e,t,n){(n=Oo(-1,n)).tag=3;var r=e.type.getDerivedStateFromError;if("function"===typeof r){var a=t.value;n.payload=function(){return r(a)},n.callback=function(){fs(0,t)}}var o=e.stateNode;return null!==o&&"function"===typeof o.componentDidCatch&&(n.callback=function(){fs(0,t),"function"!==typeof r&&(null===Hl?Hl=new Set([this]):Hl.add(this));var e=t.stack;this.componentDidCatch(t.value,{componentStack:null!==e?e:""})}),n}function vs(e,t,n){var r=e.pingCache;if(null===r){r=e.pingCache=new ps;var a=new Set;r.set(t,a)}else void 0===(a=r.get(t))&&(a=new Set,r.set(t,a));a.has(n)||(a.add(n),e=Tu.bind(null,e,t,n),t.then(e,e))}function bs(e){do{var t;if((t=13===e.tag)&&(t=null===(t=e.memoizedState)||null!==t.dehydrated),t)return e;e=e.return}while(null!==e);return null}function ys(e,t,n,r,a){return 0===(1&e.mode)?(e===t?e.flags|=65536:(e.flags|=128,n.flags|=131072,n.flags&=-52805,1===n.tag&&(null===n.alternate?n.tag=17:((t=Oo(-1,1)).tag=2,Do(n,t,1))),n.lanes|=1),e):(e.flags|=65536,e.lanes=a,e)}var gs=_.ReactCurrentOwner,_s=!1;function ws(e,t,n,r){t.child=null===e?Yo(t,null,n,r):Qo(t,e.child,n,r)}function Ss(e,t,n,r,a){n=n.render;var o=t.ref;return To(t,a),r=Ci(e,t,n,r,o,a),n=Ti(),null===e||_s?(ao&&n&&eo(t),t.flags|=1,ws(e,t,r,a),t.child):(t.updateQueue=e.updateQueue,t.flags&=-2053,e.lanes&=~a,Js(e,t,a))}function ks(e,t,n,r,a){if(null===e){var o=n.type;return"function"!==typeof o||Mu(o)||void 0!==o.defaultProps||null!==n.compare||void 0!==n.defaultProps?((e=Ou(n.type,null,r,t,t.mode,a)).ref=t.ref,e.return=t,t.child=e):(t.tag=15,t.type=o,Cs(e,t,o,r,a))}if(o=e.child,0===(e.lanes&a)){var i=o.memoizedProps;if((n=null!==(n=n.compare)?n:lr)(i,r)&&e.ref===t.ref)return Js(e,t,a)}return t.flags|=1,(e=Ru(o,r)).ref=t.ref,e.return=t,t.child=e}function Cs(e,t,n,r,a){if(null!==e){var o=e.memoizedProps;if(lr(o,r)&&e.ref===t.ref){if(_s=!1,t.pendingProps=r=o,0===(e.lanes&a))return t.lanes=e.lanes,Js(e,t,a);0!==(131072&e.flags)&&(_s=!0)}}return Fs(e,t,n,r,a)}function Ts(e,t,n){var r=t.pendingProps,a=r.children,o=null!==e?e.memoizedState:null;if("hidden"===r.mode)if(0===(1&t.mode))t.memoizedState={baseLanes:0,cachePool:null,transitions:null},xa(Rl,Ml),Ml|=n;else{if(0===(1073741824&n))return e=null!==o?o.baseLanes|n:n,t.lanes=t.childLanes=1073741824,t.memoizedState={baseLanes:e,cachePool:null,transitions:null},t.updateQueue=null,xa(Rl,Ml),Ml|=e,null;t.memoizedState={baseLanes:0,cachePool:null,transitions:null},r=null!==o?o.baseLanes:n,xa(Rl,Ml),Ml|=r}else null!==o?(r=o.baseLanes|n,t.memoizedState=null):r=n,xa(Rl,Ml),Ml|=r;return ws(e,t,a,n),t.child}function xs(e,t){var n=t.ref;(null===e&&null!==n||null!==e&&e.ref!==n)&&(t.flags|=512,t.flags|=2097152)}function Fs(e,t,n,r,a){var o=Ma(n)?Na:Pa.current;return o=Ea(t,o),To(t,a),n=Ci(e,t,n,r,o,a),r=Ti(),null===e||_s?(ao&&r&&eo(t),t.flags|=1,ws(e,t,n,a),t.child):(t.updateQueue=e.updateQueue,t.flags&=-2053,e.lanes&=~a,Js(e,t,a))}function Ps(e,t,n,r,a){if(Ma(n)){var o=!0;za(t)}else o=!1;if(To(t,a),null===t.stateNode)Us(e,t),Jo(t,n,r),Ho(t,n,r,a),r=!0;else if(null===e){var i=t.stateNode,s=t.memoizedProps;i.props=s;var l=i.context,u=n.contextType;"object"===typeof u&&null!==u?u=xo(u):u=Ea(t,u=Ma(n)?Na:Pa.current);var c=n.getDerivedStateFromProps,d="function"===typeof c||"function"===typeof i.getSnapshotBeforeUpdate;d||"function"!==typeof i.UNSAFE_componentWillReceiveProps&&"function"!==typeof i.componentWillReceiveProps||(s!==r||l!==u)&&Wo(t,i,r,u),Eo=!1;var f=t.memoizedState;i.state=f,Lo(t,r,i,a),l=t.memoizedState,s!==r||f!==l||Aa.current||Eo?("function"===typeof c&&(Bo(t,n,c,r),l=t.memoizedState),(s=Eo||Uo(t,n,s,r,f,l,u))?(d||"function"!==typeof i.UNSAFE_componentWillMount&&"function"!==typeof i.componentWillMount||("function"===typeof i.componentWillMount&&i.componentWillMount(),"function"===typeof i.UNSAFE_componentWillMount&&i.UNSAFE_componentWillMount()),"function"===typeof i.componentDidMount&&(t.flags|=4194308)):("function"===typeof i.componentDidMount&&(t.flags|=4194308),t.memoizedProps=r,t.memoizedState=l),i.props=r,i.state=l,i.context=u,r=s):("function"===typeof i.componentDidMount&&(t.flags|=4194308),r=!1)}else{i=t.stateNode,Ro(e,t),s=t.memoizedProps,u=t.type===t.elementType?s:bo(t.type,s),i.props=u,d=t.pendingProps,f=i.context,"object"===typeof(l=n.contextType)&&null!==l?l=xo(l):l=Ea(t,l=Ma(n)?Na:Pa.current);var p=n.getDerivedStateFromProps;(c="function"===typeof p||"function"===typeof i.getSnapshotBeforeUpdate)||"function"!==typeof i.UNSAFE_componentWillReceiveProps&&"function"!==typeof i.componentWillReceiveProps||(s!==d||f!==l)&&Wo(t,i,r,l),Eo=!1,f=t.memoizedState,i.state=f,Lo(t,r,i,a);var m=t.memoizedState;s!==d||f!==m||Aa.current||Eo?("function"===typeof p&&(Bo(t,n,p,r),m=t.memoizedState),(u=Eo||Uo(t,n,u,r,f,m,l)||!1)?(c||"function"!==typeof i.UNSAFE_componentWillUpdate&&"function"!==typeof i.componentWillUpdate||("function"===typeof i.componentWillUpdate&&i.componentWillUpdate(r,m,l),"function"===typeof i.UNSAFE_componentWillUpdate&&i.UNSAFE_componentWillUpdate(r,m,l)),"function"===typeof i.componentDidUpdate&&(t.flags|=4),"function"===typeof i.getSnapshotBeforeUpdate&&(t.flags|=1024)):("function"!==typeof i.componentDidUpdate||s===e.memoizedProps&&f===e.memoizedState||(t.flags|=4),"function"!==typeof i.getSnapshotBeforeUpdate||s===e.memoizedProps&&f===e.memoizedState||(t.flags|=1024),t.memoizedProps=r,t.memoizedState=m),i.props=r,i.state=m,i.context=l,r=u):("function"!==typeof i.componentDidUpdate||s===e.memoizedProps&&f===e.memoizedState||(t.flags|=4),"function"!==typeof i.getSnapshotBeforeUpdate||s===e.memoizedProps&&f===e.memoizedState||(t.flags|=1024),r=!1)}return As(e,t,n,r,o,a)}function As(e,t,n,r,a,o){xs(e,t);var i=0!==(128&t.flags);if(!r&&!i)return a&&Ia(t,n,!1),Js(e,t,o);r=t.stateNode,gs.current=t;var s=i&&"function"!==typeof n.getDerivedStateFromError?null:r.render();return t.flags|=1,null!==e&&i?(t.child=Qo(t,e.child,null,o),t.child=Qo(t,null,s,o)):ws(e,t,s,o),t.memoizedState=r.state,a&&Ia(t,n,!0),t.child}function Ns(e){var t=e.stateNode;t.pendingContext?Oa(0,t.pendingContext,t.pendingContext!==t.context):t.context&&Oa(0,t.context,!1),ai(e,t.containerInfo)}function Es(e,t,n,r,a){return mo(),ho(a),t.flags|=256,ws(e,t,n,r),t.child}var Ms,Rs,Os,Ds={dehydrated:null,treeContext:null,retryLane:0};function zs(e){return{baseLanes:e,cachePool:null,transitions:null}}function Is(e,t,n){var r,a=t.pendingProps,i=li.current,s=!1,l=0!==(128&t.flags);if((r=l)||(r=(null===e||null!==e.memoizedState)&&0!==(2&i)),r?(s=!0,t.flags&=-129):null!==e&&null===e.memoizedState||(i|=1),xa(li,1&i),null===e)return uo(t),null!==(e=t.memoizedState)&&null!==(e=e.dehydrated)?(0===(1&t.mode)?t.lanes=1:"$!"===e.data?t.lanes=8:t.lanes=1073741824,null):(l=a.children,e=a.fallback,s?(a=t.mode,s=t.child,l={mode:"hidden",children:l},0===(1&a)&&null!==s?(s.childLanes=0,s.pendingProps=l):s=zu(l,a,0,null),e=Du(e,a,n,null),s.return=t,e.return=t,s.sibling=e,t.child=s,t.child.memoizedState=zs(n),t.memoizedState=Ds,e):Ls(t,l));if(null!==(i=e.memoizedState)&&null!==(r=i.dehydrated))return function(e,t,n,r,a,i,s){if(n)return 256&t.flags?(t.flags&=-257,Zs(e,t,s,r=ds(Error(o(422))))):null!==t.memoizedState?(t.child=e.child,t.flags|=128,null):(i=r.fallback,a=t.mode,r=zu({mode:"visible",children:r.children},a,0,null),(i=Du(i,a,s,null)).flags|=2,r.return=t,i.return=t,r.sibling=i,t.child=r,0!==(1&t.mode)&&Qo(t,e.child,null,s),t.child.memoizedState=zs(s),t.memoizedState=Ds,i);if(0===(1&t.mode))return Zs(e,t,s,null);if("$!"===a.data){if(r=a.nextSibling&&a.nextSibling.dataset)var l=r.dgst;return r=l,Zs(e,t,s,r=ds(i=Error(o(419)),r,void 0))}if(l=0!==(s&e.childLanes),_s||l){if(null!==(r=Al)){switch(s&-s){case 4:a=2;break;case 16:a=8;break;case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:a=32;break;case 536870912:a=268435456;break;default:a=0}0!==(a=0!==(a&(r.suspendedLanes|s))?0:a)&&a!==i.retryLane&&(i.retryLane=a,No(e,a),nu(r,e,a,-1))}return hu(),Zs(e,t,s,r=ds(Error(o(421))))}return"$?"===a.data?(t.flags|=128,t.child=e.child,t=Fu.bind(null,e),a._reactRetry=t,null):(e=i.treeContext,ro=ua(a.nextSibling),no=t,ao=!0,oo=null,null!==e&&($a[qa++]=Ka,$a[qa++]=Qa,$a[qa++]=Ga,Ka=e.id,Qa=e.overflow,Ga=t),(t=Ls(t,r.children)).flags|=4096,t)}(e,t,l,a,r,i,n);if(s){s=a.fallback,l=t.mode,r=(i=e.child).sibling;var u={mode:"hidden",children:a.children};return 0===(1&l)&&t.child!==i?((a=t.child).childLanes=0,a.pendingProps=u,t.deletions=null):(a=Ru(i,u)).subtreeFlags=14680064&i.subtreeFlags,null!==r?s=Ru(r,s):(s=Du(s,l,n,null)).flags|=2,s.return=t,a.return=t,a.sibling=s,t.child=a,a=s,s=t.child,l=null===(l=e.child.memoizedState)?zs(n):{baseLanes:l.baseLanes|n,cachePool:null,transitions:l.transitions},s.memoizedState=l,s.childLanes=e.childLanes&~n,t.memoizedState=Ds,a}return e=(s=e.child).sibling,a=Ru(s,{mode:"visible",children:a.children}),0===(1&t.mode)&&(a.lanes=n),a.return=t,a.sibling=null,null!==e&&(null===(n=t.deletions)?(t.deletions=[e],t.flags|=16):n.push(e)),t.child=a,t.memoizedState=null,a}function Ls(e,t){return(t=zu({mode:"visible",children:t},e.mode,0,null)).return=e,e.child=t}function Zs(e,t,n,r){return null!==r&&ho(r),Qo(t,e.child,null,n),(e=Ls(t,t.pendingProps.children)).flags|=2,t.memoizedState=null,e}function js(e,t,n){e.lanes|=t;var r=e.alternate;null!==r&&(r.lanes|=t),Co(e.return,t,n)}function Bs(e,t,n,r,a){var o=e.memoizedState;null===o?e.memoizedState={isBackwards:t,rendering:null,renderingStartTime:0,last:r,tail:n,tailMode:a}:(o.isBackwards=t,o.rendering=null,o.renderingStartTime=0,o.last=r,o.tail=n,o.tailMode=a)}function Vs(e,t,n){var r=t.pendingProps,a=r.revealOrder,o=r.tail;if(ws(e,t,r.children,n),0!==(2&(r=li.current)))r=1&r|2,t.flags|=128;else{if(null!==e&&0!==(128&e.flags))e:for(e=t.child;null!==e;){if(13===e.tag)null!==e.memoizedState&&js(e,n,t);else if(19===e.tag)js(e,n,t);else if(null!==e.child){e.child.return=e,e=e.child;continue}if(e===t)break e;for(;null===e.sibling;){if(null===e.return||e.return===t)break e;e=e.return}e.sibling.return=e.return,e=e.sibling}r&=1}if(xa(li,r),0===(1&t.mode))t.memoizedState=null;else switch(a){case"forwards":for(n=t.child,a=null;null!==n;)null!==(e=n.alternate)&&null===ui(e)&&(a=n),n=n.sibling;null===(n=a)?(a=t.child,t.child=null):(a=n.sibling,n.sibling=null),Bs(t,!1,a,n,o);break;case"backwards":for(n=null,a=t.child,t.child=null;null!==a;){if(null!==(e=a.alternate)&&null===ui(e)){t.child=a;break}e=a.sibling,a.sibling=n,n=a,a=e}Bs(t,!0,n,null,o);break;case"together":Bs(t,!1,null,null,void 0);break;default:t.memoizedState=null}return t.child}function Us(e,t){0===(1&t.mode)&&null!==e&&(e.alternate=null,t.alternate=null,t.flags|=2)}function Js(e,t,n){if(null!==e&&(t.dependencies=e.dependencies),zl|=t.lanes,0===(n&t.childLanes))return null;if(null!==e&&t.child!==e.child)throw Error(o(153));if(null!==t.child){for(n=Ru(e=t.child,e.pendingProps),t.child=n,n.return=t;null!==e.sibling;)e=e.sibling,(n=n.sibling=Ru(e,e.pendingProps)).return=t;n.sibling=null}return t.child}function Ws(e,t){if(!ao)switch(e.tailMode){case"hidden":t=e.tail;for(var n=null;null!==t;)null!==t.alternate&&(n=t),t=t.sibling;null===n?e.tail=null:n.sibling=null;break;case"collapsed":n=e.tail;for(var r=null;null!==n;)null!==n.alternate&&(r=n),n=n.sibling;null===r?t||null===e.tail?e.tail=null:e.tail.sibling=null:r.sibling=null}}function Hs(e){var t=null!==e.alternate&&e.alternate.child===e.child,n=0,r=0;if(t)for(var a=e.child;null!==a;)n|=a.lanes|a.childLanes,r|=14680064&a.subtreeFlags,r|=14680064&a.flags,a.return=e,a=a.sibling;else for(a=e.child;null!==a;)n|=a.lanes|a.childLanes,r|=a.subtreeFlags,r|=a.flags,a.return=e,a=a.sibling;return e.subtreeFlags|=r,e.childLanes=n,t}function $s(e,t,n){var r=t.pendingProps;switch(to(t),t.tag){case 2:case 16:case 15:case 0:case 11:case 7:case 8:case 12:case 9:case 14:return Hs(t),null;case 1:case 17:return Ma(t.type)&&Ra(),Hs(t),null;case 3:return r=t.stateNode,oi(),Ta(Aa),Ta(Pa),di(),r.pendingContext&&(r.context=r.pendingContext,r.pendingContext=null),null!==e&&null!==e.child||(fo(t)?t.flags|=4:null===e||e.memoizedState.isDehydrated&&0===(256&t.flags)||(t.flags|=1024,null!==oo&&(iu(oo),oo=null))),Hs(t),null;case 5:si(t);var a=ri(ni.current);if(n=t.type,null!==e&&null!=t.stateNode)Rs(e,t,n,r),e.ref!==t.ref&&(t.flags|=512,t.flags|=2097152);else{if(!r){if(null===t.stateNode)throw Error(o(166));return Hs(t),null}if(e=ri(ei.current),fo(t)){r=t.stateNode,n=t.type;var i=t.memoizedProps;switch(r[fa]=t,r[pa]=i,e=0!==(1&t.mode),n){case"dialog":Zr("cancel",r),Zr("close",r);break;case"iframe":case"object":case"embed":Zr("load",r);break;case"video":case"audio":for(a=0;a<Dr.length;a++)Zr(Dr[a],r);break;case"source":Zr("error",r);break;case"img":case"image":case"link":Zr("error",r),Zr("load",r);break;case"details":Zr("toggle",r);break;case"input":K(r,i),Zr("invalid",r);break;case"select":r._wrapperState={wasMultiple:!!i.multiple},Zr("invalid",r);break;case"textarea":ae(r,i),Zr("invalid",r)}for(var l in ye(n,i),a=null,i)if(i.hasOwnProperty(l)){var u=i[l];"children"===l?"string"===typeof u?r.textContent!==u&&(!0!==i.suppressHydrationWarning&&Yr(r.textContent,u,e),a=["children",u]):"number"===typeof u&&r.textContent!==""+u&&(!0!==i.suppressHydrationWarning&&Yr(r.textContent,u,e),a=["children",""+u]):s.hasOwnProperty(l)&&null!=u&&"onScroll"===l&&Zr("scroll",r)}switch(n){case"input":H(r),X(r,i,!0);break;case"textarea":H(r),ie(r);break;case"select":case"option":break;default:"function"===typeof i.onClick&&(r.onclick=Xr)}r=a,t.updateQueue=r,null!==r&&(t.flags|=4)}else{l=9===a.nodeType?a:a.ownerDocument,"http://www.w3.org/1999/xhtml"===e&&(e=se(n)),"http://www.w3.org/1999/xhtml"===e?"script"===n?((e=l.createElement("div")).innerHTML="<script><\/script>",e=e.removeChild(e.firstChild)):"string"===typeof r.is?e=l.createElement(n,{is:r.is}):(e=l.createElement(n),"select"===n&&(l=e,r.multiple?l.multiple=!0:r.size&&(l.size=r.size))):e=l.createElementNS(e,n),e[fa]=t,e[pa]=r,Ms(e,t),t.stateNode=e;e:{switch(l=ge(n,r),n){case"dialog":Zr("cancel",e),Zr("close",e),a=r;break;case"iframe":case"object":case"embed":Zr("load",e),a=r;break;case"video":case"audio":for(a=0;a<Dr.length;a++)Zr(Dr[a],e);a=r;break;case"source":Zr("error",e),a=r;break;case"img":case"image":case"link":Zr("error",e),Zr("load",e),a=r;break;case"details":Zr("toggle",e),a=r;break;case"input":K(e,r),a=G(e,r),Zr("invalid",e);break;case"option":default:a=r;break;case"select":e._wrapperState={wasMultiple:!!r.multiple},a=I({},r,{value:void 0}),Zr("invalid",e);break;case"textarea":ae(e,r),a=re(e,r),Zr("invalid",e)}for(i in ye(n,a),u=a)if(u.hasOwnProperty(i)){var c=u[i];"style"===i?ve(e,c):"dangerouslySetInnerHTML"===i?null!=(c=c?c.__html:void 0)&&de(e,c):"children"===i?"string"===typeof c?("textarea"!==n||""!==c)&&fe(e,c):"number"===typeof c&&fe(e,""+c):"suppressContentEditableWarning"!==i&&"suppressHydrationWarning"!==i&&"autoFocus"!==i&&(s.hasOwnProperty(i)?null!=c&&"onScroll"===i&&Zr("scroll",e):null!=c&&g(e,i,c,l))}switch(n){case"input":H(e),X(e,r,!1);break;case"textarea":H(e),ie(e);break;case"option":null!=r.value&&e.setAttribute("value",""+J(r.value));break;case"select":e.multiple=!!r.multiple,null!=(i=r.value)?ne(e,!!r.multiple,i,!1):null!=r.defaultValue&&ne(e,!!r.multiple,r.defaultValue,!0);break;default:"function"===typeof a.onClick&&(e.onclick=Xr)}switch(n){case"button":case"input":case"select":case"textarea":r=!!r.autoFocus;break e;case"img":r=!0;break e;default:r=!1}}r&&(t.flags|=4)}null!==t.ref&&(t.flags|=512,t.flags|=2097152)}return Hs(t),null;case 6:if(e&&null!=t.stateNode)Os(0,t,e.memoizedProps,r);else{if("string"!==typeof r&&null===t.stateNode)throw Error(o(166));if(n=ri(ni.current),ri(ei.current),fo(t)){if(r=t.stateNode,n=t.memoizedProps,r[fa]=t,(i=r.nodeValue!==n)&&null!==(e=no))switch(e.tag){case 3:Yr(r.nodeValue,n,0!==(1&e.mode));break;case 5:!0!==e.memoizedProps.suppressHydrationWarning&&Yr(r.nodeValue,n,0!==(1&e.mode))}i&&(t.flags|=4)}else(r=(9===n.nodeType?n:n.ownerDocument).createTextNode(r))[fa]=t,t.stateNode=r}return Hs(t),null;case 13:if(Ta(li),r=t.memoizedState,null===e||null!==e.memoizedState&&null!==e.memoizedState.dehydrated){if(ao&&null!==ro&&0!==(1&t.mode)&&0===(128&t.flags))po(),mo(),t.flags|=98560,i=!1;else if(i=fo(t),null!==r&&null!==r.dehydrated){if(null===e){if(!i)throw Error(o(318));if(!(i=null!==(i=t.memoizedState)?i.dehydrated:null))throw Error(o(317));i[fa]=t}else mo(),0===(128&t.flags)&&(t.memoizedState=null),t.flags|=4;Hs(t),i=!1}else null!==oo&&(iu(oo),oo=null),i=!0;if(!i)return 65536&t.flags?t:null}return 0!==(128&t.flags)?(t.lanes=n,t):((r=null!==r)!==(null!==e&&null!==e.memoizedState)&&r&&(t.child.flags|=8192,0!==(1&t.mode)&&(null===e||0!==(1&li.current)?0===Ol&&(Ol=3):hu())),null!==t.updateQueue&&(t.flags|=4),Hs(t),null);case 4:return oi(),null===e&&Vr(t.stateNode.containerInfo),Hs(t),null;case 10:return ko(t.type._context),Hs(t),null;case 19:if(Ta(li),null===(i=t.memoizedState))return Hs(t),null;if(r=0!==(128&t.flags),null===(l=i.rendering))if(r)Ws(i,!1);else{if(0!==Ol||null!==e&&0!==(128&e.flags))for(e=t.child;null!==e;){if(null!==(l=ui(e))){for(t.flags|=128,Ws(i,!1),null!==(r=l.updateQueue)&&(t.updateQueue=r,t.flags|=4),t.subtreeFlags=0,r=n,n=t.child;null!==n;)e=r,(i=n).flags&=14680066,null===(l=i.alternate)?(i.childLanes=0,i.lanes=e,i.child=null,i.subtreeFlags=0,i.memoizedProps=null,i.memoizedState=null,i.updateQueue=null,i.dependencies=null,i.stateNode=null):(i.childLanes=l.childLanes,i.lanes=l.lanes,i.child=l.child,i.subtreeFlags=0,i.deletions=null,i.memoizedProps=l.memoizedProps,i.memoizedState=l.memoizedState,i.updateQueue=l.updateQueue,i.type=l.type,e=l.dependencies,i.dependencies=null===e?null:{lanes:e.lanes,firstContext:e.firstContext}),n=n.sibling;return xa(li,1&li.current|2),t.child}e=e.sibling}null!==i.tail&&Qe()>Vl&&(t.flags|=128,r=!0,Ws(i,!1),t.lanes=4194304)}else{if(!r)if(null!==(e=ui(l))){if(t.flags|=128,r=!0,null!==(n=e.updateQueue)&&(t.updateQueue=n,t.flags|=4),Ws(i,!0),null===i.tail&&"hidden"===i.tailMode&&!l.alternate&&!ao)return Hs(t),null}else 2*Qe()-i.renderingStartTime>Vl&&1073741824!==n&&(t.flags|=128,r=!0,Ws(i,!1),t.lanes=4194304);i.isBackwards?(l.sibling=t.child,t.child=l):(null!==(n=i.last)?n.sibling=l:t.child=l,i.last=l)}return null!==i.tail?(t=i.tail,i.rendering=t,i.tail=t.sibling,i.renderingStartTime=Qe(),t.sibling=null,n=li.current,xa(li,r?1&n|2:1&n),t):(Hs(t),null);case 22:case 23:return du(),r=null!==t.memoizedState,null!==e&&null!==e.memoizedState!==r&&(t.flags|=8192),r&&0!==(1&t.mode)?0!==(1073741824&Ml)&&(Hs(t),6&t.subtreeFlags&&(t.flags|=8192)):Hs(t),null;case 24:case 25:return null}throw Error(o(156,t.tag))}function qs(e,t){switch(to(t),t.tag){case 1:return Ma(t.type)&&Ra(),65536&(e=t.flags)?(t.flags=-65537&e|128,t):null;case 3:return oi(),Ta(Aa),Ta(Pa),di(),0!==(65536&(e=t.flags))&&0===(128&e)?(t.flags=-65537&e|128,t):null;case 5:return si(t),null;case 13:if(Ta(li),null!==(e=t.memoizedState)&&null!==e.dehydrated){if(null===t.alternate)throw Error(o(340));mo()}return 65536&(e=t.flags)?(t.flags=-65537&e|128,t):null;case 19:return Ta(li),null;case 4:return oi(),null;case 10:return ko(t.type._context),null;case 22:case 23:return du(),null;default:return null}}Ms=function(e,t){for(var n=t.child;null!==n;){if(5===n.tag||6===n.tag)e.appendChild(n.stateNode);else if(4!==n.tag&&null!==n.child){n.child.return=n,n=n.child;continue}if(n===t)break;for(;null===n.sibling;){if(null===n.return||n.return===t)return;n=n.return}n.sibling.return=n.return,n=n.sibling}},Rs=function(e,t,n,r){var a=e.memoizedProps;if(a!==r){e=t.stateNode,ri(ei.current);var o,i=null;switch(n){case"input":a=G(e,a),r=G(e,r),i=[];break;case"select":a=I({},a,{value:void 0}),r=I({},r,{value:void 0}),i=[];break;case"textarea":a=re(e,a),r=re(e,r),i=[];break;default:"function"!==typeof a.onClick&&"function"===typeof r.onClick&&(e.onclick=Xr)}for(c in ye(n,r),n=null,a)if(!r.hasOwnProperty(c)&&a.hasOwnProperty(c)&&null!=a[c])if("style"===c){var l=a[c];for(o in l)l.hasOwnProperty(o)&&(n||(n={}),n[o]="")}else"dangerouslySetInnerHTML"!==c&&"children"!==c&&"suppressContentEditableWarning"!==c&&"suppressHydrationWarning"!==c&&"autoFocus"!==c&&(s.hasOwnProperty(c)?i||(i=[]):(i=i||[]).push(c,null));for(c in r){var u=r[c];if(l=null!=a?a[c]:void 0,r.hasOwnProperty(c)&&u!==l&&(null!=u||null!=l))if("style"===c)if(l){for(o in l)!l.hasOwnProperty(o)||u&&u.hasOwnProperty(o)||(n||(n={}),n[o]="");for(o in u)u.hasOwnProperty(o)&&l[o]!==u[o]&&(n||(n={}),n[o]=u[o])}else n||(i||(i=[]),i.push(c,n)),n=u;else"dangerouslySetInnerHTML"===c?(u=u?u.__html:void 0,l=l?l.__html:void 0,null!=u&&l!==u&&(i=i||[]).push(c,u)):"children"===c?"string"!==typeof u&&"number"!==typeof u||(i=i||[]).push(c,""+u):"suppressContentEditableWarning"!==c&&"suppressHydrationWarning"!==c&&(s.hasOwnProperty(c)?(null!=u&&"onScroll"===c&&Zr("scroll",e),i||l===u||(i=[])):(i=i||[]).push(c,u))}n&&(i=i||[]).push("style",n);var c=i;(t.updateQueue=c)&&(t.flags|=4)}},Os=function(e,t,n,r){n!==r&&(t.flags|=4)};var Gs=!1,Ks=!1,Qs="function"===typeof WeakSet?WeakSet:Set,Ys=null;function Xs(e,t){var n=e.ref;if(null!==n)if("function"===typeof n)try{n(null)}catch(r){Cu(e,t,r)}else n.current=null}function el(e,t,n){try{n()}catch(r){Cu(e,t,r)}}var tl=!1;function nl(e,t,n){var r=t.updateQueue;if(null!==(r=null!==r?r.lastEffect:null)){var a=r=r.next;do{if((a.tag&e)===e){var o=a.destroy;a.destroy=void 0,void 0!==o&&el(t,n,o)}a=a.next}while(a!==r)}}function rl(e,t){if(null!==(t=null!==(t=t.updateQueue)?t.lastEffect:null)){var n=t=t.next;do{if((n.tag&e)===e){var r=n.create;n.destroy=r()}n=n.next}while(n!==t)}}function al(e){var t=e.ref;if(null!==t){var n=e.stateNode;e.tag,e=n,"function"===typeof t?t(e):t.current=e}}function ol(e){var t=e.alternate;null!==t&&(e.alternate=null,ol(t)),e.child=null,e.deletions=null,e.sibling=null,5===e.tag&&(null!==(t=e.stateNode)&&(delete t[fa],delete t[pa],delete t[ha],delete t[va],delete t[ba])),e.stateNode=null,e.return=null,e.dependencies=null,e.memoizedProps=null,e.memoizedState=null,e.pendingProps=null,e.stateNode=null,e.updateQueue=null}function il(e){return 5===e.tag||3===e.tag||4===e.tag}function sl(e){e:for(;;){for(;null===e.sibling;){if(null===e.return||il(e.return))return null;e=e.return}for(e.sibling.return=e.return,e=e.sibling;5!==e.tag&&6!==e.tag&&18!==e.tag;){if(2&e.flags)continue e;if(null===e.child||4===e.tag)continue e;e.child.return=e,e=e.child}if(!(2&e.flags))return e.stateNode}}function ll(e,t,n){var r=e.tag;if(5===r||6===r)e=e.stateNode,t?8===n.nodeType?n.parentNode.insertBefore(e,t):n.insertBefore(e,t):(8===n.nodeType?(t=n.parentNode).insertBefore(e,n):(t=n).appendChild(e),null!==(n=n._reactRootContainer)&&void 0!==n||null!==t.onclick||(t.onclick=Xr));else if(4!==r&&null!==(e=e.child))for(ll(e,t,n),e=e.sibling;null!==e;)ll(e,t,n),e=e.sibling}function ul(e,t,n){var r=e.tag;if(5===r||6===r)e=e.stateNode,t?n.insertBefore(e,t):n.appendChild(e);else if(4!==r&&null!==(e=e.child))for(ul(e,t,n),e=e.sibling;null!==e;)ul(e,t,n),e=e.sibling}var cl=null,dl=!1;function fl(e,t,n){for(n=n.child;null!==n;)pl(e,t,n),n=n.sibling}function pl(e,t,n){if(ot&&"function"===typeof ot.onCommitFiberUnmount)try{ot.onCommitFiberUnmount(at,n)}catch(s){}switch(n.tag){case 5:Ks||Xs(n,t);case 6:var r=cl,a=dl;cl=null,fl(e,t,n),dl=a,null!==(cl=r)&&(dl?(e=cl,n=n.stateNode,8===e.nodeType?e.parentNode.removeChild(n):e.removeChild(n)):cl.removeChild(n.stateNode));break;case 18:null!==cl&&(dl?(e=cl,n=n.stateNode,8===e.nodeType?la(e.parentNode,n):1===e.nodeType&&la(e,n),Vt(e)):la(cl,n.stateNode));break;case 4:r=cl,a=dl,cl=n.stateNode.containerInfo,dl=!0,fl(e,t,n),cl=r,dl=a;break;case 0:case 11:case 14:case 15:if(!Ks&&(null!==(r=n.updateQueue)&&null!==(r=r.lastEffect))){a=r=r.next;do{var o=a,i=o.destroy;o=o.tag,void 0!==i&&(0!==(2&o)||0!==(4&o))&&el(n,t,i),a=a.next}while(a!==r)}fl(e,t,n);break;case 1:if(!Ks&&(Xs(n,t),"function"===typeof(r=n.stateNode).componentWillUnmount))try{r.props=n.memoizedProps,r.state=n.memoizedState,r.componentWillUnmount()}catch(s){Cu(n,t,s)}fl(e,t,n);break;case 21:fl(e,t,n);break;case 22:1&n.mode?(Ks=(r=Ks)||null!==n.memoizedState,fl(e,t,n),Ks=r):fl(e,t,n);break;default:fl(e,t,n)}}function ml(e){var t=e.updateQueue;if(null!==t){e.updateQueue=null;var n=e.stateNode;null===n&&(n=e.stateNode=new Qs),t.forEach((function(t){var r=Pu.bind(null,e,t);n.has(t)||(n.add(t),t.then(r,r))}))}}function hl(e,t){var n=t.deletions;if(null!==n)for(var r=0;r<n.length;r++){var a=n[r];try{var i=e,s=t,l=s;e:for(;null!==l;){switch(l.tag){case 5:cl=l.stateNode,dl=!1;break e;case 3:case 4:cl=l.stateNode.containerInfo,dl=!0;break e}l=l.return}if(null===cl)throw Error(o(160));pl(i,s,a),cl=null,dl=!1;var u=a.alternate;null!==u&&(u.return=null),a.return=null}catch(c){Cu(a,t,c)}}if(12854&t.subtreeFlags)for(t=t.child;null!==t;)vl(t,e),t=t.sibling}function vl(e,t){var n=e.alternate,r=e.flags;switch(e.tag){case 0:case 11:case 14:case 15:if(hl(t,e),bl(e),4&r){try{nl(3,e,e.return),rl(3,e)}catch(v){Cu(e,e.return,v)}try{nl(5,e,e.return)}catch(v){Cu(e,e.return,v)}}break;case 1:hl(t,e),bl(e),512&r&&null!==n&&Xs(n,n.return);break;case 5:if(hl(t,e),bl(e),512&r&&null!==n&&Xs(n,n.return),32&e.flags){var a=e.stateNode;try{fe(a,"")}catch(v){Cu(e,e.return,v)}}if(4&r&&null!=(a=e.stateNode)){var i=e.memoizedProps,s=null!==n?n.memoizedProps:i,l=e.type,u=e.updateQueue;if(e.updateQueue=null,null!==u)try{"input"===l&&"radio"===i.type&&null!=i.name&&Q(a,i),ge(l,s);var c=ge(l,i);for(s=0;s<u.length;s+=2){var d=u[s],f=u[s+1];"style"===d?ve(a,f):"dangerouslySetInnerHTML"===d?de(a,f):"children"===d?fe(a,f):g(a,d,f,c)}switch(l){case"input":Y(a,i);break;case"textarea":oe(a,i);break;case"select":var p=a._wrapperState.wasMultiple;a._wrapperState.wasMultiple=!!i.multiple;var m=i.value;null!=m?ne(a,!!i.multiple,m,!1):p!==!!i.multiple&&(null!=i.defaultValue?ne(a,!!i.multiple,i.defaultValue,!0):ne(a,!!i.multiple,i.multiple?[]:"",!1))}a[pa]=i}catch(v){Cu(e,e.return,v)}}break;case 6:if(hl(t,e),bl(e),4&r){if(null===e.stateNode)throw Error(o(162));a=e.stateNode,i=e.memoizedProps;try{a.nodeValue=i}catch(v){Cu(e,e.return,v)}}break;case 3:if(hl(t,e),bl(e),4&r&&null!==n&&n.memoizedState.isDehydrated)try{Vt(t.containerInfo)}catch(v){Cu(e,e.return,v)}break;case 4:default:hl(t,e),bl(e);break;case 13:hl(t,e),bl(e),8192&(a=e.child).flags&&(i=null!==a.memoizedState,a.stateNode.isHidden=i,!i||null!==a.alternate&&null!==a.alternate.memoizedState||(Bl=Qe())),4&r&&ml(e);break;case 22:if(d=null!==n&&null!==n.memoizedState,1&e.mode?(Ks=(c=Ks)||d,hl(t,e),Ks=c):hl(t,e),bl(e),8192&r){if(c=null!==e.memoizedState,(e.stateNode.isHidden=c)&&!d&&0!==(1&e.mode))for(Ys=e,d=e.child;null!==d;){for(f=Ys=d;null!==Ys;){switch(m=(p=Ys).child,p.tag){case 0:case 11:case 14:case 15:nl(4,p,p.return);break;case 1:Xs(p,p.return);var h=p.stateNode;if("function"===typeof h.componentWillUnmount){r=p,n=p.return;try{t=r,h.props=t.memoizedProps,h.state=t.memoizedState,h.componentWillUnmount()}catch(v){Cu(r,n,v)}}break;case 5:Xs(p,p.return);break;case 22:if(null!==p.memoizedState){wl(f);continue}}null!==m?(m.return=p,Ys=m):wl(f)}d=d.sibling}e:for(d=null,f=e;;){if(5===f.tag){if(null===d){d=f;try{a=f.stateNode,c?"function"===typeof(i=a.style).setProperty?i.setProperty("display","none","important"):i.display="none":(l=f.stateNode,s=void 0!==(u=f.memoizedProps.style)&&null!==u&&u.hasOwnProperty("display")?u.display:null,l.style.display=he("display",s))}catch(v){Cu(e,e.return,v)}}}else if(6===f.tag){if(null===d)try{f.stateNode.nodeValue=c?"":f.memoizedProps}catch(v){Cu(e,e.return,v)}}else if((22!==f.tag&&23!==f.tag||null===f.memoizedState||f===e)&&null!==f.child){f.child.return=f,f=f.child;continue}if(f===e)break e;for(;null===f.sibling;){if(null===f.return||f.return===e)break e;d===f&&(d=null),f=f.return}d===f&&(d=null),f.sibling.return=f.return,f=f.sibling}}break;case 19:hl(t,e),bl(e),4&r&&ml(e);case 21:}}function bl(e){var t=e.flags;if(2&t){try{e:{for(var n=e.return;null!==n;){if(il(n)){var r=n;break e}n=n.return}throw Error(o(160))}switch(r.tag){case 5:var a=r.stateNode;32&r.flags&&(fe(a,""),r.flags&=-33),ul(e,sl(e),a);break;case 3:case 4:var i=r.stateNode.containerInfo;ll(e,sl(e),i);break;default:throw Error(o(161))}}catch(s){Cu(e,e.return,s)}e.flags&=-3}4096&t&&(e.flags&=-4097)}function yl(e,t,n){Ys=e,gl(e,t,n)}function gl(e,t,n){for(var r=0!==(1&e.mode);null!==Ys;){var a=Ys,o=a.child;if(22===a.tag&&r){var i=null!==a.memoizedState||Gs;if(!i){var s=a.alternate,l=null!==s&&null!==s.memoizedState||Ks;s=Gs;var u=Ks;if(Gs=i,(Ks=l)&&!u)for(Ys=a;null!==Ys;)l=(i=Ys).child,22===i.tag&&null!==i.memoizedState?Sl(a):null!==l?(l.return=i,Ys=l):Sl(a);for(;null!==o;)Ys=o,gl(o,t,n),o=o.sibling;Ys=a,Gs=s,Ks=u}_l(e)}else 0!==(8772&a.subtreeFlags)&&null!==o?(o.return=a,Ys=o):_l(e)}}function _l(e){for(;null!==Ys;){var t=Ys;if(0!==(8772&t.flags)){var n=t.alternate;try{if(0!==(8772&t.flags))switch(t.tag){case 0:case 11:case 15:Ks||rl(5,t);break;case 1:var r=t.stateNode;if(4&t.flags&&!Ks)if(null===n)r.componentDidMount();else{var a=t.elementType===t.type?n.memoizedProps:bo(t.type,n.memoizedProps);r.componentDidUpdate(a,n.memoizedState,r.__reactInternalSnapshotBeforeUpdate)}var i=t.updateQueue;null!==i&&Zo(t,i,r);break;case 3:var s=t.updateQueue;if(null!==s){if(n=null,null!==t.child)switch(t.child.tag){case 5:case 1:n=t.child.stateNode}Zo(t,s,n)}break;case 5:var l=t.stateNode;if(null===n&&4&t.flags){n=l;var u=t.memoizedProps;switch(t.type){case"button":case"input":case"select":case"textarea":u.autoFocus&&n.focus();break;case"img":u.src&&(n.src=u.src)}}break;case 6:case 4:case 12:case 19:case 17:case 21:case 22:case 23:case 25:break;case 13:if(null===t.memoizedState){var c=t.alternate;if(null!==c){var d=c.memoizedState;if(null!==d){var f=d.dehydrated;null!==f&&Vt(f)}}}break;default:throw Error(o(163))}Ks||512&t.flags&&al(t)}catch(p){Cu(t,t.return,p)}}if(t===e){Ys=null;break}if(null!==(n=t.sibling)){n.return=t.return,Ys=n;break}Ys=t.return}}function wl(e){for(;null!==Ys;){var t=Ys;if(t===e){Ys=null;break}var n=t.sibling;if(null!==n){n.return=t.return,Ys=n;break}Ys=t.return}}function Sl(e){for(;null!==Ys;){var t=Ys;try{switch(t.tag){case 0:case 11:case 15:var n=t.return;try{rl(4,t)}catch(l){Cu(t,n,l)}break;case 1:var r=t.stateNode;if("function"===typeof r.componentDidMount){var a=t.return;try{r.componentDidMount()}catch(l){Cu(t,a,l)}}var o=t.return;try{al(t)}catch(l){Cu(t,o,l)}break;case 5:var i=t.return;try{al(t)}catch(l){Cu(t,i,l)}}}catch(l){Cu(t,t.return,l)}if(t===e){Ys=null;break}var s=t.sibling;if(null!==s){s.return=t.return,Ys=s;break}Ys=t.return}}var kl,Cl=Math.ceil,Tl=_.ReactCurrentDispatcher,xl=_.ReactCurrentOwner,Fl=_.ReactCurrentBatchConfig,Pl=0,Al=null,Nl=null,El=0,Ml=0,Rl=Ca(0),Ol=0,Dl=null,zl=0,Il=0,Ll=0,Zl=null,jl=null,Bl=0,Vl=1/0,Ul=null,Jl=!1,Wl=null,Hl=null,$l=!1,ql=null,Gl=0,Kl=0,Ql=null,Yl=-1,Xl=0;function eu(){return 0!==(6&Pl)?Qe():-1!==Yl?Yl:Yl=Qe()}function tu(e){return 0===(1&e.mode)?1:0!==(2&Pl)&&0!==El?El&-El:null!==vo.transition?(0===Xl&&(Xl=ht()),Xl):0!==(e=gt)?e:e=void 0===(e=window.event)?16:Kt(e.type)}function nu(e,t,n,r){if(50<Kl)throw Kl=0,Ql=null,Error(o(185));bt(e,n,r),0!==(2&Pl)&&e===Al||(e===Al&&(0===(2&Pl)&&(Il|=n),4===Ol&&su(e,El)),ru(e,r),1===n&&0===Pl&&0===(1&t.mode)&&(Vl=Qe()+500,Za&&Va()))}function ru(e,t){var n=e.callbackNode;!function(e,t){for(var n=e.suspendedLanes,r=e.pingedLanes,a=e.expirationTimes,o=e.pendingLanes;0<o;){var i=31-it(o),s=1<<i,l=a[i];-1===l?0!==(s&n)&&0===(s&r)||(a[i]=pt(s,t)):l<=t&&(e.expiredLanes|=s),o&=~s}}(e,t);var r=ft(e,e===Al?El:0);if(0===r)null!==n&&qe(n),e.callbackNode=null,e.callbackPriority=0;else if(t=r&-r,e.callbackPriority!==t){if(null!=n&&qe(n),1===t)0===e.tag?function(e){Za=!0,Ba(e)}(lu.bind(null,e)):Ba(lu.bind(null,e)),ia((function(){0===(6&Pl)&&Va()})),n=null;else{switch(_t(r)){case 1:n=Xe;break;case 4:n=et;break;case 16:default:n=tt;break;case 536870912:n=rt}n=Au(n,au.bind(null,e))}e.callbackPriority=t,e.callbackNode=n}}function au(e,t){if(Yl=-1,Xl=0,0!==(6&Pl))throw Error(o(327));var n=e.callbackNode;if(Su()&&e.callbackNode!==n)return null;var r=ft(e,e===Al?El:0);if(0===r)return null;if(0!==(30&r)||0!==(r&e.expiredLanes)||t)t=vu(e,r);else{t=r;var a=Pl;Pl|=2;var i=mu();for(Al===e&&El===t||(Ul=null,Vl=Qe()+500,fu(e,t));;)try{yu();break}catch(l){pu(e,l)}So(),Tl.current=i,Pl=a,null!==Nl?t=0:(Al=null,El=0,t=Ol)}if(0!==t){if(2===t&&(0!==(a=mt(e))&&(r=a,t=ou(e,a))),1===t)throw n=Dl,fu(e,0),su(e,r),ru(e,Qe()),n;if(6===t)su(e,r);else{if(a=e.current.alternate,0===(30&r)&&!function(e){for(var t=e;;){if(16384&t.flags){var n=t.updateQueue;if(null!==n&&null!==(n=n.stores))for(var r=0;r<n.length;r++){var a=n[r],o=a.getSnapshot;a=a.value;try{if(!sr(o(),a))return!1}catch(s){return!1}}}if(n=t.child,16384&t.subtreeFlags&&null!==n)n.return=t,t=n;else{if(t===e)break;for(;null===t.sibling;){if(null===t.return||t.return===e)return!0;t=t.return}t.sibling.return=t.return,t=t.sibling}}return!0}(a)&&(2===(t=vu(e,r))&&(0!==(i=mt(e))&&(r=i,t=ou(e,i))),1===t))throw n=Dl,fu(e,0),su(e,r),ru(e,Qe()),n;switch(e.finishedWork=a,e.finishedLanes=r,t){case 0:case 1:throw Error(o(345));case 2:case 5:wu(e,jl,Ul);break;case 3:if(su(e,r),(130023424&r)===r&&10<(t=Bl+500-Qe())){if(0!==ft(e,0))break;if(((a=e.suspendedLanes)&r)!==r){eu(),e.pingedLanes|=e.suspendedLanes&a;break}e.timeoutHandle=ra(wu.bind(null,e,jl,Ul),t);break}wu(e,jl,Ul);break;case 4:if(su(e,r),(4194240&r)===r)break;for(t=e.eventTimes,a=-1;0<r;){var s=31-it(r);i=1<<s,(s=t[s])>a&&(a=s),r&=~i}if(r=a,10<(r=(120>(r=Qe()-r)?120:480>r?480:1080>r?1080:1920>r?1920:3e3>r?3e3:4320>r?4320:1960*Cl(r/1960))-r)){e.timeoutHandle=ra(wu.bind(null,e,jl,Ul),r);break}wu(e,jl,Ul);break;default:throw Error(o(329))}}}return ru(e,Qe()),e.callbackNode===n?au.bind(null,e):null}function ou(e,t){var n=Zl;return e.current.memoizedState.isDehydrated&&(fu(e,t).flags|=256),2!==(e=vu(e,t))&&(t=jl,jl=n,null!==t&&iu(t)),e}function iu(e){null===jl?jl=e:jl.push.apply(jl,e)}function su(e,t){for(t&=~Ll,t&=~Il,e.suspendedLanes|=t,e.pingedLanes&=~t,e=e.expirationTimes;0<t;){var n=31-it(t),r=1<<n;e[n]=-1,t&=~r}}function lu(e){if(0!==(6&Pl))throw Error(o(327));Su();var t=ft(e,0);if(0===(1&t))return ru(e,Qe()),null;var n=vu(e,t);if(0!==e.tag&&2===n){var r=mt(e);0!==r&&(t=r,n=ou(e,r))}if(1===n)throw n=Dl,fu(e,0),su(e,t),ru(e,Qe()),n;if(6===n)throw Error(o(345));return e.finishedWork=e.current.alternate,e.finishedLanes=t,wu(e,jl,Ul),ru(e,Qe()),null}function uu(e,t){var n=Pl;Pl|=1;try{return e(t)}finally{0===(Pl=n)&&(Vl=Qe()+500,Za&&Va())}}function cu(e){null!==ql&&0===ql.tag&&0===(6&Pl)&&Su();var t=Pl;Pl|=1;var n=Fl.transition,r=gt;try{if(Fl.transition=null,gt=1,e)return e()}finally{gt=r,Fl.transition=n,0===(6&(Pl=t))&&Va()}}function du(){Ml=Rl.current,Ta(Rl)}function fu(e,t){e.finishedWork=null,e.finishedLanes=0;var n=e.timeoutHandle;if(-1!==n&&(e.timeoutHandle=-1,aa(n)),null!==Nl)for(n=Nl.return;null!==n;){var r=n;switch(to(r),r.tag){case 1:null!==(r=r.type.childContextTypes)&&void 0!==r&&Ra();break;case 3:oi(),Ta(Aa),Ta(Pa),di();break;case 5:si(r);break;case 4:oi();break;case 13:case 19:Ta(li);break;case 10:ko(r.type._context);break;case 22:case 23:du()}n=n.return}if(Al=e,Nl=e=Ru(e.current,null),El=Ml=t,Ol=0,Dl=null,Ll=Il=zl=0,jl=Zl=null,null!==Fo){for(t=0;t<Fo.length;t++)if(null!==(r=(n=Fo[t]).interleaved)){n.interleaved=null;var a=r.next,o=n.pending;if(null!==o){var i=o.next;o.next=a,r.next=i}n.pending=r}Fo=null}return e}function pu(e,t){for(;;){var n=Nl;try{if(So(),fi.current=is,yi){for(var r=hi.memoizedState;null!==r;){var a=r.queue;null!==a&&(a.pending=null),r=r.next}yi=!1}if(mi=0,bi=vi=hi=null,gi=!1,_i=0,xl.current=null,null===n||null===n.return){Ol=1,Dl=t,Nl=null;break}e:{var i=e,s=n.return,l=n,u=t;if(t=El,l.flags|=32768,null!==u&&"object"===typeof u&&"function"===typeof u.then){var c=u,d=l,f=d.tag;if(0===(1&d.mode)&&(0===f||11===f||15===f)){var p=d.alternate;p?(d.updateQueue=p.updateQueue,d.memoizedState=p.memoizedState,d.lanes=p.lanes):(d.updateQueue=null,d.memoizedState=null)}var m=bs(s);if(null!==m){m.flags&=-257,ys(m,s,l,0,t),1&m.mode&&vs(i,c,t),u=c;var h=(t=m).updateQueue;if(null===h){var v=new Set;v.add(u),t.updateQueue=v}else h.add(u);break e}if(0===(1&t)){vs(i,c,t),hu();break e}u=Error(o(426))}else if(ao&&1&l.mode){var b=bs(s);if(null!==b){0===(65536&b.flags)&&(b.flags|=256),ys(b,s,l,0,t),ho(cs(u,l));break e}}i=u=cs(u,l),4!==Ol&&(Ol=2),null===Zl?Zl=[i]:Zl.push(i),i=s;do{switch(i.tag){case 3:i.flags|=65536,t&=-t,i.lanes|=t,Io(i,ms(0,u,t));break e;case 1:l=u;var y=i.type,g=i.stateNode;if(0===(128&i.flags)&&("function"===typeof y.getDerivedStateFromError||null!==g&&"function"===typeof g.componentDidCatch&&(null===Hl||!Hl.has(g)))){i.flags|=65536,t&=-t,i.lanes|=t,Io(i,hs(i,l,t));break e}}i=i.return}while(null!==i)}_u(n)}catch(_){t=_,Nl===n&&null!==n&&(Nl=n=n.return);continue}break}}function mu(){var e=Tl.current;return Tl.current=is,null===e?is:e}function hu(){0!==Ol&&3!==Ol&&2!==Ol||(Ol=4),null===Al||0===(268435455&zl)&&0===(268435455&Il)||su(Al,El)}function vu(e,t){var n=Pl;Pl|=2;var r=mu();for(Al===e&&El===t||(Ul=null,fu(e,t));;)try{bu();break}catch(a){pu(e,a)}if(So(),Pl=n,Tl.current=r,null!==Nl)throw Error(o(261));return Al=null,El=0,Ol}function bu(){for(;null!==Nl;)gu(Nl)}function yu(){for(;null!==Nl&&!Ge();)gu(Nl)}function gu(e){var t=kl(e.alternate,e,Ml);e.memoizedProps=e.pendingProps,null===t?_u(e):Nl=t,xl.current=null}function _u(e){var t=e;do{var n=t.alternate;if(e=t.return,0===(32768&t.flags)){if(null!==(n=$s(n,t,Ml)))return void(Nl=n)}else{if(null!==(n=qs(n,t)))return n.flags&=32767,void(Nl=n);if(null===e)return Ol=6,void(Nl=null);e.flags|=32768,e.subtreeFlags=0,e.deletions=null}if(null!==(t=t.sibling))return void(Nl=t);Nl=t=e}while(null!==t);0===Ol&&(Ol=5)}function wu(e,t,n){var r=gt,a=Fl.transition;try{Fl.transition=null,gt=1,function(e,t,n,r){do{Su()}while(null!==ql);if(0!==(6&Pl))throw Error(o(327));n=e.finishedWork;var a=e.finishedLanes;if(null===n)return null;if(e.finishedWork=null,e.finishedLanes=0,n===e.current)throw Error(o(177));e.callbackNode=null,e.callbackPriority=0;var i=n.lanes|n.childLanes;if(function(e,t){var n=e.pendingLanes&~t;e.pendingLanes=t,e.suspendedLanes=0,e.pingedLanes=0,e.expiredLanes&=t,e.mutableReadLanes&=t,e.entangledLanes&=t,t=e.entanglements;var r=e.eventTimes;for(e=e.expirationTimes;0<n;){var a=31-it(n),o=1<<a;t[a]=0,r[a]=-1,e[a]=-1,n&=~o}}(e,i),e===Al&&(Nl=Al=null,El=0),0===(2064&n.subtreeFlags)&&0===(2064&n.flags)||$l||($l=!0,Au(tt,(function(){return Su(),null}))),i=0!==(15990&n.flags),0!==(15990&n.subtreeFlags)||i){i=Fl.transition,Fl.transition=null;var s=gt;gt=1;var l=Pl;Pl|=4,xl.current=null,function(e,t){if(ea=Jt,pr(e=fr())){if("selectionStart"in e)var n={start:e.selectionStart,end:e.selectionEnd};else e:{var r=(n=(n=e.ownerDocument)&&n.defaultView||window).getSelection&&n.getSelection();if(r&&0!==r.rangeCount){n=r.anchorNode;var a=r.anchorOffset,i=r.focusNode;r=r.focusOffset;try{n.nodeType,i.nodeType}catch(w){n=null;break e}var s=0,l=-1,u=-1,c=0,d=0,f=e,p=null;t:for(;;){for(var m;f!==n||0!==a&&3!==f.nodeType||(l=s+a),f!==i||0!==r&&3!==f.nodeType||(u=s+r),3===f.nodeType&&(s+=f.nodeValue.length),null!==(m=f.firstChild);)p=f,f=m;for(;;){if(f===e)break t;if(p===n&&++c===a&&(l=s),p===i&&++d===r&&(u=s),null!==(m=f.nextSibling))break;p=(f=p).parentNode}f=m}n=-1===l||-1===u?null:{start:l,end:u}}else n=null}n=n||{start:0,end:0}}else n=null;for(ta={focusedElem:e,selectionRange:n},Jt=!1,Ys=t;null!==Ys;)if(e=(t=Ys).child,0!==(1028&t.subtreeFlags)&&null!==e)e.return=t,Ys=e;else for(;null!==Ys;){t=Ys;try{var h=t.alternate;if(0!==(1024&t.flags))switch(t.tag){case 0:case 11:case 15:case 5:case 6:case 4:case 17:break;case 1:if(null!==h){var v=h.memoizedProps,b=h.memoizedState,y=t.stateNode,g=y.getSnapshotBeforeUpdate(t.elementType===t.type?v:bo(t.type,v),b);y.__reactInternalSnapshotBeforeUpdate=g}break;case 3:var _=t.stateNode.containerInfo;1===_.nodeType?_.textContent="":9===_.nodeType&&_.documentElement&&_.removeChild(_.documentElement);break;default:throw Error(o(163))}}catch(w){Cu(t,t.return,w)}if(null!==(e=t.sibling)){e.return=t.return,Ys=e;break}Ys=t.return}h=tl,tl=!1}(e,n),vl(n,e),mr(ta),Jt=!!ea,ta=ea=null,e.current=n,yl(n,e,a),Ke(),Pl=l,gt=s,Fl.transition=i}else e.current=n;if($l&&($l=!1,ql=e,Gl=a),0===(i=e.pendingLanes)&&(Hl=null),function(e){if(ot&&"function"===typeof ot.onCommitFiberRoot)try{ot.onCommitFiberRoot(at,e,void 0,128===(128&e.current.flags))}catch(t){}}(n.stateNode),ru(e,Qe()),null!==t)for(r=e.onRecoverableError,n=0;n<t.length;n++)r((a=t[n]).value,{componentStack:a.stack,digest:a.digest});if(Jl)throw Jl=!1,e=Wl,Wl=null,e;0!==(1&Gl)&&0!==e.tag&&Su(),0!==(1&(i=e.pendingLanes))?e===Ql?Kl++:(Kl=0,Ql=e):Kl=0,Va()}(e,t,n,r)}finally{Fl.transition=a,gt=r}return null}function Su(){if(null!==ql){var e=_t(Gl),t=Fl.transition,n=gt;try{if(Fl.transition=null,gt=16>e?16:e,null===ql)var r=!1;else{if(e=ql,ql=null,Gl=0,0!==(6&Pl))throw Error(o(331));var a=Pl;for(Pl|=4,Ys=e.current;null!==Ys;){var i=Ys,s=i.child;if(0!==(16&Ys.flags)){var l=i.deletions;if(null!==l){for(var u=0;u<l.length;u++){var c=l[u];for(Ys=c;null!==Ys;){var d=Ys;switch(d.tag){case 0:case 11:case 15:nl(8,d,i)}var f=d.child;if(null!==f)f.return=d,Ys=f;else for(;null!==Ys;){var p=(d=Ys).sibling,m=d.return;if(ol(d),d===c){Ys=null;break}if(null!==p){p.return=m,Ys=p;break}Ys=m}}}var h=i.alternate;if(null!==h){var v=h.child;if(null!==v){h.child=null;do{var b=v.sibling;v.sibling=null,v=b}while(null!==v)}}Ys=i}}if(0!==(2064&i.subtreeFlags)&&null!==s)s.return=i,Ys=s;else e:for(;null!==Ys;){if(0!==(2048&(i=Ys).flags))switch(i.tag){case 0:case 11:case 15:nl(9,i,i.return)}var y=i.sibling;if(null!==y){y.return=i.return,Ys=y;break e}Ys=i.return}}var g=e.current;for(Ys=g;null!==Ys;){var _=(s=Ys).child;if(0!==(2064&s.subtreeFlags)&&null!==_)_.return=s,Ys=_;else e:for(s=g;null!==Ys;){if(0!==(2048&(l=Ys).flags))try{switch(l.tag){case 0:case 11:case 15:rl(9,l)}}catch(S){Cu(l,l.return,S)}if(l===s){Ys=null;break e}var w=l.sibling;if(null!==w){w.return=l.return,Ys=w;break e}Ys=l.return}}if(Pl=a,Va(),ot&&"function"===typeof ot.onPostCommitFiberRoot)try{ot.onPostCommitFiberRoot(at,e)}catch(S){}r=!0}return r}finally{gt=n,Fl.transition=t}}return!1}function ku(e,t,n){e=Do(e,t=ms(0,t=cs(n,t),1),1),t=eu(),null!==e&&(bt(e,1,t),ru(e,t))}function Cu(e,t,n){if(3===e.tag)ku(e,e,n);else for(;null!==t;){if(3===t.tag){ku(t,e,n);break}if(1===t.tag){var r=t.stateNode;if("function"===typeof t.type.getDerivedStateFromError||"function"===typeof r.componentDidCatch&&(null===Hl||!Hl.has(r))){t=Do(t,e=hs(t,e=cs(n,e),1),1),e=eu(),null!==t&&(bt(t,1,e),ru(t,e));break}}t=t.return}}function Tu(e,t,n){var r=e.pingCache;null!==r&&r.delete(t),t=eu(),e.pingedLanes|=e.suspendedLanes&n,Al===e&&(El&n)===n&&(4===Ol||3===Ol&&(130023424&El)===El&&500>Qe()-Bl?fu(e,0):Ll|=n),ru(e,t)}function xu(e,t){0===t&&(0===(1&e.mode)?t=1:(t=ct,0===(130023424&(ct<<=1))&&(ct=4194304)));var n=eu();null!==(e=No(e,t))&&(bt(e,t,n),ru(e,n))}function Fu(e){var t=e.memoizedState,n=0;null!==t&&(n=t.retryLane),xu(e,n)}function Pu(e,t){var n=0;switch(e.tag){case 13:var r=e.stateNode,a=e.memoizedState;null!==a&&(n=a.retryLane);break;case 19:r=e.stateNode;break;default:throw Error(o(314))}null!==r&&r.delete(t),xu(e,n)}function Au(e,t){return $e(e,t)}function Nu(e,t,n,r){this.tag=e,this.key=n,this.sibling=this.child=this.return=this.stateNode=this.type=this.elementType=null,this.index=0,this.ref=null,this.pendingProps=t,this.dependencies=this.memoizedState=this.updateQueue=this.memoizedProps=null,this.mode=r,this.subtreeFlags=this.flags=0,this.deletions=null,this.childLanes=this.lanes=0,this.alternate=null}function Eu(e,t,n,r){return new Nu(e,t,n,r)}function Mu(e){return!(!(e=e.prototype)||!e.isReactComponent)}function Ru(e,t){var n=e.alternate;return null===n?((n=Eu(e.tag,t,e.key,e.mode)).elementType=e.elementType,n.type=e.type,n.stateNode=e.stateNode,n.alternate=e,e.alternate=n):(n.pendingProps=t,n.type=e.type,n.flags=0,n.subtreeFlags=0,n.deletions=null),n.flags=14680064&e.flags,n.childLanes=e.childLanes,n.lanes=e.lanes,n.child=e.child,n.memoizedProps=e.memoizedProps,n.memoizedState=e.memoizedState,n.updateQueue=e.updateQueue,t=e.dependencies,n.dependencies=null===t?null:{lanes:t.lanes,firstContext:t.firstContext},n.sibling=e.sibling,n.index=e.index,n.ref=e.ref,n}function Ou(e,t,n,r,a,i){var s=2;if(r=e,"function"===typeof e)Mu(e)&&(s=1);else if("string"===typeof e)s=5;else e:switch(e){case k:return Du(n.children,a,i,t);case C:s=8,a|=8;break;case T:return(e=Eu(12,n,t,2|a)).elementType=T,e.lanes=i,e;case A:return(e=Eu(13,n,t,a)).elementType=A,e.lanes=i,e;case N:return(e=Eu(19,n,t,a)).elementType=N,e.lanes=i,e;case R:return zu(n,a,i,t);default:if("object"===typeof e&&null!==e)switch(e.$$typeof){case x:s=10;break e;case F:s=9;break e;case P:s=11;break e;case E:s=14;break e;case M:s=16,r=null;break e}throw Error(o(130,null==e?e:typeof e,""))}return(t=Eu(s,n,t,a)).elementType=e,t.type=r,t.lanes=i,t}function Du(e,t,n,r){return(e=Eu(7,e,r,t)).lanes=n,e}function zu(e,t,n,r){return(e=Eu(22,e,r,t)).elementType=R,e.lanes=n,e.stateNode={isHidden:!1},e}function Iu(e,t,n){return(e=Eu(6,e,null,t)).lanes=n,e}function Lu(e,t,n){return(t=Eu(4,null!==e.children?e.children:[],e.key,t)).lanes=n,t.stateNode={containerInfo:e.containerInfo,pendingChildren:null,implementation:e.implementation},t}function Zu(e,t,n,r,a){this.tag=t,this.containerInfo=e,this.finishedWork=this.pingCache=this.current=this.pendingChildren=null,this.timeoutHandle=-1,this.callbackNode=this.pendingContext=this.context=null,this.callbackPriority=0,this.eventTimes=vt(0),this.expirationTimes=vt(-1),this.entangledLanes=this.finishedLanes=this.mutableReadLanes=this.expiredLanes=this.pingedLanes=this.suspendedLanes=this.pendingLanes=0,this.entanglements=vt(0),this.identifierPrefix=r,this.onRecoverableError=a,this.mutableSourceEagerHydrationData=null}function ju(e,t,n,r,a,o,i,s,l){return e=new Zu(e,t,n,s,l),1===t?(t=1,!0===o&&(t|=8)):t=0,o=Eu(3,null,null,t),e.current=o,o.stateNode=e,o.memoizedState={element:r,isDehydrated:n,cache:null,transitions:null,pendingSuspenseBoundaries:null},Mo(o),e}function Bu(e,t,n){var r=3<arguments.length&&void 0!==arguments[3]?arguments[3]:null;return{$$typeof:S,key:null==r?null:""+r,children:e,containerInfo:t,implementation:n}}function Vu(e){if(!e)return Fa;e:{if(Ve(e=e._reactInternals)!==e||1!==e.tag)throw Error(o(170));var t=e;do{switch(t.tag){case 3:t=t.stateNode.context;break e;case 1:if(Ma(t.type)){t=t.stateNode.__reactInternalMemoizedMergedChildContext;break e}}t=t.return}while(null!==t);throw Error(o(171))}if(1===e.tag){var n=e.type;if(Ma(n))return Da(e,n,t)}return t}function Uu(e,t,n,r,a,o,i,s,l){return(e=ju(n,r,!0,e,0,o,0,s,l)).context=Vu(null),n=e.current,(o=Oo(r=eu(),a=tu(n))).callback=void 0!==t&&null!==t?t:null,Do(n,o,a),e.current.lanes=a,bt(e,a,r),ru(e,r),e}function Ju(e,t,n,r){var a=t.current,o=eu(),i=tu(a);return n=Vu(n),null===t.context?t.context=n:t.pendingContext=n,(t=Oo(o,i)).payload={element:e},null!==(r=void 0===r?null:r)&&(t.callback=r),null!==(e=Do(a,t,i))&&(nu(e,a,i,o),zo(e,a,i)),i}function Wu(e){return(e=e.current).child?(e.child.tag,e.child.stateNode):null}function Hu(e,t){if(null!==(e=e.memoizedState)&&null!==e.dehydrated){var n=e.retryLane;e.retryLane=0!==n&&n<t?n:t}}function $u(e,t){Hu(e,t),(e=e.alternate)&&Hu(e,t)}kl=function(e,t,n){if(null!==e)if(e.memoizedProps!==t.pendingProps||Aa.current)_s=!0;else{if(0===(e.lanes&n)&&0===(128&t.flags))return _s=!1,function(e,t,n){switch(t.tag){case 3:Ns(t),mo();break;case 5:ii(t);break;case 1:Ma(t.type)&&za(t);break;case 4:ai(t,t.stateNode.containerInfo);break;case 10:var r=t.type._context,a=t.memoizedProps.value;xa(yo,r._currentValue),r._currentValue=a;break;case 13:if(null!==(r=t.memoizedState))return null!==r.dehydrated?(xa(li,1&li.current),t.flags|=128,null):0!==(n&t.child.childLanes)?Is(e,t,n):(xa(li,1&li.current),null!==(e=Js(e,t,n))?e.sibling:null);xa(li,1&li.current);break;case 19:if(r=0!==(n&t.childLanes),0!==(128&e.flags)){if(r)return Vs(e,t,n);t.flags|=128}if(null!==(a=t.memoizedState)&&(a.rendering=null,a.tail=null,a.lastEffect=null),xa(li,li.current),r)break;return null;case 22:case 23:return t.lanes=0,Ts(e,t,n)}return Js(e,t,n)}(e,t,n);_s=0!==(131072&e.flags)}else _s=!1,ao&&0!==(1048576&t.flags)&&Xa(t,Ha,t.index);switch(t.lanes=0,t.tag){case 2:var r=t.type;Us(e,t),e=t.pendingProps;var a=Ea(t,Pa.current);To(t,n),a=Ci(null,t,r,e,a,n);var i=Ti();return t.flags|=1,"object"===typeof a&&null!==a&&"function"===typeof a.render&&void 0===a.$$typeof?(t.tag=1,t.memoizedState=null,t.updateQueue=null,Ma(r)?(i=!0,za(t)):i=!1,t.memoizedState=null!==a.state&&void 0!==a.state?a.state:null,Mo(t),a.updater=Vo,t.stateNode=a,a._reactInternals=t,Ho(t,r,e,n),t=As(null,t,r,!0,i,n)):(t.tag=0,ao&&i&&eo(t),ws(null,t,a,n),t=t.child),t;case 16:r=t.elementType;e:{switch(Us(e,t),e=t.pendingProps,r=(a=r._init)(r._payload),t.type=r,a=t.tag=function(e){if("function"===typeof e)return Mu(e)?1:0;if(void 0!==e&&null!==e){if((e=e.$$typeof)===P)return 11;if(e===E)return 14}return 2}(r),e=bo(r,e),a){case 0:t=Fs(null,t,r,e,n);break e;case 1:t=Ps(null,t,r,e,n);break e;case 11:t=Ss(null,t,r,e,n);break e;case 14:t=ks(null,t,r,bo(r.type,e),n);break e}throw Error(o(306,r,""))}return t;case 0:return r=t.type,a=t.pendingProps,Fs(e,t,r,a=t.elementType===r?a:bo(r,a),n);case 1:return r=t.type,a=t.pendingProps,Ps(e,t,r,a=t.elementType===r?a:bo(r,a),n);case 3:e:{if(Ns(t),null===e)throw Error(o(387));r=t.pendingProps,a=(i=t.memoizedState).element,Ro(e,t),Lo(t,r,null,n);var s=t.memoizedState;if(r=s.element,i.isDehydrated){if(i={element:r,isDehydrated:!1,cache:s.cache,pendingSuspenseBoundaries:s.pendingSuspenseBoundaries,transitions:s.transitions},t.updateQueue.baseState=i,t.memoizedState=i,256&t.flags){t=Es(e,t,r,n,a=cs(Error(o(423)),t));break e}if(r!==a){t=Es(e,t,r,n,a=cs(Error(o(424)),t));break e}for(ro=ua(t.stateNode.containerInfo.firstChild),no=t,ao=!0,oo=null,n=Yo(t,null,r,n),t.child=n;n;)n.flags=-3&n.flags|4096,n=n.sibling}else{if(mo(),r===a){t=Js(e,t,n);break e}ws(e,t,r,n)}t=t.child}return t;case 5:return ii(t),null===e&&uo(t),r=t.type,a=t.pendingProps,i=null!==e?e.memoizedProps:null,s=a.children,na(r,a)?s=null:null!==i&&na(r,i)&&(t.flags|=32),xs(e,t),ws(e,t,s,n),t.child;case 6:return null===e&&uo(t),null;case 13:return Is(e,t,n);case 4:return ai(t,t.stateNode.containerInfo),r=t.pendingProps,null===e?t.child=Qo(t,null,r,n):ws(e,t,r,n),t.child;case 11:return r=t.type,a=t.pendingProps,Ss(e,t,r,a=t.elementType===r?a:bo(r,a),n);case 7:return ws(e,t,t.pendingProps,n),t.child;case 8:case 12:return ws(e,t,t.pendingProps.children,n),t.child;case 10:e:{if(r=t.type._context,a=t.pendingProps,i=t.memoizedProps,s=a.value,xa(yo,r._currentValue),r._currentValue=s,null!==i)if(sr(i.value,s)){if(i.children===a.children&&!Aa.current){t=Js(e,t,n);break e}}else for(null!==(i=t.child)&&(i.return=t);null!==i;){var l=i.dependencies;if(null!==l){s=i.child;for(var u=l.firstContext;null!==u;){if(u.context===r){if(1===i.tag){(u=Oo(-1,n&-n)).tag=2;var c=i.updateQueue;if(null!==c){var d=(c=c.shared).pending;null===d?u.next=u:(u.next=d.next,d.next=u),c.pending=u}}i.lanes|=n,null!==(u=i.alternate)&&(u.lanes|=n),Co(i.return,n,t),l.lanes|=n;break}u=u.next}}else if(10===i.tag)s=i.type===t.type?null:i.child;else if(18===i.tag){if(null===(s=i.return))throw Error(o(341));s.lanes|=n,null!==(l=s.alternate)&&(l.lanes|=n),Co(s,n,t),s=i.sibling}else s=i.child;if(null!==s)s.return=i;else for(s=i;null!==s;){if(s===t){s=null;break}if(null!==(i=s.sibling)){i.return=s.return,s=i;break}s=s.return}i=s}ws(e,t,a.children,n),t=t.child}return t;case 9:return a=t.type,r=t.pendingProps.children,To(t,n),r=r(a=xo(a)),t.flags|=1,ws(e,t,r,n),t.child;case 14:return a=bo(r=t.type,t.pendingProps),ks(e,t,r,a=bo(r.type,a),n);case 15:return Cs(e,t,t.type,t.pendingProps,n);case 17:return r=t.type,a=t.pendingProps,a=t.elementType===r?a:bo(r,a),Us(e,t),t.tag=1,Ma(r)?(e=!0,za(t)):e=!1,To(t,n),Jo(t,r,a),Ho(t,r,a,n),As(null,t,r,!0,e,n);case 19:return Vs(e,t,n);case 22:return Ts(e,t,n)}throw Error(o(156,t.tag))};var qu="function"===typeof reportError?reportError:function(e){console.error(e)};function Gu(e){this._internalRoot=e}function Ku(e){this._internalRoot=e}function Qu(e){return!(!e||1!==e.nodeType&&9!==e.nodeType&&11!==e.nodeType)}function Yu(e){return!(!e||1!==e.nodeType&&9!==e.nodeType&&11!==e.nodeType&&(8!==e.nodeType||" react-mount-point-unstable "!==e.nodeValue))}function Xu(){}function ec(e,t,n,r,a){var o=n._reactRootContainer;if(o){var i=o;if("function"===typeof a){var s=a;a=function(){var e=Wu(i);s.call(e)}}Ju(t,i,e,a)}else i=function(e,t,n,r,a){if(a){if("function"===typeof r){var o=r;r=function(){var e=Wu(i);o.call(e)}}var i=Uu(t,r,e,0,null,!1,0,"",Xu);return e._reactRootContainer=i,e[ma]=i.current,Vr(8===e.nodeType?e.parentNode:e),cu(),i}for(;a=e.lastChild;)e.removeChild(a);if("function"===typeof r){var s=r;r=function(){var e=Wu(l);s.call(e)}}var l=ju(e,0,!1,null,0,!1,0,"",Xu);return e._reactRootContainer=l,e[ma]=l.current,Vr(8===e.nodeType?e.parentNode:e),cu((function(){Ju(t,l,n,r)})),l}(n,t,e,a,r);return Wu(i)}Ku.prototype.render=Gu.prototype.render=function(e){var t=this._internalRoot;if(null===t)throw Error(o(409));Ju(e,t,null,null)},Ku.prototype.unmount=Gu.prototype.unmount=function(){var e=this._internalRoot;if(null!==e){this._internalRoot=null;var t=e.containerInfo;cu((function(){Ju(null,e,null,null)})),t[ma]=null}},Ku.prototype.unstable_scheduleHydration=function(e){if(e){var t=Ct();e={blockedOn:null,target:e,priority:t};for(var n=0;n<Rt.length&&0!==t&&t<Rt[n].priority;n++);Rt.splice(n,0,e),0===n&&It(e)}},wt=function(e){switch(e.tag){case 3:var t=e.stateNode;if(t.current.memoizedState.isDehydrated){var n=dt(t.pendingLanes);0!==n&&(yt(t,1|n),ru(t,Qe()),0===(6&Pl)&&(Vl=Qe()+500,Va()))}break;case 13:cu((function(){var t=No(e,1);if(null!==t){var n=eu();nu(t,e,1,n)}})),$u(e,1)}},St=function(e){if(13===e.tag){var t=No(e,134217728);if(null!==t)nu(t,e,134217728,eu());$u(e,134217728)}},kt=function(e){if(13===e.tag){var t=tu(e),n=No(e,t);if(null!==n)nu(n,e,t,eu());$u(e,t)}},Ct=function(){return gt},Tt=function(e,t){var n=gt;try{return gt=e,t()}finally{gt=n}},Se=function(e,t,n){switch(t){case"input":if(Y(e,n),t=n.name,"radio"===n.type&&null!=t){for(n=e;n.parentNode;)n=n.parentNode;for(n=n.querySelectorAll("input[name="+JSON.stringify(""+t)+'][type="radio"]'),t=0;t<n.length;t++){var r=n[t];if(r!==e&&r.form===e.form){var a=wa(r);if(!a)throw Error(o(90));$(r),Y(r,a)}}}break;case"textarea":oe(e,n);break;case"select":null!=(t=n.value)&&ne(e,!!n.multiple,t,!1)}},Pe=uu,Ae=cu;var tc={usingClientEntryPoint:!1,Events:[ga,_a,wa,xe,Fe,uu]},nc={findFiberByHostInstance:ya,bundleType:0,version:"18.2.0",rendererPackageName:"react-dom"},rc={bundleType:nc.bundleType,version:nc.version,rendererPackageName:nc.rendererPackageName,rendererConfig:nc.rendererConfig,overrideHookState:null,overrideHookStateDeletePath:null,overrideHookStateRenamePath:null,overrideProps:null,overridePropsDeletePath:null,overridePropsRenamePath:null,setErrorHandler:null,setSuspenseHandler:null,scheduleUpdate:null,currentDispatcherRef:_.ReactCurrentDispatcher,findHostInstanceByFiber:function(e){return null===(e=We(e))?null:e.stateNode},findFiberByHostInstance:nc.findFiberByHostInstance||function(){return null},findHostInstancesForRefresh:null,scheduleRefresh:null,scheduleRoot:null,setRefreshHandler:null,getCurrentFiber:null,reconcilerVersion:"18.2.0-next-9e3b772b8-20220608"};if("undefined"!==typeof __REACT_DEVTOOLS_GLOBAL_HOOK__){var ac=__REACT_DEVTOOLS_GLOBAL_HOOK__;if(!ac.isDisabled&&ac.supportsFiber)try{at=ac.inject(rc),ot=ac}catch(ce){}}t.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED=tc,t.createPortal=function(e,t){var n=2<arguments.length&&void 0!==arguments[2]?arguments[2]:null;if(!Qu(t))throw Error(o(200));return Bu(e,t,null,n)},t.createRoot=function(e,t){if(!Qu(e))throw Error(o(299));var n=!1,r="",a=qu;return null!==t&&void 0!==t&&(!0===t.unstable_strictMode&&(n=!0),void 0!==t.identifierPrefix&&(r=t.identifierPrefix),void 0!==t.onRecoverableError&&(a=t.onRecoverableError)),t=ju(e,1,!1,null,0,n,0,r,a),e[ma]=t.current,Vr(8===e.nodeType?e.parentNode:e),new Gu(t)},t.findDOMNode=function(e){if(null==e)return null;if(1===e.nodeType)return e;var t=e._reactInternals;if(void 0===t){if("function"===typeof e.render)throw Error(o(188));throw e=Object.keys(e).join(","),Error(o(268,e))}return e=null===(e=We(t))?null:e.stateNode},t.flushSync=function(e){return cu(e)},t.hydrate=function(e,t,n){if(!Yu(t))throw Error(o(200));return ec(null,e,t,!0,n)},t.hydrateRoot=function(e,t,n){if(!Qu(e))throw Error(o(405));var r=null!=n&&n.hydratedSources||null,a=!1,i="",s=qu;if(null!==n&&void 0!==n&&(!0===n.unstable_strictMode&&(a=!0),void 0!==n.identifierPrefix&&(i=n.identifierPrefix),void 0!==n.onRecoverableError&&(s=n.onRecoverableError)),t=Uu(t,null,e,1,null!=n?n:null,a,0,i,s),e[ma]=t.current,Vr(e),r)for(e=0;e<r.length;e++)a=(a=(n=r[e])._getVersion)(n._source),null==t.mutableSourceEagerHydrationData?t.mutableSourceEagerHydrationData=[n,a]:t.mutableSourceEagerHydrationData.push(n,a);return new Ku(t)},t.render=function(e,t,n){if(!Yu(t))throw Error(o(200));return ec(null,e,t,!1,n)},t.unmountComponentAtNode=function(e){if(!Yu(e))throw Error(o(40));return!!e._reactRootContainer&&(cu((function(){ec(null,null,e,!1,(function(){e._reactRootContainer=null,e[ma]=null}))})),!0)},t.unstable_batchedUpdates=uu,t.unstable_renderSubtreeIntoContainer=function(e,t,n,r){if(!Yu(n))throw Error(o(200));if(null==e||void 0===e._reactInternals)throw Error(o(38));return ec(e,t,n,!1,r)},t.version="18.2.0-next-9e3b772b8-20220608"},1250:function(e,t,n){"use strict";var r=n(4164);t.createRoot=r.createRoot,t.hydrateRoot=r.hydrateRoot},4164:function(e,t,n){"use strict";!function e(){if("undefined"!==typeof __REACT_DEVTOOLS_GLOBAL_HOOK__&&"function"===typeof __REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE)try{__REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE(e)}catch(t){console.error(t)}}(),e.exports=n(4463)},6374:function(e,t,n){"use strict";var r=n(2791),a=Symbol.for("react.element"),o=Symbol.for("react.fragment"),i=Object.prototype.hasOwnProperty,s=r.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED.ReactCurrentOwner,l={key:!0,ref:!0,__self:!0,__source:!0};function u(e,t,n){var r,o={},u=null,c=null;for(r in void 0!==n&&(u=""+n),void 0!==t.key&&(u=""+t.key),void 0!==t.ref&&(c=t.ref),t)i.call(t,r)&&!l.hasOwnProperty(r)&&(o[r]=t[r]);if(e&&e.defaultProps)for(r in t=e.defaultProps)void 0===o[r]&&(o[r]=t[r]);return{$$typeof:a,type:e,key:u,ref:c,props:o,_owner:s.current}}t.Fragment=o,t.jsx=u,t.jsxs=u},9117:function(e,t){"use strict";var n=Symbol.for("react.element"),r=Symbol.for("react.portal"),a=Symbol.for("react.fragment"),o=Symbol.for("react.strict_mode"),i=Symbol.for("react.profiler"),s=Symbol.for("react.provider"),l=Symbol.for("react.context"),u=Symbol.for("react.forward_ref"),c=Symbol.for("react.suspense"),d=Symbol.for("react.memo"),f=Symbol.for("react.lazy"),p=Symbol.iterator;var m={isMounted:function(){return!1},enqueueForceUpdate:function(){},enqueueReplaceState:function(){},enqueueSetState:function(){}},h=Object.assign,v={};function b(e,t,n){this.props=e,this.context=t,this.refs=v,this.updater=n||m}function y(){}function g(e,t,n){this.props=e,this.context=t,this.refs=v,this.updater=n||m}b.prototype.isReactComponent={},b.prototype.setState=function(e,t){if("object"!==typeof e&&"function"!==typeof e&&null!=e)throw Error("setState(...): takes an object of state variables to update or a function which returns an object of state variables.");this.updater.enqueueSetState(this,e,t,"setState")},b.prototype.forceUpdate=function(e){this.updater.enqueueForceUpdate(this,e,"forceUpdate")},y.prototype=b.prototype;var _=g.prototype=new y;_.constructor=g,h(_,b.prototype),_.isPureReactComponent=!0;var w=Array.isArray,S=Object.prototype.hasOwnProperty,k={current:null},C={key:!0,ref:!0,__self:!0,__source:!0};function T(e,t,r){var a,o={},i=null,s=null;if(null!=t)for(a in void 0!==t.ref&&(s=t.ref),void 0!==t.key&&(i=""+t.key),t)S.call(t,a)&&!C.hasOwnProperty(a)&&(o[a]=t[a]);var l=arguments.length-2;if(1===l)o.children=r;else if(1<l){for(var u=Array(l),c=0;c<l;c++)u[c]=arguments[c+2];o.children=u}if(e&&e.defaultProps)for(a in l=e.defaultProps)void 0===o[a]&&(o[a]=l[a]);return{$$typeof:n,type:e,key:i,ref:s,props:o,_owner:k.current}}function x(e){return"object"===typeof e&&null!==e&&e.$$typeof===n}var F=/\/+/g;function P(e,t){return"object"===typeof e&&null!==e&&null!=e.key?function(e){var t={"=":"=0",":":"=2"};return"$"+e.replace(/[=:]/g,(function(e){return t[e]}))}(""+e.key):t.toString(36)}function A(e,t,a,o,i){var s=typeof e;"undefined"!==s&&"boolean"!==s||(e=null);var l=!1;if(null===e)l=!0;else switch(s){case"string":case"number":l=!0;break;case"object":switch(e.$$typeof){case n:case r:l=!0}}if(l)return i=i(l=e),e=""===o?"."+P(l,0):o,w(i)?(a="",null!=e&&(a=e.replace(F,"$&/")+"/"),A(i,t,a,"",(function(e){return e}))):null!=i&&(x(i)&&(i=function(e,t){return{$$typeof:n,type:e.type,key:t,ref:e.ref,props:e.props,_owner:e._owner}}(i,a+(!i.key||l&&l.key===i.key?"":(""+i.key).replace(F,"$&/")+"/")+e)),t.push(i)),1;if(l=0,o=""===o?".":o+":",w(e))for(var u=0;u<e.length;u++){var c=o+P(s=e[u],u);l+=A(s,t,a,c,i)}else if(c=function(e){return null===e||"object"!==typeof e?null:"function"===typeof(e=p&&e[p]||e["@@iterator"])?e:null}(e),"function"===typeof c)for(e=c.call(e),u=0;!(s=e.next()).done;)l+=A(s=s.value,t,a,c=o+P(s,u++),i);else if("object"===s)throw t=String(e),Error("Objects are not valid as a React child (found: "+("[object Object]"===t?"object with keys {"+Object.keys(e).join(", ")+"}":t)+"). If you meant to render a collection of children, use an array instead.");return l}function N(e,t,n){if(null==e)return e;var r=[],a=0;return A(e,r,"","",(function(e){return t.call(n,e,a++)})),r}function E(e){if(-1===e._status){var t=e._result;(t=t()).then((function(t){0!==e._status&&-1!==e._status||(e._status=1,e._result=t)}),(function(t){0!==e._status&&-1!==e._status||(e._status=2,e._result=t)})),-1===e._status&&(e._status=0,e._result=t)}if(1===e._status)return e._result.default;throw e._result}var M={current:null},R={transition:null},O={ReactCurrentDispatcher:M,ReactCurrentBatchConfig:R,ReactCurrentOwner:k};t.Children={map:N,forEach:function(e,t,n){N(e,(function(){t.apply(this,arguments)}),n)},count:function(e){var t=0;return N(e,(function(){t++})),t},toArray:function(e){return N(e,(function(e){return e}))||[]},only:function(e){if(!x(e))throw Error("React.Children.only expected to receive a single React element child.");return e}},t.Component=b,t.Fragment=a,t.Profiler=i,t.PureComponent=g,t.StrictMode=o,t.Suspense=c,t.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED=O,t.cloneElement=function(e,t,r){if(null===e||void 0===e)throw Error("React.cloneElement(...): The argument must be a React element, but you passed "+e+".");var a=h({},e.props),o=e.key,i=e.ref,s=e._owner;if(null!=t){if(void 0!==t.ref&&(i=t.ref,s=k.current),void 0!==t.key&&(o=""+t.key),e.type&&e.type.defaultProps)var l=e.type.defaultProps;for(u in t)S.call(t,u)&&!C.hasOwnProperty(u)&&(a[u]=void 0===t[u]&&void 0!==l?l[u]:t[u])}var u=arguments.length-2;if(1===u)a.children=r;else if(1<u){l=Array(u);for(var c=0;c<u;c++)l[c]=arguments[c+2];a.children=l}return{$$typeof:n,type:e.type,key:o,ref:i,props:a,_owner:s}},t.createContext=function(e){return(e={$$typeof:l,_currentValue:e,_currentValue2:e,_threadCount:0,Provider:null,Consumer:null,_defaultValue:null,_globalName:null}).Provider={$$typeof:s,_context:e},e.Consumer=e},t.createElement=T,t.createFactory=function(e){var t=T.bind(null,e);return t.type=e,t},t.createRef=function(){return{current:null}},t.forwardRef=function(e){return{$$typeof:u,render:e}},t.isValidElement=x,t.lazy=function(e){return{$$typeof:f,_payload:{_status:-1,_result:e},_init:E}},t.memo=function(e,t){return{$$typeof:d,type:e,compare:void 0===t?null:t}},t.startTransition=function(e){var t=R.transition;R.transition={};try{e()}finally{R.transition=t}},t.unstable_act=function(){throw Error("act(...) is not supported in production builds of React.")},t.useCallback=function(e,t){return M.current.useCallback(e,t)},t.useContext=function(e){return M.current.useContext(e)},t.useDebugValue=function(){},t.useDeferredValue=function(e){return M.current.useDeferredValue(e)},t.useEffect=function(e,t){return M.current.useEffect(e,t)},t.useId=function(){return M.current.useId()},t.useImperativeHandle=function(e,t,n){return M.current.useImperativeHandle(e,t,n)},t.useInsertionEffect=function(e,t){return M.current.useInsertionEffect(e,t)},t.useLayoutEffect=function(e,t){return M.current.useLayoutEffect(e,t)},t.useMemo=function(e,t){return M.current.useMemo(e,t)},t.useReducer=function(e,t,n){return M.current.useReducer(e,t,n)},t.useRef=function(e){return M.current.useRef(e)},t.useState=function(e){return M.current.useState(e)},t.useSyncExternalStore=function(e,t,n){return M.current.useSyncExternalStore(e,t,n)},t.useTransition=function(){return M.current.useTransition()},t.version="18.2.0"},2791:function(e,t,n){"use strict";e.exports=n(9117)},184:function(e,t,n){"use strict";e.exports=n(6374)},6813:function(e,t){"use strict";function n(e,t){var n=e.length;e.push(t);e:for(;0<n;){var r=n-1>>>1,a=e[r];if(!(0<o(a,t)))break e;e[r]=t,e[n]=a,n=r}}function r(e){return 0===e.length?null:e[0]}function a(e){if(0===e.length)return null;var t=e[0],n=e.pop();if(n!==t){e[0]=n;e:for(var r=0,a=e.length,i=a>>>1;r<i;){var s=2*(r+1)-1,l=e[s],u=s+1,c=e[u];if(0>o(l,n))u<a&&0>o(c,l)?(e[r]=c,e[u]=n,r=u):(e[r]=l,e[s]=n,r=s);else{if(!(u<a&&0>o(c,n)))break e;e[r]=c,e[u]=n,r=u}}}return t}function o(e,t){var n=e.sortIndex-t.sortIndex;return 0!==n?n:e.id-t.id}if("object"===typeof performance&&"function"===typeof performance.now){var i=performance;t.unstable_now=function(){return i.now()}}else{var s=Date,l=s.now();t.unstable_now=function(){return s.now()-l}}var u=[],c=[],d=1,f=null,p=3,m=!1,h=!1,v=!1,b="function"===typeof setTimeout?setTimeout:null,y="function"===typeof clearTimeout?clearTimeout:null,g="undefined"!==typeof setImmediate?setImmediate:null;function _(e){for(var t=r(c);null!==t;){if(null===t.callback)a(c);else{if(!(t.startTime<=e))break;a(c),t.sortIndex=t.expirationTime,n(u,t)}t=r(c)}}function w(e){if(v=!1,_(e),!h)if(null!==r(u))h=!0,R(S);else{var t=r(c);null!==t&&O(w,t.startTime-e)}}function S(e,n){h=!1,v&&(v=!1,y(x),x=-1),m=!0;var o=p;try{for(_(n),f=r(u);null!==f&&(!(f.expirationTime>n)||e&&!A());){var i=f.callback;if("function"===typeof i){f.callback=null,p=f.priorityLevel;var s=i(f.expirationTime<=n);n=t.unstable_now(),"function"===typeof s?f.callback=s:f===r(u)&&a(u),_(n)}else a(u);f=r(u)}if(null!==f)var l=!0;else{var d=r(c);null!==d&&O(w,d.startTime-n),l=!1}return l}finally{f=null,p=o,m=!1}}"undefined"!==typeof navigator&&void 0!==navigator.scheduling&&void 0!==navigator.scheduling.isInputPending&&navigator.scheduling.isInputPending.bind(navigator.scheduling);var k,C=!1,T=null,x=-1,F=5,P=-1;function A(){return!(t.unstable_now()-P<F)}function N(){if(null!==T){var e=t.unstable_now();P=e;var n=!0;try{n=T(!0,e)}finally{n?k():(C=!1,T=null)}}else C=!1}if("function"===typeof g)k=function(){g(N)};else if("undefined"!==typeof MessageChannel){var E=new MessageChannel,M=E.port2;E.port1.onmessage=N,k=function(){M.postMessage(null)}}else k=function(){b(N,0)};function R(e){T=e,C||(C=!0,k())}function O(e,n){x=b((function(){e(t.unstable_now())}),n)}t.unstable_IdlePriority=5,t.unstable_ImmediatePriority=1,t.unstable_LowPriority=4,t.unstable_NormalPriority=3,t.unstable_Profiling=null,t.unstable_UserBlockingPriority=2,t.unstable_cancelCallback=function(e){e.callback=null},t.unstable_continueExecution=function(){h||m||(h=!0,R(S))},t.unstable_forceFrameRate=function(e){0>e||125<e?console.error("forceFrameRate takes a positive int between 0 and 125, forcing frame rates higher than 125 fps is not supported"):F=0<e?Math.floor(1e3/e):5},t.unstable_getCurrentPriorityLevel=function(){return p},t.unstable_getFirstCallbackNode=function(){return r(u)},t.unstable_next=function(e){switch(p){case 1:case 2:case 3:var t=3;break;default:t=p}var n=p;p=t;try{return e()}finally{p=n}},t.unstable_pauseExecution=function(){},t.unstable_requestPaint=function(){},t.unstable_runWithPriority=function(e,t){switch(e){case 1:case 2:case 3:case 4:case 5:break;default:e=3}var n=p;p=e;try{return t()}finally{p=n}},t.unstable_scheduleCallback=function(e,a,o){var i=t.unstable_now();switch("object"===typeof o&&null!==o?o="number"===typeof(o=o.delay)&&0<o?i+o:i:o=i,e){case 1:var s=-1;break;case 2:s=250;break;case 5:s=1073741823;break;case 4:s=1e4;break;default:s=5e3}return e={id:d++,callback:a,priorityLevel:e,startTime:o,expirationTime:s=o+s,sortIndex:-1},o>i?(e.sortIndex=o,n(c,e),null===r(u)&&e===r(c)&&(v?(y(x),x=-1):v=!0,O(w,o-i))):(e.sortIndex=s,n(u,e),h||m||(h=!0,R(S))),e},t.unstable_shouldYield=A,t.unstable_wrapCallback=function(e){var t=p;return function(){var n=p;p=t;try{return e.apply(this,arguments)}finally{p=n}}}},5296:function(e,t,n){"use strict";e.exports=n(6813)},4836:function(e){e.exports=function(e){return e&&e.__esModule?e:{default:e}},e.exports.__esModule=!0,e.exports.default=e.exports},907:function(e,t,n){"use strict";function r(e,t){(null==t||t>e.length)&&(t=e.length);for(var n=0,r=new Array(t);n<t;n++)r[n]=e[n];return r}n.d(t,{Z:function(){return r}})},4942:function(e,t,n){"use strict";function r(e,t,n){return t in e?Object.defineProperty(e,t,{value:n,enumerable:!0,configurable:!0,writable:!0}):e[t]=n,e}n.d(t,{Z:function(){return r}})},7462:function(e,t,n){"use strict";function r(){return r=Object.assign?Object.assign.bind():function(e){for(var t=1;t<arguments.length;t++){var n=arguments[t];for(var r in n)Object.prototype.hasOwnProperty.call(n,r)&&(e[r]=n[r])}return e},r.apply(this,arguments)}n.d(t,{Z:function(){return r}})},3366:function(e,t,n){"use strict";function r(e,t){if(null==e)return{};var n,r,a={},o=Object.keys(e);for(r=0;r<o.length;r++)n=o[r],t.indexOf(n)>=0||(a[n]=e[n]);return a}n.d(t,{Z:function(){return r}})},885:function(e,t,n){"use strict";n.d(t,{Z:function(){return a}});var r=n(181);function a(e,t){return function(e){if(Array.isArray(e))return e}(e)||function(e,t){var n=null==e?null:"undefined"!==typeof Symbol&&e[Symbol.iterator]||e["@@iterator"];if(null!=n){var r,a,o=[],i=!0,s=!1;try{for(n=n.call(e);!(i=(r=n.next()).done)&&(o.push(r.value),!t||o.length!==t);i=!0);}catch(l){s=!0,a=l}finally{try{i||null==n.return||n.return()}finally{if(s)throw a}}return o}}(e,t)||(0,r.Z)(e,t)||function(){throw new TypeError("Invalid attempt to destructure non-iterable instance.\nIn order to be iterable, non-array objects must have a [Symbol.iterator]() method.")}()}},2982:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(907);var a=n(181);function o(e){return function(e){if(Array.isArray(e))return(0,r.Z)(e)}(e)||function(e){if("undefined"!==typeof Symbol&&null!=e[Symbol.iterator]||null!=e["@@iterator"])return Array.from(e)}(e)||(0,a.Z)(e)||function(){throw new TypeError("Invalid attempt to spread non-iterable instance.\nIn order to be iterable, non-array objects must have a [Symbol.iterator]() method.")}()}},181:function(e,t,n){"use strict";n.d(t,{Z:function(){return a}});var r=n(907);function a(e,t){if(e){if("string"===typeof e)return(0,r.Z)(e,t);var n=Object.prototype.toString.call(e).slice(8,-1);return"Object"===n&&e.constructor&&(n=e.constructor.name),"Map"===n||"Set"===n?Array.from(e):"Arguments"===n||/^(?:Ui|I)nt(?:8|16|32)(?:Clamped)?Array$/.test(n)?(0,r.Z)(e,t):void 0}}}},t={};function n(r){var a=t[r];if(void 0!==a)return a.exports;var o=t[r]={exports:{}};return e[r].call(o.exports,o,o.exports,n),o.exports}n.n=function(e){var t=e&&e.__esModule?function(){return e.default}:function(){return e};return n.d(t,{a:t}),t},function(){var e,t=Object.getPrototypeOf?function(e){return Object.getPrototypeOf(e)}:function(e){return e.__proto__};n.t=function(r,a){if(1&a&&(r=this(r)),8&a)return r;if("object"===typeof r&&r){if(4&a&&r.__esModule)return r;if(16&a&&"function"===typeof r.then)return r}var o=Object.create(null);n.r(o);var i={};e=e||[null,t({}),t([]),t(t)];for(var s=2&a&&r;"object"==typeof s&&!~e.indexOf(s);s=t(s))Object.getOwnPropertyNames(s).forEach((function(e){i[e]=function(){return r[e]}}));return i.default=function(){return r},n.d(o,i),o}}(),n.d=function(e,t){for(var r in t)n.o(t,r)&&!n.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},n.o=function(e,t){return Object.prototype.hasOwnProperty.call(e,t)},n.r=function(e){"undefined"!==typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},function(){"use strict";var e=n(2791),t=n(1250),r=n(7462),a=n(5513),o=(n(76),n(9886)),i=(n(2110),n(5438)),s=n(9140),l=n(2561),u=(0,o.w)((function(t,n){var r=t.styles,a=(0,s.O)([r],void 0,(0,e.useContext)(o.T)),u=(0,e.useRef)();return(0,l.j)((function(){var e=n.key+"-global",t=new n.sheet.constructor({key:e,nonce:n.sheet.nonce,container:n.sheet.container,speedy:n.sheet.isSpeedy}),r=!1,o=document.querySelector('style[data-emotion="'+e+" "+a.name+'"]');return n.sheet.tags.length&&(t.before=n.sheet.tags[0]),null!==o&&(r=!0,o.setAttribute("data-emotion",e),t.hydrate([o])),u.current=[t,r],function(){t.flush()}}),[n]),(0,l.j)((function(){var e=u.current,t=e[0];if(e[1])e[1]=!1;else{if(void 0!==a.next&&(0,i.My)(n,a.next,!0),t.tags.length){var r=t.tags[t.tags.length-1].nextElementSibling;t.before=r,t.flush()}n.insert("",a,t,!1)}}),[n,a.name]),null}));function c(){for(var e=arguments.length,t=new Array(e),n=0;n<e;n++)t[n]=arguments[n];return(0,s.O)(t)}var d=function(){var e=c.apply(void 0,arguments),t="animation-"+e.name;return{name:t,styles:"@keyframes "+t+"{"+e.styles+"}",anim:1,toString:function(){return"_EMO_"+this.name+"_"+this.styles+"_EMO_"}}};var f=n(184);function p(e){var t=e.styles,n=e.defaultTheme,r=void 0===n?{}:n,a="function"===typeof t?function(e){return t(void 0===(n=e)||null===n||0===Object.keys(n).length?r:e);var n}:t;return(0,f.jsx)(u,{styles:a})}var m=n(4205);var h=function(e){return(0,f.jsx)(p,(0,r.Z)({},e,{defaultTheme:m.Z}))},v=function(e,t){return(0,r.Z)({WebkitFontSmoothing:"antialiased",MozOsxFontSmoothing:"grayscale",boxSizing:"border-box",WebkitTextSizeAdjust:"100%"},t&&{colorScheme:e.palette.mode})},b=function(e){return(0,r.Z)({color:(e.vars||e).palette.text.primary},e.typography.body1,{backgroundColor:(e.vars||e).palette.background.default,"@media print":{backgroundColor:(e.vars||e).palette.common.white}})};var y=function(t){var n=(0,a.Z)({props:t,name:"MuiCssBaseline"}),o=n.children,i=n.enableColorScheme,s=void 0!==i&&i;return(0,f.jsxs)(e.Fragment,{children:[(0,f.jsx)(h,{styles:function(e){return function(e){var t,n,a={html:v(e,arguments.length>1&&void 0!==arguments[1]&&arguments[1]),"*, *::before, *::after":{boxSizing:"inherit"},"strong, b":{fontWeight:e.typography.fontWeightBold},body:(0,r.Z)({margin:0},b(e),{"&::backdrop":{backgroundColor:(e.vars||e).palette.background.default}})},o=null==(t=e.components)||null==(n=t.MuiCssBaseline)?void 0:n.styleOverrides;return o&&(a=[a,o]),a}(e,s)}}),o]})},g=n(885),_=n(4942),w=n(3366),S=n(8182),k=n(7312),C=n(1217),T=n(4419),x=n(8691),F=(0,n(4046).ZP)(),P=n(5080),A=["className","component","disableGutters","fixed","maxWidth","classes"],N=(0,P.Z)(),E=F("div",{name:"MuiContainer",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,t["maxWidth".concat((0,k.Z)(String(n.maxWidth)))],n.fixed&&t.fixed,n.disableGutters&&t.disableGutters]}}),M=function(e){return(0,x.Z)({props:e,name:"MuiContainer",defaultTheme:N})},R=function(e,t){var n=e.classes,r=e.fixed,a=e.disableGutters,o=e.maxWidth,i={root:["root",o&&"maxWidth".concat((0,k.Z)(String(o))),r&&"fixed",a&&"disableGutters"]};return(0,T.Z)(i,(function(e){return(0,C.Z)(t,e)}),n)};var O=n(9853),D=n(277),z=function(){var t=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},n=t.createStyledComponent,a=void 0===n?E:n,o=t.useThemeProps,i=void 0===o?M:o,s=t.componentName,l=void 0===s?"MuiContainer":s,u=a((function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({width:"100%",marginLeft:"auto",boxSizing:"border-box",marginRight:"auto",display:"block"},!n.disableGutters&&(0,_.Z)({paddingLeft:t.spacing(2),paddingRight:t.spacing(2)},t.breakpoints.up("sm"),{paddingLeft:t.spacing(3),paddingRight:t.spacing(3)}))}),(function(e){var t=e.theme;return e.ownerState.fixed&&Object.keys(t.breakpoints.values).reduce((function(e,n){var r=n,a=t.breakpoints.values[r];return 0!==a&&(e[t.breakpoints.up(r)]={maxWidth:"".concat(a).concat(t.breakpoints.unit)}),e}),{})}),(function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({},"xs"===n.maxWidth&&(0,_.Z)({},t.breakpoints.up("xs"),{maxWidth:Math.max(t.breakpoints.values.xs,444)}),n.maxWidth&&"xs"!==n.maxWidth&&(0,_.Z)({},t.breakpoints.up(n.maxWidth),{maxWidth:"".concat(t.breakpoints.values[n.maxWidth]).concat(t.breakpoints.unit)}))})),c=e.forwardRef((function(e,t){var n=i(e),a=n.className,o=n.component,s=void 0===o?"div":o,c=n.disableGutters,d=void 0!==c&&c,p=n.fixed,m=void 0!==p&&p,h=n.maxWidth,v=void 0===h?"lg":h,b=(0,w.Z)(n,A),y=(0,r.Z)({},n,{component:s,disableGutters:d,fixed:m,maxWidth:v}),g=R(y,l);return(0,f.jsx)(u,(0,r.Z)({as:s,ownerState:y,className:(0,S.Z)(g.root,a),ref:t},b))}));return c}({createStyledComponent:(0,D.ZP)("div",{name:"MuiContainer",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,t["maxWidth".concat((0,O.Z)(String(n.maxWidth)))],n.fixed&&t.fixed,n.disableGutters&&t.disableGutters]}}),useThemeProps:function(e){return(0,a.Z)({props:e,name:"MuiContainer"})}}),I=z,L=n(2421),Z=n(104),j=n(2982),B=n(2466),V=n(114),U=["sx"];function J(e){var t,n=e.sx,a=function(e){var t={systemProps:{},otherProps:{}};return Object.keys(e).forEach((function(n){V.Gc[n]?t.systemProps[n]=e[n]:t.otherProps[n]=e[n]})),t}((0,w.Z)(e,U)),o=a.systemProps,i=a.otherProps;return t=Array.isArray(n)?[o].concat((0,j.Z)(n)):"function"===typeof n?function(){var e=n.apply(void 0,arguments);return(0,B.P)(e)?(0,r.Z)({},o,e):o}:(0,r.Z)({},o,n),(0,r.Z)({},i,{sx:t})}var W=n(886),H=["className","component"];var $=n(5902),q=n(4360),G=function(){var t=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},n=t.defaultTheme,a=t.defaultClassName,o=void 0===a?"MuiBox-root":a,i=t.generateClassName,s=t.styleFunctionSx,l=void 0===s?Z.Z:s,u=(0,L.ZP)("div",{shouldForwardProp:function(e){return"theme"!==e&&"sx"!==e&&"as"!==e}})(l),c=e.forwardRef((function(e,t){var a=(0,W.Z)(n),s=J(e),l=s.className,c=s.component,d=void 0===c?"div":c,p=(0,w.Z)(s,H);return(0,f.jsx)(u,(0,r.Z)({as:d,ref:t,className:(0,S.Z)(l,i?i(o):o),theme:a},p))}));return c}({defaultTheme:(0,q.Z)(),defaultClassName:"MuiBox-root",generateClassName:$.Z.generate}),K=G,Q=JSON.parse('{"e":11,"C":[{"nctid":"NCT03839940","version_a":20,"version_b":21,"version_a_date":"2021-05-25","version_b_date":"2022-03-03","pom_a":[{"label":"1.","content":"Incidence rate of the mTOR inhibitor-associated stomatitis (mIAS)-related pain based on daily self-reports via the numerical analogue scale[ Time Frame: Up to 8 weeks ]The numerical analogue mouth pain score (NAMPS) is a single item measured on a 0 to 10 scale, with 0 corresponding to \\"No pain\\" and 10 corresponding to \\"Pain as bad as it can be.\\" Will compare the incidence rate of any mouth pain (i.e., any score greater than 0) as assessed by the NAMPS between the prevention versus early treatment approaches using a Chi-square test."},{"label":"2.","content":"Severity of mouth pain scores[ Time Frame: Up to 8 weeks ]Average Area Under the Curve per assessment (aAUCpa) of mouth pain scores as measured by NAMPS will be computed for each patient to summarize the sequence of numerical analogue mouth pain scores over the eight week study period. Scores are reported on a 0-100 scale, where 100 = better outcome QOL (i.e. less pain). The aAUCpa is the average of each AUC between each sequential assessment from treatment-initiation to the end of the treatment at 8 weeks post-treatment-initiation and will be compared between the two treatment arms."}],"pom_b":[{"label":"1.","content":"Incidence Rate of the mTOR Inhibitor-associated Stomatitis (mIAS)-Related Pain Based on Daily Self-reports Via the Numerical Analogue Scale[ Time Frame: Up to 8 weeks ]The numerical analogue mouth pain score (NAMPS) is a single item measured on a 0 to 10 scale, with 0 corresponding to \\"No pain\\" and 10 corresponding to \\"Pain as bad as it can be.\\" Will compare the incidence rate of any mouth pain (i.e., any score greater than 0) as assessed by the NAMPS between the prevention versus early treatment approaches using a Chi-square test."},{"label":"2.","content":"Severity of Mouth Pain Scores[ Time Frame: Up to 8 weeks ]Average Area Under the Curve per assessment (aAUCpa) of mouth pain scores as measured by NAMPS will be computed for each patient to summarize the sequence of numerical analogue mouth pain scores over the eight week study period. Scores are reported on a 0-100 scale, where 100 = better outcome QOL (i.e. less pain). The aAUCpa is the average of each AUC between each sequential assessment from treatment-initiation to the end of the treatment at 8 weeks post-treatment-initiation and will be compared between the two treatment arms."}],"start_date":"February 15, 2019","primary_completion_date":"December 17, 2020","completion_date":"December 17, 2020","first_posted":"February 15, 2019","results_first_posted":"August 1, 2022","last_update_posted":"August 1, 2022"},{"nctid":"NCT03757949","version_a":11,"version_b":12,"version_a_date":"2021-04-29","version_b_date":"2021-05-12","pom_a":[{"label":"1.","content":"Post-operative complications[ Time Frame: Up to 30 days post surgery ]A post-operative complication is defined as a binary indicator variable indicating whether the patient experienced any complication (any/none; Clavien-Dindo grades I-V). The primary analysis will be based on a multivariable logistic regression under intent-totreat among all randomized patients, irrespective of their eligibility status, adjusting for the specified stratification factors: a. Diversion type (neobladder versus [vs.] ileal conduit); b. Prior neoadjuvant chemotherapy (any vs. none); and c. Nutrition status (well nourished vs. moderate malnutrition). A Fisher?s exact test will also be conducted to establish whether the results are sensitive to model assumptions. A single interim analysis for efficacy will be conducted when 50% of patients achieve their endpoint at the alpha=0.005 level. Accordingly, the final analysis will be conducted at the alpha=0.045 level. A separate analysis among all eligible randomized patients will also be conducted."}],"pom_b":[{"label":"1.","content":"Post-operative complications[ Time Frame: Up to 30 days post surgery ]A post-operative complication is defined as a binary indicator variable indicating whether the patient experienced any complication (any/none; Clavien-Dindo grades I-V). The primary analysis will be based on a multivariable logistic regression under intent-totreat among all randomized patients, irrespective of their eligibility status, adjusting for the specified stratification factors: a. Diversion type (neobladder versus [vs.] ileal conduit); b. Prior neoadjuvant chemotherapy (any vs. none); and c. Nutrition status (well nourished vs. moderate malnutrition). A Fisher\'s exact test will also be conducted to establish whether the results are sensitive to model assumptions. A single interim analysis for efficacy will be conducted when 50% of patients achieve their endpoint at the alpha=0.005 level. Accordingly, the final analysis will be conducted at the alpha=0.045 level. A separate analysis among all eligible randomized patients will also be conducted."}],"start_date":"February 21, 2019","primary_completion_date":"July 1, 2023","completion_date":"May 1, 2026","first_posted":"November 29, 2018","last_update_posted":"March 16, 2022"},{"nctid":"NCT00326378","version_a":1,"version_b":2,"version_a_date":"2006-05-15","version_b_date":"2010-07-27","pom_a":[{"label":"1.","content":"time to progression"}],"pom_b":[{"label":"1.","content":"time to progression[ Time Frame: 1 year after the enrollment of the last patient ]"}],"start_date":"October 2005","primary_completion_date":"March 2013","completion_date":"May 2015","first_posted":"May 16, 2006","last_update_posted":"June 8, 2015"},{"nctid":"NCT00326378","version_a":4,"version_b":5,"version_a_date":"2012-04-25","version_b_date":"2012-11-04","pom_a":[{"label":"1.","content":"time to progression[ Time Frame: 1 year after the enrollment of the last patient ]"}],"pom_b":[{"label":"1.","content":"Progression free survival[ Time Frame: The final analysis will be conducted when 381 events (progressions or deaths) are observed. ]"}],"start_date":"October 2005","primary_completion_date":"March 2013","completion_date":"May 2015","first_posted":"May 16, 2006","last_update_posted":"June 8, 2015"},{"nctid":"NCT00160381","version_a":4,"version_b":5,"version_a_date":"2007-04-10","version_b_date":"2007-06-29","pom_a":[{"label":"1.","content":"The percent of subjects who demonstrate a clinically meaningful improvement in bleeding and do not have surgical/invasive intervention during the treatment period or who discontinue treatment because of planned surgical/invasive intervention."}],"pom_b":[{"label":"1.","content":"The percent of subjects who demonstrate a clinically meaningful improvement in bleeding and who do not require surgical/invasive intervention.[ Time Frame: Month 12 ]"}],"start_date":"September 2002","primary_completion_date":"January 2005","completion_date":"January 2005","first_posted":"September 12, 2005","last_update_posted":"May 29, 2008"},{"nctid":"NCT00160381","version_a":7,"version_b":8,"version_a_date":"2008-01-04","version_b_date":"2008-04-08","pom_a":[{"label":"1.","content":"The percent of subjects who demonstrate a clinically meaningful improvement in bleeding and who do not require surgical/invasive intervention.[ Time Frame: Month 12 ]"}],"pom_b":[{"label":"1.","content":"The percent of subjects who demonstrate a clinically meaningful improvement in bleeding and who do not require surgical/invasive intervention.[ Time Frame: Month 12 or Final Visit ]"}],"start_date":"September 2002","primary_completion_date":"January 2005","completion_date":"January 2005","first_posted":"September 12, 2005","last_update_posted":"May 29, 2008"},{"nctid":"NCT00801242","version_a":20,"version_b":21,"version_a_date":"2013-07-23","version_b_date":"2014-07-30","pom_a":[{"label":"1.","content":"Evaluate the time to PSA > 4 ng/mL[ Time Frame: Up to 24 months ]"}],"pom_b":[{"label":"1.","content":"Median and between participant variability of time to PSA >4 ng/mL during the first cycle of IAD after 7 monthly injections of degarelix induction treatment[ Time Frame: Up to 24 months after end of induction period ]Blood samples for analyses of serum PSA levels were collected at the Screening Visit, and every two months during the course of the trial, and at the End-of-Trial Visit. Analyses were performed using chemiluminometric immunoassay."}],"start_date":"December 2008","primary_completion_date":"June 2012","completion_date":"July 2013","first_posted":"December 3, 2008","results_first_posted":"September 3, 2014","last_update_posted":"September 3, 2014"},{"nctid":"NCT00801242","version_a":21,"version_b":22,"version_a_date":"2014-07-30","version_b_date":"2014-09-02","pom_a":[{"label":"1.","content":"Median and between participant variability of time to PSA >4 ng/mL during the first cycle of IAD after 7 monthly injections of degarelix induction treatment[ Time Frame: Up to 24 months after end of induction period ]Blood samples for analyses of serum PSA levels were collected at the Screening Visit, and every two months during the course of the trial, and at the End-of-Trial Visit. Analyses were performed using chemiluminometric immunoassay."}],"pom_b":[{"label":"1.","content":"Median and Between Participant Variability of Time to Prostate-specific Antigen (PSA) >4 ng/mL During the First Cycle of Intermittent Androgen Deprivation (IAD) After 7 Monthly Injections of Degarelix Induction Treatment[ Time Frame: Up to 24 months after end of induction period ]Blood samples for analyses of serum PSA levels were collected at the Screening Visit, and every two months during the course of the trial, and at the End-of-Trial Visit. Analyses were performed using chemiluminometric immunoassay."}],"start_date":"December 2008","primary_completion_date":"June 2012","completion_date":"July 2013","first_posted":"December 3, 2008","results_first_posted":"September 3, 2014","last_update_posted":"September 3, 2014"},{"nctid":"NCT00011986","version_a":25,"version_b":26,"version_a_date":"2012-06-26","version_b_date":"2014-01-09","pom_a":[],"pom_b":[{"label":"1.","content":"Overall survival[ Time Frame: Up to 9 years ]"},{"label":"2.","content":"Progression-free survival[ Time Frame: From entry onto the protocol to the date of clinical or radiologic evidence of progressive disease, up to 9 years ]"},{"label":"3.","content":"Frequency and severity of observed adverse effects assessed by Common Toxicity Criteria version 2.0[ Time Frame: Up to 9 years ]"}],"start_date":"January 2001","primary_completion_date":"March 2010","completion_date":"January 28, 2013","first_posted":"January 27, 2003","results_first_posted":"April 19, 2016","last_update_posted":"April 16, 2019"},{"nctid":"NCT00011986","version_a":26,"version_b":27,"version_a_date":"2014-01-09","version_b_date":"2016-03-17","pom_a":[{"label":"1.","content":"Overall survival[ Time Frame: Up to 9 years ]"},{"label":"2.","content":"Progression-free survival[ Time Frame: From entry onto the protocol to the date of clinical or radiologic evidence of progressive disease, up to 9 years ]"},{"label":"3.","content":"Frequency and severity of observed adverse effects assessed by Common Toxicity Criteria version 2.0[ Time Frame: Up to 9 years ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Up to 9 years ]"},{"label":"2.","content":"Progression-free Survival[ Time Frame: From the date of enrollment to first progression or death or last contact, if alive and progression free. ]Hazard ratio for progression free survival. All hazard ratios are expressed relative to the reference regimen: Carbo/taxol."},{"label":"3.","content":"Frequency and Severity of Observed Adverse Effects Assessed by Common Toxicity Criteria Version 2.0[ Time Frame: Up to 9 years ]"}],"start_date":"January 2001","primary_completion_date":"March 2010","completion_date":"January 28, 2013","first_posted":"January 27, 2003","results_first_posted":"April 19, 2016","last_update_posted":"April 16, 2019"},{"nctid":"NCT00011986","version_a":27,"version_b":28,"version_a_date":"2016-03-17","version_b_date":"2018-05-23","pom_a":[{"label":"1.","content":"Overall Survival[ Time Frame: Up to 9 years ]"},{"label":"2.","content":"Progression-free Survival[ Time Frame: From the date of enrollment to first progression or death or last contact, if alive and progression free. ]Hazard ratio for progression free survival. All hazard ratios are expressed relative to the reference regimen: Carbo/taxol."},{"label":"3.","content":"Frequency and Severity of Observed Adverse Effects Assessed by Common Toxicity Criteria Version 2.0[ Time Frame: Up to 9 years ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Up to 9 years ]"},{"label":"2.","content":"Progression-free Survival[ Time Frame: From the date of enrollment to first progression or death or last contact, if alive and progression free. ]Median duration in months of progression free survival."},{"label":"3.","content":"Frequency and Severity of Observed Adverse Effects Assessed by Common Toxicity Criteria Version 2.0[ Time Frame: Up to 9 years ]"}],"start_date":"January 2001","primary_completion_date":"March 2010","completion_date":"January 28, 2013","first_posted":"January 27, 2003","results_first_posted":"April 19, 2016","last_update_posted":"April 16, 2019"},{"nctid":"NCT00011986","version_a":28,"version_b":29,"version_a_date":"2018-05-23","version_b_date":"2019-03-21","pom_a":[{"label":"1.","content":"Overall Survival[ Time Frame: Up to 9 years ]"},{"label":"2.","content":"Progression-free Survival[ Time Frame: From the date of enrollment to first progression or death or last contact, if alive and progression free. ]Median duration in months of progression free survival."},{"label":"3.","content":"Frequency and Severity of Observed Adverse Effects Assessed by Common Toxicity Criteria Version 2.0[ Time Frame: Up to 9 years ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Up to 9 years ]Proportion of participants whose overall survival exceeded 5 years."},{"label":"2.","content":"Progression-free Survival[ Time Frame: From the date of enrollment to first progression or death or last contact, if alive and progression free. ]Median duration in months of progression free survival."}],"start_date":"January 2001","primary_completion_date":"March 2010","completion_date":"January 28, 2013","first_posted":"January 27, 2003","results_first_posted":"April 19, 2016","last_update_posted":"April 16, 2019"},{"nctid":"NCT03933449","version_a":1,"version_b":2,"version_a_date":"2019-04-29","version_b_date":"2020-02-12","pom_a":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: Up to 5 years ]"}],"pom_b":[{"label":"1.","content":"Overall Survival (OS) in All Participants[ Time Frame: From randomization through final analysis data cutoff date of 13-Feb-2019 (Up to approximately 24 months) ]OS was defined as the time from randomization to death due to any cause. Median OS in all participants is presented."},{"label":"2.","content":"Overall Survival (OS) in Participants With Programmed Death-Ligand 1 Combined Positive Score \u226510 (PD-L1 CPS \u226510)[ Time Frame: From randomization through final analysis data cutoff date of 13-Feb-2019 (Up to approximately 24 months) ]OS was defined as the time from randomization to death due to any cause. Median OS in participants with a PD-L1 CPS \u226510 is presented."},{"label":"3.","content":"Overall Survival (OS) in Participants With Squamous Cell Carcinoma (SCC) of the Esophagus[ Time Frame: From randomization through final analysis data cutoff date of 13-Feb-2019 (Up to approximately 24 months) ]OS was defined as the time from randomization to death due to any cause. Median OS in participants with SCC of the esophagus is presented."}],"start_date":"December 29, 2016","primary_completion_date":"February 13, 2019","completion_date":"March 14, 2022","first_posted":"May 1, 2019","results_first_posted":"February 26, 2020","last_update_posted":"August 17, 2022"},{"nctid":"NCT01953003","version_a":5,"version_b":6,"version_a_date":"2017-09-27","version_b_date":"2019-01-29","pom_a":[{"label":"1.","content":"progression free survival[ Time Frame: progression date will be assessed evey 6 weeks starting from the randomization date until first documented progression or date of death from any cause whichever came first assessed up to 3 years ]"}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: progression date will be assessed evey 6 weeks starting from the randomization date until first documented progression or date of death from any cause whichever came first assessed up to 3 years ]The primary endpoint for the trial is progression-free survival calculated from the date of randomisation until the date of progression or the date of death whatever the cause of death. Patient who does not progressed will be censored at the date of last tumour assessment or the date of last contact of a follow-up showing no progression."}],"start_date":"September 2013","primary_completion_date":"July 2017","completion_date":"July 2017","first_posted":"September 30, 2013","results_first_posted":"May 2, 2019","last_update_posted":"May 2, 2019"},{"nctid":"NCT04866017","version_a":1,"version_b":2,"version_a_date":"2021-04-26","version_b_date":"2021-06-14","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS) in the Intent-to-treat (ITT) Analysis set as assessed by the Independent Review Committee (IRC)[ Time Frame: Up to 16 months ]Time from the date of randomization to the date of first documentation of disease progression assessed"}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS) in the Intent-to-treat (ITT) Analysis set as assessed by the Independent Review Committee (IRC)[ Time Frame: Up to 16 months ]Time from the date of randomization to the date of first documentation of disease progression assessed"},{"label":"2.","content":"Complete Response Rate (CRR) as assessed by the Independent Review Committee (IRC)[ Time Frame: Up to 16 months ]defined as the proportion of patients who achieve a complete response (CR) per Repose Evaluation Criteria in Solid Tumors (RECIST) version 1.1 (v.1.1)"}],"start_date":"June 17, 2021","primary_completion_date":"January 30, 2025","completion_date":"September 30, 2025","first_posted":"April 29, 2021","last_update_posted":"October 25, 2021"},{"nctid":"NCT04225871","version_a":7,"version_b":8,"version_a_date":"2021-02-18","version_b_date":"2021-04-01","pom_a":[{"label":"1.","content":"Number of participants with adverse events[ Time Frame: Approximately 36 months ]"}],"pom_b":[{"label":"1.","content":"Incidence of treatment-emergent adverse events (TEAEs)[ Time Frame: From Baseline (Day 1) to Safety Follow-Up Visit (up to 36 months) ]A treatment-emergent adverse event is any untoward medical occurrence in a patient or clinical study participant, temporally associated with the use of study medication, whether or not considered related to the study medication."}],"start_date":"December 23, 2019","primary_completion_date":"May 2024","completion_date":"May 2024","first_posted":"January 13, 2020","last_update_posted":"August 17, 2022"},{"nctid":"NCT00075816","version_a":11,"version_b":12,"version_a_date":"2006-08-04","version_b_date":"2006-10-11","pom_a":[],"pom_b":[{"label":"1.","content":"Two-year survival"}],"start_date":"January 2004","primary_completion_date":"April 2013","completion_date":"April 2014","first_posted":"January 13, 2004","results_first_posted":"February 1, 2016","last_update_posted":"November 28, 2017"},{"nctid":"NCT00075816","version_a":18,"version_b":19,"version_a_date":"2007-05-11","version_b_date":"2008-10-07","pom_a":[{"label":"1.","content":"Two-year survival"}],"pom_b":[{"label":"1.","content":"Two-year survival[ Time Frame: 2 years ]"}],"start_date":"January 2004","primary_completion_date":"April 2013","completion_date":"April 2014","first_posted":"January 13, 2004","results_first_posted":"February 1, 2016","last_update_posted":"November 28, 2017"},{"nctid":"NCT00075816","version_a":19,"version_b":20,"version_a_date":"2008-10-07","version_b_date":"2009-02-19","pom_a":[{"label":"1.","content":"Two-year survival[ Time Frame: 2 years ]"}],"pom_b":[{"label":"1.","content":"Two-year survival[ Time Frame: Measured at 2 years ]"}],"start_date":"January 2004","primary_completion_date":"April 2013","completion_date":"April 2014","first_posted":"January 13, 2004","results_first_posted":"February 1, 2016","last_update_posted":"November 28, 2017"},{"nctid":"NCT00075816","version_a":26,"version_b":27,"version_a_date":"2013-12-04","version_b_date":"2015-12-28","pom_a":[{"label":"1.","content":"Two-year survival[ Time Frame: Measured at 2 years ]"}],"pom_b":[{"label":"1.","content":"Two-year Overall Survival[ Time Frame: Measured at 2 years ]Overall survival rate at 2 years according to an intention-to-treat analysis."}],"start_date":"January 2004","primary_completion_date":"April 2013","completion_date":"April 2014","first_posted":"January 13, 2004","results_first_posted":"February 1, 2016","last_update_posted":"November 28, 2017"},{"nctid":"NCT01539291","version_a":14,"version_b":15,"version_a_date":"2013-09-24","version_b_date":"2013-12-13","pom_a":[{"label":"1.","content":"Overall Response Rate[ Time Frame: 12 months ]"}],"pom_b":[{"label":"1.","content":"Overall Safety[ Time Frame: Baseline to Month 12 ]Overall safety profile of each study treatment regimen will be characterized by the type, frequency, severity, timing of onset, duration, and relationship to study therapy of any adverse events or abnormalities of laboratory tests, serious adverse events, or adverse events leading to discontinuation of study drug."}],"start_date":"October 3, 2012","primary_completion_date":"May 21, 2018","completion_date":"June 29, 2018","first_posted":"February 27, 2012","results_first_posted":"August 20, 2019","last_update_posted":"August 20, 2019"},{"nctid":"NCT01539291","version_a":30,"version_b":31,"version_a_date":"2018-10-19","version_b_date":"2019-08-12","pom_a":[{"label":"1.","content":"Overall Safety[ Time Frame: Baseline to Month 12 ]Overall safety profile of each study treatment regimen will be characterized by the type, frequency, severity, timing of onset, duration, and relationship to study therapy of any adverse events or abnormalities of laboratory tests, serious adverse events, or adverse events leading to discontinuation of study drug."}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS)[ Time Frame: GS-US-312-0116 Baseline to end of study GS-US-312-0117 (maximum: up to 67.6 months) ]PFS was defined as the interval from the start of study therapy to the earlier of the first documentation of definitive disease progression or death from any cause; definitive disease progression is chronic lymphocytic leukemia (CLL) progression based on standard criteria other than lymphocytosis alone. PFS was analyzed using Kaplan-Meier (KM) estimates."},{"label":"2.","content":"Safety: Percentage of Participants With Any Treatment-Emergent Adverse Events (TEAE), \u2265 Grade 3 TEAE, Study Drug-Related TEAE, \u2265 Grade 3 Study Drug-Related TEAE, Serious TEAE, Study Drug-Related Serious TEAE, and TEAE Leading to Study Drug Discontinuation[ Time Frame: First IDL dose date in study GS-US-312-0116 or GS-US-312-0117 to last IDL dose date in study GS-US-312-0117 (maximum: 67.3 months) plus 4 weeks ]The TEAEs were defined as events in a given study period that met one of the following criteria:Events with onset dates on or after the start of treatment and up to 30 days after the permanent discontinuation of the study treatment.The continuing adverse events (AEs) diagnosed prior to the start of treatment and worsened in severity grade, or non-serious AEs at baseline which became serious, or AEs resulting in treatment discontinuation after the start of treatment.The severity of AEs was graded by the investigator according to the common terminology criteria for adverse events (CTCAE), Version 4.03, whenever possible. The relationship of an AE to study drug (idelalisib) was assessed using clinical judgment by the investigator, describing the event as either unrelated or related. Events for which the investigator did not record relationship to study drug were considered related to study drug."}],"start_date":"October 3, 2012","primary_completion_date":"May 21, 2018","completion_date":"June 29, 2018","first_posted":"February 27, 2012","results_first_posted":"August 20, 2019","last_update_posted":"August 20, 2019"},{"nctid":"NCT01702571","version_a":52,"version_b":53,"version_a_date":"2014-01-13","version_b_date":"2014-01-22","pom_a":[{"label":"1.","content":"Safety: incidence of adverse events[ Time Frame: Up to approximately 5 years ]"}],"pom_b":[{"label":"1.","content":"Safety: incidence of adverse events[ Time Frame: Up to approximately 4 years ]"}],"start_date":"November 27, 2012","primary_completion_date":"July 31, 2020","completion_date":"July 31, 2020","first_posted":"October 8, 2012","results_first_posted":"August 5, 2021","last_update_posted":"April 4, 2022"},{"nctid":"NCT01702571","version_a":124,"version_b":125,"version_a_date":"2016-07-01","version_b_date":"2016-08-17","pom_a":[{"label":"1.","content":"Safety: incidence of adverse events[ Time Frame: Up to approximately 4 years ]"}],"pom_b":[{"label":"1.","content":"Percentage of Participants with Adverse Events[ Time Frame: Baseline up to approximately 6 years ]"}],"start_date":"November 27, 2012","primary_completion_date":"July 31, 2020","completion_date":"July 31, 2020","first_posted":"October 8, 2012","results_first_posted":"August 5, 2021","last_update_posted":"April 4, 2022"},{"nctid":"NCT01702571","version_a":139,"version_b":140,"version_a_date":"2021-04-08","version_b_date":"2021-07-14","pom_a":[{"label":"1.","content":"Percentage of Participants with Adverse Events[ Time Frame: Baseline up to approximately 6 years ]"}],"pom_b":[{"label":"1.","content":"Percentage of Participants With Adverse Events of Primary Interest (AEPIs)[ Time Frame: Baseline up to approximately 7 years ]The AEPIs in this study were defined as the following: adverse events (AEs) Grade >/= 3, specifically, hepatic events, allergic reactions, thrombocytopenia and hemorrhage events, all Grade >/= 3 AEs related to trastuzumab emtansine and pneumonitis events of all grades."}],"start_date":"November 27, 2012","primary_completion_date":"July 31, 2020","completion_date":"July 31, 2020","first_posted":"October 8, 2012","results_first_posted":"August 5, 2021","last_update_posted":"April 4, 2022"},{"nctid":"NCT00087022","version_a":20,"version_b":21,"version_a_date":"2006-09-29","version_b_date":"2006-11-08","pom_a":[],"pom_b":[{"label":"1.","content":"Disease-free survival at 3 months for 2 years, 6 months for 2 years and then at 1 year"},{"label":"2.","content":"Overall survival"}],"start_date":"July 2004","primary_completion_date":"October 2012","completion_date":"October 2012","first_posted":"July 12, 2004","results_first_posted":"September 12, 2018","last_update_posted":"November 27, 2018"},{"nctid":"NCT00087022","version_a":54,"version_b":55,"version_a_date":"2008-10-24","version_b_date":"2008-11-25","pom_a":[{"label":"1.","content":"Disease-free survival at 3 months for 2 years, 6 months for 2 years and then at 1 year"},{"label":"2.","content":"Overall survival"}],"pom_b":[{"label":"1.","content":"Disease-free survival every 3 months for 2 years, 6 months for 2 years and then at 1 year"},{"label":"2.","content":"Overall survival"}],"start_date":"July 2004","primary_completion_date":"October 2012","completion_date":"October 2012","first_posted":"July 12, 2004","results_first_posted":"September 12, 2018","last_update_posted":"November 27, 2018"},{"nctid":"NCT00087022","version_a":58,"version_b":59,"version_a_date":"2009-09-23","version_b_date":"2009-10-29","pom_a":[{"label":"1.","content":"Disease-free survival every 3 months for 2 years, 6 months for 2 years and then at 1 year"},{"label":"2.","content":"Overall survival"}],"pom_b":[{"label":"1.","content":"Disease-free survival every 3 months for 2 years, 6 months for 2 years and then annualy until recurrence"},{"label":"2.","content":"Overall survival"}],"start_date":"July 2004","primary_completion_date":"October 2012","completion_date":"October 2012","first_posted":"July 12, 2004","results_first_posted":"September 12, 2018","last_update_posted":"November 27, 2018"},{"nctid":"NCT00087022","version_a":60,"version_b":61,"version_a_date":"2011-01-15","version_b_date":"2013-05-21","pom_a":[{"label":"1.","content":"Disease-free survival every 3 months for 2 years, 6 months for 2 years and then annualy until recurrence"},{"label":"2.","content":"Overall survival"}],"pom_b":[{"label":"1.","content":"Disease-free survival[ Time Frame: Local 360 DFS events ]"},{"label":"2.","content":"Overall survival[ Time Frame: After 419 OS events or 60 months after the last patient has been enrolled, whichever is the later ]"}],"start_date":"July 2004","primary_completion_date":"October 2012","completion_date":"October 2012","first_posted":"July 12, 2004","results_first_posted":"September 12, 2018","last_update_posted":"November 27, 2018"},{"nctid":"NCT00087022","version_a":62,"version_b":63,"version_a_date":"2014-01-28","version_b_date":"2018-08-09","pom_a":[{"label":"1.","content":"Disease-free survival[ Time Frame: Local 360 DFS events ]"},{"label":"2.","content":"Overall survival[ Time Frame: After 419 OS events or 60 months after the last patient has been enrolled, whichever is the later ]"}],"pom_b":[{"label":"1.","content":"Disease-free Survival[ Time Frame: Until signs of recurrence or until 360 local DFS events have occurred (median follow-up of 4.5 years) ]Disease Free Survival (DFS) calculated from the date of randomization up to and including the date of documented relapse as confirmed by the CT, death or start of new anti-tumor therapy."},{"label":"2.","content":"Overall Survival[ Time Frame: After 419 OS events or 60 months after the last patient has been enrolled, whichever is the later (median follow-up of 4.5 years) ]Overall Survival (OS) calculated from the date of randomization to the date of death. Patients with no documented death will be censored at the date of their last study evaluation."}],"start_date":"July 2004","primary_completion_date":"October 2012","completion_date":"October 2012","first_posted":"July 12, 2004","results_first_posted":"September 12, 2018","last_update_posted":"November 27, 2018"},{"nctid":"NCT03783442","version_a":15,"version_b":16,"version_a_date":"2019-11-01","version_b_date":"2019-12-17","pom_a":[{"label":"1.","content":"PFS - defined as the time from the date of randomization to the date of first documentation of disease progression assessed by BIRC per RECIST v1.1 or death, whichever occurs first[ Time Frame: Approximately 31 months from date of the first patient randomization ]"},{"label":"2.","content":"OS - defined as the time from the date of randomization until the date of death due to any cause[ Time Frame: Approximately 31 months from date of the first patient randomization ]"}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS) - defined as the time from the date of randomization to the date of first documentation of disease progression assessed by the blinded independent review committee (BIRC) per RECIST v1.1 or death, whichever occurs first[ Time Frame: Approximately 31 months from date of the first participant randomization ]"},{"label":"2.","content":"Overall Survival (OS) - defined as the time from the date of randomization until the date of death due to any cause[ Time Frame: Approximately 31 months from date of the first participant randomization ]"}],"start_date":"December 11, 2018","primary_completion_date":"September 30, 2023","completion_date":"September 30, 2023","first_posted":"December 21, 2018","last_update_posted":"May 2, 2022"},{"nctid":"NCT03783442","version_a":22,"version_b":23,"version_a_date":"2022-04-19","version_b_date":"2022-04-26","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS) - defined as the time from the date of randomization to the date of first documentation of disease progression assessed by the blinded independent review committee (BIRC) per RECIST v1.1 or death, whichever occurs first[ Time Frame: Approximately 31 months from date of the first participant randomization ]"},{"label":"2.","content":"Overall Survival (OS) - defined as the time from the date of randomization until the date of death due to any cause[ Time Frame: Approximately 31 months from date of the first participant randomization ]"}],"pom_b":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: Up to approximately 40 months from date of the first participant randomization ]OS is defined as the time from the date of randomization until the date of death due to any cause"}],"start_date":"December 11, 2018","primary_completion_date":"September 30, 2023","completion_date":"September 30, 2023","first_posted":"December 21, 2018","last_update_posted":"May 2, 2022"},{"nctid":"NCT02549339","version_a":1,"version_b":2,"version_a_date":"2015-09-14","version_b_date":"2016-01-11","pom_a":[{"label":"1.","content":"Complete clearance of actinic keratosis (AK)[ Time Frame: 8 weeks ]"}],"pom_b":[{"label":"1.","content":"Complete clearance of actinic keratosis (AK) defined as no clinically visible AKs in the treatment area[ Time Frame: 8 weeks ]"}],"start_date":"November 13, 2015","primary_completion_date":"August 5, 2016","completion_date":"August 10, 2017","first_posted":"September 15, 2015","results_first_posted":"November 14, 2018","last_update_posted":"December 5, 2018"},{"nctid":"NCT02549339","version_a":7,"version_b":8,"version_a_date":"2017-12-19","version_b_date":"2018-10-15","pom_a":[{"label":"1.","content":"Complete clearance of actinic keratosis (AK) defined as no clinically visible AKs in the treatment area[ Time Frame: 8 weeks ]"}],"pom_b":[{"label":"1.","content":"Complete Clearance of Actinic Keratosis (AK)[ Time Frame: At Week 8 ]The number of clinically visible actinic keratosis lesions (AKs) identified in the treatment area was recorded at Day 1, Week 4, and Week 8.Complete clearance was defined as no clinically visible AKs in the treatment area.The table shows the percentage of mean number of subjects across imputations with complete clearance."}],"start_date":"November 13, 2015","primary_completion_date":"August 5, 2016","completion_date":"August 10, 2017","first_posted":"September 15, 2015","results_first_posted":"November 14, 2018","last_update_posted":"December 5, 2018"},{"nctid":"NCT01597778","version_a":8,"version_b":9,"version_a_date":"2016-02-05","version_b_date":"2016-08-01","pom_a":[{"label":"1.","content":"Progression free survival[ Time Frame: two years from the date of randomization ]The primary endpoint is PFS at 2-years from the date of randomization. PFS is defined as the time interval from date of randomization and time to relapse/progression, to death or to last follow-up."}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Year 2 ]The primary endpoint is PFS at 2-years from the date of randomization. PFS is defined as the time interval from date of randomization and time to relapse/progression, to death or to last follow-up."}],"start_date":"June 2012","primary_completion_date":"September 11, 2020","completion_date":"September 11, 2020","first_posted":"May 14, 2012","results_first_posted":"December 1, 2021","last_update_posted":"December 1, 2021"},{"nctid":"NCT01597778","version_a":15,"version_b":16,"version_a_date":"2021-02-01","version_b_date":"2021-11-02","pom_a":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Year 2 ]The primary endpoint is PFS at 2-years from the date of randomization. PFS is defined as the time interval from date of randomization and time to relapse/progression, to death or to last follow-up."}],"pom_b":[{"label":"1.","content":"Percentage of Participants With Progression Free Survival (PFS)[ Time Frame: Year 2 ]The primary endpoint is PFS at 2 years post-randomization. Death or disease relapse/progression will be considered as events. The time to event is defined as the time interval from randomization to relapse/progression, to death or to last follow-up, whichever comes first. Relapse is defined by either morphological or cytogenetic evidence of acute leukemia consistent with pre-transplant features, or radiologic evidence of progressive lymphoma. Minimal residual disease will not be considered evidence of relapse, however, minimal residual disease that progresses will be considered as relapse and the date of relapse will be the date of detection of minimal residual disease that prompted an intervention by the treating physician. Finally, institution of any therapy to treat persistent, progressive or relapsed disease, including withdrawal of immunosuppressive therapy or DLI, will be considered evidence of relapse/progression regardless of whether the criteria described above are met."}],"start_date":"June 2012","primary_completion_date":"September 11, 2020","completion_date":"September 11, 2020","first_posted":"May 14, 2012","results_first_posted":"December 1, 2021","last_update_posted":"December 1, 2021"},{"nctid":"NCT03151811","version_a":67,"version_b":68,"version_a_date":"2022-04-27","version_b_date":"2022-05-24","pom_a":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: From randomization to time of progression, or, if no progression, 24 months after end of treatment ]To compare the PFS of melflufen plus dexamethasone (Arm A) versus pomalidomide plus dexamethasone (Arm B) as assessed by the Independent Review Committee (IRC) according to the International Myeloma Working Group Uniform Response Criteria (IMWG-URC)"}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: From randomization to time of progression, or, if no progression, 24 months after end of treatment ]Progression Free Survival defined as the duration in months from randomization until first evidence of confirmed disease progression, as assessed by the Independent Review Committee (IRC) according to the International Myeloma Working Group Uniform Response Criteria (IMWG-URC)"}],"start_date":"June 12, 2017","primary_completion_date":"July 2, 2021","completion_date":"September 2024","first_posted":"May 12, 2017","results_first_posted":"July 27, 2022","last_update_posted":"August 17, 2022"},{"nctid":"NCT00054418","version_a":24,"version_b":25,"version_a_date":"2006-03-09","version_b_date":"2007-02-20","pom_a":[],"pom_b":[{"label":"1.","content":"Average intra-patient change in lumbar spine (L2-L4, PA) bone mineral density (BMD) from baseline to one year after study entry"}],"start_date":"March 2003","primary_completion_date":"April 2007","completion_date":"May 2008","first_posted":"February 6, 2003","last_update_posted":"July 13, 2016"},{"nctid":"NCT00054418","version_a":35,"version_b":36,"version_a_date":"2009-05-12","version_b_date":"2013-11-12","pom_a":[{"label":"1.","content":"Average intra-patient change in lumbar spine (L2-L4, PA) bone mineral density (BMD) from baseline to one year after study entry"}],"pom_b":[{"label":"1.","content":"Average intra-patient change in lumbar spine (L2-L4, PA) bone mineral density (BMD) from baseline to one year after study entry[ Time Frame: 1 year post study entry ]"}],"start_date":"March 2003","primary_completion_date":"April 2007","completion_date":"May 2008","first_posted":"February 6, 2003","last_update_posted":"July 13, 2016"},{"nctid":"NCT00405561","version_a":1,"version_b":2,"version_a_date":"2006-11-29","version_b_date":"2013-03-19","pom_a":[{"label":"1.","content":"Progression free survival;at 18 weeks after registration"}],"pom_b":[{"label":"1.","content":"Progression free survival;at 18 weeks after registration[ Time Frame: 2010 ]"}],"start_date":"October 2006","primary_completion_date":"January 2010","completion_date":"January 2010","first_posted":"November 30, 2006","last_update_posted":"March 20, 2013"},{"nctid":"NCT01160315","version_a":2,"version_b":3,"version_a_date":"2010-07-30","version_b_date":"2015-10-29","pom_a":[{"label":"1.","content":"Premature ovarian failure rate[ Time Frame: 2 years ]Primary endpoint is to evaluate the short and long-term efficacy of triptorelin depot plus progestin versus progestin alone to prevent POF induced by chemotherapy treatment. The ovarian function (FSH, E2, Progesterone, and AMH, presence of spontaneous menstrual cycle and pregnancies) will be evaluated every 3 months during the first 6 months after the end of chemotherapy, every 6 months during the next 18 months and once a year during an additional 5 years. All hormonal treatment has to be interrupted 10 days before the blood test."}],"pom_b":[{"label":"1.","content":"Premature ovarian failure rate[ Time Frame: 5 years ]Primary endpoint is to evaluate the short and long-term efficacy of triptorelin depot plus progestin versus progestin alone to prevent POF induced by chemotherapy treatment. The ovarian function (FSH, E2, Progesterone, and AMH, presence of spontaneous menstrual cycle and pregnancies) will be evaluated every 3 months during the first 6 months after the end of chemotherapy, every 6 months during the next 18 months and once a year during an additional 5 years. All hormonal treatment has to be interrupted 10 days before the blood test."}],"start_date":"July 2002","primary_completion_date":"June 2010","completion_date":"October 2015","first_posted":"July 12, 2010","last_update_posted":"October 30, 2015"},{"nctid":"NCT00076388","version_a":1,"version_b":2,"version_a_date":"2005-06-23","version_b_date":"2005-09-28","pom_a":[],"pom_b":[{"label":"1.","content":"To compare overall survival between ZD1839 and docetaxel"}],"start_date":"February 2004","primary_completion_date":"March 2007","completion_date":"October 2007","first_posted":"January 23, 2004","last_update_posted":"May 13, 2011"},{"nctid":"NCT01640808","version_a":5,"version_b":6,"version_a_date":"2012-09-27","version_b_date":"2015-02-08","pom_a":[{"label":"1.","content":"Recurrence-free survival"}],"pom_b":[{"label":"1.","content":"Recurrence-free survival[ Time Frame: Date of randomization to the date of recurrence of HCC (followed every 12 weeks) .or death (whichever occurs first).Participants will be followed, an expected average of 2 years. ]"}],"start_date":"April 2012","primary_completion_date":"October 2016","completion_date":"November 2016","first_posted":"July 16, 2012","results_first_posted":"December 2, 2020","last_update_posted":"December 2, 2020"},{"nctid":"NCT01640808","version_a":8,"version_b":9,"version_a_date":"2015-03-23","version_b_date":"2020-11-29","pom_a":[{"label":"1.","content":"Recurrence-free survival[ Time Frame: Date of randomization to the date of recurrence of HCC (followed every 12 weeks) .or death (whichever occurs first).Participants will be followed, an expected average of 2 years. ]"}],"pom_b":[{"label":"1.","content":"Recurrence-free Survival[ Time Frame: Date of randomization to the date of recurrence of HCC (followed every 12 weeks) or death (whichever occurs first) ]HCC recurrence was defined as the appearance of new intrahepatic lesions which was confirmed based on findings of hypervascularity (nodules enhanced in the arterial phase and washout in the late phase) by dynamic CT images, or a new extrahepatic metastasis. Recurrence of intrahepatic HCC was evaluated by an independent image reading committee.RFS was defined as the time from randomization to HCC recurrence or death from any cause, whichever occurred first. For subjects who terminated the study without HCC recurrence or death, RFS was censored at the day of the latest dynamic CT examination."}],"start_date":"April 2012","primary_completion_date":"October 2016","completion_date":"November 2016","first_posted":"July 16, 2012","results_first_posted":"December 2, 2020","last_update_posted":"December 2, 2020"},{"nctid":"NCT00171340","version_a":1,"version_b":2,"version_a_date":"2005-09-12","version_b_date":"2006-05-25","pom_a":[],"pom_b":[{"label":"1.","content":"% change in lumbar spine (L2-L4) BMD after 12 months of letrozole therapy"}],"start_date":"May 2003","primary_completion_date":"February 2010","completion_date":"February 2010","first_posted":"September 15, 2005","results_first_posted":"May 26, 2011","last_update_posted":"April 16, 2012"},{"nctid":"NCT00171340","version_a":8,"version_b":9,"version_a_date":"2011-02-10","version_b_date":"2011-02-11","pom_a":[{"label":"1.","content":"% change in lumbar spine (L2-L4) BMD after 12 months of letrozole therapy"}],"pom_b":[{"label":"1.","content":"% change in lumbar spine (L2-L4) BMD after 12 months of letrozole therapy[ Time Frame: 12 months ]"}],"start_date":"May 2003","primary_completion_date":"February 2010","completion_date":"February 2010","first_posted":"September 15, 2005","results_first_posted":"May 26, 2011","last_update_posted":"April 16, 2012"},{"nctid":"NCT00171340","version_a":10,"version_b":11,"version_a_date":"2011-03-03","version_b_date":"2011-04-27","pom_a":[{"label":"1.","content":"% change in lumbar spine (L2-L4) BMD after 12 months of letrozole therapy[ Time Frame: 12 months ]"}],"pom_b":[{"label":"1.","content":"Percentage Change in Bone Mineral Density (BMD) of the Lumbar Spine (L2-L4) at 12 Months of Therapy.[ Time Frame: Baseline, 12 months ]Bone Mineral Density (g/cm^2) of the Lumbar Spine (L2-L4) as measured by energy x-ray absorptiometry (DXA)."}],"start_date":"May 2003","primary_completion_date":"February 2010","completion_date":"February 2010","first_posted":"September 15, 2005","results_first_posted":"May 26, 2011","last_update_posted":"April 16, 2012"},{"nctid":"NCT00003599","version_a":12,"version_b":13,"version_a_date":"2009-02-06","version_b_date":"2010-09-20","pom_a":[],"pom_b":[{"label":"1.","content":"Effect of Alpha-tocopherol (AT) on 13-cis-retinoic Acid (13-cRA) Toxicity[ Time Frame: 6 Months ]"}],"first_posted":"September 13, 2004","last_update_posted":"February 22, 2012"},{"nctid":"NCT00151671","version_a":3,"version_b":4,"version_a_date":"2006-06-09","version_b_date":"2007-05-07","pom_a":[{"label":"1.","content":"Factor V at day 3 after surgery"}],"pom_b":[{"label":"1.","content":"Factor V at day 3 after surgery[ Time Frame: day 3 ]"}],"start_date":"April 2003","primary_completion_date":"April 2008","completion_date":"September 2008","first_posted":"September 9, 2005","last_update_posted":"February 27, 2012"},{"nctid":"NCT02292446","version_a":32,"version_b":33,"version_a_date":"2018-10-03","version_b_date":"2018-12-19","pom_a":[{"label":"1.","content":"Number of Participants with Adverse Events as a Measure of Safety and Tolerability[ Time Frame: 0 to 39 months ]"}],"pom_b":[{"label":"1.","content":"Number of Participants With Adverse Events - All Grades[ Time Frame: Baseline up to approximately 26 months ]Summary of adverse events (all grades)."}],"start_date":"November 21, 2014","primary_completion_date":"December 29, 2017","completion_date":"December 29, 2017","first_posted":"November 17, 2014","results_first_posted":"April 2, 2019","last_update_posted":"July 18, 2019"},{"nctid":"NCT00878709","version_a":26,"version_b":27,"version_a_date":"2011-10-19","version_b_date":"2011-11-07","pom_a":[{"label":"1.","content":"disease free survival[ Time Frame: five years ]"}],"pom_b":[{"label":"1.","content":"disease free survival[ Time Frame: two years ]"}],"start_date":"July 9, 2009","primary_completion_date":"August 21, 2014","completion_date":"October 4, 2019","first_posted":"April 9, 2009","results_first_posted":"October 9, 2017","last_update_posted":"June 11, 2021"},{"nctid":"NCT00878709","version_a":32,"version_b":33,"version_a_date":"2012-04-24","version_b_date":"2012-05-07","pom_a":[{"label":"1.","content":"disease free survival[ Time Frame: two years ]"}],"pom_b":[{"label":"1.","content":"disease free survival (DFS)[ Time Frame: Two years ]"}],"start_date":"July 9, 2009","primary_completion_date":"August 21, 2014","completion_date":"October 4, 2019","first_posted":"April 9, 2009","results_first_posted":"October 9, 2017","last_update_posted":"June 11, 2021"},{"nctid":"NCT00878709","version_a":41,"version_b":42,"version_a_date":"2017-06-27","version_b_date":"2017-10-06","pom_a":[{"label":"1.","content":"disease free survival (DFS)[ Time Frame: Two years ]"}],"pom_b":[{"label":"1.","content":"Invasive Disease-free Survival (iDFS) in Neratinib Arm Compared to Placebo Arm[ Time Frame: From randomization until time of event up to 2 years ]Invasive disease-free survival time is defined as the time from date of randomization until the first disease recurrence of the following events: invasive ipsilateral breast tumor recurrence, invasive contralateral breast cancer, local/regional invasive recurrence, distant recurrence and death from any cause."},{"label":"2.","content":"Kaplan-Meier Estimates of Invasive Disease-free Survival (iDFS) at Year 2 by Treatment Arms[ Time Frame: From randomization until time of event up to 2 years ]"}],"start_date":"July 9, 2009","primary_completion_date":"August 21, 2014","completion_date":"October 4, 2019","first_posted":"April 9, 2009","results_first_posted":"October 9, 2017","last_update_posted":"June 11, 2021"},{"nctid":"NCT00878709","version_a":54,"version_b":55,"version_a_date":"2020-08-18","version_b_date":"2020-11-19","pom_a":[{"label":"1.","content":"Invasive Disease-free Survival (iDFS) in Neratinib Arm Compared to Placebo Arm[ Time Frame: From randomization until time of event up to 2 years ]Invasive disease-free survival time is defined as the time from date of randomization until the first disease recurrence of the following events: invasive ipsilateral breast tumor recurrence, invasive contralateral breast cancer, local/regional invasive recurrence, distant recurrence and death from any cause."},{"label":"2.","content":"Kaplan-Meier Estimates of Invasive Disease-free Survival (iDFS) at Year 2 by Treatment Arms[ Time Frame: From randomization until time of event up to 2 years ]"}],"pom_b":[{"label":"1.","content":"Invasive Disease-free Survival (iDFS) in Neratinib Arm Compared to Placebo Arm at Year 2[ Time Frame: From randomization until time of event up to 2 years ]Invasive disease-free survival time is defined as the time from date of randomization until the first disease recurrence of the following events: invasive ipsilateral breast tumor recurrence, invasive contralateral breast cancer, local/regional invasive recurrence, distant recurrence and death from any cause."},{"label":"2.","content":"Kaplan-Meier Estimates of Invasive Disease-free Survival (iDFS) at Year 2 by Treatment Arms[ Time Frame: From randomization until time of event up to 2 years ]"}],"start_date":"July 9, 2009","primary_completion_date":"August 21, 2014","completion_date":"October 4, 2019","first_posted":"April 9, 2009","results_first_posted":"October 9, 2017","last_update_posted":"June 11, 2021"},{"nctid":"NCT03833154","version_a":12,"version_b":13,"version_a_date":"2020-05-11","version_b_date":"2020-08-04","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS) assessed by BICR according to RECIST 1.1 in subpopulation of patients with Stage I/II NSCLC[ Time Frame: up to 5 years ]"}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS) assessed by BICR according to RECIST 1.1 in subpopulation of patients with Stage I/II NSCLC[ Time Frame: up to 6 years ]"}],"start_date":"March 6, 2019","primary_completion_date":"June 23, 2025","completion_date":"January 31, 2028","first_posted":"February 6, 2019","last_update_posted":"August 30, 2022"},{"nctid":"NCT03833154","version_a":22,"version_b":23,"version_a_date":"2021-04-16","version_b_date":"2022-04-15","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS) assessed by BICR according to RECIST 1.1 in subpopulation of patients with Stage I/II NSCLC[ Time Frame: up to 6 years ]"}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS) assessed by Blinded Independent Central Review (BICR) according to RECIST 1.1 in subpopulation of patients with Stage I/II NSCLC[ Time Frame: from randomization up to 6 years ]Main Cohort"},{"label":"2.","content":"4-year Progression-Free Survival (4y-PFS) by ICR according to RECIST 1.1 criteria[ Time Frame: from randomization up to 5 years ]Osimertinib Cohort"}],"start_date":"March 6, 2019","primary_completion_date":"June 23, 2025","completion_date":"January 31, 2028","first_posted":"February 6, 2019","last_update_posted":"August 30, 2022"},{"nctid":"NCT00019682","version_a":15,"version_b":16,"version_a_date":"2006-10-12","version_b_date":"2006-11-08","pom_a":[],"pom_b":[{"label":"1.","content":"Whether the addition of peptide vaccine to high-dose aldesleukin is superior to alaldesleukin alone by response rates after each course of treatment"}],"start_date":"December 1999","primary_completion_date":"May 2011","completion_date":"May 2011","first_posted":"January 27, 2003","results_first_posted":"November 20, 2017","last_update_posted":"November 20, 2017"},{"nctid":"NCT00019682","version_a":57,"version_b":58,"version_a_date":"2011-10-11","version_b_date":"2012-12-21","pom_a":[{"label":"1.","content":"Whether the addition of peptide vaccine to high-dose aldesleukin is superior to alaldesleukin alone by response rates after each course of treatment"}],"pom_b":[{"label":"1.","content":"Best response rate (partial response [PR] + complete response [CR])[ Time Frame: Up to 12 years ]The Chi-squared test will be used for evaluating differences in response rates. Stratified analyses, such as Thomas\'s test for combining Fisher\'s exact tests could be used as part of the stratified analysis as well."}],"start_date":"December 1999","primary_completion_date":"May 2011","completion_date":"May 2011","first_posted":"January 27, 2003","results_first_posted":"November 20, 2017","last_update_posted":"November 20, 2017"},{"nctid":"NCT00019682","version_a":60,"version_b":61,"version_a_date":"2014-12-05","version_b_date":"2017-11-16","pom_a":[{"label":"1.","content":"Best response rate (partial response [PR] + complete response [CR])[ Time Frame: Up to 12 years ]The Chi-squared test will be used for evaluating differences in response rates. Stratified analyses, such as Thomas\'s test for combining Fisher\'s exact tests could be used as part of the stratified analysis as well."}],"pom_b":[{"label":"1.","content":"Best Response Rate (Partial Response [PR] + Complete Response [CR])[ Time Frame: Up to 12 years ]A complete response (CR) was defined as the disappearance of all clinical evidence of disease for at least 4 weeks. A partial response (PR) was defined as a 50% or greater decrease in the sum of the products of perpendicular diameters of all measurable lesions for at least one month. No new lesions could appear, and none could increase 25% or more."}],"start_date":"December 1999","primary_completion_date":"May 2011","completion_date":"May 2011","first_posted":"January 27, 2003","results_first_posted":"November 20, 2017","last_update_posted":"November 20, 2017"},{"nctid":"NCT02288897","version_a":50,"version_b":51,"version_a_date":"2019-09-30","version_b_date":"2022-01-17","pom_a":[{"label":"1.","content":"Progression-free survival (PFS)[ Time Frame: Assessed every 12 weeks up to 18 months ]"}],"pom_b":[{"label":"1.","content":"Progression-free Survival (PFS)[ Time Frame: Assessed every 12 weeks until disease progression, withdrawal of consent, or study termination; progression detected between formal assessments was documented at the time of detection; median follow-up time for PFS was 26.6 weeks, maximum was 125.8 weeks. ]PFS was estimated via Kaplan-Meier analysis using Response Evaluation Criteria In Solid Tumors (RECIST v1.1) criteria. Subjects who did not have an event of progression or death were censored at their last assessment date.Assessment of progression was performed by the sponsor based on review of lesion measurement and clinical progression data reported by each investigator. Events signaling progression included increase in size and/or number of study lesions, onset of visceral metastatic disease, and death. For target lesions (assigned prior to randomization), complete response (CR) required disappearance of all target lesions; partial response (PR) required >= 30% decrease in sum of the longest diameter (SLD) of all target lesions; progressive disease (PD) required >=20% increase in SLD of target lesions. Non-target lesions were followed for CR, PD, or non-CR/non-PD status using equivalent thresholds. Progression occurred when PD was observed in either target or non-target lesion."}],"start_date":"April 2015","primary_completion_date":"April 2019","completion_date":"September 2019","first_posted":"November 11, 2014","results_first_posted":"January 19, 2022","last_update_posted":"January 19, 2022"},{"nctid":"NCT03200912","version_a":1,"version_b":2,"version_a_date":"2017-06-26","version_b_date":"2020-01-13","pom_a":[{"label":"1.","content":"AK lesion counts[ Time Frame: 57 days ]Change from baseline, the number counts of all visible and discrete non-hyperkeratotic, non-hypertrophic AK lesions in the contiguous 25 cm2 Treatment Area at Visit 6/Day 57"}],"pom_b":[{"label":"1.","content":"Complete Clearance of AK Lesions[ Time Frame: 57 days ]Treatment success (complete clearance of AK lesions) at Day 57, where complete clearance of AK lesions was defined as having no (zero) clinically visible AK lesions in the Treatment Area"}],"start_date":"August 19, 2016","primary_completion_date":"March 7, 2017","completion_date":"March 22, 2017","first_posted":"June 27, 2017","results_first_posted":"January 14, 2020","last_update_posted":"January 14, 2020"},{"nctid":"NCT02898077","version_a":11,"version_b":12,"version_a_date":"2017-04-04","version_b_date":"2017-04-11","pom_a":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: Randomization to Date of Death from Any Cause (Approximately 12 Months) ]"}],"pom_b":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: Randomization to Date of Death from Any Cause (Approximately 12 Months) ]OS"}],"start_date":"March 2, 2017","primary_completion_date":"June 30, 2020","completion_date":"April 12, 2021","first_posted":"September 13, 2016","results_first_posted":"August 3, 2021","last_update_posted":"June 14, 2022"},{"nctid":"NCT02898077","version_a":66,"version_b":67,"version_a_date":"2021-05-12","version_b_date":"2021-07-12","pom_a":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: Randomization to Date of Death from Any Cause (Approximately 12 Months) ]OS"}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Randomization to the Date of the First Radiographically Documented Progressive Disease or Death from Any Cause (Up To 30 Months) ]PFS defined as the time from the date of randomization to the first evidence of disease progression as defined by response evaluation criteria in solid tumors (RECIST) v1.1 or death from any cause. Progressive Disease (PD) was at least a 20% increase in the sum of the diameters of target lesions, with reference being the smallest sum on study and an absolute increase of at least 5 mm, or unequivocal progression of non-target lesions, or 1 or more new lesions. If a participant does not have a complete baseline disease assessment, then the PFS time was censored at the date of randomization, regardless of whether or not objectively determined disease progression or death has been observed for the participant. If a participant was not known to have died or have objective progression as of the data inclusion cutoff date for the analysis, the PFS time was censored at the last adequate tumor assessment date."},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Randomization to Date of Death from Any Cause (Up To 37 Months) ]OS defined as the time from randomization to the date of death due to any cause. For each participant who is not known to have died as of the data-inclusion cutoff date for overall survival analysis, OS time was censored on the last date the participant is known to be alive."}],"start_date":"March 2, 2017","primary_completion_date":"June 30, 2020","completion_date":"April 12, 2021","first_posted":"September 13, 2016","results_first_posted":"August 3, 2021","last_update_posted":"June 14, 2022"},{"nctid":"NCT00116142","version_a":4,"version_b":5,"version_a_date":"2007-01-18","version_b_date":"2007-11-08","pom_a":[{"label":"1.","content":"To determine if overall survival is increased"}],"pom_b":[{"label":"1.","content":"To determine if overall survival is increased[ Time Frame: Years ]"}],"start_date":"June 2005","primary_completion_date":"June 29, 2020","completion_date":"June 29, 2020","first_posted":"June 28, 2005","results_first_posted":"July 28, 2021","last_update_posted":"January 11, 2022"},{"nctid":"NCT00116142","version_a":5,"version_b":6,"version_a_date":"2007-11-08","version_b_date":"2007-12-19","pom_a":[{"label":"1.","content":"To determine if overall survival is increased[ Time Frame: Years ]"}],"pom_b":[{"label":"1.","content":"To determine if overall survival is increased"}],"start_date":"June 2005","primary_completion_date":"June 29, 2020","completion_date":"June 29, 2020","first_posted":"June 28, 2005","results_first_posted":"July 28, 2021","last_update_posted":"January 11, 2022"},{"nctid":"NCT00116142","version_a":6,"version_b":7,"version_a_date":"2007-12-19","version_b_date":"2007-12-21","pom_a":[{"label":"1.","content":"To determine if overall survival is increased"}],"pom_b":[{"label":"1.","content":"To determine if overall survival is increased[ Time Frame: 2014 ]"}],"start_date":"June 2005","primary_completion_date":"June 29, 2020","completion_date":"June 29, 2020","first_posted":"June 28, 2005","results_first_posted":"July 28, 2021","last_update_posted":"January 11, 2022"},{"nctid":"NCT00116142","version_a":23,"version_b":24,"version_a_date":"2020-12-28","version_b_date":"2021-07-08","pom_a":[{"label":"1.","content":"To determine if overall survival is increased[ Time Frame: 2014 ]"}],"pom_b":[{"label":"1.","content":"10-Year Restricted Mean Survival Time for Overall Survival[ Time Frame: Following the end of RT patients were seen for follow up every 6 months for 5 years and annually thereafter, 10 years. ]Overall survival (OS) was measured from the date of random assignment to death from any cause, censored at the date of last follow-up in surviving patients. The 10-Year Restricted Mean Survival Time was calculated as the area under the Kaplan Meier plot for OS, from randomization to 10-years follow-up"}],"start_date":"June 2005","primary_completion_date":"June 29, 2020","completion_date":"June 29, 2020","first_posted":"June 28, 2005","results_first_posted":"July 28, 2021","last_update_posted":"January 11, 2022"},{"nctid":"NCT04166409","version_a":2,"version_b":3,"version_a_date":"2019-11-18","version_b_date":"2019-11-20","pom_a":[{"label":"1.","content":"Event-free survival (EFS)[ Time Frame: Time from randomization to the first occurrence of clinical or radiographic disease progression, disease recurrence, second malignant neoplasm, or death from any cause ]Will estimate the hazard ratio based on a stratified Cox proportional hazards model and use Kaplan Meier (KM) methods to visualize and summarize the data."}],"pom_b":[{"label":"1.","content":"Event-free survival (EFS)[ Time Frame: Time from randomization to the first occurrence of clinical or radiographic disease progression, disease recurrence, second malignant neoplasm, or death from any cause, assessed up to 10 years ]Will estimate the hazard ratio based on a stratified Cox proportional hazards model and use Kaplan Meier (KM) methods to visualize and summarize the data."}],"start_date":"January 3, 2020","primary_completion_date":"December 31, 2026","completion_date":"December 31, 2026","first_posted":"November 18, 2019","last_update_posted":"September 19, 2022"},{"nctid":"NCT04166409","version_a":88,"version_b":89,"version_a_date":"2021-01-07","version_b_date":"2021-01-09","pom_a":[{"label":"1.","content":"Event-free survival (EFS)[ Time Frame: Time from randomization to the first occurrence of clinical or radiographic disease progression, disease recurrence, second malignant neoplasm, or death from any cause, assessed up to 10 years ]Will estimate the hazard ratio based on a stratified Cox proportional hazards model and use Kaplan Meier (KM) methods to visualize and summarize the data."}],"pom_b":[{"label":"1.","content":"Event-free survival (EFS)[ Time Frame: Up to 10 years from date of randomization ]The Kaplan-Meier method will be used to estimate EFS which is defined as the interval from randomization to first occurrence of clinical or radiographic disease progression, disease recurrence, second malignant neoplasm, or death from any cause, or to the date of last follow-up. Estimates with 95% confidence intervals will be reported by treatment arm. The hazard ratio with a confidence interval will also be reported to compare treatment arms based on a Cox proportional hazards model stratified by BRAF status, tumor location and size of residual tumor."}],"start_date":"January 3, 2020","primary_completion_date":"December 31, 2026","completion_date":"December 31, 2026","first_posted":"November 18, 2019","last_update_posted":"September 19, 2022"},{"nctid":"NCT00133224","version_a":60,"version_b":61,"version_a_date":"2007-12-11","version_b_date":"2007-12-13","pom_a":[],"pom_b":[{"label":"1.","content":"Survival"}],"start_date":"July 2005","primary_completion_date":"August 2008","completion_date":"June 2009","first_posted":"August 23, 2005","last_update_posted":"September 23, 2008"},{"nctid":"NCT00133224","version_a":61,"version_b":62,"version_a_date":"2007-12-13","version_b_date":"2007-12-19","pom_a":[{"label":"1.","content":"Survival"}],"pom_b":[{"label":"1.","content":"Survival[ Time Frame: 0 ]"}],"start_date":"July 2005","primary_completion_date":"August 2008","completion_date":"June 2009","first_posted":"August 23, 2005","last_update_posted":"September 23, 2008"},{"nctid":"NCT00960440","version_a":1,"version_b":2,"version_a_date":"2009-08-14","version_b_date":"2009-08-16","pom_a":[{"label":"1.","content":"To compare the efficacy (ACR 20 response rates) of two doses of CP 690,550 versus placebo in rheumatoid arthritis subjects on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: Month 3 ]"},{"label":"2.","content":"To compare physical function status (HAQ DI response) of rheumatoid arthritis patients on background methotrexate who have had an inadequate response to a TNF inhibitor, after administration of two doses of CP 690,550 versus placebo.[ Time Frame: Month 3 ]"},{"label":"3.","content":"To compare the safety and tolerability of CP 690,550, in doses of 5 mg BID and 10 mg BID, versus placebo in patients with RA on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: 2 Years ]"}],"pom_b":[{"label":"1.","content":"To compare the efficacy (ACR 20 response rates) of two doses of CP 690,550 versus placebo in rheumatoid arthritis subjects on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: Month 3 ]"},{"label":"2.","content":"To compare physical function status (HAQ DI response) of rheumatoid arthritis patients on background methotrexate who have had an inadequate response to a TNF inhibitor, after administration of two doses of CP 690,550 versus placebo.[ Time Frame: Month 3 ]"},{"label":"3.","content":"To compare the safety and tolerability of CP 690,550, in doses of 5 mg BID and 10 mg BID, versus placebo in patients with RA on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: 6 months ]"}],"start_date":"October 2009","primary_completion_date":"March 2011","completion_date":"March 2011","first_posted":"August 17, 2009","results_first_posted":"January 10, 2013","last_update_posted":"December 19, 2018"},{"nctid":"NCT00960440","version_a":25,"version_b":26,"version_a_date":"2010-05-11","version_b_date":"2010-05-20","pom_a":[{"label":"1.","content":"To compare the efficacy (ACR 20 response rates) of two doses of CP 690,550 versus placebo in rheumatoid arthritis subjects on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: Month 3 ]"},{"label":"2.","content":"To compare physical function status (HAQ DI response) of rheumatoid arthritis patients on background methotrexate who have had an inadequate response to a TNF inhibitor, after administration of two doses of CP 690,550 versus placebo.[ Time Frame: Month 3 ]"},{"label":"3.","content":"To compare the safety and tolerability of CP 690,550, in doses of 5 mg BID and 10 mg BID, versus placebo in patients with RA on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: 6 months ]"}],"pom_b":[{"label":"1.","content":"To compare the efficacy (ACR 20 response rates) of two doses of CP 690,550 versus placebo in rheumatoid arthritis subjects on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: Month 3 ]"},{"label":"2.","content":"To compare physical function status (HAQ DI response) of rheumatoid arthritis patients on background methotrexate who have had an inadequate response to a TNF inhibitor, after administration of two doses of CP 690,550 versus placebo.[ Time Frame: Month 3 ]"},{"label":"3.","content":"To compare the rate of achieving DAS28 4(ESR) <2.6 in patients with active RA on background methotrexate who have had an inadequate response to a TNF inhibitor, after administration of CP 690,550, in doses of 5 mg BID and 10 mg BID, versus[ Time Frame: Month 3 ]"},{"label":"4.","content":"placebo.[ Time Frame: Month 3 ]"},{"label":"5.","content":"To compare the safety and tolerability of CP 690,550, in doses of 5 mg BID and 10 mg BID, versus placebo in patients with RA on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: 6 months ]"}],"start_date":"October 2009","primary_completion_date":"March 2011","completion_date":"March 2011","first_posted":"August 17, 2009","results_first_posted":"January 10, 2013","last_update_posted":"December 19, 2018"},{"nctid":"NCT00960440","version_a":47,"version_b":48,"version_a_date":"2012-11-05","version_b_date":"2012-12-06","pom_a":[{"label":"1.","content":"To compare the efficacy (ACR 20 response rates) of two doses of CP 690,550 versus placebo in rheumatoid arthritis subjects on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: Month 3 ]"},{"label":"2.","content":"To compare physical function status (HAQ DI response) of rheumatoid arthritis patients on background methotrexate who have had an inadequate response to a TNF inhibitor, after administration of two doses of CP 690,550 versus placebo.[ Time Frame: Month 3 ]"},{"label":"3.","content":"To compare the rate of achieving DAS28 4(ESR) <2.6 in patients with active RA on background methotrexate who have had an inadequate response to a TNF inhibitor, after administration of CP 690,550, in doses of 5 mg BID and 10 mg BID, versus[ Time Frame: Month 3 ]"},{"label":"4.","content":"placebo.[ Time Frame: Month 3 ]"},{"label":"5.","content":"To compare the safety and tolerability of CP 690,550, in doses of 5 mg BID and 10 mg BID, versus placebo in patients with RA on background methotrexate who have had an inadequate response to a TNF inhibitor.[ Time Frame: 6 months ]"}],"pom_b":[{"label":"1.","content":"Percentage of Participants Achieving American College of Rheumatology 20% (ACR20) Response at Month 3[ Time Frame: Month 3 ]ACR20 response: greater than or equal to (>=) 20 percent (%) improvement in tender joints count (TJC); >= 20% improvement in swollen joints count (SJC); and >= 20% improvement in at least 3 of 5 remaining ACR core measures: participant assessment of pain; participant global assessment of disease activity; physician global assessment of disease activity; self-assessed disability (disability index of the Health Assessment Questionnaire [HAQ]); and C-Reactive Protein (CRP). For comparison of CP-690,550 with placebo, placebo sequences were combined into single reporting group for Month 3 analysis."},{"label":"2.","content":"Change From Baseline in Health Assessment Questionnaire-Disability Index (HAQ-DI) Score at Month 3[ Time Frame: Baseline, Month 3 ]HAQ-DI: participant-reported assessment of ability to perform tasks in 8 categories of daily living activities:dress/groom;arise;eat; walk;reach;grip; hygiene;common activities over past week. Each item scored on 4-point scale from 0-3:0=no difficulty;1=some difficulty;2=much difficulty;3=unable to do. Overall score was computed as sum of domain scores and divided by number of domains answered. Total possible score range 0-3:0=least difficulty and 3=extreme difficulty. For comparison of CP-690,550 with placebo, placebo sequences were combined into single reporting group for Month 3 analysis."},{"label":"3.","content":"Percentage of Participants With Disease Activity Score Based on 28-Joint Count and Erythrocyte Sedimentation Rate (4 Variables) (DAS28-4 [ESR]) Less Than 2.6 at Month 3[ Time Frame: Month 3 ]DAS28-4 (ESR) was calculated from SJC and TJC using 28 joints count, erythrocyte sedimentation rate (ESR)(millimeter/hour [mm/hour]) and patient\'s global assessment (PtGA) of disease activity (participant rated arthritis activity assessment). Total score range:0-9.4, higher score=more disease activity. DAS28-4 (ESR) less than or equal to (<=)3.2 implied low disease activity, greater than (>)3.2 to 5.1 implied moderate to high disease activity, less than (<)2.6=remission. For comparison of CP-690,550 with placebo, placebo sequences were combined into single reporting group for Month 3 analysis."}],"start_date":"October 2009","primary_completion_date":"March 2011","completion_date":"March 2011","first_posted":"August 17, 2009","results_first_posted":"January 10, 2013","last_update_posted":"December 19, 2018"},{"nctid":"NCT00673049","version_a":64,"version_b":65,"version_a_date":"2010-02-02","version_b_date":"2010-02-10","pom_a":[{"label":"1.","content":"Overall Survival[ Time Frame: 24 months ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: 50 months ]"}],"start_date":"May 2008","primary_completion_date":"March 2011","completion_date":"April 2012","first_posted":"May 7, 2008","results_first_posted":"July 24, 2013","last_update_posted":"July 24, 2013"},{"nctid":"NCT00673049","version_a":93,"version_b":94,"version_a_date":"2012-05-21","version_b_date":"2013-07-22","pom_a":[{"label":"1.","content":"Overall Survival[ Time Frame: 50 months ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Baseline, assessed every cycle until disease progression and then every 4 weeks until death, up to 30.65 months ]The time from date of randomization to date of death due to any cause. For participants who were alive, overall survival was censored at the last contact."}],"start_date":"May 2008","primary_completion_date":"March 2011","completion_date":"April 2012","first_posted":"May 7, 2008","results_first_posted":"July 24, 2013","last_update_posted":"July 24, 2013"},{"nctid":"NCT00035594","version_a":7,"version_b":8,"version_a_date":"2007-12-20","version_b_date":"2008-02-28","pom_a":[],"pom_b":[{"label":"1.","content":"Proportion of subjects developing febrile neutropenia[ Time Frame: Through 4 cycles ]"}],"start_date":"February 2002","primary_completion_date":"February 2004","completion_date":"June 2004","first_posted":"May 6, 2002","last_update_posted":"May 9, 2013"},{"nctid":"NCT03462719","version_a":36,"version_b":37,"version_a_date":"2022-02-24","version_b_date":"2022-02-25","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS)[ Time Frame: From date of randomization to date of disease progression (PD) or death, whichever occurs first (Up to approximately 6 years) ]PFS is defined as the duration from date of randomization to date of disease progression (PD) or death, whichever occurs first. PD is defined according to the International Workshop on Chronic Lymphocytic Leukemia (iwCLL 2008 Guidelines)."}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Up to 2 years 10 months ]PFS: time between date of randomization and date of disease progression, as assessed by IRC, or date of death due to any cause, whichever occurs first, regardless of use of subsequent anti-cancer therapy prior to PD or death using iWCLL2008 criteria : New enlarged lymph nodes >15 mm, new hepatomegaly or splenomegaly, or other organ infiltrates, bone lesion, ascites or pleural effusion due to CLL; >=50% increase in longest diameter (LDi) from nadir in existing lymph node (LDi >15 mm) or >=50% increase from nadir in sum of diameters of multiple nodes (and at least 1 node with LDi >15 mm); >=50% increase from nadir in enlargement of liver/spleen; >=50% increase from baseline in lymphocyte count (ALC; to >=5*10^9/L); or >=50% increase from nadir in ALC in >=2 serial assessments if ALC is >=30000*10^9/L and lymphocyte doubling time is rapid unless considered treatment-related lymphocytosis; new cytopenia attributable to CLL; transformation to more aggressive histology."}],"start_date":"April 17, 2018","primary_completion_date":"February 26, 2021","completion_date":"April 5, 2024","first_posted":"March 12, 2018","results_first_posted":"March 28, 2022","last_update_posted":"August 15, 2022"},{"nctid":"NCT01740427","version_a":11,"version_b":12,"version_a_date":"2013-06-17","version_b_date":"2013-07-18","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS)[ Time Frame: Baseline up to 2.5 years ]"}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS)[ Time Frame: Baseline up to 2.5 years ]Median time from the first dose of study treatment to the first documentation of objective tumor progression or to death due to any cause, whichever occurs first."}],"start_date":"February 22, 2013","primary_completion_date":"February 26, 2016","completion_date":"August 26, 2023","first_posted":"December 4, 2012","results_first_posted":"April 26, 2017","last_update_posted":"August 25, 2022"},{"nctid":"NCT01740427","version_a":46,"version_b":47,"version_a_date":"2016-10-06","version_b_date":"2017-03-16","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS)[ Time Frame: Baseline up to 2.5 years ]Median time from the first dose of study treatment to the first documentation of objective tumor progression or to death due to any cause, whichever occurs first."}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS) as Assessed by the Investigator.[ Time Frame: From randomization date to date of first documentation of progression OR death (up to approximately 2.5 years) ]PFS is defined as the time from the date of randomization to the date of the first documentation of objective tumor progression as per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) or death due to any cause in the absence of documented PD, whichever occurs first. If tumor progression data include more than 1 date, the first date will be used. PFS (in months) will be calculated as (first event date - randomization date +1)/30.4. Progression is defined using RECIST v1.1, as a 20% increase in the sum of diameters of target measurable lesions above the smallest sum observed (over baseline if no decrease in the sum is observed during therapy), with a minimum absolute increase of 5 mm, or unequivocal progression of pre-existing non-target lesions, or the appearance of new lesions."}],"start_date":"February 22, 2013","primary_completion_date":"February 26, 2016","completion_date":"August 26, 2023","first_posted":"December 4, 2012","results_first_posted":"April 26, 2017","last_update_posted":"August 25, 2022"},{"nctid":"NCT00678535","version_a":7,"version_b":8,"version_a_date":"2012-05-30","version_b_date":"2013-03-30","pom_a":[{"label":"1.","content":"Progression Free Survival[ Time Frame: Various Timepoints ]"}],"pom_b":[{"label":"1.","content":"Progression-free Survival (PFS) Time: Independent Review Committee (IRC) Assessments[ Time Frame: Time from randomization to disease progression, death or last tumor assessment, reported between day of first participant randomized, that is, 30 Jun 2008 until cut-off date (31 Mar 2012) ]The PFS time is defined as the duration from randomization to either first observation of progressive disease (PD) or occurrence of death due to any cause within 60 days of the last tumor assessment or randomization. Participants without event are censored on the date of last tumor assessment."}],"start_date":"June 2008","primary_completion_date":"March 2012","completion_date":"February 2013","first_posted":"May 15, 2008","results_first_posted":"May 16, 2013","last_update_posted":"July 21, 2014"},{"nctid":"NCT01554852","version_a":1,"version_b":2,"version_a_date":"2012-03-14","version_b_date":"2012-03-19","pom_a":[{"label":"1.","content":"Overall survivalOverall survial for induction chemotherapy is defined as the time from initial randomisation to the trial to death from any cause or last follow-up. Overall survival for maintenance chemotherapy is defined from the time of randomisation to lenalidomide/no maintenance"},{"label":"2.","content":"Progression-free survivalProgression-free survival for induction chemotherapy comparisons is defined as the time from initial randomisation to the trial to progression or death from any cause. Patients who do not progress will be censored at the last date they were known to be alive and progression-free. Progression-free survival for maintenance therapy comparisons is defined from the time of maintenance randomisation"}],"pom_b":[{"label":"1.","content":"Overall survivalOverall survial for induction chemotherapy comparisons is defined as the time from initial randomisation to the trial to death from any cause or last follow-up. Overall survival for maintenance therapy comparisons is defined from the time of maintenance randomisation."},{"label":"2.","content":"Progression-free survivalProgression-free survival for induction chemotherapy comparisons is defined as the time from initial randomisation to the trial to progression or death from any cause. Patients who do not progress will be censored at the last date they were known to be alive and progression-free. Progression-free survival for maintenance therapy comparisons is defined from the time of maintenance randomisation"}],"start_date":"May 2010","primary_completion_date":"December 2021","completion_date":"December 2022","first_posted":"March 15, 2012","last_update_posted":"June 11, 2018"},{"nctid":"NCT01554852","version_a":2,"version_b":3,"version_a_date":"2012-03-19","version_b_date":"2016-06-10","pom_a":[{"label":"1.","content":"Overall survivalOverall survial for induction chemotherapy comparisons is defined as the time from initial randomisation to the trial to death from any cause or last follow-up. Overall survival for maintenance therapy comparisons is defined from the time of maintenance randomisation."},{"label":"2.","content":"Progression-free survivalProgression-free survival for induction chemotherapy comparisons is defined as the time from initial randomisation to the trial to progression or death from any cause. Patients who do not progress will be censored at the last date they were known to be alive and progression-free. Progression-free survival for maintenance therapy comparisons is defined from the time of maintenance randomisation"}],"pom_b":[{"label":"1.","content":"Overall survival[ Time Frame: Time from initial randomisation to the trial death from any cause or last follow-up ]Overall survival for induction chemotherapy comparisons is defined as the time from initial randomisation to the trial to death from any cause or last follow-up. Overall survival for maintenance therapy comparisons is defined from the time of maintenance randomisation."},{"label":"2.","content":"Progression-free survival[ Time Frame: time from initial randomisation to the trial to progression or death from any cause ]Progression-free survival for induction chemotherapy comparisons is defined as the time from initial randomisation to the trial to progression or death from any cause. Patients who do not progress will be censored at the last date they were known to be alive and progression-free. Progression-free survival for maintenance therapy comparisons is defined from the time of maintenance randomisation"}],"start_date":"May 2010","primary_completion_date":"December 2021","completion_date":"December 2022","first_posted":"March 15, 2012","last_update_posted":"June 11, 2018"},{"nctid":"NCT02654054","version_a":13,"version_b":14,"version_a_date":"2018-07-16","version_b_date":"2018-11-16","pom_a":[{"label":"1.","content":"Percentage of Responders based on menstrual blood loss (MBL) volume reduction at Final Month[ Time Frame: From Baseline to Final Month of Treatment Period (up through 6 months) ]Assessed using alkaline hematin methodology"}],"pom_b":[{"label":"1.","content":"Percentage of Responders With Menstrual Blood Loss (MBL) Volume of < 80 mL at Final Month and >= 50% Reduction in MBL Volume[ Time Frame: From Month 0 (Baseline) to Final Month of Treatment Period (up through 6 months) ]Participant who prematurely discontinues study drug due to \\"lack of efficacy,\\" \\"requires surgery or invasive intervention for treatment of uterine fibroids,\\" or adverse events will be considered as a non-responder regardless whether she meets the two aforementioned responder criteria or not. Assessed using alkaline hematin methodology"}],"start_date":"December 22, 2015","primary_completion_date":"January 18, 2018","completion_date":"December 12, 2018","first_posted":"January 13, 2016","results_first_posted":"June 29, 2020","last_update_posted":"June 29, 2020"},{"nctid":"NCT02654054","version_a":16,"version_b":17,"version_a_date":"2019-02-06","version_b_date":"2020-06-09","pom_a":[{"label":"1.","content":"Percentage of Responders With Menstrual Blood Loss (MBL) Volume of < 80 mL at Final Month and >= 50% Reduction in MBL Volume[ Time Frame: From Month 0 (Baseline) to Final Month of Treatment Period (up through 6 months) ]Participant who prematurely discontinues study drug due to \\"lack of efficacy,\\" \\"requires surgery or invasive intervention for treatment of uterine fibroids,\\" or adverse events will be considered as a non-responder regardless whether she meets the two aforementioned responder criteria or not. Assessed using alkaline hematin methodology"}],"pom_b":[{"label":"1.","content":"Percentage of Participants Meeting the Criteria for Responder[ Time Frame: Final Month (the last 28 days prior to and including the Reference Day), up to Month 6 ]Percentage of responders, defined as participants who met the following conditions:Menstrual blood loss (MBL) volume < 80 mL during the Final Month (the last 28 days prior to and including the Reference Day, which is defined as the last visit date during the Treatment Period [last treatment visit date] or the last dose date if there are evaluable alkaline hematin data after the last treatment visit date and prior to or on the last dose date), and\u2265 50% reduction in MBL volume from Baseline to the Final Month.Participants who prematurely discontinued study drug due to \\"lack of efficacy,\\" \\"requires surgery or invasive intervention for treatment of uterine fibroids,\\" or \\"adverse events\\" were considered non-responders regardless of whether she meets the two aforementioned responder criteria or not."}],"start_date":"December 22, 2015","primary_completion_date":"January 18, 2018","completion_date":"December 12, 2018","first_posted":"January 13, 2016","results_first_posted":"June 29, 2020","last_update_posted":"June 29, 2020"},{"nctid":"NCT03811002","version_a":288,"version_b":289,"version_a_date":"2021-06-22","version_b_date":"2021-07-08","pom_a":[{"label":"1.","content":"Progression-free survival (PFS) (Phase II)[ Time Frame: Time from randomization to any documented progression or death due to any cause, whichever occurs first, assessed up to 5 years ]Progressive disease (PD) will be determined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Will compare the distributions of PFS between treatment arms using a one-sided stratified log-rank test in all randomized eligible patients. The rates at various timepoints (e.g., every 6 months after randomization) and medians of PFS for each arm will be estimated using the Kaplan-Meier method (1958). The associated 95% confidence interval (CI) will be calculated using Greenwood\'s formula and based on a log-log transformation applied on the survival function. Results from an unstratified analysis will also be provided."},{"label":"2.","content":"Overall survival (OS) (Phase III)[ Time Frame: Time from randomization to the date of death due to any cause, assessed up to 5 years ]The primary hypotheses for the phase II and III portions will be evaluated by comparing arm 1 to arm 2 based on PFS (phase II) and OS (phase III) using a stratified log-rank test. Hazard ratios will be estimated using a stratified Cox regression model. Event rates over time will be estimated within each treatment group using the Kaplan-Meier method."}],"pom_b":[{"label":"1.","content":"Overall survival (OS)[ Time Frame: Time from randomization to the date of death due to any cause, assessed up to 5 years ]Hazard ratios will be estimated using a stratified Cox regression model. Event rates over time will be estimated within each treatment group using the Kaplan-Meier method."}],"start_date":"May 28, 2019","primary_completion_date":"December 28, 2026","completion_date":"December 28, 2026","first_posted":"January 22, 2019","last_update_posted":"September 10, 2022"},{"nctid":"NCT03811002","version_a":474,"version_b":475,"version_a_date":"2022-09-17","version_b_date":"2022-09-29","pom_a":[{"label":"1.","content":"Overall survival (OS)[ Time Frame: Time from randomization to the date of death due to any cause, assessed up to 5 years ]Hazard ratios will be estimated using a stratified Cox regression model. Event rates over time will be estimated within each treatment group using the Kaplan-Meier method."}],"pom_b":[{"label":"1.","content":"Overall survival (OS)[ Time Frame: From randomization to date of death due to any cause, assessed up to 5 years ]Hazard ratios will be estimated using a stratified Cox regression model. Event rates over time will be estimated within each treatment group using the Kaplan-Meier method."}],"start_date":"May 28, 2019","primary_completion_date":"December 28, 2026","completion_date":"December 28, 2026","first_posted":"January 22, 2019","last_update_posted":"September 10, 2022"},{"nctid":"NCT00980954","version_a":131,"version_b":132,"version_a_date":"2012-09-16","version_b_date":"2013-06-18","pom_a":[{"label":"1.","content":"Disease-free survival"}],"pom_b":[{"label":"1.","content":"Disease-free survival[ Time Frame: From randomization to date of first failure (local, regional, or distant metastases failure or death due to any cause) or last follow-up. Analysis occurs after 43 disease-free survival failure events on Cisplatin/RT Arm. ]"}],"start_date":"September 2009","primary_completion_date":"August 2022","completion_date":"August 2026","first_posted":"September 21, 2009","last_update_posted":"April 12, 2022"},{"nctid":"NCT02445391","version_a":1,"version_b":2,"version_a_date":"2015-05-14","version_b_date":"2016-09-29","pom_a":[{"label":"1.","content":"IDFS of patients with basal-like TNBC[ Time Frame: From randomization to the earliest of documented disease recurrence (local, regional and/or distant), invasive contralateral breast cancer, invasive any other second primary cancer, or death, assessed up to 86 months after study activation ]The distributions of IDFS will be estimated using the Kaplan- Meier method, with 95% confidence intervals (CI) calculated using Greenwood\'s formula. The primary analysis of IDFS comparisons between two treatment arms will be performed using stratified log-rank tests, stratifying on the randomization stratification factors. Stratified Cox proportional-hazard models will also be built to estimate the hazard ratios for treatment effect for IDFS as a supportive analysis."}],"pom_b":[{"label":"1.","content":"IDFS of patients with basal-like TNBC[ Time Frame: From randomization to the earliest of documented disease recurrence (local, regional and/or distant), invasive contralateral breast cancer, invasive any other second primary cancer, or death, assessed up to 86 months after study activation ]The distributions of IDFS will be estimated using the Kaplan- Meier method. For the non-inferiority test, the primary analysis of IDFS comparisons will be performed using the repeated confidence interval (RCI) method with hazard ratio (HR) being estimated via stratified Cox proportional hazard model, stratifying on the randomization stratification factors. For the superiority tests of IDFS, the primary analysis will be performed using stratified log-rank tests, and stratified Cox proportional-hazard models will also be built to estimate the HRs for treatment effect for this efficacy endpoint a"}],"start_date":"April 29, 2015","primary_completion_date":"May 31, 2021","completion_date":"May 31, 2024","first_posted":"May 15, 2015","last_update_posted":"May 21, 2020"},{"nctid":"NCT02445391","version_a":2,"version_b":3,"version_a_date":"2016-09-29","version_b_date":"2017-10-03","pom_a":[{"label":"1.","content":"IDFS of patients with basal-like TNBC[ Time Frame: From randomization to the earliest of documented disease recurrence (local, regional and/or distant), invasive contralateral breast cancer, invasive any other second primary cancer, or death, assessed up to 86 months after study activation ]The distributions of IDFS will be estimated using the Kaplan- Meier method. For the non-inferiority test, the primary analysis of IDFS comparisons will be performed using the repeated confidence interval (RCI) method with hazard ratio (HR) being estimated via stratified Cox proportional hazard model, stratifying on the randomization stratification factors. For the superiority tests of IDFS, the primary analysis will be performed using stratified log-rank tests, and stratified Cox proportional-hazard models will also be built to estimate the HRs for treatment effect for this efficacy endpoint a"}],"pom_b":[{"label":"1.","content":"Invasive disease-free survival (IDFS) of patients with basal-like triple-negative breast cancer (TNBC)[ Time Frame: From randomization to the earliest of documented disease recurrence (local, regional and/or distant), invasive contralateral breast cancer, invasive any other second primary cancer, or death, assessed up to 86 months after study activation ]The distributions of IDFS will be estimated using the Kaplan- Meier method. For the non-inferiority test, the primary analysis of IDFS comparisons will be performed using the repeated confidence interval (RCI) method with hazard ratio (HR) being estimated via stratified Cox proportional hazard model, stratifying on the randomization stratification factors. For the superiority tests of IDFS, the primary analysis will be performed using stratified log-rank tests, and stratified Cox proportional-hazard models will also be built to estimate the HRs for treatment effect for this efficacy endpoint a"}],"start_date":"April 29, 2015","primary_completion_date":"May 31, 2021","completion_date":"May 31, 2024","first_posted":"May 15, 2015","last_update_posted":"May 21, 2020"},{"nctid":"NCT00914628","version_a":1,"version_b":2,"version_a_date":"2009-06-04","version_b_date":"2010-03-30","pom_a":[{"label":"1.","content":"Overall Survival (OS) measured for all patients from the date of randomization until death from any cause.[ Time Frame: From randomization to death ]"},{"label":"2.","content":"Non-Relapse Mortality (NRM) defined for all patients as the probability of death related to transplantation and not to relapse (considered as competing event).[ Time Frame: From the date of HCT until to death ]"}],"pom_b":[{"label":"1.","content":"Non-Relapse Mortality (NRM), defined for all patients as the probability of death related to transplantation and not to relapse (considered as competing event).[ Time Frame: From the date of HCT until to death ]"}],"start_date":"April 12, 2010","primary_completion_date":"November 30, 2019","completion_date":"November 30, 2019","first_posted":"June 5, 2009","results_first_posted":"June 22, 2021","last_update_posted":"June 22, 2021"},{"nctid":"NCT00914628","version_a":3,"version_b":4,"version_a_date":"2010-05-13","version_b_date":"2010-10-29","pom_a":[{"label":"1.","content":"Non-Relapse Mortality (NRM), defined for all patients as the probability of death related to transplantation and not to relapse (considered as competing event).[ Time Frame: From the date of HCT until to death ]"}],"pom_b":[{"label":"1.","content":"Non-Relapse Mortality (NRM)[ Time Frame: From the date of HCT until to death ]Defined for all patients as the probability of death related to transplantation and not to relapse (considered as competing event)."}],"start_date":"April 12, 2010","primary_completion_date":"November 30, 2019","completion_date":"November 30, 2019","first_posted":"June 5, 2009","results_first_posted":"June 22, 2021","last_update_posted":"June 22, 2021"},{"nctid":"NCT00914628","version_a":5,"version_b":6,"version_a_date":"2011-05-30","version_b_date":"2011-12-30","pom_a":[{"label":"1.","content":"Non-Relapse Mortality (NRM)[ Time Frame: From the date of HCT until to death ]Defined for all patients as the probability of death related to transplantation and not to relapse (considered as competing event)."}],"pom_b":[{"label":"1.","content":"Disease-free survival (DFS)[ Time Frame: From the randomization date to relapse date or death ]"}],"start_date":"April 12, 2010","primary_completion_date":"November 30, 2019","completion_date":"November 30, 2019","first_posted":"June 5, 2009","results_first_posted":"June 22, 2021","last_update_posted":"June 22, 2021"},{"nctid":"NCT00914628","version_a":12,"version_b":13,"version_a_date":"2014-05-29","version_b_date":"2015-09-11","pom_a":[{"label":"1.","content":"Disease-free survival (DFS)[ Time Frame: From the randomization date to relapse date or death ]"}],"pom_b":[{"label":"1.","content":"Disease-free survival (DFS)[ Time Frame: From the date of randomization to the date of the first occurrence of relapse or death, whichever came first, assessed up to 12 months ]"}],"start_date":"April 12, 2010","primary_completion_date":"November 30, 2019","completion_date":"November 30, 2019","first_posted":"June 5, 2009","results_first_posted":"June 22, 2021","last_update_posted":"June 22, 2021"},{"nctid":"NCT00914628","version_a":13,"version_b":14,"version_a_date":"2015-09-11","version_b_date":"2016-04-13","pom_a":[{"label":"1.","content":"Disease-free survival (DFS)[ Time Frame: From the date of randomization to the date of the first occurrence of relapse or death, whichever came first, assessed up to 12 months ]"}],"pom_b":[{"label":"1.","content":"Disease-free survival (DFS)[ Time Frame: From the date of randomization to the date of the first occurrence of relapse (or progression) or death, whichever came first, assessed up to 12 months ]"}],"start_date":"April 12, 2010","primary_completion_date":"November 30, 2019","completion_date":"November 30, 2019","first_posted":"June 5, 2009","results_first_posted":"June 22, 2021","last_update_posted":"June 22, 2021"},{"nctid":"NCT00914628","version_a":14,"version_b":15,"version_a_date":"2016-04-13","version_b_date":"2018-09-12","pom_a":[{"label":"1.","content":"Disease-free survival (DFS)[ Time Frame: From the date of randomization to the date of the first occurrence of relapse (or progression) or death, whichever came first, assessed up to 12 months ]"}],"pom_b":[{"label":"1.","content":"Disease-free survival (DFS)[ Time Frame: from the date of randomization, assessed up to 12 months ]measured from the date of randomization until the date of relapse (or progression), or death from any cause, whichever occurs first."}],"start_date":"April 12, 2010","primary_completion_date":"November 30, 2019","completion_date":"November 30, 2019","first_posted":"June 5, 2009","results_first_posted":"June 22, 2021","last_update_posted":"June 22, 2021"},{"nctid":"NCT00914628","version_a":15,"version_b":16,"version_a_date":"2018-09-12","version_b_date":"2021-06-01","pom_a":[{"label":"1.","content":"Disease-free survival (DFS)[ Time Frame: from the date of randomization, assessed up to 12 months ]measured from the date of randomization until the date of relapse (or progression), or death from any cause, whichever occurs first."}],"pom_b":[{"label":"1.","content":"Disease-free Survival (DFS)[ Time Frame: From the date of randomization, assessed up to 12 months ]Defined as the measure from the date of randomization until the date of relapse (or progression), or death from any cause, whichever occurs first.Disease relapse or progression was determined by the Investigator based on the following disease examination:Morphology (bone marrow or peripheral blood)Confirmation of mixed or full chimerism (evaluation of the degree of chimerism between donor/host, according to institutional clinical practice, on bone marrow or peripheral blood)Cytogenetic and/or molecular and/or other tests, according to institutional clinical practice (bone marrow or peripheral blood)."}],"start_date":"April 12, 2010","primary_completion_date":"November 30, 2019","completion_date":"November 30, 2019","first_posted":"June 5, 2009","results_first_posted":"June 22, 2021","last_update_posted":"June 22, 2021"},{"nctid":"NCT01853319","version_a":23,"version_b":24,"version_a_date":"2015-10-22","version_b_date":"2015-12-24","pom_a":[{"label":"1.","content":"Number of participants with adverse events as a measure of safety and tolerability[ Time Frame: Up to 6 months ]"},{"label":"2.","content":"Number of participants with adverse events which caused withdrawal, dose reduction, interruption or discontinuation[ Time Frame: Up to 6 months ]"},{"label":"3.","content":"Number of death[ Time Frame: Up to 6 months ]"},{"label":"4.","content":"Number of participants with serious adverse events as a measure of safety and tolerability[ Time Frame: Up to 6 months ]"}],"pom_b":[{"label":"1.","content":"Number of participants with adverse events as a measure of safety and tolerability[ Time Frame: Up to 6 months ]"},{"label":"2.","content":"Number of participants with adverse events which caused withdrawal, dose reduction, interruption or discontinuation[ Time Frame: Up to 6 months ]"},{"label":"3.","content":"Number of death[ Time Frame: Up to 6 months ]"},{"label":"4.","content":"Number of participants with serious adverse events as a measure of safety and tolerability[ Time Frame: Up to 6 months ]"},{"label":"5.","content":"Progression-Free Survival (PFS)[ Time Frame: Up to 6 months ]The PFS is defined as the time from date of treatment assignment (i.e., date of first treatment) to date of first observed disease progression or death due to any cause, if death occurs while the subject is in the study (that is, by the last visit including during the safety follow-up visit date), and before progression is observed."}],"start_date":"July 24, 2013","primary_completion_date":"April 24, 2015","completion_date":"June 11, 2018","first_posted":"May 15, 2013","last_update_posted":"April 22, 2019"},{"nctid":"NCT03084939","version_a":10,"version_b":11,"version_a_date":"2018-01-03","version_b_date":"2018-02-15","pom_a":[{"label":"1.","content":"Progression-free survival (PFS)[ Time Frame: Up to approximately 29 months ]PFS is defined as the time from randomization to the first occurrence of disease progression as determined by the investigator using Response Evaluation Criteria in Solid Tumors (RECIST) Version (v1.1), or death from any cause during the study, whichever occurs first. Disease progression is defined as at least a 20% increase in the sum of diameters of target lesions with an absolute increase of at least 5 millimeter (mm) taking as reference the smallest sum during the study including baseline or the appearance of one or more new lesions. Tumor assessments will be performed with computed tomography (CT) or magnetic resonance imaging (MRI) scans."}],"pom_b":[{"label":"1.","content":"Progression-free survival (PFS)[ Time Frame: Up to approximately 17 months ]PFS is defined as the time from randomization to the first occurrence of disease progression as determined by the investigator using Response Evaluation Criteria in Solid Tumors (RECIST) Version (v1.1), or death from any cause during the study, whichever occurs first. Disease progression is defined as at least a 20% increase in the sum of diameters of target lesions with an absolute increase of at least 5 millimeter (mm) taking as reference the smallest sum during the study including baseline or the appearance of one or more new lesions. Tumor assessments will be performed with computed tomography (CT) or magnetic resonance imaging (MRI) scans."}],"start_date":"April 24, 2017","primary_completion_date":"November 23, 2018","completion_date":"September 30, 2022","first_posted":"March 21, 2017","last_update_posted":"August 30, 2022"},{"nctid":"NCT02799082","version_a":1,"version_b":2,"version_a_date":"2016-06-09","version_b_date":"2017-04-04","pom_a":[{"label":"1.","content":"Total Patient Clearance Rate[ Time Frame: 12 weeks after the last photodynamic therapy (PDT) ]AK clearance rate, defined as the number of subjects with complete remission of all AK lesions in the target area(s) assessed 12 weeks after the last PDT."}],"pom_b":[{"label":"1.","content":"Total Patient Clearance Rate 12 Weeks After the Last Photodynamic Therapy (PDT)[ Time Frame: 12 weeks after the last photodynamic therapy (PDT), up to 24 weeks ]AK clearance rate, defined as the percentage of subjects with complete remission of all AK lesions in the target area(s) assessed 12 weeks after the last PDT (12 weeks after the 1st PDT or 12 weeks after the 2nd PDT in case of retreatment)."},{"label":"2.","content":"Total Patient Clearance Rate 12 Weeks After the Last Photodynamic Therapy (PDT)[ Time Frame: 12 weeks after the last PDT, up to 24 weeks ]AK clearance rate, defined as the percentage of subjects with complete remission of all AK lesions in the target area(s) assessed 12 weeks after the last PDT (12 weeks after the 1st PDT or 12 weeks after the 2nd PDT in case of retreatment)."},{"label":"3.","content":"Total Patient Clearance Rate Treated With Narrow Spectrum Lamp 12 Weeks After the Last Photodynamic Therapy (PDT)[ Time Frame: 12 weeks after the last PDT, up to 24 weeks ]AK clearance rate, defined as the percentage of subjects with complete remission of all AK lesions in the target area(s) assessed 12 weeks after the last PDT (12 weeks after the 1st PDT or 12 weeks after the 2nd PDT in case of retreatment).Analysis was for the subgroup: treated by narrow spectrum lamps only [n=15 (vehicle), n= 31 (BF-200 ALA)]"},{"label":"4.","content":"Total Patient Clearance Rate Treated With Narrow Spectrum Lamp 12 Weeks After the Last Photodynamic Therapy (PDT)[ Time Frame: 12 weeks after the last PDT, up to 24 weeks ]AK clearance rate, defined as the percentage of subjects with complete remission of all AK lesions in the target area(s) assessed 12 weeks after the last PDT (12 weeks after the 1st PDT or 12 weeks after the 2nd PDT in case of retreatment).Analysis was for the subgroup: treated by narrow spectrum lamps only [n=13 (vehicle), n= 28 (BF-200 ALA)]"}],"start_date":"December 2007","primary_completion_date":"October 2008","completion_date":"October 2008","first_posted":"June 14, 2016","results_first_posted":"April 6, 2017","last_update_posted":"April 6, 2017"},{"nctid":"NCT02112916","version_a":301,"version_b":302,"version_a_date":"2017-09-20","version_b_date":"2017-10-04","pom_a":[{"label":"1.","content":"EFS between modified ABFM backbone with or without bortezomib in all randomized patients[ Time Frame: Up to 10 years ]Interim monitoring for efficacy and futility will be performed. The study will also be monitored for futility using the method of Freidlin and Korn."}],"pom_b":[{"label":"1.","content":"Event-free survival (EFS) between modified augmented Berlin-Frankfurt-M\xfcnster (ABFM) backbone with or without bortezomib in all randomized patients[ Time Frame: Up to 10 years ]Interim monitoring for efficacy and futility will be performed. The study will also be monitored for futility using the method of Freidlin and Korn."}],"start_date":"September 30, 2014","primary_completion_date":"March 31, 2020","completion_date":"December 31, 2027","first_posted":"April 14, 2014","results_first_posted":"February 23, 2022","last_update_posted":"February 23, 2022"},{"nctid":"NCT02112916","version_a":419,"version_b":420,"version_a_date":"2019-06-10","version_b_date":"2019-07-10","pom_a":[{"label":"1.","content":"Event-free survival (EFS) between modified augmented Berlin-Frankfurt-M\xfcnster (ABFM) backbone with or without bortezomib in all randomized patients[ Time Frame: Up to 10 years ]Interim monitoring for efficacy and futility will be performed. The study will also be monitored for futility using the method of Freidlin and Korn."}],"pom_b":[{"label":"1.","content":"Event-free survival (EFS) between modified augmented Berlin-Frankfurt-Munster backbone with or without bortezomib in all randomized patients[ Time Frame: Up to 10 years ]Interim monitoring for efficacy and futility will be performed. The study will also be monitored for futility using the method of Freidlin and Korn."}],"start_date":"September 30, 2014","primary_completion_date":"March 31, 2020","completion_date":"December 31, 2027","first_posted":"April 14, 2014","results_first_posted":"February 23, 2022","last_update_posted":"February 23, 2022"},{"nctid":"NCT02112916","version_a":462,"version_b":463,"version_a_date":"2021-02-16","version_b_date":"2021-03-11","pom_a":[{"label":"1.","content":"Event-free survival (EFS) between modified augmented Berlin-Frankfurt-Munster backbone with or without bortezomib in all randomized patients[ Time Frame: Up to 10 years ]Interim monitoring for efficacy and futility will be performed. The study will also be monitored for futility using the method of Freidlin and Korn."}],"pom_b":[{"label":"1.","content":"Event-free survival (EFS) for modified augmented Berlin-Frankfurt-Munster backbone with or without bortezomib in all randomized patients[ Time Frame: 3 years ]EFS is calculated as time from randomization at study entry to first event (induction failure, induction death, relapse, second malignancy, remission death) or date of last contact. Three-year EFS rates will be calculated for both groups."}],"start_date":"September 30, 2014","primary_completion_date":"March 31, 2020","completion_date":"December 31, 2027","first_posted":"April 14, 2014","results_first_posted":"February 23, 2022","last_update_posted":"February 23, 2022"},{"nctid":"NCT02112916","version_a":463,"version_b":464,"version_a_date":"2021-03-11","version_b_date":"2022-01-26","pom_a":[{"label":"1.","content":"Event-free survival (EFS) for modified augmented Berlin-Frankfurt-Munster backbone with or without bortezomib in all randomized patients[ Time Frame: 3 years ]EFS is calculated as time from randomization at study entry to first event (induction failure, induction death, relapse, second malignancy, remission death) or date of last contact. Three-year EFS rates will be calculated for both groups."}],"pom_b":[{"label":"1.","content":"Event-free Survival (EFS) for Modified Augmented Berlin-Frankfurt-Munster Backbone With or Without Bortezomib in All Randomized Patients[ Time Frame: 3 years ]EFS is calculated as time from randomization at study entry to first event (induction failure, induction death, relapse, second malignancy, remission death) or date of last contact. Three-year EFS rates will be calculated for both groups."}],"start_date":"September 30, 2014","primary_completion_date":"March 31, 2020","completion_date":"December 31, 2027","first_posted":"April 14, 2014","results_first_posted":"February 23, 2022","last_update_posted":"February 23, 2022"},{"nctid":"NCT00092534","version_a":2,"version_b":3,"version_a_date":"2005-09-29","version_b_date":"2006-01-12","pom_a":[],"pom_b":[{"label":"1.","content":"Tolerability; incidence of the composite endpoint of HPV 16 or HPV 18 related CIN2/3 or invasive cervical carcinoma after completion of the vaccination series for relevant HPV type"}],"start_date":"June 14, 2002","primary_completion_date":"July 31, 2007","completion_date":"March 3, 2025","first_posted":"September 28, 2004","results_first_posted":"November 26, 2009","last_update_posted":"August 23, 2022"},{"nctid":"NCT00092534","version_a":13,"version_b":14,"version_a_date":"2009-05-21","version_b_date":"2009-10-15","pom_a":[{"label":"1.","content":"Tolerability; incidence of the composite endpoint of HPV 16 or HPV 18 related CIN2/3 or invasive cervical carcinoma after completion of the vaccination series for relevant HPV type"}],"pom_b":[{"label":"1.","content":"Tolerability; Incidence of the Composite Endpoint of HPV 16 or HPV 18 Related CIN2/3 or Invasive Cervical Carcinoma After Completion of the Vaccination Series for Relevant HPV Type[ Time Frame: Follow-up through end of study (4 years) ]Tolerability = Number of subjected affected. Incidence Rate per person-years of follow-up.The tolerability objective was to demonstrate that Gardasil is generally well tolerated by females aged 16-23. The relevant data are presented in the Reported Adverse Events section. No formal statistical hypothesis testing were performed for this objective."}],"start_date":"June 14, 2002","primary_completion_date":"July 31, 2007","completion_date":"March 3, 2025","first_posted":"September 28, 2004","results_first_posted":"November 26, 2009","last_update_posted":"August 23, 2022"},{"nctid":"NCT00092534","version_a":37,"version_b":38,"version_a_date":"2018-01-23","version_b_date":"2019-11-11","pom_a":[{"label":"1.","content":"Tolerability; Incidence of the Composite Endpoint of HPV 16 or HPV 18 Related CIN2/3 or Invasive Cervical Carcinoma After Completion of the Vaccination Series for Relevant HPV Type[ Time Frame: Follow-up through end of study (4 years) ]Tolerability = Number of subjected affected. Incidence Rate per person-years of follow-up.The tolerability objective was to demonstrate that Gardasil is generally well tolerated by females aged 16-23. The relevant data are presented in the Reported Adverse Events section. No formal statistical hypothesis testing were performed for this objective."}],"pom_b":[{"label":"1.","content":"Incidence of the Composite Endpoint of Human Papillomavirus (HPV) 16/18-related Cervical Intraepithelial Neoplasia (CIN) 2 or Worse in the Base Study[ Time Frame: Up to 4 years ]This measure is defined to have occurred when, on a single cervical biopsy, endocervical curettage (ECC), loop electrosurgical excision procedure (LEEP), or conization specimen, there was HPV Vaccine consensus diagnosis of CIN 2 or worse up to 4 years after the first vaccination. For this measure, CIN 2 or worse includes CIN 2, CIN 3, adenocarcinoma in situ (AIS) or cervical cancer related to HPV 16 or 18."},{"label":"2.","content":"Incidence of the Composite Endpoint of Human Papillomavirus (HPV) 16/18-related Cervical Intraepithelial Neoplasia (CIN) 2 or Worse in the Long-term Follow-up (LTFU) Study: LTFU Extension Year 10[ Time Frame: Up to 14 years since Vaccine Dose 1 ]This measure is defined to have occurred when, on a single cervical biopsy, endocervical curettage (ECC), loop electrosurgical excision procedure (LEEP), or conization specimen, there was HPV Vaccine Nordic pathology panel (NPP) consensus diagnosis of CIN 2 or worse up to 14 years after the first vaccination. For this measure, CIN 2 or worse includes CIN 2, CIN 3, AIS or cervical cancer related to HPV 16 or 18. Only participants who received qHPV vaccine during the Base Study vaccination period and consented for inclusion in the LTFU are included. Because the objective was to demonstrate qHPV vaccine prophylactic efficacy at 14 years, Cohort 2 was not included in the analysis."}],"start_date":"June 14, 2002","primary_completion_date":"July 31, 2007","completion_date":"March 3, 2025","first_posted":"September 28, 2004","results_first_posted":"November 26, 2009","last_update_posted":"August 23, 2022"},{"nctid":"NCT00092534","version_a":38,"version_b":39,"version_a_date":"2019-11-11","version_b_date":"2020-02-21","pom_a":[{"label":"1.","content":"Incidence of the Composite Endpoint of Human Papillomavirus (HPV) 16/18-related Cervical Intraepithelial Neoplasia (CIN) 2 or Worse in the Base Study[ Time Frame: Up to 4 years ]This measure is defined to have occurred when, on a single cervical biopsy, endocervical curettage (ECC), loop electrosurgical excision procedure (LEEP), or conization specimen, there was HPV Vaccine consensus diagnosis of CIN 2 or worse up to 4 years after the first vaccination. For this measure, CIN 2 or worse includes CIN 2, CIN 3, adenocarcinoma in situ (AIS) or cervical cancer related to HPV 16 or 18."},{"label":"2.","content":"Incidence of the Composite Endpoint of Human Papillomavirus (HPV) 16/18-related Cervical Intraepithelial Neoplasia (CIN) 2 or Worse in the Long-term Follow-up (LTFU) Study: LTFU Extension Year 10[ Time Frame: Up to 14 years since Vaccine Dose 1 ]This measure is defined to have occurred when, on a single cervical biopsy, endocervical curettage (ECC), loop electrosurgical excision procedure (LEEP), or conization specimen, there was HPV Vaccine Nordic pathology panel (NPP) consensus diagnosis of CIN 2 or worse up to 14 years after the first vaccination. For this measure, CIN 2 or worse includes CIN 2, CIN 3, AIS or cervical cancer related to HPV 16 or 18. Only participants who received qHPV vaccine during the Base Study vaccination period and consented for inclusion in the LTFU are included. Because the objective was to demonstrate qHPV vaccine prophylactic efficacy at 14 years, Cohort 2 was not included in the analysis."}],"pom_b":[{"label":"1.","content":"Incidence of the Composite Endpoint of Human Papillomavirus (HPV) 16/18-related Cervical Intraepithelial Neoplasia (CIN) 2 or Worse in the Base Study[ Time Frame: Up to 4 years ]This measure is defined to have occurred when, on a single cervical biopsy, endocervical curettage (ECC), loop electrosurgical excision procedure (LEEP), or conization specimen, there was HPV Vaccine consensus diagnosis of CIN 2 or worse up to 4 years after the first vaccination. For this measure, CIN 2 or worse includes CIN 2, CIN 3, adenocarcinoma in situ (AIS) or cervical cancer related to HPV 16 or 18."},{"label":"2.","content":"Incidence of the Composite Endpoint of Human Papillomavirus (HPV) 16/18-related Cervical Intraepithelial Neoplasia (CIN) 2 or Worse in the Long-term Follow-up (LTFU) Study[ Time Frame: Up to 14 years since Vaccine Dose 1 ]This measure is defined to have occurred when, on a single cervical biopsy, endocervical curettage (ECC), loop electrosurgical excision procedure (LEEP), or conization specimen, there was HPV Vaccine Nordic pathology panel (NPP) consensus diagnosis of CIN 2 or worse up to 14 years after the first vaccination. For this measure, CIN 2 or worse includes CIN 2, CIN 3, AIS or cervical cancer related to HPV 16 or 18. Only participants who received qHPV vaccine during the Base Study vaccination period and consented for inclusion in the LTFU are included. Because the objective was to demonstrate qHPV vaccine prophylactic efficacy at 14 years, Cohort 2 was not included in the analysis."},{"label":"3.","content":"Incidence of the Composite Endpoint of HPV16/18-related CIN 2 or Worse in the Long-term Follow-up (LTFU) Study[ Time Frame: up to 22 years post Vaccination Dose 1 ]This measure is defined to have occurred when, on a single cervical biopsy, ECC, LEEP, or conization specimen, there was HPV Vaccine NPP consensus diagnosis of CIN 2 or worse up to 22 years after the first vaccination. For this measure, CIN 2 or worse includes CIN 2, CIN 3, AIS or cervical cancer related to HPV 16 or 18. Only participants who received qHPV vaccine during the Base Study vaccination period and consented for inclusion in the LTFU will be included."}],"start_date":"June 14, 2002","primary_completion_date":"July 31, 2007","completion_date":"March 3, 2025","first_posted":"September 28, 2004","results_first_posted":"November 26, 2009","last_update_posted":"August 23, 2022"},{"nctid":"NCT01326078","version_a":1,"version_b":2,"version_a_date":"2011-03-29","version_b_date":"2014-03-25","pom_a":[{"label":"1.","content":"Classification of the sedation level[ Time Frame: time 0 ]Instantly after the loss of consciousness (loss of corneal-palpebral reflex)will be measure the sedation using the Ramsay Modified Scale"}],"pom_b":[{"label":"1.","content":"Classification of the sedation level[ Time Frame: time 0 ]Instantly after the loss of consciousness (loss of corneal-palpebral reflex) will be measured the sedation using the Ramsay Modified Scale."}],"start_date":"June 2011","primary_completion_date":"July 2011","completion_date":"December 2011","first_posted":"March 30, 2011","last_update_posted":"March 26, 2014"},{"nctid":"NCT03391466","version_a":21,"version_b":22,"version_a_date":"2018-07-09","version_b_date":"2018-07-18","pom_a":[{"label":"1.","content":"Event Free Survival[ Time Frame: 3 years ]"}],"pom_b":[{"label":"1.","content":"Event Free Survival[ Time Frame: Jan 2021 ]"}],"start_date":"January 25, 2018","primary_completion_date":"January 2023","completion_date":"January 2035","first_posted":"January 5, 2018","last_update_posted":"April 29, 2022"},{"nctid":"NCT03391466","version_a":29,"version_b":30,"version_a_date":"2018-09-17","version_b_date":"2018-12-06","pom_a":[{"label":"1.","content":"Event Free Survival[ Time Frame: Jan 2021 ]"}],"pom_b":[{"label":"1.","content":"Event Free Survival[ Time Frame: Up to 5 years ]Event free survival is defined as the time from randomization to the earliest date of disease progression per Lugano Classification (Cheson et al, 2014), commencement of new lymphoma therapy, or death from any cause as determined by blinded central review"}],"start_date":"January 25, 2018","primary_completion_date":"January 2023","completion_date":"January 2035","first_posted":"January 5, 2018","last_update_posted":"April 29, 2022"},{"nctid":"NCT03391466","version_a":37,"version_b":38,"version_a_date":"2019-05-07","version_b_date":"2019-06-20","pom_a":[{"label":"1.","content":"Event Free Survival[ Time Frame: Up to 5 years ]Event free survival is defined as the time from randomization to the earliest date of disease progression per Lugano Classification (Cheson et al, 2014), commencement of new lymphoma therapy, or death from any cause as determined by blinded central review"}],"pom_b":[{"label":"1.","content":"Event Free Survival (EFS)[ Time Frame: Up to 5 years ]Event free survival is defined as the time from randomization to the earliest date of disease progression per Lugano Classification (Cheson et al, 2014), commencement of new lymphoma therapy, or death from any cause as determined by blinded central review"}],"start_date":"January 25, 2018","primary_completion_date":"January 2023","completion_date":"January 2035","first_posted":"January 5, 2018","last_update_posted":"April 29, 2022"},{"nctid":"NCT02668653","version_a":13,"version_b":14,"version_a_date":"2018-12-19","version_b_date":"2019-01-17","pom_a":[{"label":"1.","content":"Event-free Survival (EFS)[ Time Frame: Duration of study, an average of 2 years ]"}],"pom_b":[{"label":"1.","content":"Event-free Survival (EFS)[ Time Frame: anticipated 2 years ]"}],"start_date":"September 2016","primary_completion_date":"August 13, 2021","completion_date":"August 2023","first_posted":"January 29, 2016","last_update_posted":"April 15, 2022"},{"nctid":"NCT02668653","version_a":19,"version_b":20,"version_a_date":"2019-11-21","version_b_date":"2020-05-11","pom_a":[{"label":"1.","content":"Event-free Survival (EFS)[ Time Frame: anticipated 2 years ]"}],"pom_b":[{"label":"1.","content":"Event-free Survival[ Time Frame: Approximately 3 years after enrollment ]"},{"label":"2.","content":"Overall Survival[ Time Frame: Approximately 3 years after enrollment ]"}],"start_date":"September 2016","primary_completion_date":"August 13, 2021","completion_date":"August 2023","first_posted":"January 29, 2016","last_update_posted":"April 15, 2022"},{"nctid":"NCT02668653","version_a":20,"version_b":21,"version_a_date":"2020-05-11","version_b_date":"2021-06-08","pom_a":[{"label":"1.","content":"Event-free Survival[ Time Frame: Approximately 3 years after enrollment ]"},{"label":"2.","content":"Overall Survival[ Time Frame: Approximately 3 years after enrollment ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Approximately 3 years after enrollment ]"}],"start_date":"September 2016","primary_completion_date":"August 13, 2021","completion_date":"August 2023","first_posted":"January 29, 2016","last_update_posted":"April 15, 2022"},{"nctid":"NCT00922974","version_a":112,"version_b":113,"version_a_date":"2012-09-11","version_b_date":"2013-06-12","pom_a":[{"label":"1.","content":"Successful delivery of image-guided radiosurgery or stereotactic body radiotherapy in the RTOG cooperative group setting (Phase II)"},{"label":"2.","content":"Complete or partial pain response at the treated index site(s) at 3 months after study entry, as measured by the Numerical Rating Pain Scale (NRPS) (Phase III)"}],"pom_b":[{"label":"1.","content":"Successful delivery of image-guided radiosurgery or stereotactic body radiotherapy in the Radiation Therapy Oncology Group (RTOG) cooperative group setting (Phase II)[ Time Frame: End of protocol treatment ]"},{"label":"2.","content":"Complete or partial pain response at the treated index site(s) at 3 months after study entry, as measured by the Numerical Rating Pain Scale (NRPS) (Phase III)[ Time Frame: Pre-treatment to 3 months from study entry ]"}],"start_date":"November 2009","primary_completion_date":"January 2018","completion_date":"April 6, 2020","first_posted":"June 18, 2009","results_first_posted":"May 16, 2019","last_update_posted":"May 19, 2021"},{"nctid":"NCT00922974","version_a":121,"version_b":122,"version_a_date":"2018-04-09","version_b_date":"2019-04-19","pom_a":[{"label":"1.","content":"Successful delivery of image-guided radiosurgery or stereotactic body radiotherapy in the Radiation Therapy Oncology Group (RTOG) cooperative group setting (Phase II)[ Time Frame: End of protocol treatment ]"},{"label":"2.","content":"Complete or partial pain response at the treated index site(s) at 3 months after study entry, as measured by the Numerical Rating Pain Scale (NRPS) (Phase III)[ Time Frame: Pre-treatment to 3 months from study entry ]"}],"pom_b":[{"label":"1.","content":"Percentage of Patients Receiving Radiosurgery/SBRT Per Protocol or With Minor Variation (Phase II)[ Time Frame: The day of protocol treatment ]Treatment delivery was centrally reviewed by the study chair and medical physics co-chair. Success was defined as having a review of \\"per protocol\\" or \\"minor variation\\". A 70% success rate was required for continuation to the phase III component.Target volume compliance in is defined as the following levels of target coverage in reference to dose volume:Per protocol: \u2265 90%Minor variation: 80%-90%Major deviation: <80% of of dose volume.Image-Guided Radiotherapy (IGRT) compliance is defined as the following differences in IGRT images between simulation/planning and treatment, as well as at the end of treatment:Per protocol: <2 mmMinor variation: 2mm - 3mmMajor deviation: > 3mm"},{"label":"2.","content":"Percentage of Patients With Complete or Partial Pain Response at 3 Months (Phase III)[ Time Frame: Baseline and 3 months ]Pain is measured by the Numerical Rating Pain Scale (NRPS) a numerical 11-point scale (0-10) with 0 = no pain, 1-4 = mild, 5-6 = moderate, and 7-10 = severe with 10 the worst pain imaginable. Pain response is calculated as 3 month score - baseline score with a positive value indicating increased pain and a negative value indicating decreased pain. Patients with complete or partial pain response as defined below are considered responders. The index site is the lesion with the highest baseline (day of radiosurgery) pain score. If multiple sites have the same baseline pain score, the index site is the most cephalad lesion.Complete response: post-treatment pain score of 0 at the index site, no increase in narcotic pain medication, and no increase in pain score at the secondary treated site(s).Partial response: post-treatment improvement of at least 3 points at the index site, no increase in narcotic pain medication, and no increase in pain score at the secondary treated site(s)."}],"start_date":"November 2009","primary_completion_date":"January 2018","completion_date":"April 6, 2020","first_posted":"June 18, 2009","results_first_posted":"May 16, 2019","last_update_posted":"May 19, 2021"},{"nctid":"NCT01287741","version_a":133,"version_b":134,"version_a_date":"2015-08-17","version_b_date":"2016-10-20","pom_a":[{"label":"1.","content":"Progression-free survival, assessed by the investigator according to a modified version of the Revised Response Criteria for Malignant Lymphoma[ Time Frame: up to approximately 78 months ]"}],"pom_b":[{"label":"1.","content":"Progression-Free Survival, Assessed by the Investigator According to a Modified Version of the Revised Response Criteria for Malignant Lymphoma[ Time Frame: Baseline up to death or disease progression, whichever occurs first (up to approximately 64 months) ]"},{"label":"2.","content":"Progression-Free Survival, Assessed by the Independent Review Committee (IRC) According to a Modified Version of the Revised Response Criteria for Malignant Lymphoma[ Time Frame: Baseline up to death or disease progression, whichever occurs first (up to approximately 64 months) ]"}],"start_date":"July 26, 2011","primary_completion_date":"April 29, 2016","completion_date":"January 31, 2018","first_posted":"February 1, 2011","results_first_posted":"August 17, 2017","last_update_posted":"April 12, 2019"},{"nctid":"NCT01287741","version_a":134,"version_b":135,"version_a_date":"2016-10-20","version_b_date":"2017-08-15","pom_a":[{"label":"1.","content":"Progression-Free Survival, Assessed by the Investigator According to a Modified Version of the Revised Response Criteria for Malignant Lymphoma[ Time Frame: Baseline up to death or disease progression, whichever occurs first (up to approximately 64 months) ]"},{"label":"2.","content":"Progression-Free Survival, Assessed by the Independent Review Committee (IRC) According to a Modified Version of the Revised Response Criteria for Malignant Lymphoma[ Time Frame: Baseline up to death or disease progression, whichever occurs first (up to approximately 64 months) ]"}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS), Investigator-Assessed[ Time Frame: Baseline up to data cut-off (up to approximately 4 years and 9 months) ]Progression-free survival was defined as the time from randomization until the first documented day of disease progression or relapse, using a modified version of the Revised Response Criteria for Malignant Lymphoma, or death from any cause, whichever occurred first, on the basis of investigator assessments. Progression was defined as at least 50% increase in nodal lesions or >/=50% increase in any node > 1 centimeter (cm) or >/= 50% increase in other target measurable lesions (e.g., splenic or hepatic nodules) and/or appearance of any new bone marrow involvement and/or appearance of any new lesion > 1.5 cm or >/= 50% increase in any previously involved node with a diameter <\\\\/= 1 cm such that it is now >1.5 cm. Tumor measurements were obtained by computed tomography (CT) or magnetic resonance imaging (MRI)."}],"start_date":"July 26, 2011","primary_completion_date":"April 29, 2016","completion_date":"January 31, 2018","first_posted":"February 1, 2011","results_first_posted":"August 17, 2017","last_update_posted":"April 12, 2019"},{"nctid":"NCT01287741","version_a":140,"version_b":141,"version_a_date":"2018-07-30","version_b_date":"2019-04-08","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS), Investigator-Assessed[ Time Frame: Baseline up to data cut-off (up to approximately 4 years and 9 months) ]Progression-free survival was defined as the time from randomization until the first documented day of disease progression or relapse, using a modified version of the Revised Response Criteria for Malignant Lymphoma, or death from any cause, whichever occurred first, on the basis of investigator assessments. Progression was defined as at least 50% increase in nodal lesions or >/=50% increase in any node > 1 centimeter (cm) or >/= 50% increase in other target measurable lesions (e.g., splenic or hepatic nodules) and/or appearance of any new bone marrow involvement and/or appearance of any new lesion > 1.5 cm or >/= 50% increase in any previously involved node with a diameter <\\\\/= 1 cm such that it is now >1.5 cm. Tumor measurements were obtained by computed tomography (CT) or magnetic resonance imaging (MRI)."}],"pom_b":[{"label":"1.","content":"Median Time to Progression-Free Survival (PFS), Investigator-Assessed[ Time Frame: Baseline up to approximately 6.5 years (up to 31 January 2018) ]Kaplan Meier estimate of the median PFS was defined as the time at which half of the participants have progressed (progressive disease [PD]). Progression-free survival was defined as the time from randomization until the first documented day of disease progression or relapse, using a modified version of the Revised Response Criteria for Malignant Lymphoma, or death from any cause, whichever occurred first, on the basis of investigator assessments. Progression was defined as at least 50% increase in nodal lesions or >/=50% increase in any node > 1 centimeter (cm) or >/= 50% increase in other target measurable lesions (e.g., splenic or hepatic nodules) and/or appearance of any new bone marrow involvement and/or appearance of any new lesion > 1.5 cm or >/= 50% increase in any previously involved node with a diameter <\\\\/= 1 cm such that it is now >1.5 cm. Tumor measurements were obtained by computed tomography (CT) or magnetic resonance imaging (MRI)."}],"start_date":"July 26, 2011","primary_completion_date":"April 29, 2016","completion_date":"January 31, 2018","first_posted":"February 1, 2011","results_first_posted":"August 17, 2017","last_update_posted":"April 12, 2019"},{"nctid":"NCT01674140","version_a":1,"version_b":2,"version_a_date":"2012-08-24","version_b_date":"2013-02-19","pom_a":[{"label":"1.","content":"IDFS using a stratified log-rank test, assessed up to 10 years"}],"pom_b":[{"label":"1.","content":"IDFS using a stratified log-rank test, assessed up to 10 years[ Time Frame: over 10 years ]IDFS using a stratified log-rank test, assessed up to 10 years"}],"start_date":"April 2013","primary_completion_date":"December 2022","completion_date":"January 2030","first_posted":"August 28, 2012","last_update_posted":"July 13, 2022"},{"nctid":"NCT02627963","version_a":15,"version_b":16,"version_a_date":"2019-07-25","version_b_date":"2020-02-10","pom_a":[{"label":"1.","content":"Progression-free survival (PFS)[ Time Frame: 24 months ]"}],"pom_b":[{"label":"1.","content":"Progression-free Survival (PFS)[ Time Frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first. Disease progression was assessed every 8 weeks. ]Progression-Free Survival (PFS), as assessed by a blinded independent radiological review (IRR), is defined as the time from randomization to first documentation of objective tumor progression (progressive disease) or death due to any reasons whichever comes first. Disease progression per RECIST 1.1 criteria is defined as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions."}],"start_date":"April 2016","primary_completion_date":"December 2018","completion_date":"June 2021","first_posted":"December 11, 2015","results_first_posted":"February 20, 2020","last_update_posted":"January 26, 2022"},{"nctid":"NCT03539744","version_a":22,"version_b":23,"version_a_date":"2020-12-11","version_b_date":"2021-01-15","pom_a":[{"label":"1.","content":"Progression-Free Survival (PFS)[ Time Frame: Up to approximately 28 months from first randomization ]PFS is defined as the time in days from subject randomization to the date of the first documented progressive disease (PD) or death due to any cause, whichever occurs first."}],"pom_b":[{"label":"1.","content":"Progression-Free Survival (PFS)[ Time Frame: Up to approximately 43 months from first randomization ]PFS is defined as the time in days from subject randomization to the date of the first documented progressive disease (PD) or death due to any cause, whichever occurs first."}],"start_date":"October 22, 2018","primary_completion_date":"June 30, 2022","completion_date":"November 11, 2024","first_posted":"May 29, 2018","last_update_posted":"July 21, 2022"},{"nctid":"NCT01450696","version_a":43,"version_b":44,"version_a_date":"2013-08-05","version_b_date":"2013-08-21","pom_a":[{"label":"1.","content":"Overall survival[ Time Frame: approximately 8 years ]"}],"pom_b":[{"label":"1.","content":"Overall survival[ Time Frame: approximately 9 years ]"}],"start_date":"December 2011","primary_completion_date":"February 2015","completion_date":"August 2015","first_posted":"October 12, 2011","results_first_posted":"November 28, 2016","last_update_posted":"November 28, 2016"},{"nctid":"NCT01450696","version_a":124,"version_b":125,"version_a_date":"2016-04-02","version_b_date":"2016-10-05","pom_a":[{"label":"1.","content":"Overall survival[ Time Frame: approximately 9 years ]"}],"pom_b":[{"label":"1.","content":"Percentage of Participants Who Died - FAS[ Time Frame: From date of randomization until death or premature withdrawal (up to approximately 31 months or data cutoff date of 13 February 2015) ]The percentage of participants who died as of the analysis data cutoff date of 13 February 2015 was reported among participants from the FAS with available data."},{"label":"2.","content":"Overall Survival - FAS[ Time Frame: From date of randomization until death or premature withdrawal (up to approximately 31 months or data cutoff date of 13 February 2015) ]Overall survival was defined as the time from the date of randomization to the date of death from any cause. Overall survival was estimated among participants from the FAS using the Kaplan-Meier approach. The 95 percent (%) confidence interval (CI) for median was computed using the method of Brookmeyer and Crowley."}],"start_date":"December 2011","primary_completion_date":"February 2015","completion_date":"August 2015","first_posted":"October 12, 2011","results_first_posted":"November 28, 2016","last_update_posted":"November 28, 2016"},{"nctid":"NCT00171925","version_a":1,"version_b":2,"version_a_date":"2005-09-13","version_b_date":"2006-08-17","pom_a":[],"pom_b":[{"label":"1.","content":"Effect of zoledronic acid on progression free survival"}],"start_date":"August 2000","primary_completion_date":"November 2008","completion_date":"November 2008","first_posted":"September 15, 2005","results_first_posted":"April 20, 2011","last_update_posted":"April 11, 2012"},{"nctid":"NCT00171925","version_a":7,"version_b":8,"version_a_date":"2009-09-22","version_b_date":"2009-09-30","pom_a":[{"label":"1.","content":"Effect of zoledronic acid on progression free survival"}],"pom_b":[{"label":"1.","content":"Effect of zoledronic acid on progression free survival[ Time Frame: 48 months ]"}],"start_date":"August 2000","primary_completion_date":"November 2008","completion_date":"November 2008","first_posted":"September 15, 2005","results_first_posted":"April 20, 2011","last_update_posted":"April 11, 2012"},{"nctid":"NCT00171925","version_a":10,"version_b":11,"version_a_date":"2009-11-20","version_b_date":"2011-03-25","pom_a":[{"label":"1.","content":"Effect of zoledronic acid on progression free survival[ Time Frame: 48 months ]"}],"pom_b":[{"label":"1.","content":"Days of Progression Free Survival[ Time Frame: 48 months ]Progression- free survival was defined as time from date of randomization to death from any cause or one of the following events:progression in stage II or III (Salmon & Durie)skeletal related eventsunequivocal progression of osteolytic lesions"}],"start_date":"August 2000","primary_completion_date":"November 2008","completion_date":"November 2008","first_posted":"September 15, 2005","results_first_posted":"April 20, 2011","last_update_posted":"April 11, 2012"},{"nctid":"NCT00171925","version_a":11,"version_b":12,"version_a_date":"2011-03-25","version_b_date":"2011-06-24","pom_a":[{"label":"1.","content":"Days of Progression Free Survival[ Time Frame: 48 months ]Progression- free survival was defined as time from date of randomization to death from any cause or one of the following events:progression in stage II or III (Salmon & Durie)skeletal related eventsunequivocal progression of osteolytic lesions"}],"pom_b":[{"label":"1.","content":"Days of Progression Free Survival[ Time Frame: 48 months ]Progression-free survival was defined as time from date of randomization to death from any cause or one of the following events:progression to stage II or III according to Salmon & Durie classificationskeletal related events (pathologic fracture, initiation of radiotherapy or surgery on bone, spinal cord compression or hypercalcemia)unequivocal progression of osteolytic lesions (at least a 20% increase in the largest diameter of one existing osteolytic lesion which is measured in at least one dimension as 20 mm with conventional techniques), determined radiologically."}],"start_date":"August 2000","primary_completion_date":"November 2008","completion_date":"November 2008","first_posted":"September 15, 2005","results_first_posted":"April 20, 2011","last_update_posted":"April 11, 2012"},{"nctid":"NCT01674634","version_a":8,"version_b":9,"version_a_date":"2014-07-16","version_b_date":"2015-02-04","pom_a":[{"label":"1.","content":"The actual change and the percent change in degree of flexion[ Time Frame: 30 days after injection of AA4500 ]"}],"pom_b":[{"label":"1.","content":"The Percent Change in Degree of Flexion[ Time Frame: 30 days after injection of AA4500 ]"}],"start_date":"September 2012","primary_completion_date":"July 2013","completion_date":"July 2013","first_posted":"August 29, 2012","results_first_posted":"February 20, 2015","last_update_posted":"October 5, 2017"},{"nctid":"NCT01674634","version_a":9,"version_b":10,"version_a_date":"2015-02-04","version_b_date":"2015-04-22","pom_a":[{"label":"1.","content":"The Percent Change in Degree of Flexion[ Time Frame: 30 days after injection of AA4500 ]"}],"pom_b":[{"label":"1.","content":"Percent Change From Baseline in Total Fixed Flexion[ Time Frame: Baseline, Day 31 ]Total fixed flexion is defined as the sum of the fixed flexion contracture (FCC) of the 2 joints receiving treatment. Change in FFC is measured in degrees where a decrease of 100% would correspond to a reduction in contracture to 0 degrees."},{"label":"2.","content":"Change From Baseline in Total Range of Motion[ Time Frame: Baseline, Day 31 ]The total range of motion (ROM) is the sum of the range of motion measurements of the 2 treated joints. ROM is defined as difference between full flexion angle and full extension expressed in degrees. A positive change from baseline indicates increased (improved) ROM."}],"start_date":"September 2012","primary_completion_date":"July 2013","completion_date":"July 2013","first_posted":"August 29, 2012","results_first_posted":"February 20, 2015","last_update_posted":"October 5, 2017"},{"nctid":"NCT01674634","version_a":10,"version_b":11,"version_a_date":"2015-04-22","version_b_date":"2015-05-19","pom_a":[{"label":"1.","content":"Percent Change From Baseline in Total Fixed Flexion[ Time Frame: Baseline, Day 31 ]Total fixed flexion is defined as the sum of the fixed flexion contracture (FCC) of the 2 joints receiving treatment. Change in FFC is measured in degrees where a decrease of 100% would correspond to a reduction in contracture to 0 degrees."},{"label":"2.","content":"Change From Baseline in Total Range of Motion[ Time Frame: Baseline, Day 31 ]The total range of motion (ROM) is the sum of the range of motion measurements of the 2 treated joints. ROM is defined as difference between full flexion angle and full extension expressed in degrees. A positive change from baseline indicates increased (improved) ROM."}],"pom_b":[{"label":"1.","content":"Percent Change From Baseline in Total Fixed Flexion[ Time Frame: Baseline, Day 31 ]Percent change from baseline in total fixed flexion = 100 * (baseline total FFC - day 31 total FFC)/baseline total FFC, where total fixed flexion is defined as the sum of the fixed flexion contracture (FCC) of the 2 joints receiving treatment. Positive percent change from baseline indicates improvement."},{"label":"2.","content":"Change From Baseline in Total Range of Motion[ Time Frame: Baseline, Day 31 ]The total range of motion (ROM) is the sum of the range of motion measurements of the 2 treated joints. ROM is defined as difference between full flexion angle and full extension expressed in degrees. A positive change from baseline indicates increased (improved) ROM."}],"start_date":"September 2012","primary_completion_date":"July 2013","completion_date":"July 2013","first_posted":"August 29, 2012","results_first_posted":"February 20, 2015","last_update_posted":"October 5, 2017"},{"nctid":"NCT00002760","version_a":14,"version_b":15,"version_a_date":"2009-08-27","version_b_date":"2011-04-01","pom_a":[],"pom_b":[{"label":"1.","content":"Response: PSA[ Time Frame: q 8 wks, at cross over (if applic), at progression; q 6 mon in f/u ]"}],"start_date":"August 1996","primary_completion_date":"March 2004","completion_date":"April 2009","first_posted":"July 19, 2004","last_update_posted":"June 28, 2016"},{"nctid":"NCT00002760","version_a":16,"version_b":17,"version_a_date":"2013-09-27","version_b_date":"2016-06-27","pom_a":[{"label":"1.","content":"Response: PSA[ Time Frame: q 8 wks, at cross over (if applic), at progression; q 6 mon in f/u ]"}],"pom_b":[{"label":"1.","content":"Response: PSA[ Time Frame: q 8 wks, at cross over (if applicable), at progression; q 6 mon in f/u ]"}],"start_date":"August 1996","primary_completion_date":"March 2004","completion_date":"April 2009","first_posted":"July 19, 2004","last_update_posted":"June 28, 2016"},{"nctid":"NCT00014534","version_a":2,"version_b":3,"version_a_date":"2005-08-09","version_b_date":"2007-02-20","pom_a":[],"pom_b":[{"label":"1.","content":"Overall survival"}],"start_date":"March 2004","primary_completion_date":"July 2005","completion_date":"April 2009","first_posted":"June 10, 2003","last_update_posted":"July 14, 2016"},{"nctid":"NCT00014534","version_a":13,"version_b":14,"version_a_date":"2011-05-24","version_b_date":"2011-06-21","pom_a":[{"label":"1.","content":"Overall survival"}],"pom_b":[{"label":"1.","content":"Overall survival[ Time Frame: 4 years ]"}],"start_date":"March 2004","primary_completion_date":"July 2005","completion_date":"April 2009","first_posted":"June 10, 2003","last_update_posted":"July 14, 2016"},{"nctid":"NCT02684292","version_a":3,"version_b":4,"version_a_date":"2016-06-02","version_b_date":"2016-06-29","pom_a":[{"label":"1.","content":"Progression Free Survival[ Time Frame: Up to approximately 40 months ]"},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to approximately 40 months ]"}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Up to approximately 40 months ]"},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to approximately 40 months ]"}],"start_date":"May 23, 2016","primary_completion_date":"July 18, 2025","completion_date":"July 18, 2025","first_posted":"February 17, 2016","last_update_posted":"August 19, 2022"},{"nctid":"NCT02684292","version_a":30,"version_b":31,"version_a_date":"2017-11-07","version_b_date":"2017-12-15","pom_a":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Up to approximately 40 months ]"},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to approximately 40 months ]"}],"pom_b":[{"label":"1.","content":"Progression-free Survival (PFS)[ Time Frame: Up to approximately 40 months ]"},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to approximately 40 months ]"}],"start_date":"May 23, 2016","primary_completion_date":"July 18, 2025","completion_date":"July 18, 2025","first_posted":"February 17, 2016","last_update_posted":"August 19, 2022"},{"nctid":"NCT00339625","version_a":31,"version_b":32,"version_a_date":"2014-04-08","version_b_date":"2015-03-28","pom_a":[],"pom_b":[{"label":"1.","content":"Incidence of polyps in the colon[ Time Frame: Yearly for 4 years ]"}],"start_date":"June 19, 1991","primary_completion_date":"May 11, 2020","completion_date":"May 11, 2020","first_posted":"June 21, 2006","last_update_posted":"May 15, 2020"},{"nctid":"NCT00339625","version_a":47,"version_b":48,"version_a_date":"2018-03-23","version_b_date":"2018-03-28","pom_a":[{"label":"1.","content":"Incidence of polyps in the colon[ Time Frame: Yearly for 4 years ]"}],"pom_b":[{"label":"1.","content":"Incidence of polyps in the colon[ Time Frame: Yearly for 4 years ]Adenoma recurrence"}],"start_date":"June 19, 1991","primary_completion_date":"May 11, 2020","completion_date":"May 11, 2020","first_posted":"June 21, 2006","last_update_posted":"May 15, 2020"},{"nctid":"NCT01100502","version_a":41,"version_b":42,"version_a_date":"2015-03-23","version_b_date":"2015-10-07","pom_a":[{"label":"1.","content":"Progression-free survival[ Time Frame: Until disease progression or study closure ]"}],"pom_b":[{"label":"1.","content":"Progression-free Survival by Independent Review[ Time Frame: Up to approximately 4 years ]Time from date of randomization to the first documentation of disease progression by independent review or to death due to any cause, whichever comes first"}],"start_date":"April 30, 2010","primary_completion_date":"August 31, 2014","completion_date":"April 27, 2020","first_posted":"April 9, 2010","results_first_posted":"November 11, 2015","last_update_posted":"May 14, 2021"},{"nctid":"NCT00475085","version_a":28,"version_b":29,"version_a_date":"2010-10-27","version_b_date":"2010-11-08","pom_a":[{"label":"1.","content":"Severity of delayed nausea"},{"label":"2.","content":"Interference with functioning caused by nausea or emesis"}],"pom_b":[{"label":"1.","content":"Severity of delayed nausea[ Time Frame: 4 days ]"},{"label":"2.","content":"Interference with functioning caused by nausea or emesis[ Time Frame: 4 days ]"}],"start_date":"December 2006","primary_completion_date":"December 2012","first_posted":"May 17, 2007","results_first_posted":"November 3, 2013","last_update_posted":"November 10, 2015"},{"nctid":"NCT00475085","version_a":32,"version_b":33,"version_a_date":"2012-03-02","version_b_date":"2013-10-08","pom_a":[{"label":"1.","content":"Severity of delayed nausea[ Time Frame: 4 days ]"},{"label":"2.","content":"Interference with functioning caused by nausea or emesis[ Time Frame: 4 days ]"}],"pom_b":[{"label":"1.","content":"Home Record: Severity of Delayed Nausea[ Time Frame: average of day 1 afternoon, evening and night, and all of days 2 and 3 ]1=not at all nauseated to 7=extremely nauseated, therefore higher values are worse"}],"start_date":"December 2006","primary_completion_date":"December 2012","first_posted":"May 17, 2007","results_first_posted":"November 3, 2013","last_update_posted":"November 10, 2015"},{"nctid":"NCT00332280","version_a":1,"version_b":2,"version_a_date":"2006-05-31","version_b_date":"2006-09-06","pom_a":[{"label":"1.","content":"Improvement in Clinical Benefit Response"}],"pom_b":[{"label":"1.","content":"Improvement in clinical benefit response"}],"start_date":"May 2006","primary_completion_date":"January 2010","completion_date":"March 2010","first_posted":"June 1, 2006","last_update_posted":"March 20, 2013"},{"nctid":"NCT00332280","version_a":5,"version_b":6,"version_a_date":"2006-11-29","version_b_date":"2013-03-19","pom_a":[{"label":"1.","content":"Improvement in clinical benefit response"}],"pom_b":[{"label":"1.","content":"Improvement in clinical benefit response[ Time Frame: Jan 2010 ]"}],"start_date":"May 2006","primary_completion_date":"January 2010","completion_date":"March 2010","first_posted":"June 1, 2006","last_update_posted":"March 20, 2013"}]}'),Y=n(1184);var X=e.createContext(),ee=n(5878);function te(e){return(0,C.Z)("MuiGrid",e)}var ne=["auto",!0,1,2,3,4,5,6,7,8,9,10,11,12],re=(0,ee.Z)("MuiGrid",["root","container","item","zeroMinWidth"].concat((0,j.Z)([0,1,2,3,4,5,6,7,8,9,10].map((function(e){return"spacing-xs-".concat(e)}))),(0,j.Z)(["column-reverse","column","row-reverse","row"].map((function(e){return"direction-xs-".concat(e)}))),(0,j.Z)(["nowrap","wrap-reverse","wrap"].map((function(e){return"wrap-xs-".concat(e)}))),(0,j.Z)(ne.map((function(e){return"grid-xs-".concat(e)}))),(0,j.Z)(ne.map((function(e){return"grid-sm-".concat(e)}))),(0,j.Z)(ne.map((function(e){return"grid-md-".concat(e)}))),(0,j.Z)(ne.map((function(e){return"grid-lg-".concat(e)}))),(0,j.Z)(ne.map((function(e){return"grid-xl-".concat(e)}))))),ae=re,oe=["className","columns","columnSpacing","component","container","direction","item","rowSpacing","spacing","wrap","zeroMinWidth"];function ie(e){var t=parseFloat(e);return"".concat(t).concat(String(e).replace(String(t),"")||"px")}function se(e){var t=e.breakpoints,n=e.values,r="";Object.keys(n).forEach((function(e){""===r&&0!==n[e]&&(r=e)}));var a=Object.keys(t).sort((function(e,n){return t[e]-t[n]}));return a.slice(0,a.indexOf(r))}var le=(0,D.ZP)("div",{name:"MuiGrid",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState,r=n.container,a=n.direction,o=n.item,i=n.spacing,s=n.wrap,l=n.zeroMinWidth,u=n.breakpoints,c=[];r&&(c=function(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:{};if(!e||e<=0)return[];if("string"===typeof e&&!Number.isNaN(Number(e))||"number"===typeof e)return[n["spacing-xs-".concat(String(e))]];var r=[];return t.forEach((function(t){var a=e[t];Number(a)>0&&r.push(n["spacing-".concat(t,"-").concat(String(a))])})),r}(i,u,t));var d=[];return u.forEach((function(e){var r=n[e];r&&d.push(t["grid-".concat(e,"-").concat(String(r))])})),[t.root,r&&t.container,o&&t.item,l&&t.zeroMinWidth].concat((0,j.Z)(c),["row"!==a&&t["direction-xs-".concat(String(a))],"wrap"!==s&&t["wrap-xs-".concat(String(s))]],d)}})((function(e){var t=e.ownerState;return(0,r.Z)({boxSizing:"border-box"},t.container&&{display:"flex",flexWrap:"wrap",width:"100%"},t.item&&{margin:0},t.zeroMinWidth&&{minWidth:0},"wrap"!==t.wrap&&{flexWrap:t.wrap})}),(function(e){var t=e.theme,n=e.ownerState,r=(0,Y.P$)({values:n.direction,breakpoints:t.breakpoints.values});return(0,Y.k9)({theme:t},r,(function(e){var t={flexDirection:e};return 0===e.indexOf("column")&&(t["& > .".concat(ae.item)]={maxWidth:"none"}),t}))}),(function(e){var t=e.theme,n=e.ownerState,r=n.container,a=n.rowSpacing,o={};if(r&&0!==a){var i,s=(0,Y.P$)({values:a,breakpoints:t.breakpoints.values});"object"===typeof s&&(i=se({breakpoints:t.breakpoints.values,values:s})),o=(0,Y.k9)({theme:t},s,(function(e,n){var r,a=t.spacing(e);return"0px"!==a?(0,_.Z)({marginTop:"-".concat(ie(a))},"& > .".concat(ae.item),{paddingTop:ie(a)}):null!=(r=i)&&r.includes(n)?{}:(0,_.Z)({marginTop:0},"& > .".concat(ae.item),{paddingTop:0})}))}return o}),(function(e){var t=e.theme,n=e.ownerState,r=n.container,a=n.columnSpacing,o={};if(r&&0!==a){var i,s=(0,Y.P$)({values:a,breakpoints:t.breakpoints.values});"object"===typeof s&&(i=se({breakpoints:t.breakpoints.values,values:s})),o=(0,Y.k9)({theme:t},s,(function(e,n){var r,a=t.spacing(e);return"0px"!==a?(0,_.Z)({width:"calc(100% + ".concat(ie(a),")"),marginLeft:"-".concat(ie(a))},"& > .".concat(ae.item),{paddingLeft:ie(a)}):null!=(r=i)&&r.includes(n)?{}:(0,_.Z)({width:"100%",marginLeft:0},"& > .".concat(ae.item),{paddingLeft:0})}))}return o}),(function(e){var t,n=e.theme,a=e.ownerState;return n.breakpoints.keys.reduce((function(e,o){var i={};if(a[o]&&(t=a[o]),!t)return e;if(!0===t)i={flexBasis:0,flexGrow:1,maxWidth:"100%"};else if("auto"===t)i={flexBasis:"auto",flexGrow:0,flexShrink:0,maxWidth:"none",width:"auto"};else{var s=(0,Y.P$)({values:a.columns,breakpoints:n.breakpoints.values}),l="object"===typeof s?s[o]:s;if(void 0===l||null===l)return e;var u="".concat(Math.round(t/l*1e8)/1e6,"%"),c={};if(a.container&&a.item&&0!==a.columnSpacing){var d=n.spacing(a.columnSpacing);if("0px"!==d){var f="calc(".concat(u," + ").concat(ie(d),")");c={flexBasis:f,maxWidth:f}}}i=(0,r.Z)({flexBasis:u,flexGrow:0,maxWidth:u},c)}return 0===n.breakpoints.values[o]?Object.assign(e,i):e[n.breakpoints.up(o)]=i,e}),{})}));var ue=function(e){var t=e.classes,n=e.container,r=e.direction,a=e.item,o=e.spacing,i=e.wrap,s=e.zeroMinWidth,l=e.breakpoints,u=[];n&&(u=function(e,t){if(!e||e<=0)return[];if("string"===typeof e&&!Number.isNaN(Number(e))||"number"===typeof e)return["spacing-xs-".concat(String(e))];var n=[];return t.forEach((function(t){var r=e[t];if(Number(r)>0){var a="spacing-".concat(t,"-").concat(String(r));n.push(a)}})),n}(o,l));var c=[];l.forEach((function(t){var n=e[t];n&&c.push("grid-".concat(t,"-").concat(String(n)))}));var d={root:["root",n&&"container",a&&"item",s&&"zeroMinWidth"].concat((0,j.Z)(u),["row"!==r&&"direction-xs-".concat(String(r)),"wrap"!==i&&"wrap-xs-".concat(String(i))],c)};return(0,T.Z)(d,te,t)},ce=e.forwardRef((function(t,n){var o=(0,a.Z)({props:t,name:"MuiGrid"}),i=(0,W.Z)(m.Z).breakpoints,s=J(o),l=s.className,u=s.columns,c=s.columnSpacing,d=s.component,p=void 0===d?"div":d,h=s.container,v=void 0!==h&&h,b=s.direction,y=void 0===b?"row":b,g=s.item,_=void 0!==g&&g,k=s.rowSpacing,C=s.spacing,T=void 0===C?0:C,x=s.wrap,F=void 0===x?"wrap":x,P=s.zeroMinWidth,A=void 0!==P&&P,N=(0,w.Z)(s,oe),E=k||T,M=c||T,R=e.useContext(X),O=v?u||12:R,D={},z=(0,r.Z)({},N);i.keys.forEach((function(e){null!=N[e]&&(D[e]=N[e],delete z[e])}));var I=(0,r.Z)({},s,{columns:O,container:v,direction:y,item:_,rowSpacing:E,columnSpacing:M,wrap:F,zeroMinWidth:A,spacing:T},D,{breakpoints:i.keys}),L=ue(I);return(0,f.jsx)(X.Provider,{value:O,children:(0,f.jsx)(le,(0,r.Z)({ownerState:I,className:(0,S.Z)(L.root,l),as:p,ref:n},z))})})),de=ce,fe=n(2065);function pe(e){return(0,C.Z)("MuiPaper",e)}(0,ee.Z)("MuiPaper",["root","rounded","outlined","elevation","elevation0","elevation1","elevation2","elevation3","elevation4","elevation5","elevation6","elevation7","elevation8","elevation9","elevation10","elevation11","elevation12","elevation13","elevation14","elevation15","elevation16","elevation17","elevation18","elevation19","elevation20","elevation21","elevation22","elevation23","elevation24"]);var me=["className","component","elevation","square","variant"],he=function(e){return((e<1?5.11916*Math.pow(e,2):4.5*Math.log(e+1)+2)/100).toFixed(2)},ve=(0,D.ZP)("div",{name:"MuiPaper",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,t[n.variant],!n.square&&t.rounded,"elevation"===n.variant&&t["elevation".concat(n.elevation)]]}})((function(e){var t,n=e.theme,a=e.ownerState;return(0,r.Z)({backgroundColor:(n.vars||n).palette.background.paper,color:(n.vars||n).palette.text.primary,transition:n.transitions.create("box-shadow")},!a.square&&{borderRadius:n.shape.borderRadius},"outlined"===a.variant&&{border:"1px solid ".concat((n.vars||n).palette.divider)},"elevation"===a.variant&&(0,r.Z)({boxShadow:(n.vars||n).shadows[a.elevation]},!n.vars&&"dark"===n.palette.mode&&{backgroundImage:"linear-gradient(".concat((0,fe.Fq)("#fff",he(a.elevation)),", ").concat((0,fe.Fq)("#fff",he(a.elevation)),")")},n.vars&&{backgroundImage:null==(t=n.vars.overlays)?void 0:t[a.elevation]}))})),be=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiPaper"}),o=n.className,i=n.component,s=void 0===i?"div":i,l=n.elevation,u=void 0===l?1:l,c=n.square,d=void 0!==c&&c,p=n.variant,m=void 0===p?"elevation":p,h=(0,w.Z)(n,me),v=(0,r.Z)({},n,{component:s,elevation:u,square:d,variant:m}),b=function(e){var t=e.square,n=e.elevation,r=e.variant,a=e.classes,o={root:["root",r,!t&&"rounded","elevation"===r&&"elevation".concat(n)]};return(0,T.Z)(o,pe,a)}(v);return(0,f.jsx)(ve,(0,r.Z)({as:s,ownerState:v,className:(0,S.Z)(b.root,o),ref:t},h))}));function ye(e){return(0,C.Z)("MuiCard",e)}(0,ee.Z)("MuiCard",["root"]);var ge=["className","raised"],_e=(0,D.ZP)(be,{name:"MuiCard",slot:"Root",overridesResolver:function(e,t){return t.root}})((function(){return{overflow:"hidden"}})),we=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiCard"}),o=n.className,i=n.raised,s=void 0!==i&&i,l=(0,w.Z)(n,ge),u=(0,r.Z)({},n,{raised:s}),c=function(e){var t=e.classes;return(0,T.Z)({root:["root"]},ye,t)}(u);return(0,f.jsx)(_e,(0,r.Z)({className:(0,S.Z)(c.root,o),elevation:s?8:void 0,ref:t,ownerState:u},l))}));function Se(e){return(0,C.Z)("MuiCardContent",e)}(0,ee.Z)("MuiCardContent",["root"]);var ke=["className","component"],Ce=(0,D.ZP)("div",{name:"MuiCardContent",slot:"Root",overridesResolver:function(e,t){return t.root}})((function(){return{padding:16,"&:last-child":{paddingBottom:24}}})),Te=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiCardContent"}),o=n.className,i=n.component,s=void 0===i?"div":i,l=(0,w.Z)(n,ke),u=(0,r.Z)({},n,{component:s}),c=function(e){var t=e.classes;return(0,T.Z)({root:["root"]},Se,t)}(u);return(0,f.jsx)(Ce,(0,r.Z)({as:s,className:(0,S.Z)(c.root,o),ownerState:u,ref:t},l))}));function xe(e){return(0,C.Z)("MuiTypography",e)}(0,ee.Z)("MuiTypography",["root","h1","h2","h3","h4","h5","h6","subtitle1","subtitle2","body1","body2","inherit","button","caption","overline","alignLeft","alignRight","alignCenter","alignJustify","noWrap","gutterBottom","paragraph"]);var Fe=["align","className","component","gutterBottom","noWrap","paragraph","variant","variantMapping"],Pe=(0,D.ZP)("span",{name:"MuiTypography",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,n.variant&&t[n.variant],"inherit"!==n.align&&t["align".concat((0,O.Z)(n.align))],n.noWrap&&t.noWrap,n.gutterBottom&&t.gutterBottom,n.paragraph&&t.paragraph]}})((function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({margin:0},n.variant&&t.typography[n.variant],"inherit"!==n.align&&{textAlign:n.align},n.noWrap&&{overflow:"hidden",textOverflow:"ellipsis",whiteSpace:"nowrap"},n.gutterBottom&&{marginBottom:"0.35em"},n.paragraph&&{marginBottom:16})})),Ae={h1:"h1",h2:"h2",h3:"h3",h4:"h4",h5:"h5",h6:"h6",subtitle1:"h6",subtitle2:"h6",body1:"p",body2:"p",inherit:"p"},Ne={primary:"primary.main",textPrimary:"text.primary",secondary:"secondary.main",textSecondary:"text.secondary",error:"error.main"},Ee=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiTypography"}),o=function(e){return Ne[e]||e}(n.color),i=J((0,r.Z)({},n,{color:o})),s=i.align,l=void 0===s?"inherit":s,u=i.className,c=i.component,d=i.gutterBottom,p=void 0!==d&&d,m=i.noWrap,h=void 0!==m&&m,v=i.paragraph,b=void 0!==v&&v,y=i.variant,g=void 0===y?"body1":y,_=i.variantMapping,k=void 0===_?Ae:_,C=(0,w.Z)(i,Fe),x=(0,r.Z)({},i,{align:l,color:o,className:u,component:c,gutterBottom:p,noWrap:h,paragraph:b,variant:g,variantMapping:k}),F=c||(b?"p":k[g]||Ae[g])||"span",P=function(e){var t=e.align,n=e.gutterBottom,r=e.noWrap,a=e.paragraph,o=e.variant,i=e.classes,s={root:["root",o,"inherit"!==e.align&&"align".concat((0,O.Z)(t)),n&&"gutterBottom",r&&"noWrap",a&&"paragraph"]};return(0,T.Z)(s,xe,i)}(x);return(0,f.jsx)(Pe,(0,r.Z)({as:F,ref:t,ownerState:x,className:(0,S.Z)(P.root,u)},C))})),Me=n(5682),Re=["component","direction","spacing","divider","children"];function Oe(t,n){var r=e.Children.toArray(t).filter(Boolean);return r.reduce((function(t,a,o){return t.push(a),o<r.length-1&&t.push(e.cloneElement(n,{key:"separator-".concat(o)})),t}),[])}var De=(0,D.ZP)("div",{name:"MuiStack",slot:"Root",overridesResolver:function(e,t){return[t.root]}})((function(e){var t=e.ownerState,n=e.theme,a=(0,r.Z)({display:"flex",flexDirection:"column"},(0,Y.k9)({theme:n},(0,Y.P$)({values:t.direction,breakpoints:n.breakpoints.values}),(function(e){return{flexDirection:e}})));if(t.spacing){var o=(0,Me.hB)(n),i=Object.keys(n.breakpoints.values).reduce((function(e,n){return("object"===typeof t.spacing&&null!=t.spacing[n]||"object"===typeof t.direction&&null!=t.direction[n])&&(e[n]=!0),e}),{}),s=(0,Y.P$)({values:t.direction,base:i}),l=(0,Y.P$)({values:t.spacing,base:i});"object"===typeof s&&Object.keys(s).forEach((function(e,t,n){if(!s[e]){var r=t>0?s[n[t-1]]:"column";s[e]=r}}));a=(0,B.Z)(a,(0,Y.k9)({theme:n},l,(function(e,n){return{"& > :not(style) + :not(style)":(0,_.Z)({margin:0},"margin".concat((r=n?s[n]:t.direction,{row:"Left","row-reverse":"Right",column:"Top","column-reverse":"Bottom"}[r])),(0,Me.NA)(o,e))};var r})))}return a=(0,Y.dt)(n.breakpoints,a)})),ze=e.forwardRef((function(e,t){var n=J((0,a.Z)({props:e,name:"MuiStack"})),o=n.component,i=void 0===o?"div":o,s=n.direction,l=void 0===s?"column":s,u=n.spacing,c=void 0===u?0:u,d=n.divider,p=n.children,m=(0,w.Z)(n,Re),h={direction:l,spacing:c};return(0,f.jsx)(De,(0,r.Z)({as:i,ownerState:h,ref:t},m,{children:d?Oe(p,d):p}))})),Ie=ze,Le=n(1774),Ze=n.n(Le);var je=function(e){var t=e.datum,n=e.datumNumber,r=e.results,a=(e.setResults,t.pom_a),o=t.pom_b,i=t.version_a_date,s=t.version_b_date;console.log({datum:t});var l=function(e,t){return e.map((function(e){return(0,f.jsx)(we,{children:(0,f.jsx)(Te,{children:(0,f.jsxs)(Ee,{children:[(0,f.jsx)("b",{children:e.label})," ",e.content]})})},e.content)}))};return(0,f.jsxs)(de,{container:!0,spacing:2,children:[(0,f.jsx)(de,{item:!0,xs:12,children:(0,f.jsx)(we,{children:(0,f.jsx)(Te,{children:(0,f.jsxs)(de,{container:!0,children:[(0,f.jsxs)(de,{item:!0,xs:4,children:[(0,f.jsxs)(Ee,{variant:"h6",children:["Comparison Number ",n+1," of ",r.length]}),(0,f.jsxs)(Ee,{variant:"h4",children:["Trial ",t.nctid]})]}),(0,f.jsxs)(de,{item:!0,xs:4,children:[t.first_posted?(0,f.jsxs)(Ee,{children:["First Posted: ",t.first_posted]}):null,t.start_date?(0,f.jsxs)(Ee,{children:["Start Date: ",t.start_date]}):null]}),(0,f.jsxs)(de,{item:!0,xs:4,children:[t.primary_completion_date?(0,f.jsxs)(Ee,{children:["Primary Completion Date: ",t.primary_completion_date]}):null,t.last_update_posted?(0,f.jsxs)(Ee,{children:["Last Update Posted : ",t.last_update_posted]}):null]})]})})})}),(0,f.jsx)(de,{item:!0,xs:6,children:(0,f.jsx)(we,{children:(0,f.jsxs)(Te,{children:[(0,f.jsxs)(Ee,{variant:"h6",children:["Primary Outcomes for Version ",t.version_a,": ",i]}),(0,f.jsx)(Ee,{variant:"caption"}),(0,f.jsx)(Ie,{spacing:1,children:l(t.pom_a)})]})})}),(0,f.jsx)(de,{item:!0,xs:6,children:(0,f.jsx)(we,{children:(0,f.jsxs)(Te,{children:[(0,f.jsxs)(Ee,{variant:"h6",children:["Primary Outcomes for Version ",t.version_b,": ",s]}),(0,f.jsx)(Ie,{spacing:1,children:l(t.pom_b)})]})})}),(0,f.jsx)(de,{item:!0,xs:12,children:(0,f.jsx)(we,{children:(0,f.jsxs)(Te,{children:[(0,f.jsx)(Ee,{variant:"h6",children:"Compare the Raw Text"}),(0,f.jsx)(Ze(),{oldValue:JSON.stringify(a,void 0,4),newValue:JSON.stringify(o,void 0,4),splitView:!0,compareMethod:Le.DiffMethod.WORDS,styles:{variables:{light:{codeFoldGutterBackground:"#6F767E",codeFoldBackground:"#E2E4E5"}}},leftTitle:"Version ".concat(t.version_a),rightTitle:"Version ".concat(t.version_b)})]})})})]})};function Be(e){return(0,C.Z)("MuiAppBar",e)}(0,ee.Z)("MuiAppBar",["root","positionFixed","positionAbsolute","positionSticky","positionStatic","positionRelative","colorDefault","colorPrimary","colorSecondary","colorInherit","colorTransparent"]);var Ve=["className","color","enableColorOnDark","position"],Ue=function(e,t){return"".concat(null==e?void 0:e.replace(")",""),", ").concat(t,")")},Je=(0,D.ZP)(be,{name:"MuiAppBar",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,t["position".concat((0,O.Z)(n.position))],t["color".concat((0,O.Z)(n.color))]]}})((function(e){var t=e.theme,n=e.ownerState,a="light"===t.palette.mode?t.palette.grey[100]:t.palette.grey[900];return(0,r.Z)({display:"flex",flexDirection:"column",width:"100%",boxSizing:"border-box",flexShrink:0},"fixed"===n.position&&{position:"fixed",zIndex:(t.vars||t).zIndex.appBar,top:0,left:"auto",right:0,"@media print":{position:"absolute"}},"absolute"===n.position&&{position:"absolute",zIndex:(t.vars||t).zIndex.appBar,top:0,left:"auto",right:0},"sticky"===n.position&&{position:"sticky",zIndex:(t.vars||t).zIndex.appBar,top:0,left:"auto",right:0},"static"===n.position&&{position:"static"},"relative"===n.position&&{position:"relative"},!t.vars&&(0,r.Z)({},"default"===n.color&&{backgroundColor:a,color:t.palette.getContrastText(a)},n.color&&"default"!==n.color&&"inherit"!==n.color&&"transparent"!==n.color&&{backgroundColor:t.palette[n.color].main,color:t.palette[n.color].contrastText},"inherit"===n.color&&{color:"inherit"},"dark"===t.palette.mode&&!n.enableColorOnDark&&{backgroundColor:null,color:null},"transparent"===n.color&&(0,r.Z)({backgroundColor:"transparent",color:"inherit"},"dark"===t.palette.mode&&{backgroundImage:"none"})),t.vars&&(0,r.Z)({},"default"===n.color&&{"--AppBar-background":n.enableColorOnDark?t.vars.palette.AppBar.defaultBg:Ue(t.vars.palette.AppBar.darkBg,t.vars.palette.AppBar.defaultBg),"--AppBar-color":n.enableColorOnDark?t.vars.palette.text.primary:Ue(t.vars.palette.AppBar.darkColor,t.vars.palette.text.primary)},n.color&&!n.color.match(/^(default|inherit|transparent)$/)&&{"--AppBar-background":n.enableColorOnDark?t.vars.palette[n.color].main:Ue(t.vars.palette.AppBar.darkBg,t.vars.palette[n.color].main),"--AppBar-color":n.enableColorOnDark?t.vars.palette[n.color].contrastText:Ue(t.vars.palette.AppBar.darkColor,t.vars.palette[n.color].contrastText)},{backgroundColor:"var(--AppBar-background)",color:"inherit"===n.color?"inherit":"var(--AppBar-color)"},"transparent"===n.color&&{backgroundImage:"none",backgroundColor:"transparent",color:"inherit"}))})),We=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiAppBar"}),o=n.className,i=n.color,s=void 0===i?"primary":i,l=n.enableColorOnDark,u=void 0!==l&&l,c=n.position,d=void 0===c?"fixed":c,p=(0,w.Z)(n,Ve),m=(0,r.Z)({},n,{color:s,position:d,enableColorOnDark:u}),h=function(e){var t=e.color,n=e.position,r=e.classes,a={root:["root","color".concat((0,O.Z)(t)),"position".concat((0,O.Z)(n))]};return(0,T.Z)(a,Be,r)}(m);return(0,f.jsx)(Je,(0,r.Z)({square:!0,component:"header",ownerState:m,elevation:4,className:(0,S.Z)(h.root,o,"fixed"===d&&"mui-fixed"),ref:t},p))}));function He(e){return(0,C.Z)("MuiToolbar",e)}(0,ee.Z)("MuiToolbar",["root","gutters","regular","dense"]);var $e=["className","component","disableGutters","variant"],qe=(0,D.ZP)("div",{name:"MuiToolbar",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,!n.disableGutters&&t.gutters,t[n.variant]]}})((function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({position:"relative",display:"flex",alignItems:"center"},!n.disableGutters&&(0,_.Z)({paddingLeft:t.spacing(2),paddingRight:t.spacing(2)},t.breakpoints.up("sm"),{paddingLeft:t.spacing(3),paddingRight:t.spacing(3)}),"dense"===n.variant&&{minHeight:48})}),(function(e){var t=e.theme;return"regular"===e.ownerState.variant&&t.mixins.toolbar})),Ge=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiToolbar"}),o=n.className,i=n.component,s=void 0===i?"div":i,l=n.disableGutters,u=void 0!==l&&l,c=n.variant,d=void 0===c?"regular":c,p=(0,w.Z)(n,$e),m=(0,r.Z)({},n,{component:s,disableGutters:u,variant:d}),h=function(e){var t=e.classes,n={root:["root",!e.disableGutters&&"gutters",e.variant]};return(0,T.Z)(n,He,t)}(m);return(0,f.jsx)(qe,(0,r.Z)({as:s,className:(0,S.Z)(h.root,o),ref:t,ownerState:m},p))})),Ke=n(792),Qe=n(6702),Ye=n(2763);function Xe(e,t){return t||(t=e.slice(0)),Object.freeze(Object.defineProperties(e,{raw:{value:Object.freeze(t)}}))}function et(e,t){return et=Object.setPrototypeOf?Object.setPrototypeOf.bind():function(e,t){return e.__proto__=t,e},et(e,t)}var tt=e.createContext(null);function nt(t,n){var r=Object.create(null);return t&&e.Children.map(t,(function(e){return e})).forEach((function(t){r[t.key]=function(t){return n&&(0,e.isValidElement)(t)?n(t):t}(t)})),r}function rt(e,t,n){return null!=n[t]?n[t]:e.props[t]}function at(t,n,r){var a=nt(t.children),o=function(e,t){function n(n){return n in t?t[n]:e[n]}e=e||{},t=t||{};var r,a=Object.create(null),o=[];for(var i in e)i in t?o.length&&(a[i]=o,o=[]):o.push(i);var s={};for(var l in t){if(a[l])for(r=0;r<a[l].length;r++){var u=a[l][r];s[a[l][r]]=n(u)}s[l]=n(l)}for(r=0;r<o.length;r++)s[o[r]]=n(o[r]);return s}(n,a);return Object.keys(o).forEach((function(i){var s=o[i];if((0,e.isValidElement)(s)){var l=i in n,u=i in a,c=n[i],d=(0,e.isValidElement)(c)&&!c.props.in;!u||l&&!d?u||!l||d?u&&l&&(0,e.isValidElement)(c)&&(o[i]=(0,e.cloneElement)(s,{onExited:r.bind(null,s),in:c.props.in,exit:rt(s,"exit",t),enter:rt(s,"enter",t)})):o[i]=(0,e.cloneElement)(s,{in:!1}):o[i]=(0,e.cloneElement)(s,{onExited:r.bind(null,s),in:!0,exit:rt(s,"exit",t),enter:rt(s,"enter",t)})}})),o}var ot=Object.values||function(e){return Object.keys(e).map((function(t){return e[t]}))},it=function(t){var n,a;function o(e,n){var r,a=(r=t.call(this,e,n)||this).handleExited.bind(function(e){if(void 0===e)throw new ReferenceError("this hasn't been initialised - super() hasn't been called");return e}(r));return r.state={contextValue:{isMounting:!0},handleExited:a,firstRender:!0},r}a=t,(n=o).prototype=Object.create(a.prototype),n.prototype.constructor=n,et(n,a);var i=o.prototype;return i.componentDidMount=function(){this.mounted=!0,this.setState({contextValue:{isMounting:!1}})},i.componentWillUnmount=function(){this.mounted=!1},o.getDerivedStateFromProps=function(t,n){var r,a,o=n.children,i=n.handleExited;return{children:n.firstRender?(r=t,a=i,nt(r.children,(function(t){return(0,e.cloneElement)(t,{onExited:a.bind(null,t),in:!0,appear:rt(t,"appear",r),enter:rt(t,"enter",r),exit:rt(t,"exit",r)})}))):at(t,o,i),firstRender:!1}},i.handleExited=function(e,t){var n=nt(this.props.children);e.key in n||(e.props.onExited&&e.props.onExited(t),this.mounted&&this.setState((function(t){var n=(0,r.Z)({},t.children);return delete n[e.key],{children:n}})))},i.render=function(){var t=this.props,n=t.component,r=t.childFactory,a=(0,w.Z)(t,["component","childFactory"]),o=this.state.contextValue,i=ot(this.state.children).map(r);return delete a.appear,delete a.enter,delete a.exit,null===n?e.createElement(tt.Provider,{value:o},i):e.createElement(tt.Provider,{value:o},e.createElement(n,a,i))},o}(e.Component);it.propTypes={},it.defaultProps={component:"div",childFactory:function(e){return e}};var st=it;var lt=function(t){var n=t.className,r=t.classes,a=t.pulsate,o=void 0!==a&&a,i=t.rippleX,s=t.rippleY,l=t.rippleSize,u=t.in,c=t.onExited,d=t.timeout,p=e.useState(!1),m=(0,g.Z)(p,2),h=m[0],v=m[1],b=(0,S.Z)(n,r.ripple,r.rippleVisible,o&&r.ripplePulsate),y={width:l,height:l,top:-l/2+s,left:-l/2+i},_=(0,S.Z)(r.child,h&&r.childLeaving,o&&r.childPulsate);return u||h||v(!0),e.useEffect((function(){if(!u&&null!=c){var e=setTimeout(c,d);return function(){clearTimeout(e)}}}),[c,u,d]),(0,f.jsx)("span",{className:b,style:y,children:(0,f.jsx)("span",{className:_})})};var ut,ct,dt,ft,pt,mt,ht,vt,bt=(0,ee.Z)("MuiTouchRipple",["root","ripple","rippleVisible","ripplePulsate","child","childLeaving","childPulsate"]),yt=["center","classes","className"],gt=d(pt||(pt=ut||(ut=Xe(["\n  0% {\n    transform: scale(0);\n    opacity: 0.1;\n  }\n\n  100% {\n    transform: scale(1);\n    opacity: 0.3;\n  }\n"])))),_t=d(mt||(mt=ct||(ct=Xe(["\n  0% {\n    opacity: 1;\n  }\n\n  100% {\n    opacity: 0;\n  }\n"])))),wt=d(ht||(ht=dt||(dt=Xe(["\n  0% {\n    transform: scale(1);\n  }\n\n  50% {\n    transform: scale(0.92);\n  }\n\n  100% {\n    transform: scale(1);\n  }\n"])))),St=(0,D.ZP)("span",{name:"MuiTouchRipple",slot:"Root"})({overflow:"hidden",pointerEvents:"none",position:"absolute",zIndex:0,top:0,right:0,bottom:0,left:0,borderRadius:"inherit"}),kt=(0,D.ZP)(lt,{name:"MuiTouchRipple",slot:"Ripple"})(vt||(vt=ft||(ft=Xe(["\n  opacity: 0;\n  position: absolute;\n\n  &."," {\n    opacity: 0.3;\n    transform: scale(1);\n    animation-name: ",";\n    animation-duration: ","ms;\n    animation-timing-function: ",";\n  }\n\n  &."," {\n    animation-duration: ","ms;\n  }\n\n  & ."," {\n    opacity: 1;\n    display: block;\n    width: 100%;\n    height: 100%;\n    border-radius: 50%;\n    background-color: currentColor;\n  }\n\n  & ."," {\n    opacity: 0;\n    animation-name: ",";\n    animation-duration: ","ms;\n    animation-timing-function: ",";\n  }\n\n  & ."," {\n    position: absolute;\n    /* @noflip */\n    left: 0px;\n    top: 0;\n    animation-name: ",";\n    animation-duration: 2500ms;\n    animation-timing-function: ",";\n    animation-iteration-count: infinite;\n    animation-delay: 200ms;\n  }\n"]))),bt.rippleVisible,gt,550,(function(e){return e.theme.transitions.easing.easeInOut}),bt.ripplePulsate,(function(e){return e.theme.transitions.duration.shorter}),bt.child,bt.childLeaving,_t,550,(function(e){return e.theme.transitions.easing.easeInOut}),bt.childPulsate,wt,(function(e){return e.theme.transitions.easing.easeInOut})),Ct=e.forwardRef((function(t,n){var o=(0,a.Z)({props:t,name:"MuiTouchRipple"}),i=o.center,s=void 0!==i&&i,l=o.classes,u=void 0===l?{}:l,c=o.className,d=(0,w.Z)(o,yt),p=e.useState([]),m=(0,g.Z)(p,2),h=m[0],v=m[1],b=e.useRef(0),y=e.useRef(null);e.useEffect((function(){y.current&&(y.current(),y.current=null)}),[h]);var _=e.useRef(!1),k=e.useRef(null),C=e.useRef(null),T=e.useRef(null);e.useEffect((function(){return function(){clearTimeout(k.current)}}),[]);var x=e.useCallback((function(e){var t=e.pulsate,n=e.rippleX,r=e.rippleY,a=e.rippleSize,o=e.cb;v((function(e){return[].concat((0,j.Z)(e),[(0,f.jsx)(kt,{classes:{ripple:(0,S.Z)(u.ripple,bt.ripple),rippleVisible:(0,S.Z)(u.rippleVisible,bt.rippleVisible),ripplePulsate:(0,S.Z)(u.ripplePulsate,bt.ripplePulsate),child:(0,S.Z)(u.child,bt.child),childLeaving:(0,S.Z)(u.childLeaving,bt.childLeaving),childPulsate:(0,S.Z)(u.childPulsate,bt.childPulsate)},timeout:550,pulsate:t,rippleX:n,rippleY:r,rippleSize:a},b.current)])})),b.current+=1,y.current=o}),[u]),F=e.useCallback((function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},n=arguments.length>2?arguments[2]:void 0,r=t.pulsate,a=void 0!==r&&r,o=t.center,i=void 0===o?s||t.pulsate:o,l=t.fakeElement,u=void 0!==l&&l;if("mousedown"===(null==e?void 0:e.type)&&_.current)_.current=!1;else{"touchstart"===(null==e?void 0:e.type)&&(_.current=!0);var c,d,f,p=u?null:T.current,m=p?p.getBoundingClientRect():{width:0,height:0,left:0,top:0};if(i||void 0===e||0===e.clientX&&0===e.clientY||!e.clientX&&!e.touches)c=Math.round(m.width/2),d=Math.round(m.height/2);else{var h=e.touches&&e.touches.length>0?e.touches[0]:e,v=h.clientX,b=h.clientY;c=Math.round(v-m.left),d=Math.round(b-m.top)}if(i)(f=Math.sqrt((2*Math.pow(m.width,2)+Math.pow(m.height,2))/3))%2===0&&(f+=1);else{var y=2*Math.max(Math.abs((p?p.clientWidth:0)-c),c)+2,g=2*Math.max(Math.abs((p?p.clientHeight:0)-d),d)+2;f=Math.sqrt(Math.pow(y,2)+Math.pow(g,2))}null!=e&&e.touches?null===C.current&&(C.current=function(){x({pulsate:a,rippleX:c,rippleY:d,rippleSize:f,cb:n})},k.current=setTimeout((function(){C.current&&(C.current(),C.current=null)}),80)):x({pulsate:a,rippleX:c,rippleY:d,rippleSize:f,cb:n})}}),[s,x]),P=e.useCallback((function(){F({},{pulsate:!0})}),[F]),A=e.useCallback((function(e,t){if(clearTimeout(k.current),"touchend"===(null==e?void 0:e.type)&&C.current)return C.current(),C.current=null,void(k.current=setTimeout((function(){A(e,t)})));C.current=null,v((function(e){return e.length>0?e.slice(1):e})),y.current=t}),[]);return e.useImperativeHandle(n,(function(){return{pulsate:P,start:F,stop:A}}),[P,F,A]),(0,f.jsx)(St,(0,r.Z)({className:(0,S.Z)(bt.root,u.root,c),ref:T},d,{children:(0,f.jsx)(st,{component:null,exit:!0,children:h})}))})),Tt=Ct;function xt(e){return(0,C.Z)("MuiButtonBase",e)}var Ft,Pt=(0,ee.Z)("MuiButtonBase",["root","disabled","focusVisible"]),At=["action","centerRipple","children","className","component","disabled","disableRipple","disableTouchRipple","focusRipple","focusVisibleClassName","LinkComponent","onBlur","onClick","onContextMenu","onDragLeave","onFocus","onFocusVisible","onKeyDown","onKeyUp","onMouseDown","onMouseLeave","onMouseUp","onTouchEnd","onTouchMove","onTouchStart","tabIndex","TouchRippleProps","touchRippleRef","type"],Nt=(0,D.ZP)("button",{name:"MuiButtonBase",slot:"Root",overridesResolver:function(e,t){return t.root}})((Ft={display:"inline-flex",alignItems:"center",justifyContent:"center",position:"relative",boxSizing:"border-box",WebkitTapHighlightColor:"transparent",backgroundColor:"transparent",outline:0,border:0,margin:0,borderRadius:0,padding:0,cursor:"pointer",userSelect:"none",verticalAlign:"middle",MozAppearance:"none",WebkitAppearance:"none",textDecoration:"none",color:"inherit","&::-moz-focus-inner":{borderStyle:"none"}},(0,_.Z)(Ft,"&.".concat(Pt.disabled),{pointerEvents:"none",cursor:"default"}),(0,_.Z)(Ft,"@media print",{colorAdjust:"exact"}),Ft)),Et=e.forwardRef((function(t,n){var o=(0,a.Z)({props:t,name:"MuiButtonBase"}),i=o.action,s=o.centerRipple,l=void 0!==s&&s,u=o.children,c=o.className,d=o.component,p=void 0===d?"button":d,m=o.disabled,h=void 0!==m&&m,v=o.disableRipple,b=void 0!==v&&v,y=o.disableTouchRipple,_=void 0!==y&&y,k=o.focusRipple,C=void 0!==k&&k,x=o.LinkComponent,F=void 0===x?"a":x,P=o.onBlur,A=o.onClick,N=o.onContextMenu,E=o.onDragLeave,M=o.onFocus,R=o.onFocusVisible,O=o.onKeyDown,D=o.onKeyUp,z=o.onMouseDown,I=o.onMouseLeave,L=o.onMouseUp,Z=o.onTouchEnd,j=o.onTouchMove,B=o.onTouchStart,V=o.tabIndex,U=void 0===V?0:V,J=o.TouchRippleProps,W=o.touchRippleRef,H=o.type,$=(0,w.Z)(o,At),q=e.useRef(null),G=e.useRef(null),K=(0,Ke.Z)(G,W),Q=(0,Ye.Z)(),Y=Q.isFocusVisibleRef,X=Q.onFocus,ee=Q.onBlur,te=Q.ref,ne=e.useState(!1),re=(0,g.Z)(ne,2),ae=re[0],oe=re[1];h&&ae&&oe(!1),e.useImperativeHandle(i,(function(){return{focusVisible:function(){oe(!0),q.current.focus()}}}),[]);var ie=e.useState(!1),se=(0,g.Z)(ie,2),le=se[0],ue=se[1];e.useEffect((function(){ue(!0)}),[]);var ce=le&&!b&&!h;function de(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:_;return(0,Qe.Z)((function(r){return t&&t(r),!n&&G.current&&G.current[e](r),!0}))}e.useEffect((function(){ae&&C&&!b&&le&&G.current.pulsate()}),[b,C,ae,le]);var fe=de("start",z),pe=de("stop",N),me=de("stop",E),he=de("stop",L),ve=de("stop",(function(e){ae&&e.preventDefault(),I&&I(e)})),be=de("start",B),ye=de("stop",Z),ge=de("stop",j),_e=de("stop",(function(e){ee(e),!1===Y.current&&oe(!1),P&&P(e)}),!1),we=(0,Qe.Z)((function(e){q.current||(q.current=e.currentTarget),X(e),!0===Y.current&&(oe(!0),R&&R(e)),M&&M(e)})),Se=function(){var e=q.current;return p&&"button"!==p&&!("A"===e.tagName&&e.href)},ke=e.useRef(!1),Ce=(0,Qe.Z)((function(e){C&&!ke.current&&ae&&G.current&&" "===e.key&&(ke.current=!0,G.current.stop(e,(function(){G.current.start(e)}))),e.target===e.currentTarget&&Se()&&" "===e.key&&e.preventDefault(),O&&O(e),e.target===e.currentTarget&&Se()&&"Enter"===e.key&&!h&&(e.preventDefault(),A&&A(e))})),Te=(0,Qe.Z)((function(e){C&&" "===e.key&&G.current&&ae&&!e.defaultPrevented&&(ke.current=!1,G.current.stop(e,(function(){G.current.pulsate(e)}))),D&&D(e),A&&e.target===e.currentTarget&&Se()&&" "===e.key&&!e.defaultPrevented&&A(e)})),xe=p;"button"===xe&&($.href||$.to)&&(xe=F);var Fe={};"button"===xe?(Fe.type=void 0===H?"button":H,Fe.disabled=h):($.href||$.to||(Fe.role="button"),h&&(Fe["aria-disabled"]=h));var Pe=(0,Ke.Z)(te,q),Ae=(0,Ke.Z)(n,Pe);var Ne=(0,r.Z)({},o,{centerRipple:l,component:p,disabled:h,disableRipple:b,disableTouchRipple:_,focusRipple:C,tabIndex:U,focusVisible:ae}),Ee=function(e){var t=e.disabled,n=e.focusVisible,r=e.focusVisibleClassName,a=e.classes,o={root:["root",t&&"disabled",n&&"focusVisible"]},i=(0,T.Z)(o,xt,a);return n&&r&&(i.root+=" ".concat(r)),i}(Ne);return(0,f.jsxs)(Nt,(0,r.Z)({as:xe,className:(0,S.Z)(Ee.root,c),ownerState:Ne,onBlur:_e,onClick:A,onContextMenu:pe,onFocus:we,onKeyDown:Ce,onKeyUp:Te,onMouseDown:fe,onMouseLeave:ve,onMouseUp:he,onDragLeave:me,onTouchEnd:ye,onTouchMove:ge,onTouchStart:be,ref:Ae,tabIndex:h?-1:U,type:H},Fe,$,{children:[u,ce?(0,f.jsx)(Tt,(0,r.Z)({ref:K,center:l},J)):null]}))})),Mt=Et;function Rt(e){return(0,C.Z)("MuiIconButton",e)}var Ot=(0,ee.Z)("MuiIconButton",["root","disabled","colorInherit","colorPrimary","colorSecondary","edgeStart","edgeEnd","sizeSmall","sizeMedium","sizeLarge"]),Dt=["edge","children","className","color","disabled","disableFocusRipple","size"],zt=(0,D.ZP)(Mt,{name:"MuiIconButton",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,"default"!==n.color&&t["color".concat((0,O.Z)(n.color))],n.edge&&t["edge".concat((0,O.Z)(n.edge))],t["size".concat((0,O.Z)(n.size))]]}})((function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({textAlign:"center",flex:"0 0 auto",fontSize:t.typography.pxToRem(24),padding:8,borderRadius:"50%",overflow:"visible",color:(t.vars||t).palette.action.active,transition:t.transitions.create("background-color",{duration:t.transitions.duration.shortest})},!n.disableRipple&&{"&:hover":{backgroundColor:t.vars?"rgba(".concat(t.vars.palette.action.activeChannel," / ").concat(t.vars.palette.action.hoverOpacity,")"):(0,fe.Fq)(t.palette.action.active,t.palette.action.hoverOpacity),"@media (hover: none)":{backgroundColor:"transparent"}}},"start"===n.edge&&{marginLeft:"small"===n.size?-3:-12},"end"===n.edge&&{marginRight:"small"===n.size?-3:-12})}),(function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({},"inherit"===n.color&&{color:"inherit"},"inherit"!==n.color&&"default"!==n.color&&(0,r.Z)({color:(t.vars||t).palette[n.color].main},!n.disableRipple&&{"&:hover":{backgroundColor:t.vars?"rgba(".concat(t.vars.palette[n.color].mainChannel," / ").concat(t.vars.palette.action.hoverOpacity,")"):(0,fe.Fq)(t.palette[n.color].main,t.palette.action.hoverOpacity),"@media (hover: none)":{backgroundColor:"transparent"}}}),"small"===n.size&&{padding:5,fontSize:t.typography.pxToRem(18)},"large"===n.size&&{padding:12,fontSize:t.typography.pxToRem(28)},(0,_.Z)({},"&.".concat(Ot.disabled),{backgroundColor:"transparent",color:(t.vars||t).palette.action.disabled}))})),It=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiIconButton"}),o=n.edge,i=void 0!==o&&o,s=n.children,l=n.className,u=n.color,c=void 0===u?"default":u,d=n.disabled,p=void 0!==d&&d,m=n.disableFocusRipple,h=void 0!==m&&m,v=n.size,b=void 0===v?"medium":v,y=(0,w.Z)(n,Dt),g=(0,r.Z)({},n,{edge:i,color:c,disabled:p,disableFocusRipple:h,size:b}),_=function(e){var t=e.classes,n=e.disabled,r=e.color,a=e.edge,o=e.size,i={root:["root",n&&"disabled","default"!==r&&"color".concat((0,O.Z)(r)),a&&"edge".concat((0,O.Z)(a)),"size".concat((0,O.Z)(o))]};return(0,T.Z)(i,Rt,t)}(g);return(0,f.jsx)(zt,(0,r.Z)({className:(0,S.Z)(_.root,l),centerRipple:!0,focusRipple:!h,disabled:p,ref:t,ownerState:g},y,{children:s}))})),Lt=n(2156),Zt=n(5129);n(8472),(0,q.Z)({palette:{neutral:{main:"#fff",contrastText:"#000"}}});function jt(e){var t=e.datumNumber,n=e.setDatumNumber,r=e.numComparisons,a=(e.outputData,e.batchNum),o=function(){n(t-1)},i=function(){n(t+1)};return(0,f.jsx)(K,{sx:{flexGrow:1},children:(0,f.jsx)(We,{position:"static",children:(0,f.jsxs)(Ge,{children:[(0,f.jsxs)(Ee,{component:"div",variant:"h6",sx:{flexGrow:1},children:["Compare Trial Versions for Batch ",a]}),(0,f.jsxs)(Ee,{component:"div",children:[t>0?(0,f.jsx)(It,{color:"inherit",variant:"text",onClick:o,children:(0,f.jsx)(Lt.Z,{})}):null,t<r-1?(0,f.jsx)(It,{color:"inherit",variant:"text",onClick:i,children:(0,f.jsx)(Zt.Z,{})}):null]})]})})})}for(var Bt=JSON.parse('{"1":"Add endpoint to composite endpoint","2":"Add endpoint","3":"Change endpoint","4":"Change endpoint, add endpoint","5":"Change in endpoint in a composite endpoint","6":"Change method of analysis","7":"Change number of events","8":"Change population","9":"Change readers","10":"Change timepoint","11":"Error","12":"From nothing to something","13":"Refine definition","14":"Remove endpoint","15":"Shuffle Endpoints","16":"Syntax","":""}'),Vt=[],Ut=Q.e,Jt=Q.C,Wt=Jt.length,Ht=0;Ht<Wt;Ht++)Vt.push("");var $t=function(){var t=(0,e.useState)(0),n=(0,g.Z)(t,2),r=n[0],a=n[1],o=(0,e.useState)(Jt[r]),i=(0,g.Z)(o,2),s=i[0],l=i[1],u=(0,e.useState)(Vt),c=(0,g.Z)(u,2),d=c[0],p=c[1],m=(0,e.useState)([]),h=(0,g.Z)(m,2),v=h[0],b=h[1];return(0,e.useEffect)((function(){l(Jt[r])}),[r]),(0,e.useEffect)((function(){for(var e=[],t=0;t<Wt;t++){var n={};n.nctid=Jt[t].nctid,n.version_a=Jt[t].version_a,n.version_b=Jt[t].version_b,n.classification_number=d[t],n.classification_meaning=Bt[d[t]],e.push(n)}b(e)}),[d]),(0,f.jsxs)(e.Fragment,{children:[(0,f.jsx)(jt,{datumNumber:r,setDatumNumber:a,numComparisons:Wt,outputData:v,batchNum:Ut}),(0,f.jsx)(I,{children:(0,f.jsx)(K,{sx:{flexGrow:1,m:1},children:(0,f.jsx)(je,{datum:s,datumNumber:r,results:d,setResults:p})})})]})};t.createRoot(document.getElementById("root")).render((0,f.jsxs)(e.StrictMode,{children:[(0,f.jsx)(y,{}),(0,f.jsx)($t,{})]}))}()}();
//# sourceMappingURL=main.ea9af442.js.map